Science.gov

Sample records for beta-emitting therapeutic radionuclides

  1. Bremsstrahlung dosimetric parameters of beta-emitting therapeutic radionuclides

    NASA Astrophysics Data System (ADS)

    Manjunatha, H. C.

    2016-03-01

    Dosimetric parameters such as efficiency of bremsstrahlung, probability of energy loss of beta during bremsstrahlung production, intensity and dose rate of high, medium and low-energy beta-emitting therapeutic radionuclides in different tissues of human organs are computed. These parameters are lower in adipose tissue than all other studied tissues. The efficiency, intensity and dose rate of bremsstrahlung increases with maximum energy of the beta nuclide (Emax) and modified atomic number (Zmod) of the target tissue. The estimated bremsstrahlung efficiency, intensity and dose rate are useful in the calculations of photon track-length distributions. These parameters are useful to determine the quality and quantity of the bremsstrahlung radiation (known as the source term). Precise estimation of this source term is very important in planning for radiotherapy and diagnosis.

  2. Relationships between tumor size and curablity for uniformly targeted therapy with beta-emitting radionuclides

    SciTech Connect

    O`Donoghue, J.A.; Bardies, M.; Wheldon, T.E. |

    1995-10-01

    Targeted radionuclide therapy is a new form of radiotherapy that differs in some important respects from external beam irradiation. One of the most important differences is due to the finite range of ionizing beta particles emitted as a result of radionuclide disintegration. The effects of particle range have important implications for the curability of tumors. We used a mathematical model to examine tumor curability and its relationship to tumor size for 22 beta-emitting radionuclides that may have therapeutic potential. The model assumed a uniform distribution of radionuclide throughout. For targeted radionuclide therapy, the relationship between tumor curability and tumor size is different from that for conventional external beam radiotherapy. With targeted radionuclides, there is an optimal tumor size for cure. Tumors smaller than the optimal size are less vulnerable to irradiation from radionuclides because a substantial proportion of the disintegration energy escapes and is deposited outside the tumor volume. We found an optimal tumor size for radiocurability by each of the 22 radionuclides considered. Optimal cure diameters range from less than 1 mm for short-range emitters such as {sup 199}Au and {sup 33}P to several centimeters for long-range emitters such as {sup 90}Y and {sup 188}Re. The energy emitted per disintegration may be used to predict optimal cure size for uniform distributions of radionuclide. 17 refs., 8 figs., 3 tabs.

  3. Radionuclide labeled lymphocytes for therapeutic use

    DOEpatents

    Srivastava, Suresh C.; Fawwaz, Rashid A.; Richards, Powell

    1985-01-01

    Lymphocytes labelled with .beta.-emitting radionuclides are therapeutically useful, particularly for lymphoid ablation. They are prepared by incubation of the lymphocytes with the selected radionuclide-oxine complex.

  4. Radionuclide labeled lymphocytes for therapeutic use

    DOEpatents

    Srivastava, S.C.; Fawwaz, R.A.; Richards, P.

    1983-05-03

    Lymphocytes labelled with ..beta..-emitting radionuclides are therapeutically useful, particularly for lymphoid ablation. They are prepared by incubation of the lymphocytes with the selected radionuclide-oxine complex.

  5. Simulation of the dose rate per activity of beta-emitting radionuclides.

    PubMed

    Behrens, R

    2015-12-01

    The dose rate per activity was simulated for 10 beta-emitting radionuclides and for different activity distributions (point source, areal sources and a semi-infinite volume source). The results are given for 7 different distances from the source (from 0.01 to 2 m) for both contributions: the beta- and electron-emission, and the X- and gamma-emission. Data are provided for both operational quantities and organ doses: Hp(0.07), Hp(3), Hp(10), Hskin and Hlens. Finally, a software applicaton to interpolate the dose rate per activity due to the beta-emission of arbitrary radionuclides is presented and a simple superposition of these data and of gamma-ray dose constants to calculate the total dose rate is described.

  6. Verification of 3D Dose Distributions of a Beta-Emitting Radionuclide Using PRESAGE^ Dosimeters

    NASA Astrophysics Data System (ADS)

    Crowder, Mandi; Grant, Ryan; Ibbott, Geoff; Wendt, Richard

    2010-11-01

    Liquid Brachytherapy involves the direct administration of a beta-emitting radioactive solution into the selected tissue. The solution does not migrate from the injection point and uses the limited range of beta particles to produce a three-dimensional dose distribution. We simulated distributions by beta-dose kernels and validated those estimates by irradiating PRESAGE^ polyurethane dosimeters that measure the three-dimensional dose distributions by a change in optical density that is proportional to dose. The dosimeters were injected with internal beta-emitting radionuclide yttrium-90, exposed for 5.75 days, imaged with optical tomography, and analyzed with radiotherapy software. Dosimeters irradiated with an electron beam to 2 or 3 Gy were used for calibration. The shapes and dose distributions in the PRESAGE^ dosimeters were consistent with the predicted dose kernels. Our experiments have laid the groundwork for future application to individualized patient therapy by ultimately designing a treatment plan that conforms to the shape of any appropriate tumor.

  7. Experimental studies of the early effects of inhaled beta-emitting radionuclides for nuclear accident risk assessment: Phase 2 report

    SciTech Connect

    Scott, B.R.; Hahn, F.F.; Newton, G.J.; Snipes, M.B.; Damon, E.G.; Mauderly, J.L.; Boecker, B.B.; Gray, D.H.

    1987-11-01

    This report summarizes a series of experiments concerning the effect of linear energy transfer and temporal radiation dose pattern to the lung from inhaled beta-emitting radionuclides. The results were used to test the validity of a hazard-function mathematical model for predicting death from radiation pneumonitis. Both morbidity and mortality within 18 months after exposure were examined in rats exposed to beta-emitting radionuclides, giving brief or protracted irradiation of the lung or having weak or strong beta emissions. Protraction of the radiation dose to the lung from a half-time in the lung of less than three days to a half-time with a long-term component of about 150 days has a sparing effect. The median lethal dose for the protracted irradiation is about 1.7 times the median lethal dose for the brief irradiation. Low energy beta emissions from /sup 147/Pm have a similar effectiveness in producing lethal injury as high energy beta emissions from /sup 90/Sr. Changes in three parameters of morbidity were measured: body weight, hematology and pulmonary function; only changes in pulmonary function correlated well with pulmonary radiation injury. The doses of radiation required to produce impaired function, however, were not significantly different from those that produced death. The hazard-function model for predicting death from radiation pneumonitis, which was developed from previously obtained data for inhalation exposures of dogs to beta-emitting radionuclides, adequately predicted the median lethal doses for rats receiving one of several different beta dose rate patterns to the lung, thus strengthening the validity of the mathematical model. 23 refs., 41 figs., 12 tabs.

  8. Alpha- versus beta-emitting radionuclides for pretargeted radioimmunotherapy of CEA-expressing human colon cancer xenografts.

    PubMed

    Heskamp, Sandra; Hernandez, Reinier; Molkenboer-Kuenen, Janneke D M; Essler, Markus; Bruchertseifer, Frank; Morgenstern, Alfred; Steenbergen, Erik; Cai, Weibo; Seidl, Christof; McBride, William; Goldenberg, David; Boerman, Otto

    2017-02-23

    Rational: Pretargeted radionuclide therapy (PRIT) with the beta-emitting radionuclide (177)Lu is an attractive approach to treat CEA-expressing tumors. The therapeutic efficacy of PRIT could be improved by using alpha-emitting radionuclides such as (213)Bi. Herein, we report and compare the tumor targeting properties and therapeutic efficacy of (213)Bi and (177)Lu for PRIT of CEA-expressing xenografts, using the bispecific antibody TF2 (anti-CEA x anti-HSG) and the di-HSG-DOTA peptide IMP288. Methods: The in vitro binding characteristics of (213)Bi-IMP288 were compared with those of (177)Lu-IMP288. Tumor targeting of (213)Bi-IMP288 and (177)Lu-IMP288 was studied in mice bearing subcutaneous (s.c.) LS174T tumors that were pretargeted with the bispecific antibody TF2. Finally, the effect of (213)Bi-IMP288 (6, 12, or 17 MBq) and (177)Lu-IMP288 (60 MBq) on tumor growth and survival was assessed. Toxicity was determined by monitoring body weight, analyzing blood samples for haematological and renal toxicity (haemoglobin, leucocytes, platelets, creatinine), and by immunohistochemical analysis of the kidneys. Results: The in vitro binding characteristics of (213)Bi-IMP288 (Kd = 0.45 ± 0.20 nM) to TF-2 pretargeted LS174T cells were similar to those of (177)Lu-IMP288 (Kd = 0.53 ± 0.12 nM). In vivo accumulation of (213)Bi-IMP288 in LS174T tumors was observed as early as 15 min post injection (9.2 ± 2.0 %ID/g). (213)Bi-IMP288 cleared rapidly from the circulation; at 30 min post injection the blood levels were 0.44 ± 0.28 %ID/g. Uptake in normal tissues was very low, except for the kidneys where uptake was 1.8 ± 1.1 %ID/g, at 30 min p.i. The biodistribution of (213)Bi-IMP288 was comparable to that of (177)Lu-IMP288. Mice treated with a single dose of (213)Bi-IMP288 or (177)Lu-IMP288 showed significant inhibition of tumor growth. Median survival for the PBS, 6 MBq (213)Bi-IMP288, 12 MBq (213)Bi-IMP288, and 60 MBq (177)Lu-IMP288 treated groups was 22, 31, 45, and 42 days

  9. Monte Carlo simulation of age-dependent radiation dose from alpha- and beta-emitting radionuclides to critical trabecular bone and bone marrow targets

    NASA Astrophysics Data System (ADS)

    Dant, James T.; Richardson, Richard B.; Nie, Linda H.

    2013-05-01

    Alpha (α) particles and low-energy beta (β) particles present minimal risk for external exposure. While these particles can induce leukemia and bone cancer due to internal exposure, they can also be beneficial for targeted radiation therapies. In this paper, a trabecular bone model is presented to investigate the radiation dose from bone- and marrow-seeking α and β emitters to different critical compartments (targets) of trabecular bone for different age groups. Two main issues are addressed with Monte Carlo simulations. The first is the absorption fractions (AFs) from bone and marrow to critical targets within the bone for different age groups. The other issue is the application of 223Ra for the radiotherapy treatment of bone metastases. Both a static model and a simulated bone remodeling process are established for trabecular bone. The results show significantly lower AFs from radionuclide sources in the bone volume to the peripheral marrow and the haematopoietic marrow for adults than for newborns and children. The AFs from sources on the bone surface and in the bone marrow to peripheral marrow and haematopoietic marrow also varies for adults and children depending on the energy of the particles. Regarding the use of 223Ra as a radionuclide for the radiotherapy of bone metastases, the simulations show a significantly higher dose from 223Ra and its progeny in forming bone to the target compartment of bone metastases than that from two other more commonly used β-emitting radiopharmaceuticals, 153Sm and 89Sr. There is also a slightly lower dose from 223Ra in forming bone to haematopoietic marrow than that from 153Sm and 89Sr. These results indicate a higher therapy efficiency and lower marrow toxicity from 223Ra and its progeny. In conclusion, age-related changes in bone dimension and cellularity seem to significantly affect the internal dose from α and β emitters in the bone and marrow to critical targets, and 223Ra may be a more efficient

  10. Monte Carlo simulation of age-dependent radiation dose from alpha- and beta-emitting radionuclides to critical trabecular bone and bone marrow targets.

    PubMed

    Dant, James T; Richardson, Richard B; Nie, Linda H

    2013-05-21

    Alpha (α) particles and low-energy beta (β) particles present minimal risk for external exposure. While these particles can induce leukemia and bone cancer due to internal exposure, they can also be beneficial for targeted radiation therapies. In this paper, a trabecular bone model is presented to investigate the radiation dose from bone- and marrow-seeking α and β emitters to different critical compartments (targets) of trabecular bone for different age groups. Two main issues are addressed with Monte Carlo simulations. The first is the absorption fractions (AFs) from bone and marrow to critical targets within the bone for different age groups. The other issue is the application of (223)Ra for the radiotherapy treatment of bone metastases. Both a static model and a simulated bone remodeling process are established for trabecular bone. The results show significantly lower AFs from radionuclide sources in the bone volume to the peripheral marrow and the haematopoietic marrow for adults than for newborns and children. The AFs from sources on the bone surface and in the bone marrow to peripheral marrow and haematopoietic marrow also varies for adults and children depending on the energy of the particles. Regarding the use of (223)Ra as a radionuclide for the radiotherapy of bone metastases, the simulations show a significantly higher dose from (223)Ra and its progeny in forming bone to the target compartment of bone metastases than that from two other more commonly used β-emitting radiopharmaceuticals, (153)Sm and (89)Sr. There is also a slightly lower dose from (223)Ra in forming bone to haematopoietic marrow than that from (153)Sm and (89)Sr. These results indicate a higher therapy efficiency and lower marrow toxicity from (223)Ra and its progeny. In conclusion, age-related changes in bone dimension and cellularity seem to significantly affect the internal dose from α and β emitters in the bone and marrow to critical targets, and (223)Ra may be a more

  11. Therapeutic radionuclides: Making the right choice

    SciTech Connect

    Srivastava, S.C.

    1996-08-01

    Recently, there has been a resurgence of interest in nuclear medicine therapeutic procedures. Using unsealed sources for therapy is not a new concept; it has been around since the beginnings of nuclear medicine. Treatment of thyroid disorders with radioiodine is a classic example. The availability of radionuclides with suitable therapeutic properties for specific applications, as well as methods for their selective targeting to diseased tissue have, however, remained the main obstacles for therapy to assume a more widespread role in nuclear medicine. Nonetheless, a number of new techniques that have recently emerged, (e.g., tumor therapy with radiolabeled monoclonal antibodies, treatment of metastatic bone pain, etc.) appear to have provided a substantial impetus to research on production of new therapeutic radionuclides. Although there are a number of new therapeutic approaches requiring specific radionuclides, only selected broad areas will be used as examples in this article.

  12. Therapeutic Radionuclides: Biophysical and Radiobiologic Principles

    PubMed Central

    Kassis, Amin I.

    2008-01-01

    Although the general radiobiologic principles underlying external beam therapy and radionuclide therapy are the same, there are significant differences in the biophysical and radiobiologic effects from the two types of radiation. In addition to the emission of particulate radiation, targeted radionuclide therapy is characterized by (i) extended exposures and, usually, declining dose rates; (ii) nonuniformities in the distribution of radioactivity and, thus, absorbed dose; and (iii) particles of varying ionization density and, hence, quality. This chapter explores the special features that distinguish the biologic effects consequent to the traversal of charged particles through mammalian cells. It also highlights what has been learned when these radionuclides and radiotargeting pharmaceuticals are used to treat cancers. PMID:18662557

  13. Therapeutic radionuclides in nuclear medicine: current and future prospects

    PubMed Central

    Yeong, Chai-Hong; Cheng, Mu-hua; Ng, Kwan-Hoong

    2014-01-01

    The potential use of radionuclides in therapy has been recognized for many decades. A number of radionuclides, such as iodine-131 (131I), phosphorous-32 (32P), strontium-90 (90Sr), and yttrium-90 (90Y), have been used successfully for the treatment of many benign and malignant disorders. Recently, the rapid growth of this branch of nuclear medicine has been stimulated by the introduction of a number of new radionuclides and radiopharmaceuticals for the treatment of metastatic bone pain and neuroendocrine and other malignant or non-malignant tumours. Today, the field of radionuclide therapy is enjoying an exciting phase and is poised for greater growth and development in the coming years. For example, in Asia, the high prevalence of thyroid and liver diseases has prompted many novel developments and clinical trials using targeted radionuclide therapy. This paper reviews the characteristics and clinical applications of the commonly available therapeutic radionuclides, as well as the problems and issues involved in translating novel radionuclides into clinical therapies. PMID:25294374

  14. Therapeutic radionuclides in nuclear medicine: current and future prospects.

    PubMed

    Yeong, Chai-Hong; Cheng, Mu-hua; Ng, Kwan-Hoong

    2014-10-01

    The potential use of radionuclides in therapy has been recognized for many decades. A number of radionuclides, such as iodine-131 ((131)I), phosphorous-32 ((32)P), strontium-90 ((90)Sr), and yttrium-90 ((90)Y), have been used successfully for the treatment of many benign and malignant disorders. Recently, the rapid growth of this branch of nuclear medicine has been stimulated by the introduction of a number of new radionuclides and radiopharmaceuticals for the treatment of metastatic bone pain and neuroendocrine and other malignant or non-malignant tumours. Today, the field of radionuclide therapy is enjoying an exciting phase and is poised for greater growth and development in the coming years. For example, in Asia, the high prevalence of thyroid and liver diseases has prompted many novel developments and clinical trials using targeted radionuclide therapy. This paper reviews the characteristics and clinical applications of the commonly available therapeutic radionuclides, as well as the problems and issues involved in translating novel radionuclides into clinical therapies.

  15. On the Radiochemical Separations of the Beta-emitting Fission Products

    NASA Astrophysics Data System (ADS)

    Chang, Zheng; Sudowe, Ralf

    2013-04-01

    This research aims at developing fast and effective radiochemical procedures for separation of the beta-emitting fission products that are difficult to analyze by gamma-spectrometry. Post-detonation analysis, as one of the major tasks of nuclear forensics, can provide crucial information for identification of the explosion levels, fuel sources, and industrial processes of a nuclear device. However, a dozen of radionuclides with high fission yields such as Zr-93, Tc-99, Sr-90 are either pure beta-emitters or only emitting gamma-rays that are difficult to analyze. Although the analysis of these radionuclides was thoroughly studied, samples from unknown nuclear detonations can be complicated by the number of fission products, radioactivity levels, sample matrices, and time limits for analysis. The challenge facing the forensic analysis should not be underestimated. A sequential separation procedure is designed to analyze the major beta-emitting fission products. Radiochemical techniques such as solvent extraction, precipitation, and column chromatography are utilized. The procedure will be tested and improved by experiments. The final procedure should be capable of analyzing the fission products under various sample conditions effectively and rapidly.

  16. Power output and efficiency of beta-emitting microspheres

    NASA Astrophysics Data System (ADS)

    Cheneler, David; Ward, Michael

    2015-01-01

    Current standard methods to calculate the dose of radiation emitted during medical applications by beta-minus emitting microspheres rely on an over-simplistic formalism. This formalism is a function of the average activity of the radioisotope used and the physiological dimensions of the patient only. It neglects the variation in energy of the emitted beta particle due to self-attenuation, or self-absorption, effects related to the finite size of the sphere. Here it is assumed the sphere is comprised of a pure radioisotope with beta particles being emitted isotropically throughout the material. The full initial possible kinetic energy distribution of a beta particle is taken into account as well as the energy losses due to scattering by other atoms in the microsphere and bremsstrahlung radiation. By combining Longmire's theory of the mean forward range of charged particles and the Rayleigh distribution to take into account the statistical nature of scattering and energy straggling, the linear attenuation, or self-absorption, coefficient for beta-emitting radioisotopes has been deduced. By analogy with gamma radiation transport in spheres, this result was used to calculate the rate of energy emitted by a beta-emitting microsphere and its efficiency. Comparisons to standard point dose kernel formulations generated using Monte Carlo data show the efficacy of the proposed method. Yttrium-90 is used as a specific example throughout, as a medically significant radioisotope, frequently used in radiation therapy for treating cancer.

  17. OPTIMAL BETA-RAY SHIELDING THICKNESSES FOR DIFFERENT THERAPEUTIC RADIONUCLIDES AND SHIELDING MATERIALS.

    PubMed

    Cho, Yong In; Kim, Ja Mee; Kim, Jung Hoon

    2016-04-06

    To better understand the distribution of deposited energy of beta and gamma rays according to changes in shielding materials and thicknesses when radionuclides are used for therapeutic nuclear medicine, a simulation was conducted. The results showed that due to the physical characteristics of each therapeutic radionuclide, the thicknesses of shielding materials at which beta-ray shielding takes place varied. Additional analysis of the shielding of gamma ray was conducted for radionuclides that emit both beta and gamma rays simultaneously with results showing shielding effects proportional to the atomic number and density of the shielding materials. Also, analysis of bremsstrahlung emission after beta-ray interactions in the simulation revealed that the occurrence of bremsstrahlung was relatively lower than theoretically calculated and varied depending on different radionuclides.

  18. Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects

    NASA Astrophysics Data System (ADS)

    Bhardwaj, R.; van der Meer, A.; Das, S. K.; de Bruin, M.; Gascon, J.; Wolterbeek, H. T.; Denkova, A. G.; Serra-Crespo, P.

    2017-03-01

    177Lu has sprung as a promising radionuclide for targeted therapy. The low soft tissue penetration of its β‑ emission results in very efficient energy deposition in small-size tumours. Because of this, 177Lu is used in the treatment of neuroendocrine tumours and is also clinically approved for prostate cancer therapy. In this work, we report a separation method that achieves the challenging separation of the physically and chemically identical nuclear isomers, 177mLu and 177Lu. The separation method combines the nuclear after-effects of the nuclear decay, the use of a very stable chemical complex and a chromatographic separation. Based on this separation concept, a new type of radionuclide generator has been devised, in which the parent and the daughter radionuclides are the same elements. The 177mLu/177Lu radionuclide generator provides a new production route for the therapeutic radionuclide 177Lu and can bring significant growth in the research and development of 177Lu based pharmaceuticals.

  19. Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects.

    PubMed

    Bhardwaj, R; van der Meer, A; Das, S K; de Bruin, M; Gascon, J; Wolterbeek, H T; Denkova, A G; Serra-Crespo, P

    2017-03-13

    (177)Lu has sprung as a promising radionuclide for targeted therapy. The low soft tissue penetration of its β(-) emission results in very efficient energy deposition in small-size tumours. Because of this, (177)Lu is used in the treatment of neuroendocrine tumours and is also clinically approved for prostate cancer therapy. In this work, we report a separation method that achieves the challenging separation of the physically and chemically identical nuclear isomers, (177m)Lu and (177)Lu. The separation method combines the nuclear after-effects of the nuclear decay, the use of a very stable chemical complex and a chromatographic separation. Based on this separation concept, a new type of radionuclide generator has been devised, in which the parent and the daughter radionuclides are the same elements. The (177m)Lu/(177)Lu radionuclide generator provides a new production route for the therapeutic radionuclide (177)Lu and can bring significant growth in the research and development of (177)Lu based pharmaceuticals.

  20. Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects

    PubMed Central

    Bhardwaj, R.; van der Meer, A.; Das, S. K.; de Bruin, M.; Gascon, J.; Wolterbeek, H. T.; Denkova, A. G.; Serra-Crespo, P.

    2017-01-01

    177Lu has sprung as a promising radionuclide for targeted therapy. The low soft tissue penetration of its β− emission results in very efficient energy deposition in small-size tumours. Because of this, 177Lu is used in the treatment of neuroendocrine tumours and is also clinically approved for prostate cancer therapy. In this work, we report a separation method that achieves the challenging separation of the physically and chemically identical nuclear isomers, 177mLu and 177Lu. The separation method combines the nuclear after-effects of the nuclear decay, the use of a very stable chemical complex and a chromatographic separation. Based on this separation concept, a new type of radionuclide generator has been devised, in which the parent and the daughter radionuclides are the same elements. The 177mLu/177Lu radionuclide generator provides a new production route for the therapeutic radionuclide 177Lu and can bring significant growth in the research and development of 177Lu based pharmaceuticals. PMID:28287131

  1. Prostate specific membrane antigen (PSMA) from diagnostic to therapeutic target: radionuclide therapy comes of age in prostate cancer.

    PubMed

    Violet, John A; Hofman, Michael S

    2017-04-05

    Without doubt, molecular imaging using PET/CT directed against prostate specific membrane antigen (PSMA) has generated much interest for its impressive accuracy in detecting prostate cancer, particularly for biochemical recurrence[1]. PSMA expression is up regulated in advanced prostate cancer, including metastatic castration resistant prostate cancer (mCRPC), and provides a novel therapeutic target for radionuclide therapy directed towards PSMA-avid disease. Radionuclide therapy relies on the identification of a suitable tumour associated 'target' and an appropriate 'vehicle' that can bind to this with high selectivity and specificity to allow delivery of a therapeutic radionuclide. This article is protected by copyright. All rights reserved.

  2. New calculations for internal dosimetry of beta-emitting radiopharmaceuticals.

    PubMed

    Zankl, M; Petoussi-Henss, N; Janzen, T; Uusijärvi, H; Schlattl, H; Li, W B; Giussani, A; Hoeschen, C

    2010-01-01

    The calculation of absorbed dose from internally incorporated radionuclides is based on the so-called specific absorbed fractions (SAFs) which represent the fraction of energy emitted in a given source region that is absorbed per unit mass in a specific target organ. Until recently, photon SAFs were calculated using MIRD-type mathematical phantoms. For electrons, the energy released was assumed to be absorbed locally ('ICRP 30 approach'). For this work, photon and electron SAFs were derived with Monte Carlo simulations in the new male voxel-based reference computational phantom adopted by the ICRP and ICRU. The present results show that the assumption of electrons being locally absorbed is not always true at energies above 300-500 keV. For source/target organ pairs in close vicinity, high-energy electrons escaping from the source organ may result in cross-fire electron SAFs in the same order of magnitude as those from photons. Examples of organ absorbed doses per unit activity are given for (18)F-choline and (123)I-iodide. The impact of the new electron SAFs used for absorbed dose calculations compared with the previously used assumptions was found to be small. The organ dose coefficients for the two approaches differ by not more than 6 % for most organs. Only for irradiation of the urinary bladder wall by activity in the contents, the ICRP 30 approach presents an overestimation of approximately 40-50%.

  3. Novel beta-emitting poly(ethylene terephthalate) surface modification.

    PubMed

    Qu, X; Weinberger, J

    2000-12-05

    Restenosis after percutaneous interventions in coronary and peripheral arteries leads to repeat procedures and surgery in a significant number of patients. We have previously demonstrated that irradiation of an arterial site using an endovascular source (brachytherapy) is highly effective in preventing the restenotic process. To this end, a novel beta radiation delivery system was developed, based on the adsorption of (32)P (o-phosphoric acid) by pH-sensitive chitosan hydrogel on a poly(ethylene terephthalate) (PET) balloon surface. The PET balloon surface was treated with oxygen plasma and coated with chitosan hydrogel. Covalent bonds, ionic bonds, and hydrogen bonds all contribute to the adhesion between chitosan hydrogel and PET. In the aqueous phosphoric acid (PA) solution, the -NH(2) groups of chitosan were protonated by PA and the adsorption of PA occurred at the same time. The effect of PA concentration and temperature on adsorption efficiency and kinetics were studied. More than 70% PA was adsorbed on the sample surface in 0.2 mM PA solution. The surface of samples was also investigated by attenuated total reflection-Fourier transform infrared spectroscopy and scanning electron microscopy. PET surface may be modified to carry high activity beta emitters; such materials may be useful in a therapeutic setting

  4. Radionuclide Generators

    NASA Astrophysics Data System (ADS)

    Rösch, F.; Knapp, F. F. (Russ)

    Radionuclide generator systems continue to play a key role in providing both diagnostic and therapeutic radionuclides for various applications in nuclear medicine, oncology, and interventional cardiology. Although many parent/daughter pairs have been evaluated as radionuclide generator systems, there are a relatively small number of generators, which are currently in routine clinical and research use. Essentially every conceivable approach has been used for parent/separation strategies, including sublimation, thermochromatographic separation, solvent extraction, and adsorptive column chromatography. The most widely used radionuclide generator for clinical applications is the 99Mo/99mTc generator system, but recent years have seen an enormous increase in the use of generators to provide therapeutic radionuclides, which has paralleled the development of complementary technologies for targeting agents for therapy and in the general increased interest in the use of unsealed therapeutic radioactive sources. More recently, use of the 68Ge/68Ga generator is showing great potential as a source of positron-emitting 68Ga for positron emission tomography (PET)/CT imaging. Key advantages for the use of radionuclide generators include reasonable costs, the convenience of obtaining the desired daughter radionuclide on demand, and availability of the daughter radionuclide in high specific activity, no-carrier added form.

  5. The "edge effect" after implantation of beta-emitting (55Co) stents with high initial activity.

    PubMed

    Cervinka, Pavel; St'ásek, Josef; Costa, Marco Aurelio; Stursa, Jan; Fiser, Miloslav; Vodnanský, Petr; Kocisová, Michaela; Veselka, Josef; Pleskot, Miloslav; Malý, Jaroslav

    2004-01-01

    The aim of this study was to evaluate the incidence and the cause of "edge restenosis" after implantation of high activity 41.1 microCi +/- 1.2 microCi = 1520 kBq +/- 44 kBq, beta-emitting (55Co) stents. Proton bombarding in cyclotron has brought the radioactivity. Intravascular ultrasound (IVUS) investigation has been completed in 10 patients. The angiographies performed at 6 month revealed restenosis >50% in 5 cases (50%). The analysis of edges (5 mm distally and proximally to the last stent struts) showed no significant changes in TVV (187.3 +/- 62.60 mm3 and 176.9 +/- 53.5 mm3) but PMV increase significantly (i.e. neointimal proliferation) from 61.9 +/- 31.2 mm3 to 82.2 +/- 43.4 mm3 (p<0.04) and was the major contributor (from 66%) to lumen volume loss (125.4 +/- 40.7 mm3 and 94.7 +/- 22.2 mm3, p<0.02). In conclusion, neither statistically significant positive nor negative remodelling at the "stent edges", were present. Statistically significant increase in plaque +/- media volume (i.e. neointimal hyperplasia) and reduction in lumen volume were found. The cause of "edge restenosis" was especially (from 66%) due to increase in plaque +/- media volume (i.e. neointimal hyperplasia). Probably, main reason for "edge effect"/neointimal hyperplasia was in this trial sharp fall-off in radiation at the edges of the stents.

  6. Cyclotron produced {sup 67}Ga, a potential radionuclide for diagnostic and therapeutic applications

    SciTech Connect

    Khandaker, Mayeen Uddin Kassim, Hasan Abu; Haba, Hiromitsu

    2015-04-29

    Production cross-sections of the {sup nat}Zn(d,x){sup 67}Ga reactions have been measured from a 24-MeV deuteron energy down to the threshold by using a stacked-foil activation technique combined with HPGe γ-ray spectrometry. An overall good agreement is found with some of the earlier measurements, whereas a partial agreement is obtained with the theoretical data extracted from the TENDL-2013 library. Physical thick target yield for the {sup 67}Ga radionuclide was deduced using the measured cross-sections, and found in agreement with the directly measured yield available in the literature. This study reveals that a low deuteron energy (<11 MeV) cyclotron and an enriched {sup 66}Zn target could be used to obtain {sup 67}Ga in no carrier added form.

  7. Production of {sup 177}Lu, a potential radionuclide for diagnostic and therapeutic applications

    SciTech Connect

    Khandaker, Mayeen Uddin; Kassim, Hasan Abu; Haba, Hiromitsu

    2015-04-24

    {sup 177g}Lu (T{sub 1/2}=6.647d; E{sub β{sup −max}}=498.3KeV, I{sub β{sup −total}}=100%; E{sub γ} = 112.9498 keV, I{sub γ} = 6.17%; E{sub γ} = 208.3662 keV, I {sub γ} = 10.36%) is widely used in many clinical procedures due to its excellent decay characteristics. Production cross-sections of the {sup nat}Yb(d,x){sup 177g}Lu reactions have been measured from a 24-MeV deuteron energy down to the threshold by using a stacked-foil activation technique combined with high resolution γ-ray spectrometry. An overall good agreement is found with some of the earlier measurements, whereas a partial agreement is obtained with the theoretical data extracted from the TENDL-2013 library. Physical thick target yield for the {sup 177g}Lu radionuclide was deduced using the measured cross-sections. The deduced yield curves indicate that a low energy (<11 MeV) cyclotron and a highly enriched {sup 176}Yb target could be used to obtain {sup 177g}Lu with negligible impurity from {sup 177m}Lu.

  8. A comprehensive evaluation of charged-particle data for production of the therapeutic radionuclide (103)Pd.

    PubMed

    Hussain, M; Sudar, S; Aslam, M N; Shah, H A; Ahmad, R; Malik, A A; Qaim, S M

    2009-10-01

    (103)Pd is an important radionuclide having a half-life of 16.99d, which is suitable for internal radiation therapy, especially used for the treatment of prostate cancer. Its production in no-carrier-added form is done via charged-particle-induced reactions and the data are available in EXFOR library. We evaluated six charged-particle-induced reactions, namely (nat)Ag(p,x)(103)Pd, (103)Rh(p,n)(103)Pd, (103)Rh(d,2n)(103)Pd, (100)Ru(alpha,n)(103)Pd, (101)Ru(alpha,2n)(103)Pd, and (102)Ru((3)He,2n)(103)Pd process. In the first case, analysis was done up to about 100MeV but in other cases only up to about 25 or 40MeV. Furthermore, an evaluation of the data for the (nat)Ag(p,x)(103)Ag process was also done since it may serve as a typical example for the (103)Ag-->(103)Pd precursor system. A statistical procedure supported by nuclear model calculations using the codes STAPRE, EMPIRE 2.19, and TALYS was used to validate and fit the experimental data. The recommended sets of data derived together with confidence limits are reported. The application of those data, particularly in the calculation of integral yields, is discussed. A comparison of the investigated routes from the viewpoint of practical applicability to the production of (103)Pd is given. Presently the (103)Rh(p,n)(103)Pd reaction is the method of choice.

  9. Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: Effects of nonuniform intratumoral dose distribution

    SciTech Connect

    Hrycushko, Brian A.; Li Shihong; Goins, Beth; Otto, Randal A.; Bao, Ande

    2011-03-15

    Purpose: Focused radiation therapy by direct intratumoral infusion of lipid nanoparticle (liposome)-carried beta-emitting radionuclides has shown promising results in animal model studies; however, little is known about the impact the intratumoral liposomal radionuclide distribution may have on tumor control. The primary objective of this work was to investigate the effects the intratumoral absorbed dose distributions from this cancer therapy modality have on tumor control and treatment planning by combining dosimetric and radiobiological modeling with in vivo imaging data. Methods: {sup 99m}Tc-encapsulated liposomes were intratumorally infused with a single injection location to human head and neck squamous cell carcinoma xenografts in nude rats. High resolution in vivo planar imaging was performed at various time points for quantifying intratumoral retention following infusion. The intratumoral liposomal radioactivity distribution was obtained from 1 mm resolution pinhole collimator SPECT imaging coregistered with CT imaging of excised tumors at 20 h postinfusion. Coregistered images were used for intratumoral dosimetric and radiobiological modeling at a voxel level following extrapolation to the therapeutic analogs, {sup 186}Re/{sup 188}Re liposomes. Effective uniform dose (EUD) and tumor control probability (TCP) were used to assess therapy effectiveness and possible methods of improving upon tumor control with this radiation therapy modality. Results: Dosimetric analysis showed that average tumor absorbed doses of 8.6 Gy/MBq (318.2 Gy/mCi) and 5.7 Gy/MBq (209.1 Gy/mCi) could be delivered with this protocol of radiation delivery for {sup 186}Re/{sup 188}Re liposomes, respectively, and 37-92 MBq (1-2.5 mCi)/g tumor administered activity; however, large intratumoral absorbed dose heterogeneity, as seen in dose-volume histograms, resulted in insignificant values of EUD and TCP for achieving tumor control. It is indicated that the use of liposomes encapsulating

  10. New Cross Section Data for Production of the Therapeutic Radionuclides 64Cu, 140Nd, and 192Ir

    NASA Astrophysics Data System (ADS)

    Hilgers, K.; Qaim, S. M.; Coenen, H. H.

    2005-05-01

    For production of the therapeutic radionuclides 64Cu, 140Nd and 192Ir new cross section data are reported, all measured using the stacked-foil technique. In the case of 64Cu, the 66Zn(d,α)64Cu reaction was investigated radiochemically over the energy range of 5 to 14 MeV using highly enriched target material. From the measured excitation function the thick target yield of 64Cu was calculated as 6.6 MBq/μAṡh. A comparison with other production routes is given. For production of 140Nd, both natCe(3He,xn)140Nd and 141Pr(p,2n)140Nd processes were studied. For the 141Pr(p,2n)140Nd reaction the results are consistent with the literature data in the early rising part of the excitation function; at higher energies, however, our values differ considerably. The yields of 140Nd via these reactions amount to 22 and 128 MBq/μAṡh, respectively. The excitation function of the 192Os(p,n)192Ir reaction was measured from 6 to 20 MeV and the yield of 192Ir was calculated to be 0.16 MBq/μAṡh.

  11. Radionuclide Therapy

    NASA Astrophysics Data System (ADS)

    Zalutsky, M. R.

    Radionuclide therapy utilizes unsealed sources of radionuclides as a treatment for cancer or other pathological conditions such as rheumatoid arthritis. Radionuclides that decay by the emission of β and α particles, as well as those that emit Auger electrons, have been used for this purpose. In this chapter, radiochemical aspects of radionuclide therapy, including criteria for radionuclide selection, radionuclide production, radiolabeling chemistry, and radiation dosimetry are discussed.

  12. Dose assessment of bremsstrahlung induced by beta-emitting radioisotopes of uranium-238 series and lead in human tissues.

    PubMed

    Manjunatha, H C

    2014-01-01

    In the natural uranium-238 decay series, pure beta isotopes such as (234)Th, (234)Pa, (214)Pb, (214)Bi, (210)Pb and (210)Bi are released. The few lead isotopes such as (211)Pb, (212)Pb, (213)Pb and (215)Pb are good beta emitters. In certain nuclear reactions of reactor these isotopes are released. These beta isotopes have maximum beta energies, which induce the bremsstrahlung radiation. The bremsstrahlung component of these beta isotopes has been traditionally ignored in dosimetry calculations. The shapes of bremsstrahlung spectra are a basic ingredient in the understanding and quantification of beta-ray dosimetry. The bremsstrahlung spectra produced by these high-energy isotopes such as (234)Th, (234)Pa, (214)Pb, (214)Bi, (210)Pb, (210)Bi, (211)Pb, (212)Pb, (213)Pb and (215)Pb in bone, muscle and teeth are studied, and the computed spectral distributions are presented. The spectral shapes are primarily responsible for variations in the shapes of depth-dose distributions. They are intended to provide a quick and convenient reference for spectral shapes and to give an indication of the wide variation in these shapes. The evaluated beta bremsstrahlung dose as a function distance for the studied nuclides is also presented. The efficiency, intensity and dose rate of bremsstrahlung induced by beta isotopes of natural uranium-238 decay series and beta-emitting lead isotopes in human tissues such as brain, breast, heart, kidney, liver, muscle, pancreas and bone have also been studied in the present investigation. The values of bremsstrahlung dosimetric parameters are low for pancreas, but they are high for bone. For all studied tissues these parameters are high for (234)Pa, but low for (210)Pb.

  13. Radionuclide trap

    DOEpatents

    McGuire, Joseph C.

    1978-01-01

    The deposition of radionuclides manganese-54, cobalt-58 and cobalt-60 from liquid sodium coolant is controlled by providing surfaces of nickel or high nickel alloys to extract the radionuclides from the liquid sodium, and by providing surfaces of tungsten, molybdenum or tantalum to prevent or retard radionuclide deposition.

  14. Reactor-Produced Medical Radionuclides

    SciTech Connect

    Mirzadeh, Saed; Mausner, Leonard; Garland, Marc A

    2011-01-01

    The therapeutic use of radionuclides in nuclear medicine, oncology and cardiology is the most rapidly growing use of medical radionuclides. Since most therapeutic radionuclides are neutron rich and decay by beta emission, they are reactor-produced. This chapter deals mainly with production approaches with neutrons. Neutron interactions with matter, neutron transmission and activation rates, and neutron spectra of nuclear reactors are discussed in some detail. Further, a short discussion of the neutron-energy dependence of cross sections, reaction rates in thermal reactors, cross section measurements and flux monitoring, and general equations governing the reactor production of radionuclides are presented. Finally, the chapter is concluded by providing a number of examples encompassing the various possible reaction routes for production of a number of medical radionuclides in a reactor.

  15. Hot beta particles in the lung: Results from dogs exposed to fission product radionuclides

    SciTech Connect

    Hahn, F.F.; Griffith, W.C.; Hobbs, C.H.

    1995-12-01

    The Chernobyl nuclear reactor accident resulted in the release of uranium dioxide fuel and fission product radionuclides into the environment with the fallout of respirable, highly radioactive particles that have been termed {open_quotes}hot beta particles.{close_quotes} There is concern that these hot beta particles (containing an average of 150-20,000 Bq/particle), when inhaled and deposited in the lung, may present an extraordinary hazard for the induction of lung cancer. We reviewed data from a group of studies in dogs exposed to different quantities of beta-emitting radionuclides with varied physical half-lives to determine if those that inhaled hot beta particles were at unusual risk for lung cancer. This analysis indicates that the average dose to the lung is adequate to predict biologic effects of lung cancer for inhaled beta-emitting radionuclides in the range of 5-50 Gy to the lung and with particle activities in the range of 0.10-50 Bq/particle.

  16. Radionuclide cisternogram

    MedlinePlus

    ... please enable JavaScript. A radionuclide cisternogram is a nuclear scan test. It is used to diagnose problems ... damage. The amount of radiation used during the nuclear scan is very small. Almost all of the ...

  17. Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?

    PubMed

    Guerard, F; Barbet, J; Chatal, J F; Kraeber-Bodere, F; Cherel, M; Haddad, F

    2015-06-01

    Beta-emitting radionuclides are not able to kill isolated tumor cells disseminated in the body, even if a high density of radiolabeled molecules can be targeted at the surface of these cells because the vast majority of emitted electrons deliver their energy outside the targeted cells. Alpha-particle emitting radionuclides may overcome this limitation. It is thus of primary importance to test and validate the radionuclide of choice, the most appropriate carrier molecule and the most promising clinical indication. Four α-particle emitting radionuclides have been or are clinically tested in phase I studies namely 213Bi, 225Ac, 212Pb and 211At. Clinical safety has been documented and encouraging efficacy has been shown for some of them (213Bi and 211At). 211At has been the most studied and could be the most promising radionuclide but 225Ac and 212Pb are also of potential great interest. Any carrier molecule that has been labeled with β-emitting radionuclides could be labeled with alpha particle-emitting radionuclide using, for some of them, the same chelating agents. However, the physical half-life of the radionuclide should match the biological half-life of the radioconjugate or its catabolites. Finally everybody agrees, based on the quite short range of alpha particles, on the fact that the clinical indications for alpha-immunotherapy should be limited to the situation of disseminated minimal residual diseases made of small clusters of malignant cells or isolated tumor cells.

  18. Monte Carlo investigation of single cell beta dosimetry for intraperitoneal radionuclide therapy.

    PubMed

    Syme, A M; Kirkby, C; Riauka, T A; Fallone, B G; McQuarrie, S A

    2004-05-21

    Single event spectra for five beta-emitting radionuclides (Lu-177, Cu-67, Re-186, Re-188, Y-90) were calculated for single cells from two source geometries. The first was a surface-bound isotropically emitting point source and the second was a bath of free radioactivity in which the cell was submerged. Together these represent a targeted intraperitoneal radionuclide therapy. Monoenergetic single event spectra were calculated over an energy range of 11 keV to 2500 keV using the EGSnrc Monte Carlo system. Radionuclide single event spectra were constructed by weighting monoenergetic single event spectra according to radionuclide spectra appropriate for each source geometry. In the case of surface-bound radioactivity, these were radionuclide beta decay spectra. For the free radioactivity, a continuous slowing down approximation spectrum was used that was calculated based on the radionuclide decay spectra. The frequency mean specific energy per event increased as the energy of the beta emitter decreased. This is because, at these energies, the stopping power of the electrons decreases with increasing energy. The free radioactivity produced a higher frequency mean specific energy per event than the corresponding surface-bound value. This was primarily due to the longer mean path length through the target for this geometry. This information differentiates the radionuclides in terms of the physical process of energy deposition and could be of use in the radionuclide selection procedure for this type of therapy.

  19. Radionuclide therapy for arthritic knees

    SciTech Connect

    Doepel, L.K.

    1985-02-08

    A new radionuclide therapeutic approach for rheumatoid arthritis of the knee is described. This therapy combines a short-lived radionuclide with a carrier whose physical and chemical characteristics aid retention of the radioactive particles within the joint. Joining a radionuclide to a particulate carrier had not been explored previously as a potential method for inhibiting radiation leakage. The treatment couples the rare earth element dysprosium 165 to ferric hydroxide in macroaggregate form (size range: 3 to 10 ..mu..m). After the relatively inert iron complex penetrates the synovium, it causes cell death. Macrophages and phagocytes clear away the cellular debris, essentially eliminating the synovium.

  20. A mathematical model for predicting the probability of acute mortality in a human population exposed to accidentally released airborne radionuclides. Final report for Phase I of the project: early effects of inhaled radionuclides

    SciTech Connect

    Filipy, R.E.; Borst, F.J.; Cross, F.T.; Park, J.F.; Moss, O.R.

    1980-06-01

    The report presents a mathematical model for the purpose of predicting the fraction of human population which would die within 1 year of an accidental exposure to airborne radionuclides. The model is based on data from laboratory experiments with rats, dogs and baboons, and from human epidemiological data. Doses from external, whole-body irradiation and from inhaled, alpha- and beta-emitting radionuclides are calculated for several organs. The probabilities of death from radiation pneumonitis and from bone marrow irradiation are predicted from doses accumulated within 30 days of exposure to the radioactive aerosol. The model is compared with existing similar models under hypothetical exposure conditions. Suggestions for further experiments with inhaled radionuclides are included.

  1. Radionuclide removal

    SciTech Connect

    Sorg, T.J.

    1991-01-01

    The U.S. Environmental Protection Agency proposed new and revised regulations on radionuclide contaminants in drinking water in June 1991. During the 1980's, the Drinking Water Research Division, USEPA conducted a research program to evaluate various technologies to remove radium, uranium and radon from drinking water. The research consisted of laboratory and field studies conducted by USEPA, universities and consultants. The paper summarizes the results of the most significant projects completed. General information is also presented on the general chemistry of the three radionuclides. The information presented indicates that the most practical treatment methods for radium are ion exchange and lime-soda softening and reverse osmosis. The methods tested for radon are aeration and granular activated carbon and the methods for uranium are anion exchange and reverse osmosis.

  2. Radionuclide carriers for targeting of cancer

    PubMed Central

    Sofou, Stavroula

    2008-01-01

    This review describes strategies for the delivery of therapeutic radionuclides to tumor sites. Therapeutic approaches are summarized in terms of tumor location in the body, and tumor morphology. These determine the radionuclides of choice for suggested targeting ligands, and the type of delivery carriers. This review is not exhaustive in examples of radionuclide carriers for targeted cancer therapy. Our purpose is two-fold: to give an integrated picture of the general strategies and molecular constructs currently explored for the delivery of therapeutic radionuclides, and to identify challenges that need to be addressed. Internal radiotherapies for targeting of cancer are at a very exciting and creative stage. It is expected that the current emphasis on multidisciplinary approaches for exploring such therapeutic directions should enable internal radiotherapy to reach its full potential. PMID:18686778

  3. 21 CFR 892.5750 - Radionuclide radiation therapy system.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Radionuclide radiation therapy system. 892.5750... (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5750 Radionuclide radiation therapy system. (a) Identification. A radionuclide radiation therapy system is a device intended to permit...

  4. Selection and manipulation of immunoglobulins for radionuclide delivery

    SciTech Connect

    Steplewski, Z.; Curtis, P.; Hainfeld, J.; Mausner, L.; Mease, R.; Srivastava, S.

    1992-12-31

    This report describes a collection of monoclonal antibodies that are candidates for use in radioimmunotherapy towards neoplasms of the gastrointestinal tract, breast, or of astrocytomas. In addition a large series of candidate radionuclides to conjugate to antibodies for therapeutic uses are discussed with respect to potential therapeutic utility and to means of radionuclide production.

  5. Mathematical model for predicting the probability of acute mortality in a human population exposed to accidentally released airborne radionuclides. Final report for Phase I

    SciTech Connect

    Filipy, R.E.; Borst, F.J.; Cross, F.T.; Park, J.F.; Moss, O.R.; Roswell, R.L.; Stevens, D.L.

    1980-05-01

    A mathematical model was constructed for the purpose of predicting the fraction of human population which would die within 1 year of an accidental exposure to airborne radionuclides. The model is based on data from laboratory experiments with rats, dogs and baboons, and from human epidemiological data. Doses from external, whole-body irradiation and from inhaled, alpha- and beta-emitting radionuclides are calculated for several organs. The probabilities of death from radiation pneumonitis and from bone marrow irradiation are predicted from doses accumulated within 30 days of exposure to the radioactive aerosol. The model is compared with existing similar models under hypothetical exposure conditions. Suggestions for further experiments with inhaled radionuclides are included. 25 refs., 16 figs., 13 tabs.

  6. Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

    PubMed Central

    2014-01-01

    Background Peptide receptor radionuclide therapy (PRRT) is routinely used for advanced or metastasized neuroendocrine tumours (NET). To prevent nephrotoxicity, positively charged amino acids (AA) are co-infused. The aim of this study was to correlate the risk for therapy-related hyperkalaemia with the total amount of AA infused. Methods Twenty-two patients undergoing PRRT with standard activities of 177Lu-DOTATATE/-TOC were monitored during two following treatment cycles with co-infusion of 75 and 50 g of AA (l-arginine and l-lysine), respectively. Mean serum levels of potassium and other parameters (glomerular filtration rate [GFR], creatinine, blood urea nitrogen [BUN], phosphate, chloride, lactate dehydrogenase) prior to, 4 h and 24 h after AA infusion were compared. Results Self-limiting hyperkalaemia (>5.0 mmol/l) resolving after 24 h occurred in 91% (20/22) of patients in both protocols. Potassium levels, BUN, creatinine, GFR, phosphate, chloride and LDH showed a similar range at 4 h after co-infusion of 75 or 50 g of AA, respectively (p?>?0.05). Only GFR and creatinine levels at 24 h varied significantly between the two co-infusion protocols (p?

  7. Natural Radionuclides in Ground Water.

    ERIC Educational Resources Information Center

    Davis, Stanley N.

    1988-01-01

    Described are the natural trace radionuclides in ground water. Indicates the geologic origin of these radionuclides. Discusses the importance of these radionuclides. Suggests future uses of a number of additional radionuclides. (CW)

  8. Radionuclide deposition control

    DOEpatents

    Brehm, William F.; McGuire, Joseph C.

    1980-01-01

    The deposition of radionuclides manganese-54, cobalt-58 and cobalt-60 from liquid sodium coolant is controlled by providing surfaces of nickel or high nickel alloys to extract the radionuclides from the liquid sodium, and by providing surfaces of tungsten, molybdenum or tantalum to prevent or retard radionuclide deposition.

  9. Radionuclide synovectomy - essentials for rheumatologists.

    PubMed

    Chojnowski, Marek M; Felis-Giemza, Anna; Kobylecka, Małgorzata

    2016-01-01

    Radionuclide synovectomy is a minimally invasive method of treating persistent joint inflammation. It involves intra-articular injection of radioactive colloids which induce necrosis and fibrosis of hypertrophic synovial membrane. The most common indication for radiosynovectomy is rheumatoid arthritis, although patients with seronegative spondyloarthropathies, unclassified arthritis, haemophilic arthropathy and other less common arthropathies can also benefit from this method. Radiosynovectomy is safe, well tolerated and efficacious. About 70-80% of patients respond well to the therapy. However, the therapeutic effects are considerably worse in patients with co-existent osteoarthritis and advanced joint degeneration. Despite its advantages, radionuclide synovectomy is not performed as often as it could be, so greater knowledge and understanding of this method are needed. The authors present the most important facts about radiosynovectomy that may help rheumatologists in their daily clinical practice.

  10. 21 CFR 892.5730 - Radionuclide brachytherapy source.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Radionuclide brachytherapy source. 892.5730 Section 892.5730 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5730 Radionuclide...

  11. 21 CFR 892.5730 - Radionuclide brachytherapy source.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Radionuclide brachytherapy source. 892.5730 Section 892.5730 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5730 Radionuclide...

  12. 21 CFR 892.5730 - Radionuclide brachytherapy source.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Radionuclide brachytherapy source. 892.5730 Section 892.5730 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5730 Radionuclide...

  13. 21 CFR 892.5730 - Radionuclide brachytherapy source.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Radionuclide brachytherapy source. 892.5730 Section 892.5730 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5730 Radionuclide...

  14. 21 CFR 892.5740 - Radionuclide teletherapy source.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Radionuclide teletherapy source. 892.5740 Section 892.5740 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5740 Radionuclide teletherapy...

  15. 21 CFR 892.5740 - Radionuclide teletherapy source.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Radionuclide teletherapy source. 892.5740 Section 892.5740 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5740 Radionuclide teletherapy...

  16. 21 CFR 892.5650 - Manual radionuclide applicator system.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Manual radionuclide applicator system. 892.5650 Section 892.5650 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5650 Manual radionuclide...

  17. 21 CFR 892.5740 - Radionuclide teletherapy source.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Radionuclide teletherapy source. 892.5740 Section 892.5740 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5740 Radionuclide teletherapy...

  18. 21 CFR 892.5740 - Radionuclide teletherapy source.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Radionuclide teletherapy source. 892.5740 Section 892.5740 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5740 Radionuclide teletherapy...

  19. 21 CFR 892.5650 - Manual radionuclide applicator system.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Manual radionuclide applicator system. 892.5650 Section 892.5650 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5650 Manual radionuclide...

  20. 21 CFR 892.5730 - Radionuclide brachytherapy source.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Radionuclide brachytherapy source. 892.5730 Section 892.5730 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5730 Radionuclide...

  1. 21 CFR 892.5740 - Radionuclide teletherapy source.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Radionuclide teletherapy source. 892.5740 Section 892.5740 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5740 Radionuclide teletherapy...

  2. Radionuclide bone imaging and densitometry

    SciTech Connect

    Mettler, F.A.

    1988-01-01

    This book contains 13 selections. Some of the titles are: Radionuclides and the Normal Bone Scan; The Radionuclide Bone Scan in Malignant Disease; Pediatric Applications of Radionuclide Bone Imaging; The Radionuclide Bone Scan in Arthritis and Metabolic and Miscellaneous Disorders; and Soft Tissue Activity on the Radionuclide Bone Scan.

  3. A simple and rapid technique for radiochemical separation of iodine radionuclides from irradiated tellurium using an activated charcoal column.

    PubMed

    Chattopadhyay, Sankha; Saha Das, Sujata

    2009-10-01

    A simple and inexpensive method for the separation of medically useful no-carrier-added (nca) iodine radionuclides from bulk amounts of irradiated tellurium dioxide (TeO(2)) target was developed. The beta(-) emitting (131)I radionuclide, produced by the decay of (131)Te through the (nat)Te(n, gamma)(131)Te nuclear reaction, was used for standardization of the radiochemical separation procedure. The radiochemical separation was performed by precipitation followed by column (activated charcoal) chromatography. Quantitative post-irradiation recovery of the TeO(2) target material (98-99%), in a form suitable for reuse in future irradiations, was achieved. The overall radiochemical yield for the complete separation of (131)I was 75-85% (n=8). The separated nca (131)I was of high, approximately 99%, radionuclidic and radiochemical purities and did not contain detectable amounts of the target material. This method can be adopted for the radiochemical separation of other different iodine radionuclides produced from tellurium matrices through cyclotron as well as reactor irradiation.

  4. Preparation of Radiopharmaceuticals Labeled with Metal Radionuclides

    SciTech Connect

    Welch, M.J.

    2012-02-16

    oxygen retention of the tissue and the significantly greater retention amounting in hypoxic tissue. This hypothesis was confirmed in a series of animal studies. Cu-64 can be used both as an imaging radionuclide and a therapeutic radionuclide. The therapeutic efficacy of Cu-64 ATSM was proven in hamsters bearing the CW39 human colorectal tumors. The administration of Cu-64 ATSM significantly increased the survival time of tumor-bearing animals with no acute toxicity. This copper agent therefore shows promise for radiotherapy. The flow tracer Cu-64 PTSM also demonstrates therapeutic potential by inhibiting cancer cells implanted in animal models. Again, this inhibition occurred at doses which showed no sign of toxicity to the animals. Cu-ATSM was translated to humans, under other support a series of tumors were investigated; these included head and neck cancer, non-small cell lung cancer, cervical cancer and renal cancer. Another radionuclide that was investigated was titanium 45. This radionuclide was successfully produced by radiation of a scandium foil with 15 MeV protons. The titanium 45 was processed and separated from residual scandium by high exchange chomotrophy. Titanium titanocene has been utilized as a therapeutic agent; this compound was prepared and studied in vitro and in vivo. Another project was the preparation of cyclodextrin dimers as a new pre-targeting approach for tumor uptake. Beta-cyclodextradin and two other dimers were synthesized. These dimers were studied for the in vivo application. Work continued on the application of the radionuclide already discussed. Technetium 94m, a positron emitting radionuclide of the widely used 99m Tc nuclide was also prepared. This allows the quantification of the uptake of technetium radiopharmaceuticals. In collaboration with Professor David Piwnica-Worms, technetium 94m, sestamibi was studied in animal models and in a limited number of human subjects.

  5. Radionuclide removal by apatite

    SciTech Connect

    Rigali, Mark J.; Brady, Patrick V.; Moore, Robert C.

    2016-12-01

    In this study, a growing body of research supports widespread future reliance on apatite for radioactive waste cleanup. Apatite is a multi-functional radionuclide sorbent that lowers dissolved radionuclide concentrations by surface sorption, ion exchange, surface precipitation, and by providing phosphate to precipitate low-solubility radionuclide-containing minerals. Natural apatites are rich in trace elements, and apatite’s stability in the geologic record suggest that radionuclides incorporated into apatite, whether in a permeable reactive barrier or a waste form, are likely to remain isolated from the biosphere for long periods of time. Here we outline the mineralogic and surface origins of apatite-radionuclide reactivity and show how apatites might be used to environmental advantage in the future.

  6. Radionuclide removal by apatite

    DOE PAGES

    Rigali, Mark J.; Brady, Patrick V.; Moore, Robert C.

    2016-12-01

    In this study, a growing body of research supports widespread future reliance on apatite for radioactive waste cleanup. Apatite is a multi-functional radionuclide sorbent that lowers dissolved radionuclide concentrations by surface sorption, ion exchange, surface precipitation, and by providing phosphate to precipitate low-solubility radionuclide-containing minerals. Natural apatites are rich in trace elements, and apatite’s stability in the geologic record suggest that radionuclides incorporated into apatite, whether in a permeable reactive barrier or a waste form, are likely to remain isolated from the biosphere for long periods of time. Here we outline the mineralogic and surface origins of apatite-radionuclide reactivity andmore » show how apatites might be used to environmental advantage in the future.« less

  7. Radionuclides in US coals

    SciTech Connect

    Bisselle, C. A.; Brown, R. D.

    1984-03-01

    The current state of knowledge with respect to radionuclide concentrations in US coals is discussed. Emphasis is placed on the levels of uranium in coal (and lignite) which are considered to represent a concern resulting from coal combustion; areas of the US where such levels have been found; and possible origins of high radionuclide levels in coal. The report reviews relevant studies and presents new data derived from a computerized search of radionuclide content in about 4000 coal samples collected throughout the coterminous US. 103 references, 5 figures, 5 tables.

  8. Radionuclides in Diagnosis.

    ERIC Educational Resources Information Center

    Williams, E. D.

    1989-01-01

    Discussed is a radionuclide imaging technique, including the gamma camera, image analysis computer, radiopharmaceuticals, and positron emission tomography. Several pictures showing the use of this technique are presented. (YP)

  9. A compact automated radionuclide separation system for nuclear medical applications

    NASA Astrophysics Data System (ADS)

    Bond, A. H.; Horwitz, E. P.; Hines, J. J.; Young, J. E.

    2003-01-01

    The purification of radionuclides for medical applications presents unique challenges; most notably the needs for chemical purity, radionuclidic purity, and reliable production. To address these considerations, a new generator technology and instrument have been developed to permit the rapid chromatographic purification of clinically useful quantities of radionuclides for use in diagnostic or therapeutic nuclear medicine. The device comprises a separations module containing miniature chromatographic columns, a computer controller with driver software, and the fluid delivery components. This instrument is well suited for use in radionuclide generators as separations can typically be performed in <5 min with overall decontamination factors of >106. Chromatographic experiments targeting application in a 212Bi generator have demonstrated the usefulness of the Automated Radionuclide Separator as a low-pressure chromatography system.

  10. Method and apparatus for separating radionuclides from non-radionuclides

    DOEpatents

    Harp, Richard J.

    1990-01-01

    In an apparatus for separating radionuclides from non-radionuclides in a mixture of nuclear waste, a vessel is provided wherein the mixture is heated to a temperature greater than the temperature of vaporization for the non-radionuclides but less than the temperature of vaporization for the radionuclides. Consequently the non-radionuclides are vaporized while the non-radionuclides remain the solid or liquid state. The non-radionuclide vapors are withdrawn from the vessel and condensed to produce a flow of condensate. When this flow decreases the heat is reduced to prevent temperature spikes which might otherwise vaporize the radionuclides. The vessel is removed and capped with the radioactive components of the apparatus and multiple batches of the radionuclide residue disposed therein. Thus the vessel ultimately provides a burial vehicle for all of the radioactive components of the process.

  11. Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine.

    PubMed

    Pillai, Ambikalmajan M R; Knapp, Furn F Russ

    2015-01-01

    Lutetium-177 ((177)Lu) is a late entrant into the nuclear medicine therapy arena but is expected to become one of the most widely used therapeutic radionuclides. This paper analyses the reason for the increasing preference of (177)Lu as a therapeutic radionuclide. While the radionuclidic properties favor its use for several therapeutic applications, the potential for large scale production of (177)Lu is also an important aspect for its acceptability as a therapeutic radionuclide. This introductory discussion also summarizes some developing clinical uses and suggested future directions for applications of (177)Lu.

  12. Initial Radionuclide Inventories

    SciTech Connect

    H. Miller

    2004-09-19

    The purpose of this analysis is to provide an initial radionuclide inventory (in grams per waste package) and associated uncertainty distributions for use in the Total System Performance Assessment for the License Application (TSPA-LA) in support of the license application for the repository at Yucca Mountain, Nevada. This document is intended for use in postclosure analysis only. Bounding waste stream information and data were collected that capture probable limits. For commercially generated waste, this analysis considers alternative waste stream projections to bound the characteristics of wastes likely to be encountered using arrival scenarios that potentially impact the commercial spent nuclear fuel (CSNF) waste stream. For TSPA-LA, this radionuclide inventory analysis considers U.S. Department of Energy (DOE) high-level radioactive waste (DHLW) glass and two types of spent nuclear fuel (SNF): CSNF and DOE-owned (DSNF). These wastes are placed in two groups of waste packages: the CSNF waste package and the codisposal waste package (CDSP), which are designated to contain DHLW glass and DSNF, or DHLW glass only. The radionuclide inventory for naval SNF is provided separately in the classified ''Naval Nuclear Propulsion Program Technical Support Document'' for the License Application. As noted previously, the radionuclide inventory data presented here is intended only for TSPA-LA postclosure calculations. It is not applicable to preclosure safety calculations. Safe storage, transportation, and ultimate disposal of these wastes require safety analyses to support the design and licensing of repository equipment and facilities. These analyses will require radionuclide inventories to represent the radioactive source term that must be accommodated during handling, storage and disposition of these wastes. This analysis uses the best available information to identify the radionuclide inventory that is expected at the last year of last emplacement, currently identified as

  13. Radionuclide studies in impotence

    SciTech Connect

    Hilson, A.J.; Lewis, C.A. )

    1991-04-01

    Impotence may be of physiological origin with causes including vascular or neurological pathology. Alternatively, it may be of psychogenic origin. Clinicians can distinguish between psychological and organic impotence by observing nocturnal penile tumescence. Non-radionuclide investigations for organic impotence include penile plethysmography or pulse Doppler analysis for arterial supply, cavernosometry for venous drainage, and biothesiometry or evoked potentials for neurological pathology. Radionuclide studies are primarily based on the use of technetium 99m-pertechnetate, 99mTc-red blood cells, or xenon 133 to study the blood flow, with or without pharmacological intervention, commonly papaverine. 26 references.

  14. The development and use of radionuclide generators in nuclear medicine -- recent advances and future perspectives

    SciTech Connect

    Knapp, F.F. Jr.

    1998-03-01

    Although the trend in radionuclide generator research has declined, radionuclide generator systems continue to play an important role in nuclear medicine. Technetium-99m obtained from the molybdenum-99/technetium-99m generator system is used in over 80% of all diagnostic clinical studies and there is increasing interest and use of therapeutic radioisotopes obtained from generator systems. This paper focuses on a discussion of the major current areas of radionuclide generator research, and the expected areas of future research and applications.

  15. Gallbladder radionuclide scan

    MedlinePlus

    ... please enable JavaScript. Gallbladder radionuclide scan is a test that uses radioactive material to check gallbladder function. It is also used ... for bile duct blockage or leak. How the Test is Performed ... called a gamma emitting tracer into a vein. This material collects mostly in the liver. It will then ...

  16. Computational methods in radionuclide dosimetry

    NASA Astrophysics Data System (ADS)

    Bardiès, M.; Myers, M. J.

    1996-10-01

    The various approaches in radionuclide dosimetry depend on the size and spatial relation of the sources and targets considered in conjunction with the emission range of the radionuclide used. We present some of the frequently reported computational techniques on the basis of the source/target size. For whole organs, or for sources or targets bigger than some centimetres, the acknowledged standard was introduced 30 years ago by the MIRD committee and is still being updated. That approach, based on the absorbed fraction concept, is mainly used for radioprotection purposes but has been updated to take into account the dosimetric challenge raised by therapeutic use of vectored radiopharmaceuticals. At this level, the most important computational effort is in the field of photon dosimetry. On the millimetre scale, photons can often be disregarded, and or electron dosimetry is generally reported. Heterogeneities at this level are mainly above the cell level, involving groups of cell or a part of an organ. The dose distribution pattern is often calculated by generalizing a point source dose distribution, but direct calculation by Monte Carlo techniques is also frequently reported because it allows media of inhomogeneous density to be considered. At the cell level, and electron (low-range or Auger) are the predominant emissions examined. Heterogeneities in the dose distribution are taken into account, mainly to determine the mean dose at the nucleus. At the DNA level, Auger electrons or -particles are considered from a microdosimetric point of view. These studies are often connected with radiobiological experiments on radionuclide toxicity.

  17. Labeling of monoclonal antibodies with radionuclides

    SciTech Connect

    Bhargava, K.K.; Acharya, S.A. )

    1989-07-01

    Antibodies, specifically monoclonal antibodies, are potentially very useful and powerful carriers of therapeutic agents to target tissues and diagnostic agents. The loading or charging of antibodies with agents, especially radiotracers, is reviewed here. The choice of radioisotope for immunodetection and/or immunotherapy is based on its availability, half-life, nature of the radiation emitted, and the metabolic pathways of the radionuclide in the body. Most important of all are the derivatization techniques available for labeling the antibody with the given radionuclide. Isotopes of iodine and divalent metal ions are the most commonly used radionuclides. Antibodies labeled with iodine at tyrosine residues are metabolized rapidly in vivo. This leads to the incorporation of metabolized radioactive iodine into various tissues, mainly the thyroid gland and stomach, and to the accumulation of high levels of circulating iodine in the blood, which masks tumor uptake considerably. To overcome these limitations, the use of iodohippurate as an iodine-anchoring molecule to the protein should be considered. When divalent or multivalent metal ions are used as the preferred radionuclide, bifunctional chelating reagents such as EDTA or DTPA are first coupled to the protein or antibody. These chelating molecules are attached to the protein by formation of an isopeptide linkage between the carboxylate of the chelating reagent and the amino group of the protein. Several procedures are available to generate the isopeptide linkage. When the anchoring of the chelating agent through isopeptide linkage results in the inactivation of the antibody, periodate oxidation of the carbohydrate moiety of the antibody, followed by reductive coupling of chelator, could be considered as an alternative. There is still a need for better, simpler, and more direct methods for labeling antibodies with radionuclides. 78 references.

  18. Radionuclide synovectomy – essentials for rheumatologists

    PubMed Central

    Felis-Giemza, Anna; Kobylecka, Małgorzata

    2016-01-01

    Radionuclide synovectomy is a minimally invasive method of treating persistent joint inflammation. It involves intra-articular injection of radioactive colloids which induce necrosis and fibrosis of hypertrophic synovial membrane. The most common indication for radiosynovectomy is rheumatoid arthritis, although patients with seronegative spondyloarthropathies, unclassified arthritis, haemophilic arthropathy and other less common arthropathies can also benefit from this method. Radiosynovectomy is safe, well tolerated and efficacious. About 70–80% of patients respond well to the therapy. However, the therapeutic effects are considerably worse in patients with co-existent osteoarthritis and advanced joint degeneration. Despite its advantages, radionuclide synovectomy is not performed as often as it could be, so greater knowledge and understanding of this method are needed. The authors present the most important facts about radiosynovectomy that may help rheumatologists in their daily clinical practice. PMID:27504020

  19. Therapeutic proteins.

    PubMed

    Dimitrov, Dimiter S

    2012-01-01

    Protein-based therapeutics are highly successful in clinic and currently enjoy unprecedented recognition of their potential. More than 100 genuine and similar number of modified therapeutic proteins are approved for clinical use in the European Union and the USA with 2010 sales of US$108 bln; monoclonal antibodies (mAbs) accounted for almost half (48%) of the sales. Based on their pharmacological activity, they can be divided into five groups: (a) replacing a protein that is deficient or abnormal; (b) augmenting an existing pathway; (c) providing a novel function or activity; (d) interfering with a molecule or organism; and (e) delivering other compounds or proteins, such as a radionuclide, cytotoxic drug, or effector proteins. Therapeutic proteins can also be grouped based on their molecular types that include antibody-based drugs, Fc fusion proteins, anticoagulants, blood factors, bone morphogenetic proteins, engineered protein scaffolds, enzymes, growth factors, hormones, interferons, interleukins, and thrombolytics. They can also be classified based on their molecular mechanism of activity as (a) binding non-covalently to target, e.g., mAbs; (b) affecting covalent bonds, e.g., enzymes; and (c) exerting activity without specific interactions, e.g., serum albumin. Most protein therapeutics currently on the market are recombinant and hundreds of them are in clinical trials for therapy of cancers, immune disorders, infections, and other diseases. New engineered proteins, including bispecific mAbs and multispecific fusion proteins, mAbs conjugated with small molecule drugs, and proteins with optimized pharmacokinetics, are currently under development. However, in the last several decades, there are no conceptually new methodological developments comparable, e.g., to genetic engineering leading to the development of recombinant therapeutic proteins. It appears that a paradigm change in methodologies and understanding of mechanisms is needed to overcome major

  20. EBS Radionuclide Transport Abstraction

    SciTech Connect

    R. Schreiner

    2001-06-27

    The purpose of this work is to develop the Engineered Barrier System (EBS) radionuclide transport abstraction model, as directed by a written development plan (CRWMS M&O 1999a). This abstraction is the conceptual model that will be used to determine the rate of release of radionuclides from the EBS to the unsaturated zone (UZ) in the total system performance assessment-license application (TSPA-LA). In particular, this model will be used to quantify the time-dependent radionuclide releases from a failed waste package (WP) and their subsequent transport through the EBS to the emplacement drift wall/UZ interface. The development of this conceptual model will allow Performance Assessment Operations (PAO) and its Engineered Barrier Performance Department to provide a more detailed and complete EBS flow and transport abstraction. The results from this conceptual model will allow PA0 to address portions of the key technical issues (KTIs) presented in three NRC Issue Resolution Status Reports (IRSRs): (1) the Evolution of the Near-Field Environment (ENFE), Revision 2 (NRC 1999a), (2) the Container Life and Source Term (CLST), Revision 2 (NRC 1999b), and (3) the Thermal Effects on Flow (TEF), Revision 1 (NRC 1998). The conceptual model for flow and transport in the EBS will be referred to as the ''EBS RT Abstraction'' in this analysis/modeling report (AMR). The scope of this abstraction and report is limited to flow and transport processes. More specifically, this AMR does not discuss elements of the TSPA-SR and TSPA-LA that relate to the EBS but are discussed in other AMRs. These elements include corrosion processes, radionuclide solubility limits, waste form dissolution rates and concentrations of colloidal particles that are generally represented as boundary conditions or input parameters for the EBS RT Abstraction. In effect, this AMR provides the algorithms for transporting radionuclides using the flow geometry and radionuclide concentrations determined by other

  1. EBS Radionuclide Transport Abstraction

    SciTech Connect

    J. Prouty

    2006-07-14

    The purpose of this report is to develop and analyze the engineered barrier system (EBS) radionuclide transport abstraction model, consistent with Level I and Level II model validation, as identified in Technical Work Plan for: Near-Field Environment and Transport: Engineered Barrier System: Radionuclide Transport Abstraction Model Report Integration (BSC 2005 [DIRS 173617]). The EBS radionuclide transport abstraction (or EBS RT Abstraction) is the conceptual model used in the total system performance assessment (TSPA) to determine the rate of radionuclide releases from the EBS to the unsaturated zone (UZ). The EBS RT Abstraction conceptual model consists of two main components: a flow model and a transport model. Both models are developed mathematically from first principles in order to show explicitly what assumptions, simplifications, and approximations are incorporated into the models used in the TSPA. The flow model defines the pathways for water flow in the EBS and specifies how the flow rate is computed in each pathway. Input to this model includes the seepage flux into a drift. The seepage flux is potentially split by the drip shield, with some (or all) of the flux being diverted by the drip shield and some passing through breaches in the drip shield that might result from corrosion or seismic damage. The flux through drip shield breaches is potentially split by the waste package, with some (or all) of the flux being diverted by the waste package and some passing through waste package breaches that might result from corrosion or seismic damage. Neither the drip shield nor the waste package survives an igneous intrusion, so the flux splitting submodel is not used in the igneous scenario class. The flow model is validated in an independent model validation technical review. The drip shield and waste package flux splitting algorithms are developed and validated using experimental data. The transport model considers advective transport and diffusive transport

  2. Outpatient therapeutic nuclear oncology.

    PubMed

    Turner, J Harvey

    2012-05-01

    In the beginning, nuclear medicine was radionuclide therapy, which has evolved into molecular tumour-targeted control of metastatic cancer. Safe, efficacious, clinical practice of therapeutic nuclear oncology may now be based upon accurate personalised dosimetry by quantitative gamma SPECT/CT imaging to prescribe tumoricidal activities without critical organ toxicity. Preferred therapy radionuclides possess gamma emission of modest energy and abundance to enable quantitative SPECT/CT imaging for calculation of the beta therapy dosimetry, without radiation exposure risk to hospital personnel, carers, family or members of the public. The safety of outpatient radiopharmaceutical therapy of cancer with Iodine-131, Samarium-153, Holmium-166, Rhenium-186, Rhenium-188, Lutetium-177 and Indium-111 is reviewed. Measured activity release rates and radiation exposure to carers and the public are all within recommendations and guidelines of international regulatory agencies and, when permitted by local regulatory authorities allow cost-effective, safe, outpatient radionuclide therapy of cancer without isolation in hospital.

  3. Osteoid osteoma: radionuclide diagnosis

    SciTech Connect

    Helms, C.A.; Hattner, R.S.; Vogler, J.B.

    1984-06-01

    The double-density sign, seen on radionuclide bone scans, is described for diagnosing osteoid osteomas and for localizing the nidus. Its use in differentiating the nidus of an osteoid osteoma from osteomyelitis is also described. The utility of computed tomography in localization of the nidus is also illustrated. The double-density sign was helpful in diagnosing seven cases of surgically confirmed osteoid osteoma.

  4. 21 CFR 892.5700 - Remote controlled radionuclide applicator system.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Remote controlled radionuclide applicator system. 892.5700 Section 892.5700 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5700 Remote...

  5. Image guidance, treatment planning and evaluation of cancer interstitial focal therapy using liposomal radionuclides

    NASA Astrophysics Data System (ADS)

    Ware, Steve William

    Focally ablative therapy of cancer has gained significant interest recently. Improvements in diagnostic techniques have created possibilities for treatment which were once clinically unfeasible. Imaging must be capable of allowing accurate diagnosis, staging and planning upon initiation of therapy. Recent improvements in MRI and molecular imaging techniques have made it possible to accurately localize lesions and in so doing, improve the accuracy of proposed focal treatments. Using multimodality imaging it is now possible to target, plan and evaluate interstitial focal treatment using liposome encapsulated beta emitting radionuclides in a variety of cancer types. Since most absorbed dose is deposited early and heterogeneously in beta-radionuclide therapy, investigation of the resultant molecular and cellular events during this time is important for evaluating treatment efficacy. Additionally, investigating a multifocal entity such as prostate cancer is helpful for determining whether MRI is capable of discriminating the proper lesion for therapy. Correlation of MRI findings with histopathology can further improve the accuracy of interstitial focal radionuclide therapy by providing non-invasive surrogates for tissue compartment sizes. In the application of such therapies, compartmental sizes are known to heavily influence the distribution of injected agents. This has clear dosimetric implications with the potential to significantly alter the efficacy of treatment. The hypothesis of this project was that multimodality imaging with magnetic resonance imaging (MRI), autoradiography (AR), and single photon emission computed tomography (SPECT) could be used to target, plan, and evaluate interstitial focal therapy with non-sealed source, liposome-encapsulated 186Re beta emitting radionuclides. The specific aims of this project were to 1) Identify suitable targets for interstitial focal therapy. This was done by retrospectively analyzing MRI data to characterize the tumor

  6. EBS Radionuclide Transport Abstraction

    SciTech Connect

    J.D. Schreiber

    2005-08-25

    The purpose of this report is to develop and analyze the engineered barrier system (EBS) radionuclide transport abstraction model, consistent with Level I and Level II model validation, as identified in ''Technical Work Plan for: Near-Field Environment and Transport: Engineered Barrier System: Radionuclide Transport Abstraction Model Report Integration'' (BSC 2005 [DIRS 173617]). The EBS radionuclide transport abstraction (or EBS RT Abstraction) is the conceptual model used in the total system performance assessment for the license application (TSPA-LA) to determine the rate of radionuclide releases from the EBS to the unsaturated zone (UZ). The EBS RT Abstraction conceptual model consists of two main components: a flow model and a transport model. Both models are developed mathematically from first principles in order to show explicitly what assumptions, simplifications, and approximations are incorporated into the models used in the TSPA-LA. The flow model defines the pathways for water flow in the EBS and specifies how the flow rate is computed in each pathway. Input to this model includes the seepage flux into a drift. The seepage flux is potentially split by the drip shield, with some (or all) of the flux being diverted by the drip shield and some passing through breaches in the drip shield that might result from corrosion or seismic damage. The flux through drip shield breaches is potentially split by the waste package, with some (or all) of the flux being diverted by the waste package and some passing through waste package breaches that might result from corrosion or seismic damage. Neither the drip shield nor the waste package survives an igneous intrusion, so the flux splitting submodel is not used in the igneous scenario class. The flow model is validated in an independent model validation technical review. The drip shield and waste package flux splitting algorithms are developed and validated using experimental data. The transport model considers

  7. Radiation-induced liver lesions in beagle dogs

    SciTech Connect

    Hahn, F.F.; Muggenburg, B.A.; Boecker, B.B.

    1994-11-01

    The risk for liver disease from internally deposited beta-emitting radionuclides is unknown because there are no human populations exposed to hepatotropic beta-emitting radionuclides available for study. In this report, we discuss the hepatic lesion in dogs exposed to a beta-emitting radionuclide, {sup 144}CeCl{sub 3}, and held for their life spans.

  8. Targeted radionuclide therapy

    PubMed Central

    Williams, Lawrence E.; DeNardo, Gerald L.; Meredith, Ruby F.

    2008-01-01

    Targeted radionuclide therapy (TRT) seeks molecular and functional targets within patient tumor sites. A number of agents have been constructed and labeled with beta, alpha, and Auger emitters. Radionuclide carriers spanning a broad range of sizes; e.g., antibodies, liposomes, and constructs such as nanoparticles have been used in these studies. Uptake, in percent-injected dose per gram of malignant tissue, is used to evaluate the specificity of the targeting vehicle. Lymphoma (B-cell) has been the primary clinical application. Extension to solid tumors will require raising the macroscopic absorbed dose by several-fold over values found in present technology. Methods that may effect such changes include multistep targeting, simultaneous chemotherapy, and external sequestration of the agent. Toxicity has primarily involved red marrow so that marrow replacement can also be used to enhance future TRT treatments. Correlation of toxicities and treatment efficiency has been limited by relatively poor absorbed dose estimates partly because of using standard (phantom) organ sizes. These associations will be improved in the future by obtaining patient-specific organ size and activity data with hybrid SPECT∕CT and PET∕CT scanners. PMID:18697529

  9. Radionuclide imaging of osteomyelitis.

    PubMed

    Palestro, Christopher J

    2015-01-01

    Radionuclide procedures frequently are performed as part of the diagnostic workup of osteomyelitis. Bone scintigraphy accurately diagnoses osteomyelitis in bones not affected by underlying conditions. Degenerative joint disease, fracture, and orthopedic hardware decrease the specificity of the bone scan, making it less useful in these situations. Gallium-67 scintigraphy was often used as an adjunct to bone scintigraphy for diagnosing osteomyelitis. However, now it is used primarily for spinal infections when (18)F-FDG imaging cannot be performed. Except for the spine, in vitro-labeled leukocyte imaging is the nuclear medicine test of choice for diagnosing complicating osteomyelitis. Leukocytes accumulate in bone marrow as well as in infection. Performing complementary bone marrow imaging with (99m)Tc-sulfur colloid facilitates the differentiation between osteomyelitis and normal marrow and improves test overall accuracy. Antigranulocyte antibodies and antibody fragments, such as (99m)Tc-besilesomab and (99m)Tc-sulesomab, were developed to eliminate the disadvantages associated with in vitro-labeled leukocytes. These agents, however, have their own shortcomings and are not widely available. As biotin is used as a growth factor by certain bacteria, (111)In-biotin is useful to diagnose spinal infections. Radiolabeled synthetic fragments of ubiquicidin, a naturally occurring human antimicrobial peptide that targets bacteria, can differentiate infection from sterile inflammation and may be useful to monitor response to treatment. (18)F-FDG is extremely useful in the diagnostic workup of osteomyelitis. Sensitivity in excess of 95% and specificity ranging from 75%-99% have been reported. (18)F-FDG is the radionuclide test of choice for spinal infection. The test is sensitive, with a high negative predictive value, and reliably differentiates degenerative from infectious vertebral body end-plate abnormalities. Data on the accuracy of (18)F-FDG for diagnosing diabetic pedal

  10. Radionuclide Retention in Concrete Wasteforms

    SciTech Connect

    Bovaird, Chase C.; Jansik, Danielle P.; Wellman, Dawn M.; Wood, Marcus I.

    2011-09-30

    Assessing long-term performance of Category 3 waste cement grouts for radionuclide encasement requires knowledge of the radionuclide-cement interactions and mechanisms of retention (i.e., sorption or precipitation); the mechanism of contaminant release; the significance of contaminant release pathways; how wasteform performance is affected by the full range of environmental conditions within the disposal facility; the process of wasteform aging under conditions that are representative of processes occurring in response to changing environmental conditions within the disposal facility; the effect of wasteform aging on chemical, physical, and radiological properties; and the associated impact on contaminant release. This knowledge will enable accurate prediction of radionuclide fate when the wasteforms come in contact with groundwater. The information present in the report provides data that (1) measures the effect of concrete wasteform properties likely to influence radionuclide migration; and (2) quantifies the rate of carbonation of concrete materials in a simulated vadose zone repository.

  11. Drift-Scale Radionuclide Transport

    SciTech Connect

    J. Houseworth

    2004-09-22

    The purpose of this model report is to document the drift scale radionuclide transport model, taking into account the effects of emplacement drifts on flow and transport in the vicinity of the drift, which are not captured in the mountain-scale unsaturated zone (UZ) flow and transport models ''UZ Flow Models and Submodels'' (BSC 2004 [DIRS 169861]), ''Radionuclide Transport Models Under Ambient Conditions'' (BSC 2004 [DIRS 164500]), and ''Particle Tracking Model and Abstraction of Transport Process'' (BSC 2004 [DIRS 170041]). The drift scale radionuclide transport model is intended to be used as an alternative model for comparison with the engineered barrier system (EBS) radionuclide transport model ''EBS Radionuclide Transport Abstraction'' (BSC 2004 [DIRS 169868]). For that purpose, two alternative models have been developed for drift-scale radionuclide transport. One of the alternative models is a dual continuum flow and transport model called the drift shadow model. The effects of variations in the flow field and fracture-matrix interaction in the vicinity of a waste emplacement drift are investigated through sensitivity studies using the drift shadow model (Houseworth et al. 2003 [DIRS 164394]). In this model, the flow is significantly perturbed (reduced) beneath the waste emplacement drifts. However, comparisons of transport in this perturbed flow field with transport in an unperturbed flow field show similar results if the transport is initiated in the rock matrix. This has led to a second alternative model, called the fracture-matrix partitioning model, that focuses on the partitioning of radionuclide transport between the fractures and matrix upon exiting the waste emplacement drift. The fracture-matrix partitioning model computes the partitioning, between fractures and matrix, of diffusive radionuclide transport from the invert (for drifts without seepage) into the rock water. The invert is the structure constructed in a drift to provide the floor of the

  12. Video instrumentation for radionuclide angiocardiography.

    NASA Technical Reports Server (NTRS)

    Kriss, J. P.

    1973-01-01

    Two types of videoscintiscopes for performing radioisotopic angiocardiography with a scintillation camera are described, and use of these instruments in performing clinical studies is illustrated. Radionuclide angiocardiography is a simple, quick and accurate procedure recommended as a screening test for patients with a variety of congenital and acquired cardiovascular lesions. When performed in conjunction with coronary arterial catheterization, dynamic radionuclide angiography may provide useful information about regional myocardial perfusion. Quantitative capabilities greatly enhance the potential of this diagnostic tool.

  13. Anthropogenic radionuclides in the environment

    SciTech Connect

    Hu, Q; Weng, J; Wang, J

    2007-11-15

    Studies of radionuclides in the environment have entered a new era with the renaissance of nuclear energy and associated fuel reprocessing, geological disposal of high-level nuclear wastes, and concerns about national security with respect to nuclear non-proliferation. This work presents an overview of anthropogenic radionuclide contamination in the environment, as well as the salient geochemical behavior of important radionuclides. We first discuss the following major anthropogenic sources and current development that contribute to the radionuclide contamination of the environment: (1) nuclear weapons program; (2) nuclear weapons testing; (3) nuclear power plants; (4) commercial fuel reprocessing; (5) geological repository of high-level nuclear wastes, and (6) nuclear accidents. Then, we summarize the geochemical behavior for radionuclides {sup 99}Tc, {sup 129}I, and {sup 237}Np, because of their complex geochemical behavior, long half-lives, and presumably high mobility in the environment. Biogeochemical cycling and environment risk assessment must take into account speciation of these redox-sensitive radionuclides.

  14. Development of gamma-photon/Cerenkov-light hybrid system for simultaneous imaging of I-131 radionuclide

    NASA Astrophysics Data System (ADS)

    Yamamoto, Seiichi; Suzuki, Mayumi; Kato, Katsuhiko; Watabe, Tadashi; Ikeda, Hayato; Kanai, Yasukazu; Ogata, Yoshimune; Hatazawa, Jun

    2016-09-01

    Although iodine 131 (I-131) is used for radionuclide therapy, high resolution images are difficult to obtain with conventional gamma cameras because of the high energy of I-131 gamma photons (364 keV). Cerenkov-light imaging is a possible method for beta emitting radionuclides, and I-131 (606 MeV maximum beta energy) is a candidate to obtain high resolution images. We developed a high energy gamma camera system for I-131 radionuclide and combined it with a Cerenkov-light imaging system to form a gamma-photon/Cerenkov-light hybrid imaging system to compare the simultaneously measured images of these two modalities. The high energy gamma imaging detector used 0.85-mm×0.85-mm×10-mm thick GAGG scintillator pixels arranged in a 44×44 matrix with a 0.1-mm thick reflector and optical coupled to a Hamamatsu 2 in. square position sensitive photomultiplier tube (PSPMT: H12700 MOD). The gamma imaging detector was encased in a 2 cm thick tungsten shield, and a pinhole collimator was mounted on its top to form a gamma camera system. The Cerenkov-light imaging system was made of a high sensitivity cooled CCD camera. The Cerenkov-light imaging system was combined with the gamma camera using optical mirrors to image the same area of the subject. With this configuration, we simultaneously imaged the gamma photons and the Cerenkov-light from I-131 in the subjects. The spatial resolution and sensitivity of the gamma camera system for I-131 were respectively 3 mm FWHM and 10 cps/MBq for the high sensitivity collimator at 10 cm from the collimator surface. The spatial resolution of the Cerenkov-light imaging system was 0.64 mm FWHM at 10 cm from the system surface. Thyroid phantom and rat images were successfully obtained with the developed gamma-photon/Cerenkov-light hybrid imaging system, allowing direct comparison of these two modalities. Our developed gamma-photon/Cerenkov-light hybrid imaging system will be useful to evaluate the advantages and disadvantages of these two

  15. Radiochemical Separations:. Useful Methods for the Preparation of No-Carrier Solutions of Different Radionuclides for Metabolic Radiotherapy

    NASA Astrophysics Data System (ADS)

    Zona, C.; Groppi, F.; Persico, E.; Canella, L.; Bonardi, M. L.; Chinol, M.; Abbas, K.; Holzwarth, U.; Gibson, N.

    2008-06-01

    In Nuclear Medicine, radionuclides are used in the detection and the treatment for cancers and others diseases. We must obtain, for therapeutic purposes, solutions of radionuclides in the required chemical form, with an high specific activity (AS). To reach our goal we must, first, obtain no-carrier-added (NCA) solutions. In this work we present different methods for the production of NCA radionuclides, based on either wet-chemistry, or thermc- and radio-chromatography. We set up four different methods: two for the preparation of the alpha emitter 211At, and two for the beta emitters 186gRe and 90Y. These radionuclides had been chosen because of their chemical and nuclear properties as their half-life, type, abundance and energy of emissions, that make them among the most promising radionuclides to label compounds for the metabolic radionuclide therapy.

  16. Radionuclide imaging and treatment of thyroid cancer.

    PubMed

    Wang, Xiu Juan; Li, XianFeng; Ren, Yuan

    2016-06-01

    Over the past decades, the diagnostic methods and therapeutic tools for thyroid cancer (TC) have been greatly improved. In addition to the classical method of ingestion of radioactive iodine-131 (I131) and subsequent I123 and I124 positron emission tomography (PET) in therapy and examination, I124 PET-based 3-dimensional imaging, Ga68-labeled [1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-NaI(3)-octreotide (DOTANOC) PET/computed tomography (CT), Tc99m tetrofosmin, pre-targeted radioimmunotherapy, and peptide receptor radionuclide therapy have all been used clinically. These novel methods are useful in diagnosis and therapy of TC, but also have unavoidable adverse effects. In this review, we will discuss the development of nuclear medicine in TC examination and treatment.

  17. Prospects for the methods of radionuclide production

    SciTech Connect

    Karamian, S. A. Dmitriev, S. N.

    2015-03-30

    In the present report, methods of radionuclide production for the nuclear-medicine purposes are described. In a budget approach, the application of low-energy accelerators is especially advantageous. Intense flux of bremsstrahlung at electron accelerators or high-current cyclotron beams of alpha particles must supply a great yield for many isotopes. The choice of a target material and of the projectile energy provides enough variation for concrete species formation. The innovating procedures are here proposed for optimizing of methods, for instance, application of the noble-gas target for production and transport of activities. The known and new variants of the “generator” scheme are discussed. Many isotopes are listed as promising in the context of the therapeutic and theragnostic applications. Among them are isotopes/isomers emitting soft radiation for the selective and careful body treatment, also the positron emitters for PET, and the halogen and alkali-metal species convenient for chemical separation.

  18. Prospects for the methods of radionuclide production

    NASA Astrophysics Data System (ADS)

    Karamian, S. A.; Dmitriev, S. N.

    2015-03-01

    In the present report, methods of radionuclide production for the nuclear-medicine purposes are described. In a budget approach, the application of low-energy accelerators is especially advantageous. Intense flux of bremsstrahlung at electron accelerators or high-current cyclotron beams of alpha particles must supply a great yield for many isotopes. The choice of a target material and of the projectile energy provides enough variation for concrete species formation. The innovating procedures are here proposed for optimizing of methods, for instance, application of the noble-gas target for production and transport of activities. The known and new variants of the "generator" scheme are discussed. Many isotopes are listed as promising in the context of the therapeutic and theragnostic applications. Among them are isotopes/isomers emitting soft radiation for the selective and careful body treatment, also the positron emitters for PET, and the halogen and alkali-metal species convenient for chemical separation.

  19. Radionuclide injury to the lung.

    PubMed Central

    Dagle, G E; Sanders, C L

    1984-01-01

    Radionuclide injury to the lung has been studied in rats, hamsters, dogs, mice and baboons. Exposure of the lung to high dose levels of radionuclides produces a spectrum of progressively more severe functional and morphological changes, ranging from radiation pneumonitis and fibrosis to lung tumors. These changes are somewhat similar for different species. Their severity can be related to the absorbed radiation dose (measured in rads) produced by alpha, beta or gamma radiation emanating from various deposited radionuclides. The chemicophysical forms of radionuclides and spatial-temporal factors are also important variables. As with other forms of injury to the lung, repair attempts are highlighted by fibrosis and proliferation of pulmonary epithelium. Lung tumors are the principal late effect observed in experimental animals following pulmonary deposition of radionuclides at dose levels that do not result in early deaths from radiation pneumonitis or fibrosis. The predominant lung tumors described have been of epithelial origin and have been classified, in decreasing frequency of occurrence, as adenocarcinoma, bronchioloalveolar carcinoma, epidermoid carcinomas and combined epidermoid and adenocarcinoma. Mesothelioma and fibrosarcoma have been observed in rats, but less commonly in other species. Hemangiosarcomas were frequency observed in dogs exposed to beta-gamma emitters, and occasionally in rats exposed to alpha emitters. These morphologic changes in the lungs of experimental animals were reviewed and issues relevant to the prediction of human hazards discussed. PMID:6376095

  20. Radionuclide Retention in Concrete Wasteforms

    SciTech Connect

    Wellman, Dawn M.; Jansik, Danielle P.; Golovich, Elizabeth C.; Cordova, Elsa A.

    2012-09-24

    Assessing long-term performance of Category 3 waste cement grouts for radionuclide encasement requires knowledge of the radionuclide-cement interactions and mechanisms of retention (i.e., sorption or precipitation); the mechanism of contaminant release; the significance of contaminant release pathways; how wasteform performance is affected by the full range of environmental conditions within the disposal facility; the process of wasteform aging under conditions that are representative of processes occurring in response to changing environmental conditions within the disposal facility; the effect of wasteform aging on chemical, physical, and radiological properties; and the associated impact on contaminant release. This knowledge will enable accurate prediction of radionuclide fate when the wasteforms come in contact with groundwater. Data collected throughout the course of this work will be used to quantify the efficacy of concrete wasteforms, similar to those used in the disposal of LLW and MLLW, for the immobilization of key radionuclides (i.e., uranium, technetium, and iodine). Data collected will also be used to quantify the physical and chemical properties of the concrete affecting radionuclide retention.

  1. Radionuclide detection devices and associated methods

    DOEpatents

    Mann, Nicholas R.; Lister, Tedd E.; Tranter, Troy J.

    2011-03-08

    Radionuclide detection devices comprise a fluid cell comprising a flow channel for a fluid stream. A radionuclide collector is positioned within the flow channel and configured to concentrate one or more radionuclides from the fluid stream onto at least a portion of the radionuclide collector. A scintillator for generating scintillation pulses responsive to an occurrence of a decay event is positioned proximate at least a portion of the radionuclide collector and adjacent to a detection system for detecting the scintillation pulses. Methods of selectively detecting a radionuclide are also provided.

  2. Radionuclides in Chesapeake Bay sediments

    NASA Technical Reports Server (NTRS)

    Cressy, P. J., Jr.

    1976-01-01

    Natural and manmade gamma-ray emitting radionuclides were measured in Chesapeake Bay sediments taken near the Calvert Cliffs Nuclear Power Plant site. Samples represented several water depths, at six locations, for five dates encompassing a complete seasonal cycle. Radionuclide contents of dry sediments ranged as follows: Tl-208, 40 to 400 pCi/kg; Bi-214, 200 to 800 pCi/kg; K, 0.04 to 2.1 percent; Cs-137 5 to 1900 pCi/kg; Ru106, 40 to 1000 pCikg Co60, 1 to 27 pCi/kg. In general, radionuclide contents were positively correlated with each other and negatively correlated with sediment grain size.

  3. 100 years of radionuclide metrology.

    PubMed

    Judge, S M; Arnold, D; Chauvenet, B; Collé, R; De Felice, P; García-Toraño, E; Wätjen, U

    2014-05-01

    The discipline of radionuclide metrology at national standards institutes started in 1913 with the certification by Curie, Rutherford and Meyer of the first primary standards of radium. In early years, radium was a valuable commodity and the aim of the standards was largely to facilitate trade. The focus later changed to providing standards for the new wide range of radionuclides, so that radioactivity could be used for healthcare and industrial applications while minimising the risk to patients, workers and the environment. National measurement institutes responded to the changing demands by developing new techniques for realising primary standards of radioactivity. Looking ahead, there are likely to be demands for standards for new radionuclides used in nuclear medicine, an expansion of the scope of the field into quantitative imaging to facilitate accurate patient dosimetry for nuclear medicine, and an increasing need for accurate standards for radioactive waste management and nuclear forensics.

  4. Radionuclide Imaging of Cardiovascular Infection.

    PubMed

    Ahmed, Fozia Zahir; James, Jackie; Memmott, Matthew J; Arumugam, Parthiban

    2016-02-01

    Owing to expanding clinical indications, cardiac implantable electronic devices (CIEDs) are being increasingly used. Despite improved surgical techniques and the use of prophylactic antimicrobial therapy, the rate of CIED-related infection is also increasing. Infection is a potentially serious complication, with clinical manifestations ranging from surgical site infection and local symptoms in the region of the generator pocket to fulminant endocarditis. The utility of radionuclide imaging as a stand-alone noninvasive diagnostic imaging test in patients with suspected endocarditis has been less frequently examined. This article summarizes the recent advances in radionuclide imaging for evaluation of patients with suspected cardiovascular infections.

  5. Conditions and processes affecting radionuclide transport

    USGS Publications Warehouse

    Simmons, Ardyth M.; Neymark, Leonid A.

    2012-01-01

    Understanding of unsaturated-zone transport is based on laboratory and field-scale experiments. Fractures provide advective transport pathways. Sorption and matrix diffusion may contribute to retardation of radionuclides. Conversely, sorption onto mobile colloids may enhance radionuclide transport.

  6. Radionuclide Sensors for Subsurface Water Monitoring

    SciTech Connect

    Timothy DeVol

    2006-06-30

    Contamination of the subsurface by radionuclides is a persistent and vexing problem for the Department of Energy. These radionuclides must be measured in field studies and monitoed in the long term when they cannot be removed. However, no radionuclide sensors existed for groundwater monitoring prior to this team's research under the EMSP program Detection of a and b decays from radionuclides in water is difficult due to their short ranges in condensed media.

  7. Measurement of radionuclides in waste packages

    DOEpatents

    Brodzinski, Ronald L.; Perkins, Richard W.; Rieck, Henry G.; Wogman, Ned A.

    1986-01-01

    A method is described for non-destructively assaying the radionuclide content of solid waste in a sealed container by analysis of the waste's gamma-ray spectrum and neutron emissions. Some radionuclides are measured by characteristic photopeaks in the gamma-ray spectrum; transuranic nuclides are measured by neutron emission rate; other radionuclides are measured by correlation with those already measured.

  8. [Role of Radionuclide Technologies in Medicine].

    PubMed

    Chernyaev, A P; Belousov, A V; Varzar, S M; Borchegovskaya, P Y; Nikolaeva, A A; Krusanov, G A

    2016-01-01

    The paper describes the role of radionuclide technologies among the nuclear-physical methods used in medicine. The condition and prospects of the development of nuclear technology with use of radionuclides in medicine, and in particular, the method of brachytherapy are analyzed. The analysis of the current state of applying radionuclide facilities in medicine is provided.

  9. TECHNOLOGIES FOR RADON AND RADIONUCLIDE REMOVAL

    EPA Science Inventory

    This paper provides a summary of the technologies that are currently being used to remove radionuclides from drinking water. The radionuclides that are featured are the radionuclides currently regulated by EPA; radium, radon and uranium. Tehnologies effective for removal of eac...

  10. Measurement of radionuclides in waste packages

    DOEpatents

    Brodzinski, R.L.; Perkins, R.W.; Rieck, H.G.; Wogman, N.A.

    1984-09-12

    A method is described for non-destructively assaying the radionuclide content of solid waste in a sealed container by analysis of the waste's gamma-ray spectrum and neutron emissions. Some radionuclides are measured by characteristic photopeaks in the gamma-ray spectrum; transuranic nuclides are measured by neutron emission rate; other radionuclides are measured by correlation with those already measured.

  11. Radionuclide evaluation in childhood injuries

    SciTech Connect

    Sty, J.R.; Starshak, R.J.; Hubbard, A.M.

    1983-07-01

    Radionuclide techniques serve an important role in evaluating childhood injuries. Frequently, they can be employed as the initial and definitive examination. At times they represent the only modality that will detect specific injuries such as the skeletal system. Familiarity with the advantages and limitations of tracer techniques will insure appropriate management of childhood injuries.

  12. Natural radionuclide accumulation by raindrops

    NASA Astrophysics Data System (ADS)

    Gusev, Anatoly; Martin, Inacio; Shkevov, Rumen; Alves, Mauro

    2016-07-01

    The laboratory of environmental radiation of ITA (São José dos Campos, 23°11'11″S, 45°52'43″W, 650 MAMSL) performs simultaneous monitoring of a natural radiation background and meteorological parameters. A time resolution of up to 1 minute allows a detailed comparison of changes in meteorological parameters with those of a concentration of ambient radon progenies in the atmosphere. Results of a study of variation of a fallout of radon progenies ^{214}Pb and ^{214}Bi concomitanting rainfalls are present. The radionuclide fallout rate is reconstructed from the observed gamma rate through a simulation of the first kind Volterra integral equation with difference kernel, determined by ratio of precipitating rates of 214Pb and 214Bi and their decay half times. An original straightforward step-by-step procedure was used for the numerical solution of the equation. The radionuclide concentration in the rainwater is calculated as a ratio of the reconstructed fallout to the measured rainfall. It was observed that the radionuclide fallout rate increases as the rainfall one in approximately power 0.6, i.e. the same as the mean raindrop volume. The concentration thereafter decreases as the rainfall rate in power 0.4. A numerical simulation of the process of accumulation of the radionuclides during diffusion and coalescence drop growth and aerosol scavenging during a passage from a cloud to the ground was performed. The results of the simulations agree with the experimental data.

  13. Tumor Immunotargeting Using Innovative Radionuclides

    PubMed Central

    Kraeber-Bodéré, Françoise; Rousseau, Caroline; Bodet-Milin, Caroline; Mathieu, Cédric; Guérard, François; Frampas, Eric; Carlier, Thomas; Chouin, Nicolas; Haddad, Ferid; Chatal, Jean-François; Faivre-Chauvet, Alain; Chérel, Michel; Barbet, Jacques

    2015-01-01

    This paper reviews some aspects and recent developments in the use of antibodies to target radionuclides for tumor imaging and therapy. While radiolabeled antibodies have been considered for many years in this context, only a few have reached the level of routine clinical use. However, alternative radionuclides, with more appropriate physical properties, such as lutetium-177 or copper-67, as well as alpha-emitting radionuclides, including astatine-211, bismuth-213, actinium-225, and others are currently reviving hopes in cancer treatments, both in hematological diseases and solid tumors. At the same time, PET imaging, with short-lived radionuclides, such as gallium-68, fluorine-18 or copper-64, or long half-life ones, particularly iodine-124 and zirconium-89 now offers new perspectives in immuno-specific phenotype tumor imaging. New antibody analogues and pretargeting strategies have also considerably improved the performances of tumor immunotargeting and completely renewed the interest in these approaches for imaging and therapy by providing theranostics, companion diagnostics and news tools to make personalized medicine a reality. PMID:25679452

  14. Radionuclides in the management of thyroid cancer

    PubMed Central

    2007-01-01

    Abstract Nuclear medicine imaging was born over 60 years ago with imaging of thyroid conditions. Most of our present imaging devices were developed for imaging of the thyroid and thyroid cancer. Millions of patients in over 100 countries have been diagnosed and treated for thyroid cancer using nuclear medicine techniques. It remains, however, one of the most dynamic areas of development in nuclear medicine with new roles for positron emission tomography and receptor based imaging. In addition to this is research into combinations of genetic therapy and radioisotopes and receptor based therapy using beta emitting analogues of somatostatin. Despite the use of ultrasound computed tomography and magnetic resonance, nuclear medicine techniques remain central to both imaging and therapy in thyroid disease and the field has recently become one of the most dynamic within the specialty. PMID:18083649

  15. Modeling Radionuclide Transport in Clays

    SciTech Connect

    Zheng, Liange; Li, Lianchong; Rutqvist, Jonny; Liu, Hui -Hai; Birkholzer, Jens

    2012-05-01

    Clay/shale has been considered as potential host rock for geological disposal of high-level nuclear waste throughout the world, because of its low permeability, low diffusion coefficient, high retention capacity for radionuclides, and capability to self-seal fractures induced by tunnel excavation. For example, Callovo-Oxfordian argillites at the Bure site, France (Fouche et al., 2004), Toarcian argillites at the Tournemire site, France (Patriarche et al., 2004), Opalinus Clay at the Mont Terri site, Switzerland (Meier et al., 2000), and Boom clay at the Mol site, Belgium (Barnichon and Volckaert, 2003) have all been under intensive scientific investigation (at both field and laboratory scales) for understanding a variety of rock properties and their relationships to flow and transport processes associated with geological disposal of nuclear waste. Clay/shale formations may be generally classified as indurated or plastic clays (Tsang and Hudson, 2010). The latter (including Boom clay) is a softer material without high cohesion; its deformation is dominantly plastic. During the lifespan of a clay repository, the repository performance is affected by complex thermal, hydrogeological, mechanical, chemical (THMC) processes, such as heat release due to radionuclide decay, multiphase flow, formation of damage zones, radionuclide transport, waste dissolution, and chemical reactions. All these processes are related to each other. An in-depth understanding of these coupled processes is critical for the performance assessment (PA) of the repository. These coupled processes may affect radionuclide transport by changing transport paths (e.g., formation and evolution of excavation damaged zone (EDZ)) and altering flow, mineral, and mechanical properties that are related to radionuclide transport. While radionuclide transport in clay formation has been studied using laboratory tests (e,g, Appelo et al. 2010, Garcia-Gutierrez et al., 2008, Maes et al., 2008), short-term field

  16. Natural chelating agents for radionuclide decorporation

    DOEpatents

    Premuzic, E.T.

    1985-06-11

    This invention relates to the production of metal-binding compounds useful for the therapy of heavy metal poisoning, for biological mining and for decorporation of radionuclides. The present invention deals with an orderly and effective method of producing new therapeutically effective chelating agents. This method uses challenge biosynthesis for the production of chelating agents that are specific for a particular metal. In this approach, the desired chelating agents are prepared from microorganisms challenged by the metal that the chelating agent is designed to detoxify. This challenge induces the formation of specific or highly selective chelating agents. The present invention involves the use of the challenge biosynthetic method to produce new complexing/chelating agents that are therapeutically useful to detoxify uranium, plutonium, thorium and other toxic metals. The Pseudomonas aeruginosa family of organisms is the referred family of microorganisms to be used in the present invention to produce the new chelating agent because this family is known to elaborate strains resistant to toxic metals.

  17. Radioimmunotherapy with α-particle-emitting radionuclides.

    PubMed

    Seidl, Christof

    2014-01-01

    α-particle-emitting radionuclides are highly cytotoxic and are thus promising candidates for use in targeted radioimmunotherapy of cancer. Due to their high linear energy transfer (LET) combined with a short path length in tissue, α-particles cause severe DNA double-strand breaks that are repaired inaccurately and finally trigger cell death. For radioimmunotherapy, α-emitters such as (225)Ac, (211)At, (212)Bi/(212)Pb, (213)Bi and (227)Th are coupled to antibodies via appropriate chelating agents. The α-emitter immunoconjugates preferably target proteins that are overexpressed or exclusively expressed on cancer cells. Application of α-emitter immunoconjugates seems particularly promising in treatment of disseminated cancer cells and small tumor cell clusters that are released during the resection of a primary tumor. α-emitter immunoconjugates have been successfully administered in numerous experimental studies for therapy of ovarian, colon, gastric, blood, breast and bladder cancer. Initial clinical trials evaluating α-emitter immunoconjugates in terms of toxicity and therapeutic efficacy have also shown positive results in patients with melanoma, ovarian cancer, acute myeloid lymphoma and glioma. The present problems in terms of availability of therapeutically effiective α-emitters will presumably be solved by use of alternative production routes and installation of additional production facilities in the near future. Therefore, clinical establishment of targeted α-emitter radioimmunotherapy as one part of a multimodal concept for therapy of cancer is a promising, middle-term concept.

  18. Water-Chemistry Evolution and Modeling of Radionuclide Sorption and Cation Exchange during Inundation of Frenchman Flat Playa

    SciTech Connect

    Hershey, Ronald; Cablk, Mary; LeFebre, Karen; Fenstermaker, Lynn; Decker, David

    2013-08-01

    valuable information about chemical processes occurring during inundation as the water disappeared. Important observations from water-chemistry analyses included: 1) total dissolved solids (TDS) and chloride ion (Cl-) concentrations were very low (TDS: < 200 mg/L and Cl-: < 3.0 mg/L, respectively) for all water samples regardless of time or areal extent; 2) all dissolved constituents were at concentrations well below what might be expected for evaporating shallow surface waters on a playa, even when 98 to 99 percent of the water had disappeared; 3) the amount of evaporation for the last water samples collected at the end of inundation, estimated with the stable isotopic ratios δ2H or δ18O, was approximately 60 percent; and 4) water samples analyzed by gamma spectroscopy did not show any man-made radioactivity; however, the short scanning time (24 hours) and relative chemical diluteness of the water samples (TDS ranged between 39 and 190 mg/L) may have contributed to none being detected. Additionally, any low-energy beta emitting radionuclides would not have been detected by gamma spectroscopy. From these observations, it was apparent that a significant portion of water on the playa did not evaporate, but rather infiltrated into the subsurface (approximately 40 percent). Consistent with this water chemistry-based conclusion is particle-size analysis of two archived Frenchman Flat playa soils samples, which showed low clay content in the near surface soil that also suggested infiltration. Infiltration of water from the playa during inundation into the subsurface does not necessarily imply that groundwater recharge is occurring, but it does provide a mechanism for moving residual radionuclides downward into the subsurface of Frenchman Flat playa. Water-mineral geochemical reactions were modeled so that changes in the water chemistry could be identified and the extent of reactions quantified. Geochemical modeling showed that evaporation; equilibrium with atmospheric carbon

  19. Identification of CSF fistulas by radionuclide counting

    SciTech Connect

    Yamamoto, Y.; Kunishio, K.; Sunami, N.; Yamamoto, Y.; Satoh, T.; Suga, M.; Asari, S. )

    1990-07-01

    A radionuclide counting method, performed with the patient prone and the neck flexed, was used successfully to diagnose CSF rhinorrhea in two patients. A normal radionuclide ratio (radionuclide counts in pledget/radionuclide counts in 1-ml blood sample) was obtained in 11 normal control subjects. Significance was determined to be a ratio greater than 0.37. Use of radionuclide counting method of determining CSF rhinorrhea is recommended when other methods have failed to locate a site of leakage or when posttraumatic meningitis suggests subclinical CSF rhinorrhea.

  20. Chernobyl radionuclide distribution and migration.

    PubMed

    Izrael, Yury A

    2007-11-01

    The accident at Unit No. 4 of the Chernobyl Nuclear Power Plant on 26 April 1986 presented severe challenges in radiation protection. Early activity measurements defined the contaminated areas in order to determine what persons should be evacuated on the basis of the exposure limit at that time of 100 mSv (10 rem) for accidents. The immediate definition of these areas was accomplished with specially equipped aircraft capable of measuring external gamma-exposure rate and radionuclide spectra. Over time, maps of 137Cs contamination (the most important long-lived radionuclide) have become more and more sophisticated and have been used for further determinations of the control of the consequences of the accident. About 70% of the total release of 137Cs was deposited in Belarus, the Russian Federation, and Ukraine; but there was also widespread deposition throughout the countries of Western Europe. Two atlases of contamination throughout Europe were prepared, and the Russian atlas included data on other radionuclides and on external gamma-exposure rates. The radiocesiums behaved as volatile radionuclides because of the volatility of cesium. In contrast to the typical pattern after nuclear weapons tests, 90Sr behaved only as a refractory element, as its volatile precursors krypton and rubidium had already decayed within the reactor. Nearly all of the refractory elements (strontium, plutonium, etc.) released by the accident were confined to the 30-km zone around the reactor. A proposal is made to develop a more complete atlas of 137Cs deposition from the accident that would include the entire Northern Hemisphere. Water was not an important vector of exposure to human beings following the accident.

  1. Natural chelates for radionuclide decorporation

    DOEpatents

    Premuzic, E.T.

    1983-08-25

    This invention relates to the method and resulting chelates of desorbing a radionuclide selected from thorium, uranium, and plutonium containing cultures in a bioavailable form involving pseudomonas or other microorganisms. A preferred microorganism is Pseudomonas aeruginosa which forms multiple chelates with thorium in the range of molecular weight 1000 to 1000 and also forms chelates with uranium of molecular weight in the area of 100 to 1000 and 1000 to 2000.

  2. Radionuclide behavior in the environment

    SciTech Connect

    Tveten, U. )

    1991-09-01

    The purpose of this report is to document the results of the following task: Review for quality and consistency the available data on measurements of initial ground contamination of Chernobyl radionuclides in various parts of Norway and subsequent concentrations of these radionuclides in various environmental media as functions of time. Utilize the data obtained to verify the existing models, or to improve them, for describing radionuclide behavior in the environment. Some of the processes standard were: migration into soil; weathering; resuspension; food-chain contamination; and loss or reconcentration by run-off. The task performed within this contract has been to use post-Chernobyl data from Norway to verify or find areas for possible improvement in the chronic exposure pathway models utilized in MACCS. Work has consisted mainly of collecting and evaluating post-Chernobyl information from Norway or other countries when relevant; but has also included experimental work performed specifically for the current task. In most connections the data available show the models and data in MACCS to be appropriate. A few areas where the data indicate that the MACCS approach is faulty or inadequate are, however, pointed out in the report. These should be examined carefully, and appropriate modifications should eventually be made. 14 refs., 12 figs., 22 tabs.

  3. Radionuclide daughter inventory generator code: DIG

    SciTech Connect

    Fields, D.E.; Sharp, R.D.

    1985-09-01

    The Daughter Inventory Generator (DIG) code accepts a tabulation of radionuclide initially present in a waste stream, specified as amounts present either by mass or by activity, and produces a tabulation of radionuclides present after a user-specified elapsed time. This resultant radionuclide inventory characterizes wastes that have undergone daughter ingrowth during subsequent processes, such as leaching and transport, and includes daughter radionuclides that should be considered in these subsequent processes or for inclusion in a pollutant source term. Output of the DIG code also summarizes radionuclide decay constants. The DIG code was developed specifically to assist the user of the PRESTO-II methodology and code in preparing data sets and accounting for possible daughter ingrowth in wastes buried in shallow-land disposal areas. The DIG code is also useful in preparing data sets for the PRESTO-EPA code. Daughter ingrowth in buried radionuclides and in radionuclides that have been leached from the wastes and are undergoing hydrologic transport are considered, and the quantities of daughter radionuclide are calculated. Radionuclide decay constants generated by DIG and included in the DIG output are required in the PRESTO-II code input data set. The DIG accesses some subroutines written for use with the CRRIS system and accesses files containing radionuclide data compiled by D.C. Kocher. 11 refs.

  4. Methods of separating short half-life radionuclides from a mixture of radionuclides

    DOEpatents

    Bray, L.A.; Ryan, J.L.

    1998-09-15

    The present invention is a method of obtaining a radionuclide product selected from the group consisting of {sup 223}Ra and {sup 225}Ac, from a radionuclide ``cow`` of {sup 227}Ac or {sup 229}Th respectively. The method comprises the steps of (a) permitting ingrowth of at least one radionuclide daughter from said radionuclide ``cow`` forming an ingrown mixture; (b) insuring that the ingrown mixture is a nitric acid ingrown mixture; (c) passing the nitric acid ingrown mixture through a first nitrate form ion exchange column which permits separating the ``cow`` from at least one radionuclide daughter; (d) insuring that the at least one radionuclide daughter contains the radionuclide product; (e) passing the at least one radionuclide daughter through a second ion exchange column and separating the at least one radionuclide daughter from the radionuclide product and (f) recycling the at least one radionuclide daughter by adding it to the ``cow``. In one embodiment the radionuclide ``cow`` is the {sup 227}Ac, the at least one daughter radionuclide is a {sup 227}Th and the product radionuclide is the {sup 223}Ra and the first nitrate form ion exchange column passes the {sup 227}Ac and retains the {sup 227}Th. In another embodiment the radionuclide ``cow`` is the {sup 229}Th, the at least one daughter radionuclide is a {sup 225}Ra and said product radionuclide is the {sup 225}Ac and the {sup 225}Ac and nitrate form ion exchange column retains the {sup 229}Th and passes the {sup 225}Ra/Ac. 8 figs.

  5. Methods of separating short half-life radionuclides from a mixture of radionuclides

    DOEpatents

    Bray, Lane A.; Ryan, Jack L.

    1998-01-01

    The present invention is a method of obtaining a radionuclide product selected from the group consisting of .sup.223 Ra and .sup.225 Ac, from a radionuclide "cow" of .sup.227 Ac or .sup.229 Th respectively. The method comprises the steps of a) permitting ingrowth of at least one radionuclide daughter from said radionuclide "cow" forming an ingrown mixture; b) insuring that the ingrown mixture is a nitric acid ingrown mixture; c) passing the nitric acid ingrown mixture through a first nitrate form ion exchange column which permits separating the "cow" from at least one radionuclide daughter; d) insuring that the at least one radionuclide daughter contains the radionuclide product; e) passing the at least one radionuclide daughter through a second ion exchange column and separating the at least one radionuclide daughter from the radionuclide product and f) recycling the at least one radionuclide daughter by adding it to the "cow". In one embodiment the radionuclide "cow" is the .sup.227 Ac, the at least one daughter radionuclide is a .sup.227 Th and the product radionuclide is the .sup.223 Ra and the first nitrate form ion exchange column passes the .sup.227 Ac and retains the .sup.227 Th. In another embodiment the radionuclide "cow"is the .sup.229 Th, the at least one daughter radionuclide is a .sup.225 Ra and said product radionuclide is the .sup.225 Ac and the .sup.225 Ac and nitrate form ion exchange column retains the .sup.229 Th and passes the .sup.225 Ra/Ac.

  6. Physiological considerations in radionuclide imaging of the penis during impotence therapy

    SciTech Connect

    Chaudhuri, T.K.; Fink, S.; Burger, R.H.; Netto, I.C.; Palmer, J.D. )

    1989-01-01

    The increased use of intracorporeal drugs in the treatment of impotence has advanced our understanding of erectile physiology. Radionuclide imaging of the penis (nuclear penogram) has provided clinicians with a noninvasive, objective measure of blood flow and blood pool changes during erection and with assistance in the quantitative documentation of therapeutic effect. 39 references.

  7. Microbial Transformations of Actinides and Other Radionuclides

    SciTech Connect

    Francis,A.J.; Dodge, C. J.

    2009-01-07

    Microorganisms can affect the stability and mobility of the actinides and other radionuclides released from nuclear fuel cycle and from nuclear fuel reprocessing plants. Under appropriate conditions, microorganisms can alter the chemical speciation, solubility and sorption properties and thus could increase or decrease the concentrations of radionuclides in solution in the environment and the bioavailability. Dissolution or immobilization of radionuclides is brought about by direct enzymatic action or indirect non-enzymatic action of microorganisms. Although the physical, chemical, and geochemical processes affecting dissolution, precipitation, and mobilization of radionuclides have been extensively investigated, we have only limited information on the effects of microbial processes and biochemical mechanisms which affect the stability and mobility of radionuclides. The mechanisms of microbial transformations of the major and minor actinides U, Pu, Cm, Am, Np, the fission products and other radionuclides such as Ra, Tc, I, Cs, Sr, under aerobic and anaerobic conditions in the presence of electron donors and acceptors are reviewed.

  8. Chemical speciation of radionuclides migrating in groundwaters

    SciTech Connect

    Robertson, D.; Schilk, A.; Abel, K.; Lepel, E.; Thomas, C.; Pratt, S.; Cooper, E.; Hartwig, P.; Killey, R.

    1994-04-01

    In order to more accurately predict the rates and mechanisms of radionuclide migration from low-level waste disposal facilities via groundwater transport, ongoing studies are being conducted at field sites at Chalk River Laboratories to identify and characterize the chemical speciation of mobile, long-lived radionuclides migrating in groundwaters. Large-volume water sampling techniques are being utilized to separate and concentrate radionuclides into particular, cationic, anionic, and nonionic chemical forms. Most radionuclides are migrating as soluble, anionic species that appear to be predominantly organoradionuclide complexes. Laboratory studies utilizing anion exchange chromatography have separated several anionically complexed radionuclides, e.g., {sup 60}Co and {sup 106}Ru, into a number of specific compounds or groups of compounds. Further identification of the anionic organoradionuclide complexes is planned utilizing high resolution mass spectrometry. Large-volume ultra-filtration experiments are characterizing the particulate forms of radionuclides being transported in these groundwaters.

  9. Targeted Radionuclide Therapy of Human Tumors

    PubMed Central

    Gudkov, Sergey V.; Shilyagina, Natalya Yu.; Vodeneev, Vladimir A.; Zvyagin, Andrei V.

    2015-01-01

    Targeted radionuclide therapy is one of the most intensively developing directions of nuclear medicine. Unlike conventional external beam therapy, the targeted radionuclide therapy causes less collateral damage to normal tissues and allows targeted drug delivery to a clinically diagnosed neoplastic malformations, as well as metastasized cells and cellular clusters, thus providing systemic therapy of cancer. The methods of targeted radionuclide therapy are based on the use of molecular carriers of radionuclides with high affinity to antigens on the surface of tumor cells. The potential of targeted radionuclide therapy has markedly grown nowadays due to the expanded knowledge base in cancer biology, bioengineering, and radiochemistry. In this review, progress in the radionuclide therapy of hematological malignancies and approaches for treatment of solid tumors is addressed. PMID:26729091

  10. DKPRO: A radionuclide decay and reprocessing code

    SciTech Connect

    Wootan, D.; Schmittroth, F.A.

    1997-07-14

    The DKPRO code solves the general problem of modeling complex nuclear wastes streams using ORIGEN2 radionuclide production files. There is a continuing need for estimates of Hanford radionuclides. Physical measurements are one basis; calculational estimates, the approach represented here, are another. Given a known nuclear fuel history, it is relatively straightforward to calculate radionuclide inventories with codes such as the widely-used Oak Ridge National Laboratory code ORIGEN2.

  11. Colloid labelled with radionuclide and method

    DOEpatents

    Atcher, R.W.; Hines, J.J.

    1990-11-13

    A ferric hydroxide colloid having an alpha-emitting radionuclide essentially on the outer surfaces and a method of forming same. The method includes oxidizing a ferrous hydroxide to ferric hydroxide in the presence of a preselected radionuclide to form a colloid having the radionuclide on the outer surface thereof, and thereafter washing the colloid, and suspending the washed colloid in a suitable solution. The labelled colloid is useful in cancer therapy and for the treatment of inflamed joints. No Drawings

  12. Method of making colloid labeled with radionuclide

    DOEpatents

    Atcher, Robert W.; Hines, John J.

    1991-01-01

    A ferric hydroxide colloid having an alpha-emitting radionuclide essentially on the outer surfaces and a method of forming same. The method includes oxidizing a ferrous hydroxide to ferric hydroxide in the presence of a preselected radionuclide to form a colloid having the radionuclide on the outer surface thereof, and thereafter washing the colloid, and suspending the washed colloid in a suitable solution. The labelled colloid is useful in cancer therapy and for the treatment of inflamed joints.

  13. Colloid labelled with radionuclide and method

    DOEpatents

    Atcher, Robert W.; Hines, John J.

    1990-01-01

    A ferric hydroxide colloid having an alpha-emitting radionuclide essentially on the outer surfaces and a method of forming same. The method includes oxidizing a ferrous hydroxide to ferric hydroxide in the presence of a preselected radionuclide to form a colloid having the radionuclide on the outer surface thereof, and thereafter washing the colloid, and suspending the washed colloid in a suitable solution. The labelled colloid is useful in cancer therapy and for the treatment of inflamed joints.

  14. Therapy for incorporated radionuclides: scope and need

    SciTech Connect

    Smith, V.H.

    1981-03-01

    In the United States the recent termination of funding for research on therapy for incorporated radionuclides has virtually halted progress on improved or new agents and procedures for removing radioactivity from the body. Research was eliminated, but is still needed on new removal agents, improved delivery system, in vitro test systems, and the toxicology of treatments. For many radionuclides, no adequate therapy exists. The relationship between radionuclide removal and reduction in cancer risk is still unanswered. Without proper research support, needed improvements in the treatment for incorporated radionuclides in the US are uncertain.

  15. Ion binding compounds, radionuclide complexes, methods of making radionuclide complexes, methods of extracting radionuclides, and methods of delivering radionuclides to target locations

    DOEpatents

    Chen, Xiaoyuan; Wai, Chien M.; Fisher, Darrell R.

    2000-01-01

    The invention pertains to compounds for binding lanthanide ions and actinide ions. The invention further pertains to compounds for binding radionuclides, and to methods of making radionuclide complexes. Also, the invention pertains to methods of extracting radionuclides. Additionally, the invention pertains to methods of delivering radionuclides to target locations. In one aspect, the invention includes a compound comprising: a) a calix[n]arene group, wherein n is an integer greater than 3, the calix[n]arene group comprising an upper rim and a lower rim; b) at least one ionizable group attached to the lower rim; and c) an ion selected from the group consisting of lanthanide and actinide elements bound to the ionizable group. In another aspect, the invention includes a method of extracting a radionuclide, comprising: a) providing a sample comprising a radionuclide; b) providing a calix[n]arene compound in contact with the sample, wherein n is an integer greater than 3; and c) extracting radionuclide from the sample into the calix[n]arene compound. In yet another aspect, the invention includes a method of delivering a radionuclide to a target location, comprising: a) providing a calix[n]arene compound, wherein n is an integer greater than 3, the calix[n]arene compound comprising at least one ionizable group; b) providing a radionuclide bound to the calix[n]arene compound; and c) providing an antibody attached to the calix[n]arene compound, the antibody being specific for a material found at the target location.

  16. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.

    PubMed

    Arena, Julieta E; Stoessl, A Jon

    2016-01-01

    Parkinson's disease (PD) and other disorders characterized by basal ganglia dysfunction are often associated with limited structural imaging changes that might assist in the clinical or research setting. Radionuclide imaging has been used to assess characteristic functional changes. Presynaptic dopaminergic dysfunction in PD can be revealed through the imaging of different steps in the process of dopamine synthesis and storage: L-aromatic amino acid decarboxylase (AADC) activity, Vesicular Monoamine Transporter type 2 (VMAT2) binding or its reuptake via the dopamine transporter (DAT). Postsynaptic dopamine dysfunction can also be studied with a variety of different tracers that primarily assess D2-like dopamine receptor availability. The function of other neurotransmitters such as norepinephrine, serotonin and acetylcholine can be imaged as well, giving important information about the underlying pathophysiologic process of PD and its complications. The imaging of metabolic activity and pathologic changes has also provided great advances in the field. Together, these techniques have allowed for a better understanding of PD, may be of aid for differentiating PD from other forms of parkinsonism and will undoubtedly be useful for the establishment of new therapeutic targets.

  17. Functional imaging for prostate cancer: therapeutic implications.

    PubMed

    Mari Aparici, Carina; Seo, Youngho

    2012-09-01

    Functional radionuclide imaging modalities, now commonly combined with anatomical imaging modalities computed tomography (CT) or magnetic resonance imaging (single photon emission computed tomography [SPECT]/CT, positron emission tomography [PET]/CT, and PET/magnetic resonance imaging), are promising tools for the management of prostate cancer, particularly for therapeutic implications. Sensitive detection capability of prostate cancer using these imaging modalities is one issue; however, the treatment of prostate cancer using the information that can be obtained from functional radionuclide imaging techniques is another challenging area. There are not many SPECT or PET radiotracers that can cover the full spectrum of the management of prostate cancer from initial detection to staging, prognosis predictor, and all the way to treatment response assessment. However, when used appropriately, the information from functional radionuclide imaging improves, and sometimes significantly changes, the whole course of the cancer management. The limitations of using SPECT and PET radiotracers with regard to therapeutic implications are not so much different from their limitations solely for the task of detecting prostate cancer; however, the specific imaging target and how this target is reliably imaged by SPECT and PET can potentially make significant impact in the treatment of prostate cancer. Finally, although the localized prostate cancer is considered manageable, there is still significant need for improvement in noninvasive imaging of metastatic prostate cancer, in treatment guidance, and in response assessment from functional imaging, including radionuclide-based techniques. In this review article, we present the rationale of using functional radionuclide imaging and the therapeutic implications for each of radionuclide imaging agent that have been studied in human subjects.

  18. Radionuclide imaging in ischemic stroke.

    PubMed

    Heiss, Wolf-Dieter

    2014-11-01

    Ischemic stroke is caused by interruption or significant impairment of blood supply to the brain, which leads to a cascade of metabolic and molecular alterations resulting in functional disturbance and morphologic damage. The changes in regional cerebral blood flow and regional metabolism can be assessed by radionuclide imaging, especially SPECT and PET. SPECT and PET have broadened our understanding of flow and metabolic thresholds critical for maintenance of brain function and morphology: PET was essential in the transfer of the concept of the penumbra to clinical stroke and thereby had a great impact on developing treatment strategies. Receptor ligands can be applied as early markers of irreversible neuronal damage and can predict the size of the final infarcts, which is important for decisions on invasive therapy in large ("malignant") infarction. With SPECT and PET, the reserve capacity of the blood supply can be tested in obstructive arteriosclerosis, which is essential for planning interventions. The effect of a stroke on surrounding and contralateral primarily unaffected tissue can be investigated, helping to understand symptoms caused by disturbance in functional networks. Activation studies are useful to demonstrate alternative pathways to compensate for lesions and to test the effect of rehabilitative therapy. Radioisotope studies help to detect neuroinflammation and its effect on extension of tissue damage. Despite the limitations of broad clinical application of radionuclide imaging, this technology has a great impact on research in cerebrovascular diseases and still has various applications in the management of stroke.

  19. Hysterosalpingo-radionuclide scintigraphy (HERS)

    SciTech Connect

    Iturralde, M.; Venter, P.F.

    1981-10-01

    A radionuclide procedure, hysterosalpingo-radionuclide scintigraphy (HERS), was designed to evaluate the migration of a particulate radioactive tracer from the vagina to the peritoneal cavity and ovaries as well as to image and functionally outline the patency of the pathways between these two extremes of the female reproductive system. Technetium-99m human albumin microspheres (99mTc-HAM) were deposited in the posterior fornices of patients who were divided into two specific groups. Group I consisted of patients who were to undergo different elective gynecologic operations, in which besides obtaining sequential images, radioactivity levels were measured in the removed organs and tissues. Group II consisted of patients referred by the Infertility Clinic for evaluation of their reproductive system pathways patency. In this latter group, HERS was compared with contrast hysterosalpingography (HSG) and peritoneoscopy (PCP). The results obtained from measurements of radioactivity levels on the removed surgical specimens and comparison with other conventional gynecologic diagnostic procedures provide accurate evidence of the migration of 99mTc-HAM from the vagina, through the uterus and tubes, to the peritoneal cavity and ovaries, and show that HERS is a simple noninvasive method for functionally imaging and assessing the patency of the female reproductive system pathways.

  20. Radionuclide transit in esophageal varices

    SciTech Connect

    Yeh, S.H.; Wang, S.J.; Wu, L.C.; Liu, R.S.; Tsai, Y.T.; Chiang, T.T.

    1985-05-01

    This study assessed esophageal motility in patients with esophageal varices by radionuclide transit studies. Data were acquired in list mode after an oral dose of 0.5 mCi Tc-99m sulfur colloid in 10 ml of water in the supine position above a low-energy all-purpose collimator of a gamma camera. The condensed image (CI) superimposed with a centroid curve was also produced in each case. Twenty-five normal subjects (N) and 32 patients (pts) with esophageal varices by endoscopy (large varices in Grades IV and V in 8 and small varices in Grade III or less in 24) were studied. TMTT, RTT, RF, and RI were all significantly increased in pts as compared to N. Especially, the transit time for the middle third (6.7 +- 2.6 sec vs 3.5 +- 0.9 sec in N, rho < 0.005) had the optimal sensitivy and specificity of 88% each at the cutoff value of 4.2 sec as determined by ROC analysis. In summary, radionuclide transit disorders occur in the majority of pts with esopageal varices. The middle RTT and CI are both optimal in sensitivity and specificity for detecting the abnormalities.

  1. Modeling Radionuclide Decay Chain Migration Using HYDROGEOCHEM

    NASA Astrophysics Data System (ADS)

    Lin, T. C.; Tsai, C. H.; Lai, K. H.; Chen, J. S.

    2014-12-01

    Nuclear technology has been employed for energy production for several decades. Although people receive many benefits from nuclear energy, there are inevitably environmental pollutions as well as human health threats posed by the radioactive materials releases from nuclear waste disposed in geological repositories or accidental releases of radionuclides from nuclear facilities. Theoretical studies have been undertaken to understand the transport of radionuclides in subsurface environments because that the radionuclide transport in groundwater is one of the main pathway in exposure scenarios for the intake of radionuclides. The radionuclide transport in groundwater can be predicted using analytical solution as well as numerical models. In this study, we simulate the transport of the radionuclide decay chain using HYDROGEOCHEM. The simulated results are verified against the analytical solution available in the literature. Excellent agreements between the numerical simulation and the analytical are observed for a wide spectrum of concentration. HYDROGECHEM is a useful tool assessing the ecological and environmental impact of the accidental radionuclide releases such as the Fukushima nuclear disaster where multiple radionuclides leaked through the reactor, subsequently contaminating the local groundwater and ocean seawater in the vicinity of the nuclear plant.

  2. Radionuclide Releases During Normal Operations for Ventilated Tanks

    SciTech Connect

    Blunt, B.

    2001-09-24

    This calculation estimates the design emissions of radionuclides from Ventilated Tanks used by various facilities. The calculation includes emissions due to processing and storage of radionuclide material.

  3. 188Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy

    PubMed Central

    Boschi, Alessandra; Martini, Petra; Uccelli, Licia

    2017-01-01

    The favorable nuclear properties of rhenium-188 for therapeutic application are described, together with new methods for the preparation of high yield and stable 188Re radiopharmaceuticals characterized by the presence of the nitride rhenium core in their final chemical structure. 188Re is readily available from an 188W/188Re generator system and a parallelism between the general synthetic procedures applied for the preparation of nitride technetium-99m and rhenium-188 theranostics radiopharmaceuticals is reported. Although some differences between the chemical characteristics of the two metallic nitrido fragments are highlighted, it is apparent that the same general procedures developed for the labelling of biologically active molecules with technetium-99m can be applied to rhenium-188 with minor modification. The availability of these chemical strategies, that allow the obtainment, in very high yield and in physiological condition, of 188Re radiopharmaceuticals, gives a new attractive prospective to employ this radionuclide for therapeutic applications. PMID:28106830

  4. Sensors and Automated Analyzers for Radionuclides

    SciTech Connect

    Grate, Jay W.; Egorov, Oleg B.

    2003-03-27

    The production of nuclear weapons materials has generated large quantities of nuclear waste and significant environmental contamination. We have developed new, rapid, automated methods for determination of radionuclides using sequential injection methodologies to automate extraction chromatographic separations, with on-line flow-through scintillation counting for real time detection. This work has progressed in two main areas: radionuclide sensors for water monitoring and automated radiochemical analyzers for monitoring nuclear waste processing operations. Radionuclide sensors have been developed that collect and concentrate radionuclides in preconcentrating minicolumns with dual functionality: chemical selectivity for radionuclide capture and scintillation for signal output. These sensors can detect pertechnetate to below regulatory levels and have been engineered into a prototype for field testing. A fully automated process monitor has been developed for total technetium in nuclear waste streams. This instrument performs sample acidification, speciation adjustment, separation and detection in fifteen minutes or less.

  5. Detecting low levels of radionuclides in fluids

    DOEpatents

    Patch, Keith D.; Morgan, Dean T.

    2000-01-01

    An apparatus and method for detecting low levels of one or more radionuclides in a fluid sample uses a substrate that includes an ion exchange resin or other sorbent material to collect the radionuclides. A collecting apparatus includes a collecting chamber that exposes the substrate to a measured amount of the fluid sample such that radionuclides in the fluid sample are collected by the ion exchange resin. A drying apparatus, which can include a drying chamber, then dries the substrate. A measuring apparatus measures emissions from radionuclides collected on the substrate. The substrate is positioned in a measuring chamber proximate to a detector, which provides a signal in response to emissions from the radionuclides. Other analysis methods can be used to detect non-radioactive analytes, which can be collected with other types of sorbent materials.

  6. Targeted Radionuclide Therapy: Practical Applications and Future Prospects

    PubMed Central

    Zukotynski, Katherine; Jadvar, Hossein; Capala, Jacek; Fahey, Frederic

    2016-01-01

    In recent years, there has been a proliferation in the development of targeted radionuclide cancer therapy. It is now possible to use baseline clinical and imaging assessments to determine the most effective therapy and to tailor this therapy during the course of treatment based on radiation dosimetry and tumor response. Although this personalized approach to medicine has the advantage of maximizing therapeutic effect while limiting toxicity, it can be challenging to implement and expensive. Further, in order to use targeted radionuclide therapy effectively, there is a need for multidisciplinary awareness, education, and collaboration across the scientific, industrial, and medical communities. Even more important, there is a growing understanding that combining radiopharmaceuticals with conventional treatment such as chemotherapy and external beam radiotherapy may limit patient morbidity while improving survival. Developments in radiopharmaceuticals as biomarkers capable of predicting therapeutic response and targeting disease are playing a central role in medical research. Adoption of a practical approach to manufacturing and delivering radiopharmaceuticals, assessing patient eligibility, optimizing post-therapy follow-up, and addressing reimbursement issues will be essential for their success. PMID:27226737

  7. Targeted radionuclide therapy for solid tumors: An overview

    SciTech Connect

    De Nardo, Sally J.

    2006-10-01

    Although radioimmunotherapy (RIT) has been effective in non-Hodgkin's lymphoma (NHL) as a single agent, solid tumors have shown less clinically significant therapeutic response to RIT alone. The clinical impact of RIT or other forms of targeted radionuclide therapy for solid tumors depends on the development of a high therapeutic index (TI) for the tumor vs. normal tissue effect, and the implementation of RIT as part of synergistic combined modality therapy (CMRIT). Preclinical and clinical studies have provided a wealth of information, and new prototypes or paradigms have shed light on future possibilities in many instances. Evidence suggests that combination and sequencing of RIT in CMRIT appropriately can provide effective treatment for many solid tumors. Vascular targets provide RIT enhancement opportunities and nanoparticles may prove to be effective carriers for RIT combined with intracellular drug delivery or alternating magnetic frequency (AMF) induced thermal tumor necrosis. The sequence and timing of combined modality treatments will be of critical importance to achieve synergy for therapy while minimizing toxicity. Fortunately, the radionuclide used for RIT also provides a signal useful for nondestructive quantitation of the influence of sequence and timing of CMRIT on events in animals and patients. This can be readily accomplished clinically using quantitative high-resolution imaging (e.g., positron emission tomography [PET])

  8. Drift-Scale Radionuclide Transport

    SciTech Connect

    P.R. Dixon

    2004-02-17

    The purpose of this Model Report is to document two models for drift-scale radionuclide transport. This has been developed in accordance with ''Technical Work Plan for: Performance Assessment Unsaturated Zone'' (Bechtel SAIC Company, LLC (BSC) 2002 [160819]), which includes planning documents for the technical work scope, content, and management of this Model Report in Section 1.15, Work Package AUZM11, ''Drift-Scale Radionuclide Transport.'' The technical work scope for this Model Report calls for development of a process-level model and an abstraction model representing diffusive release from the invert to the rocks, partitioned between fracture and matrix, as compared to the fracture-release approach used in the Site Recommendation. The invert is the structure constructed in a drift to provide the floor of that drift. The plan for validation of the models documented in this Model Report is given in Section I-5 of Attachment I in BSC (2002 [160819]). Note that the model validation presented in Section 7 deviates from the technical work plan (BSC 2002 [160819], Section I-5) in that an independent technical review specifically for model validation has not been conducted, nor publication in a peer-reviewed journal. Model validation presented in Section 7 is based on corroboration with alternative mathematical models, which is also called out by the technical work plan (BSC 2002 [160819], Section I-5), and is sufficient based on the requirements of AP-SIII.10Q for model validation. See Section 7 for additional discussion. The phenomenon of flow and transport in the vicinity of the waste emplacement drift are evaluated in this model report under ambient thermal, chemical, and mechanical conditions. This includes the effects of water diversion around an emplacement drift and the flow and transport behavior expected in a fractured rock below the drift. The reason for a separate assessment of drift-scale transport is that the effects of waste emplacement drifts on flow

  9. Transverse section radionuclide scanning system

    DOEpatents

    Kuhl, David E.; Edwards, Roy Q.

    1976-01-01

    This invention provides a transverse section radionuclide scanning system for high-sensitivity quantification of brain radioactivity in cross-section picture format in order to permit accurate assessment of regional brain function localized in three-dimensions. High sensitivity crucially depends on overcoming the heretofore known raster type scanning, which requires back and forth detector movement involving dead-time or partial enclosure of the scan field. Accordingly, this invention provides a detector array having no back and forth movement by interlaced detectors that enclose the scan field and rotate as an integral unit around one axis of rotation in a slip ring that continuously transmits the detector data by means of laser emitting diodes, with the advantages that increased amounts of data can be continuously collected, processed and displayed with increased sensitivity according to a suitable computer program.

  10. Cosmogenic radionuclides in stone meteorites

    NASA Technical Reports Server (NTRS)

    Cressy, P. J., Jr.

    1976-01-01

    This document presents the techniques and compilation of results of cosmogenic Al-26 measurements at Goddard Space Flight Center on 91 samples of 76 stone meteorites. Short-lived radionuclides, including Na-22, Sc-46, Mn-54, and Co-60, were measured in 13 of these meteorites. About one-third of these data has not previously been published. The results are discussed briefly in terms of (1) depletion of Al-26 and natural potassium due to weathering, (2) possible exposure of several chondrites to an unusually high cosmic-ray flux, (3) comparison of Al-26, Na-22, Sc-46, and Mn5-54 in chondrites with the spallation Ne-22/Ne-21 ratio as a shielding indicator, and (4) comparison of (Al-26)-(Ne-22)/Ne-21 data for achondrite classes with the chondrite trend.

  11. Radionuclides in surface and groundwater

    USGS Publications Warehouse

    Campbell, Kate M.

    2009-01-01

    Unique among all the contaminants that adversely affect surface and water quality, radioactive compounds pose a double threat from both toxicity and damaging radiation. The extreme energy potential of many of these materials makes them both useful and toxic. The unique properties of radioactive materials make them invaluable for medical, weapons, and energy applications. However, mining, production, use, and disposal of these compounds provide potential pathways for their release into the environment, posing a risk to both humans and wildlife. This chapter discusses the sources, uses, and regulation of radioactive compounds in the United States, biogeochemical processes that control mobility in the environment, examples of radionuclide contamination, and current work related to contaminated site remediation.

  12. Illicit Trafficking of Natural Radionuclides

    NASA Astrophysics Data System (ADS)

    Friedrich, Steinhäusler; Lyudmila, Zaitseva

    2008-08-01

    Natural radionuclides have been subject to trafficking worldwide, involving natural uranium ore (U 238), processed uranium (yellow cake), low enriched uranium (<20% U 235) or highly enriched uranium (>20% U 235), radium (Ra 226), polonium (Po 210), and natural thorium ore (Th 232). An important prerequisite to successful illicit trafficking activities is access to a suitable logistical infrastructure enabling an undercover shipment of radioactive materials and, in case of trafficking natural uranium or thorium ore, capable of transporting large volumes of material. Covert en route diversion of an authorised uranium transport, together with covert diversion of uranium concentrate from an operating or closed uranium mines or mills, are subject of case studies. Such cases, involving Israel, Iran, Pakistan and Libya, have been analyzed in terms of international actors involved and methods deployed. Using international incident data contained in the Database on Nuclear Smuggling, Theft and Orphan Radiation Sources (DSTO) and international experience gained from the fight against drug trafficking, a generic Trafficking Pathway Model (TPM) is developed for trafficking of natural radionuclides. The TPM covers the complete trafficking cycle, ranging from material diversion, covert material transport, material concealment, and all associated operational procedures. The model subdivides the trafficking cycle into five phases: (1) Material diversion by insider(s) or initiation by outsider(s); (2) Covert transport; (3) Material brokerage; (4) Material sale; (5) Material delivery. An Action Plan is recommended, addressing the strengthening of the national infrastructure for material protection and accounting, development of higher standards of good governance, and needs for improving the control system deployed by customs, border guards and security forces.

  13. Illicit Trafficking of Natural Radionuclides

    SciTech Connect

    Friedrich, Steinhaeusler; Lyudmila, Zaitseva

    2008-08-07

    Natural radionuclides have been subject to trafficking worldwide, involving natural uranium ore (U 238), processed uranium (yellow cake), low enriched uranium (<20% U 235) or highly enriched uranium (>20% U 235), radium (Ra 226), polonium (Po 210), and natural thorium ore (Th 232). An important prerequisite to successful illicit trafficking activities is access to a suitable logistical infrastructure enabling an undercover shipment of radioactive materials and, in case of trafficking natural uranium or thorium ore, capable of transporting large volumes of material. Covert en route diversion of an authorised uranium transport, together with covert diversion of uranium concentrate from an operating or closed uranium mines or mills, are subject of case studies. Such cases, involving Israel, Iran, Pakistan and Libya, have been analyzed in terms of international actors involved and methods deployed. Using international incident data contained in the Database on Nuclear Smuggling, Theft and Orphan Radiation Sources (DSTO) and international experience gained from the fight against drug trafficking, a generic Trafficking Pathway Model (TPM) is developed for trafficking of natural radionuclides. The TPM covers the complete trafficking cycle, ranging from material diversion, covert material transport, material concealment, and all associated operational procedures. The model subdivides the trafficking cycle into five phases: (1) Material diversion by insider(s) or initiation by outsider(s); (2) Covert transport; (3) Material brokerage; (4) Material sale; (5) Material delivery. An Action Plan is recommended, addressing the strengthening of the national infrastructure for material protection and accounting, development of higher standards of good governance, and needs for improving the control system deployed by customs, border guards and security forces.

  14. Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model

    PubMed Central

    Liu, Wenge; MacKay, J. Andrew; Dreher, Matthew R.; Chen, Mingnan; McDaniel, Jonathan R.; Simnick, Andrew J.; Callahan, Daniel J.; Zalutsky, Michael R.; Chilkoti, Ashutosh

    2010-01-01

    This study evaluated a biodegradable drug delivery system for local cancer radiotherapy consisting of a thermally sensitive elastin-like polypeptide (ELP) conjugated to a therapeutic radionuclide. Two ELPs (49 kD) were synthesized using genetic engineering to test the hypothesis that injectable biopolymeric depots can retain radionuclides locally and reduce the growth of tumors. A thermally sensitive polypeptide, ELP1, was designed to spontaneously undergo a soluble-insoluble phase transition (forming viscous microparticles) between room temperature and body temperature upon intratumoral injection, while ELP2 was designed to remain soluble upon injection and to serve as a negative control for the effect of aggregate assembly. After intratumoral administration of radionuclide conjugates of ELPs into implanted tumor xenografts in nude mice, their retention within the tumor, spatio-temporal distribution, and therapeutic effect were quantified. The residence time of the radionuclide-ELP1 in the tumor was significantly longer than the thermally insensitive ELP2 conjugate. In addition, the thermal transition of ELP1 significantly protected the conjugated radionuclide from dehalogenation, whereas the conjugated radionuclide on ELP2 was quickly eliminated from the tumor and cleaved from the biopolymer. These attributes of the thermally sensitive ELP1 depot improved the antitumor efficacy of iodine-131 compared to the soluble ELP2 control. This novel injectable and biodegradable depot has the potential to control advanced-stage cancers by reducing the bulk of inoperable tumors, enabling surgical removal of de-bulked tumors, and preserving healthy tissues. PMID:20117157

  15. Radionuclides: Accumulation and Transport in Plants.

    PubMed

    Gupta, D K; Chatterjee, S; Datta, S; Voronina, A V; Walther, C

    Application of radioactive elements or radionuclides for anthropogenic use is a widespread phenomenon nowadays. Radionuclides undergo radioactive decays releasing ionizing radiation like gamma ray(s) and/or alpha or beta particles that can displace electrons in the living matter (like in DNA) and disturb its function. Radionuclides are highly hazardous pollutants of considerable impact on the environment, food chain and human health. Cleaning up of the contaminated environment through plants is a promising technology where the rhizosphere may play an important role. Plants belonging to the families of Brassicaceae, Papilionaceae, Caryophyllaceae, Poaceae, and Asteraceae are most important in this respect and offer the largest potential for heavy metal phytoremediation. Plants like Lactuca sativa L., Silybum marianum Gaertn., Centaurea cyanus L., Carthamus tinctorius L., Helianthus annuus and H. tuberosus are also important plants for heavy metal phytoremediation. However, transfer factors (TF) of radionuclide from soil/water to plant ([Radionuclide]plant/[Radionuclide]soil) vary widely in different plants. Rhizosphere, rhizobacteria and varied metal transporters like NRAMP, ZIP families CDF, ATPases (HMAs) family like P1B-ATPases, are involved in the radio-phytoremediation processes. This review will discuss recent advancements and potential application of plants for radionuclide removal from the environment.

  16. Discrete beta dose kernel matrices for nuclides applied in targeted radionuclide therapy (TRT) calculated with MCNP5

    SciTech Connect

    Reiner, Dora; Blaickner, Matthias; Rattay, Frank

    2009-11-15

    Purpose: Radiopharmaceuticals administered in targeted radionuclide therapy (TRT) rely to a great extent not only on beta-emitting nuclides but also on emitters of monoenergetic electrons. Recent advances like combined PET/CT devices, the consequential coregistration of both data, the concept of using beta couples for diagnosis and therapy, respectively, as well as the development of voxel models offer a great potential for developing TRT dose calculation systems similar to those available for external beam treatment planning. The deterministic algorithms in question for this task are based on the convolution of three-dimensional matrices, one representing the activity distribution and the other the dose point kernel. This study aims to report on three-dimensional kernel matrices for various nuclides used in TRT. Methods: The Monte Carlo code MCNP5 was used to calculate discrete dose kernels of beta particles including the contributions from their respective secondary radiation in soft tissue for the following nuclides: {sup 32}P, {sup 33}P, {sup 67}Cu, {sup 89}Sr, {sup 90}Y, {sup 103}Rh{sup m}, {sup 131}I, {sup 177}Lu, {sup 186}Re, and {sup 188}Re. For each nuclide a kernel cube of 10x10x10 mm{sup 3} was calculated, the dimensions of a voxel being 1 mm{sup 3}. Additional kernels with voxel sizes of 3x3x3 mm{sup 3} were simulated. Results: Comparison with the S-value data regarding {sup 32}P, {sup 89}Sr, {sup 90}Y, and {sup 131}I of the MIRD committee which were calculated with the EGS4 code showed a very good agreement, the secondary particle transport of {sup 90}Y being the only exception. Documented analytical kernels on the other side show deviations very close and very far to the source. Conclusions: The good accordance with the only discrete dose kernels published up to date justifies the method chosen. Together with the additional six nuclides, this report provides a considerable database for three-dimensional kernel matrices with regard to beta

  17. 2008 LANL radionuclide air emissions report

    SciTech Connect

    Fuehne, David P.

    2009-06-01

    The emissions of radionuclides from Department of Energy Facilities such as Los Alamos National Laboratory (LANL) are regulated by the Amendments to the Clean Air Act of 1990, National Emissions Standards for Hazardous Air Pollutants (40 CFR 61 Subpart H). These regulations established an annual dose limit of 10 mrem to the maximally exposed member of the public attributable to emissions of radionuclides. This document describes the emissions of radionuclides from LANL and the dose calculations resulting from these emissions for calendar year 2008. This report meets the reporting requirements established in the regulations.

  18. 2009 LANL radionuclide air emissions report

    SciTech Connect

    Fuehne, David P.

    2010-06-01

    The emissions of radionuclides from Department of Energy Facilities such as Los Alamos National Laboratory (LANL) are regulated by the Amendments to the Clean Air Act of 1990, National Emissions Standards for Hazardous Air Pollutants (40 CFR 61 Subpart H). These regulations established an annual dose limit of 10 mrem to the maximally exposed member of the public attributable to emissions of radionuclides. This document describes the emissions of radionuclides from LANL and the dose calculations resulting from these emissions for calendar year 2009. This report meets the reporting requirements established in the regulations.

  19. 2010 LANL radionuclide air emissions report /

    SciTech Connect

    Fuehne, David P.

    2011-06-01

    The emissions of radionuclides from Department of Energy Facilities such as Los Alamos National Laboratory (LANL) are regulated by the Amendments to the Clean Air Act of 1990, National Emissions Standards for Hazardous Air Pollutants (40 CFR 61 Subpart H). These regulations established an annual dose limit of 10 mrem to the maximally exposed member of the public attributable to emissions of radionuclides. This document describes the emissions of radionuclides from LANL and the dose calculations resulting from these emissions for calendar year 2010. This report meets the reporting requirements established in the regulations.

  20. [Application of radioisotopes for theranostics, a combination of diagnostics and therapy].

    PubMed

    Saji, Hideo

    2015-01-01

    Radioisotopes emit radiation with various characteristics. These characteristics have been used for various applications of radioisotopes in clinical fields. For example, diagnostic nuclear medicine is a technique that uses gamma-emitted radionuclides with high permeability into the body and can visualize changes in physiological and biochemical processes throughout the distributed and interrelated systems of living tissues and organs. Therapeutic nuclear medicine is a technique that uses beta-emitted radionuclides with high radiation damage to the cell and can be used for internal radiation therapy. Therefore, a strategy in which the same ligand is labeled with beta-emitted or gamma-emitted radioisotopes, i.e., a theranostics approach, is useful because an extensive availability of diagnostics and therapeutics is possible. In this presentation, some examples of a theranostics approach for radiolabeled compounds will be reported, including the results of our recent research.

  1. Cyclotron production of cesium radionuclides as analogues for francium-221 biodistribution

    NASA Astrophysics Data System (ADS)

    Finn, R.; McDevitt, M.; Sheh, Y.; Lom, C.; Qiao, J.; Cai, S.; Burnazi, E.; Nacca, A.; Pillarsetty, N.; Jaggi, J.; Scheinberg, D.

    2005-12-01

    In our clinical investigations focussing on improved therapeutic treatment of specific tumors we have concentrated on a targeted therapy approach utilizing designed radiolabeled monoclonal antibodies as the cytotoxic reagent. The physical characteristics of the alpha particle emitting radionuclide bismuth-213 including the short half-life of 45.6 min, has shown promise for the treatment of specific cancers such as leukemias and lymphomas or micrometastatic carcinomas. In an effort to increase the cytocidal effect of the HuM195, a humanized monoclonal antibody carrier to the CD33 antigen expressed on leukemia cells, our focus is directed toward an "internal" nano-generator composed of Ac-225 radionuclide, the parent of the bismuth-213. The actinium-225 radionuclide decays through several short-lived, alpha emitting daughters including francium-221, astatine-217 and bismuth-213. In order to study the biodistribution and the pharmacokinetics of the individual daughter nuclide, francium-221, the cyclotron production and separation of cesium radionuclides, specifically cesium-132, from a natural xenon gas target was undertaken. The choice of cesium as an analogue for francium was predicated upon both elements being in Group 1A alkali metals and cesium radionuclide possesses a sufficient half-life to allow biodistribution studies to be performed. The preliminary experimental results of this investigation are presented.

  2. System and method for assaying a radionuclide

    DOEpatents

    Cadieux, James R; King, III, George S; Fugate, Glenn A

    2014-12-23

    A system for assaying a radionuclide includes a liquid scintillation detector, an analyzer connected to the liquid scintillation detector, and a delay circuit connected to the analyzer. A gamma detector and a multi-channel analyzer are connected to the delay circuit and the gamma detector. The multi-channel analyzer produces a signal reflective of the radionuclide in the sample. A method for assaying a radionuclide includes selecting a sample, detecting alpha or beta emissions from the sample with a liquid scintillation detector, producing a first signal reflective of the alpha or beta emissions, and delaying the first signal a predetermined time. The method further includes detecting gamma emissions from the sample, producing a second signal reflective of the gamma emissions, and combining the delayed first signal with the second signal to produce a third signal reflective of the radionuclide.

  3. Dosimetry and Case Studies for Selected Radionuclides

    SciTech Connect

    Leggett, Richard Wayne

    2009-01-01

    This is a comprehensive review and analysis of biokinetic and dosimetric information for those radionuclides most likely to be involved in accidental exposures to workers or members of the public or used in radiological terrorism.

  4. Livermore Accelerator Source for Radionuclide Science (LASRS)

    SciTech Connect

    Anderson, Scott; Bleuel, Darren; Johnson, Micah; Rusnak, Brian; Soltz, Ron; Tonchev, Anton

    2016-05-05

    The Livermore Accelerator Source for Radionuclide Science (LASRS) will generate intense photon and neutron beams to address important gaps in the study of radionuclide science that directly impact Stockpile Stewardship, Nuclear Forensics, and Nuclear Material Detection. The co-location of MeV-scale neutral and photon sources with radiochemical analytics provides a unique facility to meet current and future challenges in nuclear security and nuclear science.

  5. Alchemy with short-lived radionuclides

    SciTech Connect

    Rubio, F.F.; Finn, R.D.; Gilson, A.J.

    1981-04-01

    A variety of short-lived radionuclides are produced and subsequently incorporated into radiopharmaceutical compounds in the radionuclide production program currently being conducted at the Cyclotron Facility of Mount Sinai Medical Center. The recovery of high specific activity oxygen-15 labelled water prepared by means of an inexpensive system operating in conjunction with an on-line radiogas target routinely utilized for oxygen-15 labelled carbon dioxide studies is currently receiving particular attention.

  6. Radionuclide Air Emissions Report for 2012

    SciTech Connect

    Wahl, Linnea

    2013-05-01

    Berkeley Lab operates facilities where radionuclides are produced, handled, store d, and potentially emitted . These facilities are subject to the EPA radioactive air emission regulations in 40 CFR 61, Subpart H (EPA 1989a). Radionuclides may be emitted from stacks or vents on buildings where radionuclide production or use is authorized or they may be emitted as diffuse sources. In 2012, all Berkeley Lab sources were minor sources of radionuclides (sources resulting in a potential dose of less than 0.1 mrem/yr [0.001 mSv/yr]) . These minor sources include d about 140 stack sources and no diffuse sources . T here were no unplanned airborne radionuclide emissions from Berkeley Lab operations . Emissions from minor sources were measured by sampling or monitoring or were calculated based on quantities used, received for use, or produced during the year. Using measured and calculated emissions, and building- specific and common parameters, Laboratory personnel applied the EPA -approved computer code s, CAP88-PC and COMPLY , to calculate doses to the maximally exposed individual (MEI) at any offsite point where there is a residence, school, business, or office. Because radionuclides are used at three noncontiguous locations (the main site, Berkeley West Bio center, and Joint BioEnergy Institute), three different MEIs were identified.

  7. Radionuclide scintigraphy of bacterial nephritis

    SciTech Connect

    Conway, J.J.; Weiss, S.C.; Shkolnik, A.; Yogev, R.; Firlit, C.; Traisman, E.S.

    1984-01-01

    Pyelonephritis is a leading cause of renal failure and is expected to cost as much as three billion dollars in 1984. The diagnosis of urinary tract infection is usually not difficult. However, localization of the infection within the renal parenchyma as opposed to the collecting system is much more difficult. Flank pain, fever, bacteiuria and evidence of parenchymal involvement by intravenous urography may be absent or unrecognized particularly in the infant. Ultrasound and Nuclear Medicine are advocated as better methods to define parenchymal involvement. Such definition is important in the consideration of treatment since parenchymal involvement of the kidney carries a much more ominous potential outcome than infection restricted to within the collecting system. 38 children with a clinical diagnosis of urinary tract infection were studied. 26 of the patients demonstrated abnormal renal parenchymal findings with Gallium-67 Citrate or Tc-99m Glucoheptonate scintigraphy. Intravenous urography was notably ineffective with only 5 of the 20 interpreted as abnormal due to parenchymal disease or decreased function. 11 were entirely normal while only 5 demonstrated scars or hydronephrosis. Only 10 of 17 patients demonstrated intranvesicoureteral reflux on x-ray or nuclear cystography. Ultrasound depicted 6 of 20 patients as having parenchymal abnormalities. Seven were normal. Nonspecific findings such as dilitation of the renal pelvis or renal enlargement was noted in 11 of the 20 patients. Radionuclide Scintigraphy is the most efficacious modality to detect since acute bacterial nephritis.

  8. Radionuclides in an underground environment

    SciTech Connect

    Thompson, J.L.

    1996-08-01

    In the 100 years since Becquerel recognized radioactivity, mankind has been very successful in producing large amounts of radioactive materials. We have been less successful in reaching a consensus on how to dispose of the billions of curies of fission products and transuranics resulting from nuclear weapons testing, electrical power generation, medical research, and a variety of other human endeavors. Many countries, including the United States, favor underground burial as a means of disposing of radioactive wastes. There are, however, serious questions about how such buried wastes may behave in the underground environment and particularly how they might eventually contaminate water, air and soil resources on which we are dependent. This paper describes research done in the United States in the state of Nevada on the behavior of radioactive materials placed underground. During the last thirty years, a series of ``experiments`` conducted for other purposes (testing of nuclear weapons) have resulted in a wide variety of fission products and actinides being injected in rock strata both above and below the water table. Variables which seem to control the movement of these radionuclides include the physical form (occlusion versus surface deposition), the chemical oxidation state, sorption by mineral phases of the host rock, and the hydrologic properties of the medium. The information gained from these studies should be relevant to planning for remediation of nuclear facilities elsewhere in the world and for long-term storage of nuclear wastes.

  9. Solubility limits on radionuclide dissolution

    SciTech Connect

    Kerrisk, J.F.

    1984-12-31

    This paper examines the effects of solubility in limiting dissolution rates of a number of important radionuclides from spent fuel and high-level waste. Two simple dissolution models were used for calculations that would be characteristics of a Yucca Mountain repository. A saturation-limited dissolution model, in which the water flowing through the repository is assumed to be saturated with each waste element, is very conservative in that it overestimates dissolution rates. A diffusion-limited dissolution model, in which element-dissolution rates are limited by diffusion of waste elements into water flowing past the waste, is more realistic, but it is subject to some uncertainty at this time. Dissolution rates of some elements (Pu, Am, Sn, Th, Zr, Sm) are always limited by solubility. Dissolution rates of other elements (Cs, Tc, Np, Sr, C, I) are never solubility limited; their release would be limited by dissolution of the bulk waste form. Still other elements (U, Cm, Ni, Ra) show solubility-limited dissolution under some conditions. 9 references, 3 tables.

  10. Therapeutic implications of iodine-125 cytotoxicity

    SciTech Connect

    Bloomer, W.D.; McLaughlin, W.H.; Adelstein, S.J.

    1982-11-01

    The biological consequences of differential subcellular radionuclide accumulation within nuclear stuctures have important implications for the design and development of new therapeutic agents for cancer management. A growing body of experimental data demonstrates that localization of /sup 125/I within the genome results in marked cytotoxicity. Investigations of iodine-125 labeled iododeoxyuridine, DNA intercalators and tamoxifen are reviewed as representative of this new group of potential radiotherapeutic agents.

  11. Therapeutic implications of iodine-125 cytotoxicity

    SciTech Connect

    Bloomer, W.D.; McLaughlin, W.H.; Adelstein, S.J.

    1982-11-01

    The biological consequences of differential subcellular radionuclide accumulation within nuclear structures have important implications for the design and development of new therapeutic agents for cancer management. A growing body of experimental data demonstrates that localization of /sup 125/I within the genome results in marked cytotoxicity. Investigations of iodine-125 labeled iododeoxyuridine, DNA intercalators and tamoxifen are reviewed as representative of this new group of potential radiotherapeutic agents.

  12. Radionuclide Imaging of Neurohormonal System of the Heart

    PubMed Central

    Chen, Xinyu; Werner, Rudolf A.; Javadi, Mehrbod S.; Maya, Yoshifumi; Decker, Michael; Lapa, Constantin; Herrmann, Ken; Higuchi, Takahiro

    2015-01-01

    Heart failure is one of the growing causes of death especially in developed countries due to longer life expectancy. Although many pharmacological and instrumental therapeutic approaches have been introduced for prevention and treatment of heart failure, there are still limitations and challenges. Nuclear cardiology has experienced rapid growth in the last few decades, in particular the application of single photon emission computed tomography (SPECT) and positron emission tomography (PET), which allow non-invasive functional assessment of cardiac condition including neurohormonal systems involved in heart failure; its application has dramatically improved the capacity for fundamental research and clinical diagnosis. In this article, we review the current status of applying radionuclide technology in non-invasive imaging of neurohormonal system in the heart, especially focusing on the tracers that are currently available. A short discussion about disadvantages and perspectives is also included. PMID:25825596

  13. Radionuclide imaging of neurohormonal system of the heart.

    PubMed

    Chen, Xinyu; Werner, Rudolf A; Javadi, Mehrbod S; Maya, Yoshifumi; Decker, Michael; Lapa, Constantin; Herrmann, Ken; Higuchi, Takahiro

    2015-01-01

    Heart failure is one of the growing causes of death especially in developed countries due to longer life expectancy. Although many pharmacological and instrumental therapeutic approaches have been introduced for prevention and treatment of heart failure, there are still limitations and challenges. Nuclear cardiology has experienced rapid growth in the last few decades, in particular the application of single photon emission computed tomography (SPECT) and positron emission tomography (PET), which allow non-invasive functional assessment of cardiac condition including neurohormonal systems involved in heart failure; its application has dramatically improved the capacity for fundamental research and clinical diagnosis. In this article, we review the current status of applying radionuclide technology in non-invasive imaging of neurohormonal system in the heart, especially focusing on the tracers that are currently available. A short discussion about disadvantages and perspectives is also included.

  14. In Vivo Radionuclide Generators for Diagnostics and Therapy

    PubMed Central

    Edem, Patricia E.; Fonslet, Jesper; Kjær, Andreas; Herth, Matthias

    2016-01-01

    In vivo radionuclide generators make complex combinations of physical and chemical properties available for medical diagnostics and therapy. Perhaps the best-known in vivo generator is 212Pb/212Bi, which takes advantage of the extended half-life of 212Pb to execute a targeted delivery of the therapeutic short-lived α-emitter 212Bi. Often, as in the case of 81Rb/81Kr, chemical changes resulting from the transmutation of the parent are relied upon for diagnostic value. In other instances such as with extended alpha decay chains, chemical changes may lead to unwanted consequences. This article reviews some common and not-so-common in vivo generators with the purpose of understanding their value in medicine and medical research. This is currently relevant in light of a recent push for alpha emitters in targeted therapies, which often come with extended decay chains. PMID:28058040

  15. Therapeutic Recreation

    ERIC Educational Resources Information Center

    Parks and Recreation, 1971

    1971-01-01

    Graphic profiles of (1) the professional membership of the National Therapeutic Recreation Society, (2) state-level employment opportunities in the field, and (3) educational opportunities at U.S. colleges and universities. (MB)

  16. Enhancing the effect of radionuclide tumor targeting, using lysosomotropic weak bases

    SciTech Connect

    Sundberg, Asa Liljegren . E-mail: Asa.Liljegren@bms.uu.se; Steffen, Ann-Charlott

    2007-01-01

    Purpose: The aim of the present study was to investigate if treatment with lysosomotropic weak bases could increase the intracellular retention of radiohalogens and thereby increase the therapeutic effect of radionuclide tumor targeting. Methods and Materials: Four different lysosomotropic bases, chloroquine, ammonium chloride, amantadine, and thioridazine, were investigated for their ability to increase radiohalogen retention in vitro. The two most promising substances, chloroquine and ammonium chloride, were studied in several cell lines (A431, U343MGaCl2:6, SKOV-3, and SKBR-3) in combination with radiolabeled epidermal growth factor (EGF) or the HER2 binding affibody (Z{sub HER2:4}){sub 2}. Results: The uptake and retention of radionuclides was found to be substantially increased by simultaneous treatment with the lysosomotropic bases. The effect was, however, more pronounced in the epidermal growth factor:epidermal growth factor receptor (EGF:EGFR) system than in the (Z{sub HER2:4}){sub 2}:HER2 system. The therapeutic effect of ammonium chloride treatment combined with {sup 211}At-EGF was also studied. The effect obtained after combined treatment was found to be much better than after {sup 211}At-EGF treatment alone. Conclusions: The encouraging results from the present study indicate that the use of lysosomotropic weak bases is a promising approach for increasing the therapeutic effect of radionuclide targeting with radiohalogens.

  17. Production cross sections of short-lived silver radionuclides from natPd(p,xn) nuclear processes

    NASA Astrophysics Data System (ADS)

    Khandaker, Mayeen Uddin; Kim, Kwangsoo; Kim, Guinyun

    2012-03-01

    Production cross-sections of short-lived 103Ag, 104mAg and 104gAg radionuclides from proton-induced reactions on natural palladium (Pd) were measured up to 41 MeV by using a stacked-foil activation technique combined with high resolution γ-ray spectrometry. The present results are compared with the available literature values as well as theoretical data calculated by the TALYS and the ALICE-IPPE computer codes. Note that production cross-sections of the 104mAg radionuclide from natPd(p,xn) processes has been measured here for the first time. Physical thick target yields for the investigated radionuclides were deduced from the respective threshold energy to 41 MeV taking into account that the total energy is absorbed in the targets. Measured data of the short-lived 103Ag radionuclide are noteworthy due to its possible applications as a precursor for the indirect production of widely used therapeutic 103Pd radionuclide via natPd(p,xn)103Ag → 103Pd processes. On the other hand, the investigated 104Ag radionuclide finds importance due to its potential use as a diagnostic and positron emission tomography (PET) imaging analogue. Above all, measured data will enrich the literature database leading to various applications in science and technology.

  18. Radionuclide Retention in Concrete Waste Forms

    SciTech Connect

    Mattigod, Shas V.; Bovaird, Chase C.; Wellman, Dawn M.; Wood, Marcus I.

    2010-09-30

    Assessing long-term performance of Category 3 waste cement grouts for radionuclide encasement requires knowledge of the radionuclide-cement interactions and mechanisms of retention (i.e., sorption or precipitation); the mechanism of contaminant release; the significance of contaminant release pathways; how waste form performance is affected by the full range of environmental conditions within the disposal facility; the process of waste form aging under conditions that are representative of processes occurring in response to changing environmental conditions within the disposal facility; the effect of waste form aging on chemical, physical, and radiological properties; and the associated impact on contaminant release. This knowledge will enable accurate prediction of radionuclide fate when the waste forms come in contact with groundwater. The information presented in the report provides data that 1) quantify radionuclide retention within concrete waste form materials similar to those used to encapsulate waste in the Low-Level Waste Burial Grounds (LLBG); 2) measure the effect of concrete waste form properties likely to influence radionuclide migration; and 3) quantify the stability of uranium-bearing solid phases of limited solubility in concrete.

  19. Radionuclide Retention in Concrete Wasteforms - FY13

    SciTech Connect

    Snyder, Michelle MV; Golovich, Elizabeth C.; Wellman, Dawn M.; Crum, Jarrod V.; Lapierre, Robert; Dage, Denomy C.; Parker, Kent E.; Cordova, Elsa A.

    2013-10-15

    Assessing long-term performance of Category 3 waste cement grouts for radionuclide encasement requires knowledge of the radionuclide-cement interactions and mechanisms of retention (i.e., sorption or precipitation); the mechanism of contaminant release; the significance of contaminant release pathways; how wasteform performance is affected by the full range of environmental conditions within the disposal facility; the process of wasteform aging under conditions that are representative of processes occurring in response to changing environmental conditions within the disposal facility; the effect of wasteform aging on chemical, physical, and radiological properties; and the associated impact on contaminant release. This knowledge will enable accurate prediction of radionuclide fate when the wasteforms come in contact with groundwater. Data collected throughout the course of this work will be used to quantify the efficacy of concrete wasteforms, similar to those used in the disposal of low-level waste and mixed low-level waste, for the immobilization of key radionuclides (i.e., uranium, technetium, and iodine). Data collected will also be used to quantify the physical and chemical properties of the concrete affecting radionuclide retention.

  20. Radionuclide Mobility at the Nevada Test Site

    SciTech Connect

    Hu, Q; Smith, D; Rose, T; Glascoe, L; Steefel, C; Zavarin, M

    2003-11-13

    Underground nuclear tests conducted at the Nevada Test Site (NTS) are characterized by abundant fission product and actinide source terms. Included are {sup 99}Tc and other soluble radionuclides ({sup 3}H, {sup 14}C, {sup 36}Cl, {sup 85}Kr, and {sup 129}I), which are presumably mobile in groundwater and potentially toxic to down-gradient receptors. NTS provides the Office of Civilian Radioactive Waste Management (OCRWM) with an analog of the release of these radionuclides from a nuclear waste repository in the absence of engineered barriers. The investigation described in this report synthesizes a substantial body of data collected on the identity and distribution of soluble radionuclides at field scales over distances of hundreds of meters, for durations up to 40 years, and under hydrogeologic conditions very similar to the proposed geological repository at Yucca Mountain. This body of data is complemented by laboratory transport studies and a synthesis of recent modeling investigations from the NTS, with an emphasis on the ongoing Yucca Mountain Program (YMP) efforts. Overall, understanding the controls of radionuclide mobility associated with these nuclear tests will provide insight into the repository's future performance as well as bounds and calibrations for the numerical predictions of long-term radionuclide releases and migration.

  1. Idaho radionuclide exposure study: Literature review

    SciTech Connect

    Baker, E.G.; Freeman, H.D.; Hartley, J.N.

    1987-10-01

    Phosphate ores contain elevated levels of natural radioactivity, some of which is released to the environment during processing or use of solid byproducts. The effect of radionuclides from Idaho phosphate processing operations on the local communities has been the subject of much research and study. The literature is reviewed in this report. Two primary radionuclide pathways to the environment have been studied in detail: (1) airborne release of volatile radionuclides, primarily /sup 210/Po, from calciner stacks at the two elemental phosphorus plants; and (2) use of byproduct slag as an aggregate for construction in Soda Springs and Pocatello. Despite the research, there is still no clear understanding of the population dose from radionuclide emissions, effluents, and solid wastes from phosphate processing plants. Two other potential radionuclide pathways to the environment have been identified: radon exhalation from phosphogypsum and ore piles and contamination of surface and ground waters. Recommendations on further study needed to develop a data base for a complete risk assssment are given in the report.

  2. Fast analysis of radionuclide decay chain migration

    NASA Astrophysics Data System (ADS)

    Chen, J. S.; Liang, C. P.; Liu, C. W.; Li, L.

    2014-12-01

    A novel tool for rapidly predicting the long-term plume behavior of an arbitrary length radionuclide decay chain is presented in this study. This fast tool is achieved based on generalized analytical solutions in compact format derived for a set of two-dimensional advection-dispersion equations coupled with sequential first-order decay reactions in groundwater system. The performance of the developed tool is evaluated by a numerical model using a Laplace transform finite difference scheme. The results of performance evaluation indicate that the developed model is robust and accurate. The developed model is then used to fast understand the transport behavior of a four-member radionuclide decay chain. Results show that the plume extents and concentration levels of any target radionuclide are very sensitive to longitudinal, transverse dispersion, decay rate constant and retardation factor. The developed model are useful tools for rapidly assessing the ecological and environmental impact of the accidental radionuclide releases such as the Fukushima nuclear disaster where multiple radionuclides leaked through the reactor, subsequently contaminating the local groundwater and ocean seawater in the vicinity of the nuclear plant.

  3. 2014 LANL Radionuclide Air Emissions Report

    SciTech Connect

    Fuehne, David Patrick

    2015-07-21

    This report describes the emissions of airborne radionuclides from operations at Los Alamos National Laboratory (LANL) for calendar year 2014, and the resulting off-site dose from these emissions. This document fulfills the requirements established by the National Emissions Standards for Hazardous Air Pollutants in 40 CFR 61, Subpart H – Emissions of Radionuclides other than Radon from Department of Energy Facilities, commonly referred to as the Radionuclide NESHAP or Rad-NESHAP. Compliance with this regulation and preparation of this document is the responsibility of LANL’s RadNESHAP compliance program, which is part of the Environmental Protection Division. The information in this report is required under the Clean Air Act and is being submitted to the U.S. Environmental Protection Agency (EPA) Region 6.

  4. Radionuclide migration as a function of mineralogy

    SciTech Connect

    Triay, I.R.; Mitchell, A.J.; Ott, M.A.

    1991-02-01

    The migration of radionuclides is studied as a function of mineralogy utilizing batch sorption and column experiments. The transport behavior of alkaline, alkaline-earth, and transition metals, and actinide species is studied in pure mineral separates. The solid phases utilized for these investigations are silicates, alumino-silicates, carbonates, and metal oxides and oxyhydroxides. The results of this effort are utilized to aid in the elucidation of the dominant chemical mechanisms of radionuclide migration, the prediction of radionuclide transport in conditions similar to those expected at the proposed high-level nuclear waste repository at Yucca Mountain, Nevada, and the identification of materials that act as natural geological barriers or that can be utilized as strong sorbers in engineered barriers. 9 refs., 2 figs., 2 tabs.

  5. Diffusion of Radionuclides in Concrete and Soil

    SciTech Connect

    Mattigod, Shas V.; Wellman, Dawn M.; Bovaird, Chase C.; Parker, Kent E.; Recknagle, Kurtis P.; Clayton, Libby N.; Wood, Marcus I.

    2012-04-25

    One of the methods being considered for safely disposing of Category 3 low-level radioactive wastes is to encase the waste in concrete. Such concrete encasement would contain and isolate the waste packages from the hydrologic environment and would act as an intrusion barrier. Any failure of concrete encasement may result in water intrusion and consequent mobilization of radionuclides from the waste packages. The mobilized radionuclides may escape from the encased concrete by mass flow and/or diffusion and move into the surrounding subsurface environment. Therefore, it is necessary to assess the performance of the concrete encasement structure and the ability of the surrounding soil to retard radionuclide migration. The objective of our study was to measure the diffusivity of Re, Tc and I in concrete containment and the surrounding vadose zone soil. Effects of carbonation, presence of metallic iron, and fracturing of concrete and the varying moisture contents in soil on the diffusivities of Tc and I were evaluated.

  6. Radioimmunotherapy with alpha-particle emitting radionuclides.

    PubMed

    Zalutsky, M R; Pozzi, O R

    2004-12-01

    An important consideration in the development of effective strategies for radioimmunotherapy is the nature of the radiation emitted by the radionuclide. Radionuclides decaying by the emission of alpha-particles offer the possibility of matching the cell specific reactivity of monoclonal antibodies with radiation with a range of only a few cell diameters. Furthermore, alpha-particles have important biological advantages compared with external beam radiation and beta-particles including a higher biological effectiveness, which is nearly independent of oxygen concentration, dose rate and cell cycle position. In this review, the clinical settings most likely to benefit from alpha-particle radioimmunotherapy will be discussed. The current status of preclinical and clinical research with antibodies labeled with 3 promising alpha-particle emitting radionuclides - (213)Bi, (225)Ac, and (211)At - also will be summarized.

  7. Data Authentication Demonstration for Radionuclide Stations

    SciTech Connect

    Harris, Mark; Herrington, Pres; Miley, Harry; Ellis, J. Edward; McKinnon, David; St. Pierre, Devon

    1999-08-03

    Data authentication is required for certification of sensor stations in the International Monitoring System (IMS). Authentication capability has been previously demonstrated for continuous waveform stations (seismic and infrasound). This paper addresses data surety for the radionuclide stations in the IMS, in particular the Radionuclide Aerosol Sampler/Analyzer (RASA) system developed by Pacific Northwest National Laboratory (PNNL). Radionuclide stations communicate data by electronic mail using formats defined in IMS 1.0, Formats and Protocols for Messages. An open message authentication standard exists, called S/MIME (Secure/Multipurpose Internet Mail Extensions), which has been proposed for use with all IMS radionuclide station message communications. This standard specifies adding a digital signature and public key certificate as a MIME attachment to the e-mail message. It is advantageous because it allows authentication to be added to all IMS 1.0 messages in a standard format and is commercially supported in e-mail software. For command and control, the RASA system uses a networked Graphical User Interface (GUI) based upon Common Object Request Broker Architecture (CORBA) communications, which requires special authentication procedures. The authors have modified the RASA system to meet CTBTO authentication guidelines, using a FORTEZZA card for authentication functions. They demonstrated signing radionuclide data messages at the RASA, then sending, receiving, and verifying the messages at a data center. They demonstrated authenticating command messages and responses from the data center GUI to the RASA. Also, the particular authentication system command to change the private/public key pair and retrieve the new public key was demonstrated. This work shows that data surety meeting IMS guidelines may be immediately applied to IMS radionuclide systems.

  8. Laboratory studies of radionuclide migration in tuff

    SciTech Connect

    Rundberg, R.S.; Mitchell, A.J.; Ott, M.A.; Thompson, J.L.; Triay, I.R.

    1989-10-01

    The movement of selected radionuclides has been observed in crushed tuff, intact tuff, and fractured tuff columns. Retardation factors and dispersivities were determined from the elution profiles. Retardation factors have been compared with those predicted on the basis of batch sorption studies. This comparison forms a basis for either validating distribution coefficients or providing evidence of speciation, including colloid formation. Dispersivities measured as a function of velocity provide a means of determining the effect of sorption kinetics or mass transfer on radionuclide migration. Dispersion is also being studied in the context of scaling symmetry to develop a basis for extrapolating from the laboratory scale to the field. 21 refs., 6 figs., 2 tabs.

  9. Radionuclide imaging of the urinary tract

    SciTech Connect

    Velchik, M.G.

    1985-11-01

    This article describes the role of nuclear medicine in the evaluation of the genitourinary tract. The technical aspects of radionuclide imaging (radiopharmaceuticals, radiation dosimetry, instrumentation, and method) are briefly presented, and each of the indications for renal scintigraphy--including the evaluation of differential renal function, hypertension, obstruction, renal transplants, masses, trauma, congenital anomalies, vesicoureteral reflux, and infection--are discussed. The relative advantages and disadvantages of radionuclide imaging with respect to alternative radiographic examinations (such as intravenous urography, ultrasonography, CT, angiography, and magnetic resonance imaging) are emphasized wherever applicable. 136 references.

  10. Radionuclide imaging of the urinary tract.

    PubMed

    Velchik, M G

    1985-11-01

    This article describes the role of nuclear medicine in the evaluation of the genitourinary tract. The technical aspects of radionuclide imaging (radiopharmaceuticals, radiation dosimetry, instrumentation, and method) are briefly presented, and each of the indications for renal scintigraphy--including the evaluation of differential renal function, hypertension, obstruction, renal transplants, masses, trauma, congenital anomalies, vesicoureteral reflux, and infection--are discussed. The relative advantages and disadvantages of radionuclide imaging with respect to alternative radiographic examinations (such as intravenous urography, ultrasonography, CT, angiography, and magnetic resonance imaging) are emphasized wherever applicable.

  11. External accumulation of radionuclide in hepatic hydrothorax

    SciTech Connect

    Albin, R.J.; Johnston, G.S.

    1989-05-01

    Hepatic hydrothorax is a complication in approximately 5% of patients with cirrhosis. Ascites is almost always present and helps to suggest the correct diagnosis. However, when ascites is absent, radionuclide imaging has proven to be helpful in establishing that the pleural effusion originated from ascitic fluid. When pleural fluid is rapidly removed, such as by thoracostomy tube drainage, the radioisotope may accumulate outside the thorax and produce a negative scan of the chest. When the radionuclide scan is nondiagnostic and the pleural space is being rapidly drained, the pleural fluid collecting system should always be imaged before rejecting a diagnosis of hepatic hydrothorax.

  12. The Watchboy Radionuclide Detector Deployment and Analysis

    SciTech Connect

    Dazeley, S.; Bernstein, A.; Bowden, N.

    2014-09-30

    The Watchboy detector was designed to measure the rate of radionuclide production in water created via muon spallation. The three primary nuclei of interest, 11Li, 8He and 9Li, can mimic an antineutrino induced inverse beta decay, producing a high energy beta particle in coincidence with a neutron. Their signature in Watchboy would be the passage of a muon through the target, followed some time later, characterized by the decay time of the radionuclide, by a beta and a neutron emitted in coincidence.

  13. A proposed methodology to select radioisotopes for use in radionuclide therapy.

    PubMed

    Cuaron, J J; Hirsch, J A; Medich, D C; Rosenstein, B S; Martel, C B; Hirsch, A E

    2009-11-01

    The American Journal of Neuroradiology has played a seminal role in the history of vertebral augmentation (VA). Because VA is increasingly being included in the multidisciplinary management of malignant vertebral compression fractures (VCFs), combined therapeutic approaches that include strategies to treat metastatic disease along with the fracture have become appealing options for patients. To that end, we recently investigated the dosimetric feasibility of treating malignant VCFs with radionuclide therapy. The goal would be to provide local control of the systemic disease beyond the pain relief and structural support provided by polymethylmethacrylate cement. The purpose of this article is to propose a methodology for evaluating radionuclides for use in radiation therapy that takes into account a number of factors including radiation characteristics, biochemical effects, production capacity, and safety. The goal of such a methodology is to introduce a systematic approach to selecting radionuclides in designing treatment regimens and future investigations and also to stimulate discussion and experimentation involving new radionuclides that may provide more effective treatments than the current isotopes in widespread use.

  14. MACROMOLECULAR THERAPEUTICS

    PubMed Central

    Yang, Jiyuan; Kopeček, Jindřich

    2014-01-01

    This review covers water-soluble polymer-drug conjugates and macromolecules that possess biological activity without attached low molecular weight drugs. The main design principles of traditional and backbone degradable polymer-drug conjugates as well as the development of a new paradigm in nanomedicines – (low molecular weight) drug-free macromolecular therapeutics are discussed. To address the biological features of cancer, macromolecular therapeutics directed to stem/progenitor cells and the tumor microenvironment are deliberated. Finally, the future perspectives of the field are briefly debated. PMID:24747162

  15. Macromolecular therapeutics.

    PubMed

    Yang, Jiyuan; Kopeček, Jindřich

    2014-09-28

    This review covers water-soluble polymer-drug conjugates and macromolecules that possess biological activity without attached low molecular weight drugs. The main design principles of traditional and backbone degradable polymer-drug conjugates as well as the development of a new paradigm in nanomedicines - (low molecular weight) drug-free macromolecular therapeutics are discussed. To address the biological features of cancer, macromolecular therapeutics directed to stem/progenitor cells and the tumor microenvironment are deliberated. Finally, the future perspectives of the field are briefly debated.

  16. Assessment of Radionuclides in the Savannah River Site Environment Summary

    SciTech Connect

    Carlton, W.H.

    1999-01-26

    This document summarizes the impact of radionuclide releases from Savannah River Site (SRS) facilities from 1954 through 1996. The radionuclides reported here are those whose release resulted in the highest dose to people living near SRS.

  17. Therapeutic Nanodevices

    NASA Astrophysics Data System (ADS)

    Lee, Stephen C.; Ruegsegger, Mark; Barnes, Philip D.; Smith, Bryan R.; Ferrari, Mauro

    Therapeutic nanotechnology offers minimally invasive therapies with high densities of function concentrated in small volumes, features that may reduce patient morbidity and mortality. Unlike other areas of nanotechnology, novel physical properties associated with nanoscale dimensionality are not the raison d'etre of therapeutic nanotechnology, whereas the aggregation of multiple biochemical (or comparably precise) functions into controlled nanoarchitectures is. Multifunctionality is a hallmark of emerging nanotherapeutic devices, and multifunctionality can allow nanotherapeutic devices to perform multi-step work processes, with each functional component contributing to one or more nanodevice subroutine such that, in aggregate, subroutines sum to a cogent work process. Cannonical nanotherapeutic subroutines include tethering (targeting) to sites of disease, dispensing measured doses of drug (or bioactive compound), detection of residual disease after therapy and communication with an external clinician/operator. Emerging nanotherapeutics thus blur the boundaries between medical devices and traditional pharmaceuticals. Assembly of therapeutic nanodevices generally exploits either (bio)material self assembly properties or chemoselective bioconjugation techniques, or both. Given the complexity, composition, and the necessity for their tight chemical and structural definition inherent in the nature of nanotherapeutics, their cost of goods (COGs) might exceed that of (already expensive) biologics. Early therapeutic nanodevices will likely be applied to disease states which exhibit significant unmet patient need (cancer and cardiovascular disease), while application to other disease states well-served by conventional therapy may await perfection of nanotherapeutic design and assembly protocols.

  18. Therapeutic Nanodevices

    NASA Astrophysics Data System (ADS)

    Lee, Stephen; Ruegsegger, Mark; Barnes, Philip; Smith, Bryan; Ferrari, Mauro

    Therapeutic nanotechnology offers minimally invasive therapies with high densities of function concentrated in small volumes, features that may reduce patient morbidity and mortality. Unlike other areas of nanotechnology, novel physical properties associated with nanoscale dimensionality are not the raison d'être of therapeutic nanotechnology, whereas the aggregation of multiple biochemical (or comparably precise) functions into controlled nanoarchitectures is. Multifunctionality is a hallmark of emerging nanotherapeutic devices, and multifunctionality can allow nanotherapeutic devices to perform multistep work processes, with each functional component contributing to one or more nanodevice subroutine such that, in aggregate, subroutines sum to a cogent work process. Cannonical nanotherapeutic subroutines include tethering (targeting) to sites of disease, dispensing measured doses of drug (or bioactive compound), detection of residual disease after therapy and communication with an external clinician/operator. Emerging nanotherapeutics thus blur the boundaries between medical devices and traditional pharmaceuticals. Assembly of therapeutic nanodevices generally exploits either (bio)material self-assembly properties or chemoselective bioconjugation techniques, or both. Given the complexity, composition, and the necessity for their tight chemical and structural definition inherent in the nature of nanotherapeutics, their cost of goods (COGs) might exceed that of (already expensive) biologics. Early therapeutic nanodevices will likely be applied to disease states which exhibit significant unmet patient need (cancer and cardiovascular disease), while application to other disease states well-served by conventional therapy may await perfection of nanotherapeutic design and assembly protocols.

  19. 21 CFR 892.5700 - Remote controlled radionuclide applicator system.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Remote controlled radionuclide applicator system. 892.5700 Section 892.5700 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN... radionuclide applicator system. (a) Identification. A remote controlled radionuclide applicator system is...

  20. 21 CFR 892.5700 - Remote controlled radionuclide applicator system.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Remote controlled radionuclide applicator system. 892.5700 Section 892.5700 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN... radionuclide applicator system. (a) Identification. A remote controlled radionuclide applicator system is...

  1. 21 CFR 892.5700 - Remote controlled radionuclide applicator system.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Remote controlled radionuclide applicator system. 892.5700 Section 892.5700 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN... radionuclide applicator system. (a) Identification. A remote controlled radionuclide applicator system is...

  2. 21 CFR 892.5700 - Remote controlled radionuclide applicator system.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Remote controlled radionuclide applicator system. 892.5700 Section 892.5700 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN... radionuclide applicator system. (a) Identification. A remote controlled radionuclide applicator system is...

  3. Understanding Radionuclide Interactions with Layered Materials

    NASA Astrophysics Data System (ADS)

    Wang, Y.

    2015-12-01

    Layered materials play an important role in nuclear waste management and environmental cleanup. Better understanding of radionuclide interactions with those materials is critical for engineering high-performance materials for various applications. This presentation will provide an overview on radionuclide interactions with two general categories of layered materials - cationic clays and anionic clays - from a perspective of nanopore confinement. Nanopores are widely present in layered materials, either as the interlayers or as inter-particle space. Nanopore confinement can significantly modify chemical reactions in those materials. This effect may cause the preferential enrichment of radionuclides in nanopores and therefore directly impact the mobility of the radionuclides. This effect also implies that conventional sorption measurements using disaggregated samples may not represent chemical conditions in actual systems. The control of material structures on ion exchange, surface complexation, and diffusion in layered materials will be systematically examined, and the related modeling approaches will be discussed. This work was performed at Sandia National Laboratories, which is a multiprogram laboratory operated by Sandia Corporation, a Lockheed-Martin Company, for the DOE under contract DE-AC04-94AL8500.

  4. REMOVAL OF RADIONUCLIDES BY ELECTROKINETIC SOIL PROCESSING

    EPA Science Inventory

    Electrokinetics promises to be an innovative treatment process for in-situ treatment of soils and groundwater contaminated with heavy metals and radionuclides. Electrokinetics refers to the movement of ionic liquids and charged particles relative to one another under the action ...

  5. RADIONUCLIDE TRANSPORT MODELS UNDER AMBIENT CONDITIONS

    SciTech Connect

    S. Magnuson

    2004-11-01

    The purpose of this model report is to document the unsaturated zone (UZ) radionuclide transport model, which evaluates, by means of three-dimensional numerical models, the transport of radioactive solutes and colloids in the UZ, under ambient conditions, from the repository horizon to the water table at Yucca Mountain, Nevada.

  6. Sediment and radionuclide transport in rivers: radionuclide transport modeling for Cattaraugus and Buttermilk Creeks, New York

    SciTech Connect

    Onishi, Y.; Yabusaki, S.B.; Kincaid, C.T.; Skaggs, R.L.; Walters, W.H.

    1982-12-01

    SERATRA, a transient, two-dimensional (laterally-averaged) computer model of sediment-contaminant transport in rivers, satisfactorily resolved the distribution of sediment and radionuclide concentrations in the Cattaraugus Creek stream system in New York. By modeling the physical processes of advection, diffusion, erosion, deposition, and bed armoring, SERATRA routed three sediment size fractions, including cohesive soils, to simulate three dynamic flow events. In conjunction with the sediment transport, SERATRA computed radionuclide levels in dissolved, suspended sediment, and bed sediment forms for four radionuclides (/sup 137/Cs, /sup 90/Sr, /sup 239/ /sup 240/Pu, and /sup 3/H). By accounting for time-dependent sediment-radionuclide interaction in the water column and bed, SERATA is a physically explicit model of radionuclide fate and migration. Sediment and radionuclide concentrations calculated by SERATA in the Cattaraugus Creek stream system are in reasonable agreement with measured values. SERATRA is in the field performance phase of an extensive testing program designed to establish the utility of the model as a site assessment tool. The model handles not only radionuclides but other contaminants such as pesticides, heavy metals and other toxic chemicals. Now that the model has been applied to four field sites, including the latest study of the Cattaraugus Creek stream system, it is recommended that a final model be validated through comparison of predicted results with field data from a carefully controlled tracer test at a field site. It is also recommended that a detailed laboratory flume be tested to study cohesive sediment transport, deposition, and erosion characteristics. The lack of current understanding of these characteristics is one of the weakest areas hindering the accurate assessment of the migration of radionuclides sorbed by fine sediments of silt and clay.

  7. 2006 LANL Radionuclide Air Emissions Report

    SciTech Connect

    David P. Fuehne

    2007-06-30

    This report describes the impacts from emissions of radionuclides at Los Alamos National Laboratory (LANL) for calendar year 2006. This report fulfills the requirements established by the Radionuclide National Emissions Standards for Hazardous Air Pollutants (Rad-NESHAP). This report is prepared by LANL's Rad-NESHAP compliance team, part of the Environmental Protection Division. The information in this report is required under the Clean Air Act and is being reported to the U.S. Environmental Protection Agency (EPA). The highest effective dose equivalent (EDE) to an off-site member of the public was calculated using procedures specified by the EPA and described in this report. LANL's EDE was 0.47 mrem for 2006. The annual limit established by the EPA is 10 mrem per year. During calendar year 2006, LANL continuously monitored radionuclide emissions at 28 release points, or stacks. The Laboratory estimates emissions from an additional 58 release points using radionuclide usage source terms. Also, LANL uses a network of air samplers around the Laboratory perimeter to monitor ambient airborne levels of radionuclides. To provide data for dispersion modeling and dose assessment, LANL maintains and operates meteorological monitoring systems. From these measurement systems, a comprehensive evaluation is conducted to calculate the EDE for the Laboratory. The EDE is evaluated as any member of the public at any off-site location where there is a residence, school, business, or office. In 2006, this location was the Los Alamos Airport Terminal. The majority of this dose is due to ambient air sampling of plutonium emitted from 2006 clean-up activities at an environmental restoration site (73-002-99; ash pile). Doses reported to the EPA for the past 10 years are shown in Table E1.

  8. Syringe calibration factors for the NPL Secondary Standard Radionuclide Calibrator for selected medical radionuclides.

    PubMed

    Tyler, D K; Woods, M J

    2003-01-01

    Before a radiopharmaceutical is administered to a patient, its activity needs to be accurately assayed. This is normally done via a radionuclide calibrator, using a glass vial as the calibration device. The radionuclide is then transferred to a syringe and it is now becoming common practice to re-measure the syringe and use this value as the activity administered to the patient. Due to elemental composition and geometrical differences, etc. between the glass vial and the syringe, the calibration factors are different for the two containers and this can lead to an incorrect activity being given to the patient unless a correction is applied for these differences. To reduce the uncertainty on syringe measurements, syringe calibration factors and volume correction factors for the NPL Secondary Standard Radionuclide Calibrator have been derived by NPL for several medically important radionuclides. It was found that the differences between the calibration factors for the syringes and glass vials depend on the energies of the photon emissions from the decay of the radionuclides; the lower the energy, the greater the difference. As expected, large differences were observed for 125I (70%) and only small differences for 131I. However, for radionuclides such as 99mTc and 67Ga, differences of up to 30% have been observed. This work has shown the need for the use of specifically derived syringe calibration factors as well as highlighting the complexity of the problem with regard to syringe types, procurement, etc.

  9. Calibration of the NPL secondary standard radionuclide calibrator for 125I seeds used for prostate brachytherapy. National Physical Laboratory.

    PubMed

    Baker, M; Bass, G A; Woods, M J

    2002-01-01

    In the therapeutic use of radionuclides, by far the most rapid growth in recent years is that of 125I seeds used for the treatment of prostate cancer. Large numbers of these seeds are used in each treatment and there is a need for a simple but accurate means of confirming their dose rates. This mechanism requires a transfer device for which the calibration factors are traceable to national standards. The NPL secondary standard radionuclide calibrator, because of its guaranteed reproducibility and traceable calibration procedure, is ideally suited for this purpose. A series of characterisation measurements have been performed on the NPL radionuclide calibrator in order to estimate the uncertainty levels that can be achieved and these are presented together with the relevant calibration factors for some typical seeds.

  10. PSMA PET and Radionuclide Therapy in Prostate Cancer.

    PubMed

    Bouchelouche, Kirsten; Turkbey, Baris; Choyke, Peter L

    2016-11-01

    Prostate cancer (PCa) is the most common malignancy in men and a major cause of cancer death. Accurate imaging plays an important role in diagnosis, staging, restaging, detection of biochemical recurrence, and for therapy of patients with PCa. Because no effective treatment is available for advanced PCa, there is an urgent need to develop new and more effective therapeutic strategies. To optimize treatment outcome, especially in high-risk patients with PCa, therapy for PCa is moving rapidly toward personalization. Medical imaging, including positron emission tomography (PET)/computed tomography (CT), plays an important role in personalized medicine in oncology. In the recent years, much focus has been on prostate-specific membrane antigen (PSMA) as a promising target for imaging and therapy with radionuclides, as it is upregulated in most PCa. In the prostate, one potential role for PSMA PET imaging is to help guide focal therapy. Several studies have shown great potential of PSMA PET/CT for initial staging, lymph node staging, and detection of recurrence of PCa, even at very low prostate-specific antigen values after primary therapy. Furthermore, studies have shown that PSMA PET/CT has a higher detection rate than choline PET/CT. Radiolabeled PSMA ligands for therapy show promise in several studies with metastatic PCa and is an area of active investigation. The "image and treat" strategy, with radiolabeled PSMA ligands, has the potential to improve the treatment outcome of patients with PCa and is paving the way for precision medicine in PCa. The aim of this review is to give an overview of recent advancement in PSMA PET and radionuclide therapy for PCa.

  11. National Low-Level Waste Management Program Radionuclide Report Series

    SciTech Connect

    Rudin, M.J.; Garcia, R.S.

    1992-02-01

    This volume serves as an introduction to the National Low-Level Radioactive Waste Management Program Radionuclide Report Series. This report includes discussions of radionuclides listed in Title 10 of the Code of Federal Regulations Part 61.55, Tables 1 and 2 (including alpha-emitting transuranics with half-lives greater than five years). Each report includes information regarding radiological and chemical characteristics of specific radionuclides. Information is also included discussing waste streams and waste forms that may contain each radionuclide, and radionuclide behavior in the environment and in the human body. Not all radionuclides commonly found at low-level radioactive waste sites are included in this report. The discussion in this volume explains the rationale of the radionuclide selection process.

  12. Uptake by plants of radionuclides from FUSRAP waste materials

    SciTech Connect

    Knight, M.J.

    1983-04-01

    Radionuclides from FUSRAP wastes potentially may be taken up by plants during remedial action activities and permanent near-surface burial of contaminated materials. In order to better understand the propensity of radionuclides to accumulate in plant tissue, soil and plant factors influencing the uptake and accumulation of radionuclides by plants are reviewed. In addition, data describing the uptake of the principal radionuclides present in FUSRAP wastes (uranium-238, thorium-230, radium-226, lead-210, and polonium-210) are summarized. All five radionuclides can accumulate in plant root tissue to some extent, and there is potential for the translocation and accumulation of these radionuclides in plant shoot tissue. Of these five radionuclides, radium-226 appears to have the greatest potential for translocation and accumulation in plant shoot tissue. 28 references, 1 figure, 3 tables.

  13. Calibration of the NPL secondary standard radionuclide calibrator for the new 10R Schott, type 1+ vials.

    PubMed

    Baker, M

    2005-07-01

    For many years, P6 vials have been used for the distribution of a wide range of diagnostic and therapeutic radioactive solutions. The activity measurements were performed in this geometry and, in time, the UK calibration system for nuclear medicine was based on this container as a standard. However, one major supplier of radiopharmaceuticals has replaced the P6 vial with the 10R Type 1+ Schott vial. As the dimensions of the new vial are different from those of the P6 vial and the responses of radionuclide calibrators are known to be container dependent, the need for re-calibration became apparent. Preliminary measurements made on some typical radionuclide calibrators for (125)I solution indicated a difference in response of about 10% between the two vials. The master ionisation chamber of the NPL secondary standard radionuclide calibrator has been re-calibrated and new calibration factors and volume correction factors for 10R Schott vials have been derived for the relevant medical radionuclides. The standard holder was also modified to accommodate the new larger vial. The complete list of factors and the method used to determine them is presented in this paper. The availability of these new factors will improve the quality of activity measurements in nuclear medicine, as calibration services can now be provided by NPL for the new container. These factors can also be employed for all commercial NPL secondary standard radionuclide calibrators (now known as the NPL-CRC and previously as the 671 or ISOCAL IV).

  14. Improving cancer treatment with cyclotron produced radionuclides

    SciTech Connect

    Larson, S.M. Finn, R.D.

    1992-08-04

    This report describes the author's continuing long term goal of promoting nuclear medicine applications by improving the scientific basis for tumor diagnosis treatment and treatment follow-up based on the use of cyclotron produced radiotracers in oncology. The program has 3 interactive components: Radiochemistry /Cyclotron; Pharmacology; and Immunology. An essential strategy is as follows: novel radionuclides and radiotracers developed in the Radiochemistry/Cyclotron section under the DOE grant during the 1989--1992 grant period, will be employed in the Pharmacology and Immunology sections of the DOE grant during the 1992--1995 grant period. The development of novel radionuclides and tracers is of course useful in and of itself, but their utility is greatly enhanced by the interaction with the immunology and pharmacology components of the program.

  15. Decline of radionuclides in Columbia River biota

    SciTech Connect

    Cushing, C.E.; Watson, D.G.; Scott, A.J.; Gurtisen, J.M.

    1980-03-01

    In January 1971, the last of nine plutonium production reactors using direct discharge of once-through cooling waters into the Columbia River was closed. Sampling was initiated at three stations on the Columbia River to document the decline of the radionuclide body burdens in the biota of the Columbia River ecosystem. The data show that in a river-reservoir complex, the measurable body burden of fission-produced radionuclides decreased to essentially undetectable levels within 18 to 24 mo after cessation of discharge of once-through cooling water into the river. On the basis of data from the free-flowing station, we believe that this decrease would be even more rapid in an unimpounded river.

  16. Methods and systems for detection of radionuclides

    DOEpatents

    Coates, Jr., John T.; DeVol, Timothy A.

    2010-05-25

    Disclosed are materials and systems useful in determining the existence of radionuclides in an aqueous sample. The materials provide the dual function of both extraction and scintillation to the systems. The systems can be both portable and simple to use, and as such can beneficially be utilized to determine presence and optionally concentration of radionuclide contamination in an aqueous sample at any desired location and according to a relatively simple process without the necessity of complicated sample handling techniques. The disclosed systems include a one-step process, providing simultaneous extraction and detection capability, and a two-step process, providing a first extraction step that can be carried out in a remote field location, followed by a second detection step that can be carried out in a different location.

  17. Radionuclide demonstration of intrapulmonary shunting in cirrhosis

    SciTech Connect

    Bank, E.R.; Thrall, J.H.; Dantzker, D.R.

    1983-05-01

    The association of hepatic cirrhosis and severe arterial hypoxemia has been well described. Although alterations in ventilatory function may partially account for the hypoxemia, the principal mechanism is thought to be a microangiopathic change in the pulmonary arteriovenous shunting with resultant systemic desaturation. Whole-body radionuclide scans with technetium-99m macroaggrregated albumin (/sup 99m/Tc MAA) labeling have been diagnostic of right-to-left shunting by their demonstration of tracer accumulation within the extrapulmonary circulation. A case of severe pulmonary arteriovenous shunting in an alcoholic patient in whom hepatic disease had not been of apparent clinical significance before radionuclide scanning is reported. He did not have cutaneous angiomata as have all other patients with alcoholic cirrhosis and hypoxemia.

  18. Radionuclide demonstration of intrapulmonary shunting in cirrhosis

    SciTech Connect

    Bank, E.R.; Thrall, J.H.; Dantzker, D.R.

    1983-05-01

    The association of hepatic cirrhosis and severe arterial hypoxemia has been well described. Although alterations in ventilatory function may partially account for the hypoxemia, the principal mechanism is thought to be a microangiopathic change in the pulmonary vasculature resulting in intrapulmonary arteriovenous shunting with resultant systemic desaturation. Whole-body radionuclide scans with technetium-99m macroaggregated albumin labeling have been diagnostic of right-to-left shunting by their demonstration of tracer accumulation within the extrapulmonary circulation. A case of severe pulmonary arteriovenous shunting in an alcoholic patient in whom hepatic disease had not been of apparent clinical significance before radionuclide scanning is reported. He did not have cuntaeous angiomata as have all other patients with alcoholic cirrhosis and hypoxemia.

  19. Cadastral valuation of lands polluted with radionuclides

    NASA Astrophysics Data System (ADS)

    Makarov, O. A.; Tsvetnov, E. V.; Shcheglov, A. I.; Romashkina, A. D.; Ermiyaev, Ya. R.

    2016-11-01

    The major method to correct the cadastral value of land for contamination with radionuclides is to reduce it by the sum of expenses necessary for land remediation and for special measures ensuring the obtaining of agricultural and forestry products satisfying safety norms. Lands contaminated with radionuclides and used in agriculture and forestry are often removed from the system of land taxation. In this case, their cadastral value becomes an excessive element of the state cadaster of real estate. An approach toward cadastral valuation of such lands suggested by the authors assumes the creation of a system of compensation payments as the main source of financing of land rehabilitation and soil conservation measures. An original system of calculation of such payments has been tested for radioactively contaminated lands in Plavsk district of Tula oblast. It is argued that compensation payments for radioactively contaminated agrocenoses should be higher than those for natural cenoses.

  20. Radionuclide transfer from feed to camel milk.

    PubMed

    Al-Masri, M S; Al-Hamwi, A; Amin, Y; Safieh, M B; Zarkawi, M; Soukouti, A; Dayyoub, R; Voigt, G; Fesenko, S

    2014-06-01

    The transfer of (137)Cs, (85)Sr, (131)I, (210)Po, (210)Pb and (238)U from feed to camel's milk was investigated in a pilot experiment with three lactating camels. For a period of 60 days, the animals were fed on spiked feed containing the studied radionuclides. They were subsequently returned to a contamination-free diet and monitored for another 90 days. The activity concentrations of (137)Cs, (85)Sr and (131)I in milk decreased with time and reached background levels after 20 days. Equilibrium transfer coefficients and biological half-lives were estimated and transfer coefficients were calculated as (8.1 ± 3.6) × 10(-4), (4.4 ± 1.6) × 10(-2), (7.8 ± 3.9) × 10(-4), (2.7 ± 3.5) × 10(-4), (1.8 ± 1.5) × 10(-4) and (7.0 ± 3.6) × 10(-3) d L(-1) for (85)Sr, (131)I, (137)Cs, (210)Po, (210)Pb and (238)U, respectively. The biological half-lives were estimated to be 6.4, 4.2, 8.9, and 53.3 days for (85)Sr, (131)I, (137)Cs, and (238)U, respectively. Estimates of the half-lives were based on a one component model: it was found that the half-life values measured for artificial radionuclides were slightly shorter than those for natural radionuclides. The data obtained in the study are the first published experimental data on radionuclide transfer to camel milk.

  1. Breast-Dedicated Radionuclide Imaging Systems.

    PubMed

    Hsu, David F C; Freese, David L; Levin, Craig S

    2016-02-01

    Breast-dedicated radionuclide imaging systems show promise for increasing clinical sensitivity for breast cancer while minimizing patient dose and cost. We present several breast-dedicated coincidence-photon and single-photon camera designs that have been described in the literature and examine their intrinsic performance, clinical relevance, and impact. Recent tracer development is mentioned, results from recent clinical tests are summarized, and potential areas for improvement are highlighted.

  2. Radionuclide Air Emission Report for 2009

    SciTech Connect

    Wahl, Linnea

    2010-06-01

    Berkeley Lab operates facilities where radionuclides are handled and stored. These facilities are subject to the EPA radioactive air emission regulations in 40CFR61, Subpart H (EPA 1989). Radionuclides may be emitted from stacks or vents on buildings where radionuclide production or use is authorized or they may be emitted as diffuse sources. In 2009, all Berkeley Lab sources were minor sources of radionuclides (sources resulting in a potential dose of less than 0.1 mrem/yr [0.001 mSv/yr]). These minor sources included more than 100 stack sources and one source of diffuse emissions. There were no unplanned emissions from the Berkeley Lab site. Emissions from minor sources (stacks and diffuse emissions) either were measured by sampling or monitoring or were calculated based on quantities used, received for use, or produced during the year. Using measured and calculated emissions, and building-specific and common parameters, Laboratory personnel applied the EPA-approved computer code, CAP88-PC, to calculate the effective dose equivalent to the maximally exposed individual (MEI). The effective dose equivalent from all sources at Berkeley Lab in 2009 is 7.0 x 10{sup -3} mrem/yr (7.0 x 10{sup -5} mSv/yr) to the MEI, well below the 10 mrem/yr (0.1 mSv/yr) dose standard. The location of the MEI is at the University of California (UC) Lawrence Hall of Science, a public science museum about 1500 ft (460 m) east of Berkeley Lab's Building 56. The estimated collective effective dose equivalent to persons living within 50 mi (80 km) of Berkeley Lab is 1.5 x 10{sup -1} person-rem (1.5 x 10{sup -3} person-Sv) attributable to the Lab's airborne emissions in 2009.

  3. Radionuclide Air Emission Report for 2007

    SciTech Connect

    Wahl, Linnea; Wahl, Linnea

    2008-06-13

    Berkeley Lab operates facilities where radionuclides are handled and stored. These facilities are subject to the U.S. Environmental Protection Agency (EPA) radioactive air emission regulations in Code of Federal Regulations (CFR) Title 40, Part 61, Subpart H (EPA 1989). The EPA regulates radionuclide emissions that may be released from stacks or vents on buildings where radionuclide production or use is authorized or that may be emitted as diffuse sources. In 2007, all Berkeley Lab sources were minor stack or building emissions sources of radionuclides (sources resulting in a potential dose of less than 0.1 mrem/yr [0.001 mSv/yr]), there were no diffuse emissions, and there were no unplanned emissions. Emissions from minor sources either were measured by sampling or monitoring or were calculated based on quantities received for use or produced during the year. Using measured and calculated emissions, and building-specific and common parameters, Laboratory personnel applied the EPA-approved computer code, CAP88-PC, Version 3.0, to calculate the effective dose equivalent to the maximally exposed individual (MEI). The effective dose equivalent from all sources at Berkeley Lab in 2007 is 1.2 x 10{sup -2} mrem/yr (1.2 x 10{sup -4} mSv/yr) to the MEI, well below the 10 mrem/yr (0.1 mSv/yr) EPA dose standard. The location of the MEI is at the University of California (UC) Lawrence Hall of Science, a public science museum about 1500 ft (460 m) east of Berkeley Lab's Building 56. The estimated collective effective dose equivalent to persons living within 50 mi (80 km) of Berkeley Lab is 3.1 x 10{sup -1} person-rem (3.1 x 10{sup -3} person-Sv) attributable to the Lab's airborne emissions in 2007.

  4. Radionuclide bone scintigraphy in pediatric orthopedics

    SciTech Connect

    Conway, J.J.

    1986-12-01

    Radionuclide bone scintigraphy is highly sensitive and specific for diagnosing the musculoskeletal disorders of childhood. Conditions such as neonatal osteomyelitis, septic arthritis, diskitis of childhood, Legg-Calve-Perthes disease, the osteochondroses, the toddler's fracture, sports injuries, spondylolysis, myositis ossificians, and reflex sympathetic dystrophy are readily defined. High-quality state-of-the-art scintigraphy is essential in infants and young children. 64 references.

  5. Radionuclide Air Emission Report for 2008

    SciTech Connect

    Wahl, Linnea

    2009-05-21

    Berkeley Lab operates facilities where radionuclides are handled and stored. These facilities are subject to the U.S. Environmental Protection Agency (EPA) radioactive air emission regulations in Code of Federal Regulations (CFR) Title 40, Part 61, Subpart H (EPA 1989). Radionuclides may be emitted from stacks or vents on buildings where radionuclide production or use is authorized or they may be emitted as diffuse sources. In 2008, all Berkeley Lab sources were minor sources of radionuclides (sources resulting in a potential dose of less than 0.1 mrem/yr [0.001 mSv/yr]). These minor sources include more than 100 stack sources and one source of diffuse emissions. There were no unplanned emissions from the Berkeley Lab site. Emissions from minor sources (stacks and diffuse emissions) either were measured by sampling or monitoring or were calculated based on quantities used, received for use, or produced during the year. Using measured and calculated emissions, and building-specific and common parameters, Laboratory personnel applied the EPA-approved computer code, CAP88-PC, to calculate the effective dose equivalent to the maximally exposed individual (MEI). The effective dose equivalent from all sources at Berkeley Lab in 2008 is 5.2 x 10{sup -3} mrem/yr (5.2 x 10{sup -5} mSv/yr) to the MEI, well below the 10 mrem/yr (0.1 mSv/yr) dose standard. The location of the MEI is at the University of California (UC) Lawrence Hall of Science, a public science museum about 1500 ft (460 m) east of Berkeley Lab's Building 56. The estimated collective effective dose equivalent to persons living within 50 mi (80 km) of Berkeley Lab is 1.1 x 10{sup -1} person-rem (1.1 x 10{sup -3} person-Sv) attributable to the Lab's airborne emissions in 2008.

  6. Concrete Property and Radionuclide Migration Tests

    SciTech Connect

    Wellman, Dawn M.; Mattigod, Shas V.; Powers, Laura; Parker, Kent E.; Clayton, Libby N.; Wood, Marcus I.

    2008-10-01

    The Waste Management Project provides safe, compliant, and cost-effective waste management services for the Hanford Site and the DOE Complex. Part of theses services includes safe disposal of LLW and MLLW at the Hanford Low-Level Waste Burial Grounds (LLBG) in accordance with the requirements listed in DOE Order 435.1, Radioactive Waste Management. To partially satisfy these requirements, a Performance Assessment (PA) analyses were completed and approved. DOE Order 435.1 also requires that continuing data collection be conducted to enhance confidence in the critical assumptions used in these analyses to characterize the operational features of the disposal facility that are relied upon to satisfy the performance objectives identified in the Order. One critical assumption is that concrete will frequently be used as waste form or container material to control and minimize the release of radionuclide constituents in waste into the surrounding environment. Data was collected to (1) quantify radionuclide migration through concrete materials similar to those used to encapsulate waste in the LLBG, (2) measure the properties of the concrete materials, especially those likely to influence radionuclide migration, and (3) quantify the stability of U-bearing solid phases of limited solubility in concrete.

  7. UPTAKE OF RADIONUCLIDE METALS BY SPME FIBERS

    SciTech Connect

    Duff, M; S Crump, S; Robert02 Ray, R; Keisha Martin, K; Donna Beals, D

    2006-08-28

    The Federal Bureau of Investigation (FBI) Laboratory currently does not have on site facilities for handling radioactive evidentiary materials and there are no established FBI methods or procedures for decontaminating high explosive (HE) and fire debris (FD) evidence while maintaining evidentiary value. One experimental method for the isolation of HE and FD residue involves using solid phase microextraction or SPME fibers to remove residue of interest. Due to their high affinity for organics, SPME fibers should have little affinity for most metals. However, no studies have measured the affinity of radionuclides for SPME fibers. The focus of this research was to examine the affinity of dissolved radionuclide ({sup 239/240}Pu, {sup 238}U, {sup 237}Np, {sup 85}Sr, {sup 133}Ba, {sup 137}Cs, {sup 60}Co and {sup 226}Ra) and stable radionuclide surrogate metals (Sr, Co, Ir, Re, Ni, Ba, Cs, Nb, Zr, Ru, and Nd) for SPME fibers at the exposure conditions that favor the uptake of HE and FD residues. Our results from radiochemical and mass spectrometric analyses indicate these metals have little measurable affinity for these SPME fibers during conditions that are conducive to HE and FD residue uptake with subsequent analysis by liquid or gas phase chromatography with mass spectrometric detection.

  8. [Biosorption of Radionuclide Uranium by Deinococcus radiodurans].

    PubMed

    Yang, Jie; Dong, Fa-qin; Dai, Qun-wei; Liu, Ming-xue; Nie, Xiao-qin; Zhang, Dong; Ma, Jia-lin; Zhou, Xian

    2015-04-01

    As a biological adsorbent, Living Deinococcus radiodurans was used for removing radionuclide uranium in the aqueous solution. The effect factors on biosorption of radionuclide uranium were researched in the present paper, including solution pH values and initial uranium concentration. Meanwhile, the biosorption mechanism was researched by the method of FTIR and SEM/EDS. The results show that the optimum conditions for biosorption are as follows: pH = 5, co = 100 mg · L(-1) and the maximum biosorption capacity is up to 240 mgU · g(-1). According to the SEM results and EDXS analysis, it is indicated that the cell surface is attached by lots of sheet uranium crystals, and the main biosorpiton way of uranium is the ion exchange or surface complexation. Comparing FTIR spectra and FTIR fitting spectra before and after biosorption, we can find that the whole spectra has a certain change, particularly active groups (such as amide groups of the protein, hydroxy, carboxyl and phosphate group) are involved in the biosorption process. Then, there is a new peak at 906 cm(-1) and it is a stretching vibration peak of UO2(2+). Obviously, it is possible that as an anti radiation microorganism, Deinococcus radiodurans could be used for removing radionuclide uranium in radiation environment.

  9. Mathematical Simulation of Sediment and Radionuclide Transport in Surface Waters

    SciTech Connect

    ,

    1981-04-01

    The study objective of "The Mathematical Simulation of Sediment and Radionuclide Transport in Surface Waters" is to synthesize and test radionuclide transport models capable of realistically assessing radionuclide transport in various types of surface water bodies by including the sediment-radionuclide interactions. These interactions include radionuclide adsorption by sediment; desorption from sediment into water; and transport, deposition, and resuspension of sorbed radionuclides controlled by the sediment movements. During FY-1979, the modification of sediment and contaminant (radionuclide) transport model, FETRA, was completed to make it applicable to coastal waters. The model is an unsteady, two-dimensional (longitudinal and lateral) model that consists of three submodels (for sediment, dissolved-contaminant, and particulate-contaminant transport), coupled to include the sediment-contaminant interactions. In estuaries, flow phenomena and consequent sediment and radionuclide migration are often three-dimensional in nature mainly because of nonuniform channel cross-sections, salinity intrusion, and lateral-flow circulation. Thus, an unsteady, three-dimensional radionuclide transport model for estuaries is also being synthesized by combining and modifying a PNL unsteady hydrothermal model and FETRA. These two radionuclide transport models for coastal waters and estuaries will be applied to actual sites to examine the validity of the codes.

  10. Transuranic radionuclides from resuspension in the environment, a bibliography

    SciTech Connect

    Stoker, A.C.; Shinn, J.H.; Noshkin, V.E.

    1994-04-01

    The purpose of this project was to compile a bibliography of references containing environmental transuranic radionuclide data. Our intent was to identify those parameters affecting transuranic radionuclide transport that may be generic and those that may be dependent on chemical form and/or environmental conditions. An understanding of the unique characteristics and similarities between source terms and environmental conditions relative to transuranic radionuclide transport and cycling will provide the ability to assess and predict the long term impact on man and the environment. An additional goal of our literature review, was to extract the ranges of environmental transuranic radionuclide data from the identified references for inclusion in a data base. Related to source term, these ranges of data can be used to calculate the dose to man from the radionuclides, and to perform uncertainty analyses on these dose assessments. On the basis of our reviews, we have arbitrarily outlined five general source terms. These are fallout, fuel cycle waste, accidents, disposal sites and resuspension. Resuspension of the transuranic radionuclides is an unique source term, in that the radionuclides can originate from any of the other source terms. If these transuranic radionuclides become resuspended into the air, they then become important as a source of inhaled radionuclides. This bibliography is a compilation of the references containing studies of plutonium and americium in the environment as a result of resuspension.

  11. Mathematical simulation of sediment and radionuclide transport in estuaries

    SciTech Connect

    Onishi, Y.; Trent, D.S.

    1982-11-01

    The finite element model LFESCOT (Flow, Energy, Salinity, Sediment and Contaminant Transport Model) was synthesized under this study to simulate radionuclide transport in estuaries to obtain accurate radionuclide distributions which are affected by these factors: time variance, three-dimensional flow, temperature, salinity, and sediments. Because sediment transport and radionuclide adsorption/desorption depend strongly on sizes or types of sediments, FLESCOT simulates sediment and a sediment-sorbed radionuclide for the total of three sediment-size fractions (or sediment types) of both cohesive and noncohesive sediments. It also calculates changes of estuarine bed conditions, including bed elevation changes due to sediment erosion/deposition, and three-dimensional distributions of three bed sediment sizes and sediment-sorbed radionuclides within the bed. Although the model was synthesized for radionuclide transport, it is general enough to also handle other contaminants such as heavy metals, pesticides, or toxic chemicals. The model was checked for its capability for flow, water surface elevation change, salinity, sediment and radionuclide transport under various simple conditions first, confirming the general validity of the model's computational schemes. These tests also revealed that FLESCOT can use large aspect ratios of computational cells, which are necessary in handling long estuarine study areas. After these simple tests, FLESCOT was applied to the Hudson River estuary between Chelsea and the mouth of the river to examine how well the model can predict radionuclide transport through simulating tidally influenced three-dimensional flow, salinity, sediment and radionuclide movements with their interactions.

  12. Selected radionuclides important to low-level radioactive waste management

    SciTech Connect

    1996-11-01

    The purpose of this document is to provide information to state representatives and developers of low level radioactive waste (LLW) management facilities about the radiological, chemical, and physical characteristics of selected radionuclides and their behavior in the environment. Extensive surveys of available literature provided information for this report. Certain radionuclides may contribute significantly to the dose estimated during a radiological performance assessment analysis of an LLW disposal facility. Among these are the radionuclides listed in Title 10 of the Code of Federal Regulations Part 61.55, Tables 1 and 2 (including alpha emitting transuranics with half-lives greater than 5 years). This report discusses these radionuclides and other radionuclides that may be significant during a radiological performance assessment analysis of an LLW disposal facility. This report not only includes essential information on each radionuclide, but also incorporates waste and disposal information on the radionuclide, and behavior of the radionuclide in the environment and in the human body. Radionuclides addressed in this document include technetium-99, carbon-14, iodine-129, tritium, cesium-137, strontium-90, nickel-59, plutonium-241, nickel-63, niobium-94, cobalt-60, curium -42, americium-241, uranium-238, and neptunium-237.

  13. Radionuclide and radiation protection data handbook 2nd edition (2002).

    PubMed

    Delacroix, D; Guerre, J P; Leblanc, P; Hickman, C

    2002-01-01

    This handbook is a reference source of radionuclide and radiation protection information. Its purpose is to provide users of radionuclides in medicine, research and industry with consolidated and appropriate information and data to handle and transport radioactive substances safely. It is mainly intended for users in low and intermediate activity laboratories. Individual data sheets are provided for a wide range of commonly used radionuclides (144 in total). These radionuclides are classified into five different groups as a function of risk level, represented by colours red, orange, yellow, green and blue, in descending order of risk.

  14. Transuranic radionuclides dispersed into the aquatic environment, a bibliography

    SciTech Connect

    Noshkin, V.E.; Stoker, A.C.; Wong, Kai M.

    1994-04-01

    The purpose of this project was to compile a bibliography of references containing environmental transuranic radionuclide data. Our intent was to identify those parameters affecting transuranic radionuclide transport that may be generic and those that may be dependent on chemical form and/or environmental conditions (i.e., site specific) in terrestrial, aquatic and atmospheric environments An understanding of the unique characteristics and similarities between source terms and environmental conditions relative to transuranic radionuclide transport and cycling will provide the ability to assess and predict the long term impact on man and the environment. An additional goal of our literature review, was to extract the ranges of environmental transuranic radionuclide data from the identified references for inclusion in a data base. Related to source term, these ranges of data can be used to calculate the dose to man from the radionuclides, and to perform uncertainty analyses on these dose assessments. On the basis of our reviews, we have arbitrarily outlined five general source terms. These are fallout, fuel cycle waste, accidents, disposal sites and resuspension. Resuspension of the transuranic radionuclides is a unique source term, in that the radionuclides can originate from any of the other source terms. If these transuranic radionuclides become resuspended into the air, they then become important as a source of inhaled radionuclides.

  15. Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.

    PubMed

    Lo Russo, Giuseppe; Pusceddu, Sara; Prinzi, Natalie; Imbimbo, Martina; Proto, Claudia; Signorelli, Diego; Vitali, Milena; Ganzinelli, Monica; Maccauro, Marco; Buzzoni, Roberto; Seregni, Ettore; de Braud, Filippo; Garassino, Marina Chiara

    2016-10-01

    Well-differentiated bronchial neuroendocrine tumors (B-NETs) are rare. They represent 1-5 % of all lung cancers. The incidence of these neoplasms has risen over the past 30 years and, especially for advanced or metastatic disease, management is complex and requires a multidisciplinary approach. Treatment with somatostatin analogs (SSAs) is the most important first-line therapy, in particular in well-differentiated NETs with high somatostatin type receptor (SSTR) expression. In these tumors, the role of mammalian target of rapamycin (m-TOR) inhibitors and the potential utility of other target therapies remain unclear while chemotherapy represents the gold standard treatment only for aggressive forms with low SSTR expression. Peptide receptor radionuclide therapy (PRRT) is an emerging treatment modality for advanced NETs. There are many cumulative evidences about the effectiveness and tolerability of this therapeutic approach, especially in gastro-entero-pancreatic (GEP)-NETs. For B-NETs, scientific research is moving more slowly. Here, we performed a review in order to evaluate the efficacy and toxicity of PRRT with a focus on patients with inoperable or metastatic well-differentiated B-NETs.

  16. Visualizing plumes of heavy metals and radionuclides

    NASA Astrophysics Data System (ADS)

    Prigiobbe, V.; Liu, T.; Bryant, S. L.; Hesse, M. A.

    2015-12-01

    The understanding of the transport behaviors in porous media resides on the ability to reproduce fundamental phenomena in a lab setting. Experiments with quasi 2D tanks filled with beads are performed to study physical phenomena induced by chemical and fluid dynamic processes. When an alkaline solution containing heavy metals or radionuclides invades a low pH region, mixing due to longitudinal dispersion induces destabilization of the front forming a fast travelling pulse [1]. When the two fluids travel in parallel, instead, mixing induced by transverse dispersion creates a continuous leakage from the alkaline region into the acidic one forming a fast travelling plume [2] (Figure 1). Impact of these phenomena are on aquifers upon leaking of alkaline fluids, rich in heavy metals and radionuclides, from waste storage sites. Here, we report the results from a study where experiments with a quasi 2D tank are performed to analyze the effect of transverse mixing on strontium (Sr2+) transport. To visualize the leaking plume, a fluorescent dye (Fura-2) is added the acidic solution, which has been widely used in biomedical applications [3]. It is the aim of this work to optimize its application under the conditions relevant to this work. Spectrometric measurements of absorption and fluorescence show sensitivity of the dye to the presence of Sr2+ throughout a broad range of pH and Sr2+ concentration (Figure 2). In the absence of Sr2+, no significant absorption and fluorescence was measured, but as Sr2+ was added the relevant peaks increase significantly and sample dilution of tenfold was required to remain within the measuring threshold. These results show a strong sensitivity of the dye to the cation opening the opportunity to use Fura-2 as a tool to visualize heavy metals and radionuclides plumes. References[1] Prigiobbe et al. (2012) GRL 39, L18401. [2] Prigiobbe and Hesse (2015) in preparation. [3] Xu-Friedman and Regehr (2000) J. Neurosci. 20(12) 4414-4422.

  17. Method of separating short half-life radionuclides from a mixture of radionuclides

    DOEpatents

    Bray, Lane A.; Ryan, Jack L.

    1999-01-01

    The present invention is a method of removing an impurity of plutonium, lead or a combination thereof from a mixture of radionuclides that contains the impurity and at least one parent radionuclide. The method has the steps of (a) insuring that the mixture is a hydrochloric acid mixture; (b) oxidizing the acidic mixture and specifically oxidizing the impurity to its highest oxidation state; and (c) passing the oxidized mixture through a chloride form anion exchange column whereupon the oxidized impurity absorbs to the chloride form anion exchange column and the 22.sup.9 Th or 2.sup.27 Ac "cow" radionuclide passes through the chloride form anion exchange column. The plutonium is removed for the purpose of obtaining other alpha emitting radionuclides in a highly purified form suitable for medical therapy. In addition to plutonium; lead, iron, cobalt, copper, uranium, and other metallic cations that form chloride anionic complexes that may be present in the mixture; are removed from the mixture on the chloride form anion exchange column.

  18. Method of separating short half-life radionuclides from a mixture of radionuclides

    DOEpatents

    Bray, L.A.; Ryan, J.L.

    1999-03-23

    The present invention is a method of removing an impurity of plutonium, lead or a combination thereof from a mixture of radionuclides that contains the impurity and at least one parent radionuclide. The method has the steps of (a) insuring that the mixture is a hydrochloric acid mixture; (b) oxidizing the acidic mixture and specifically oxidizing the impurity to its highest oxidation state; and (c) passing the oxidized mixture through a chloride form anion exchange column whereupon the oxidized impurity absorbs to the chloride form anion exchange column and the {sup 229}Th or {sup 227}Ac ``cow`` radionuclide passes through the chloride form anion exchange column. The plutonium is removed for the purpose of obtaining other alpha emitting radionuclides in a highly purified form suitable for medical therapy. In addition to plutonium, lead, iron, cobalt, copper, uranium, and other metallic cations that form chloride anionic complexes that may be present in the mixture are removed from the mixture on the chloride form anion exchange column. 8 figs.

  19. Sustainable production of orphan radionuclides at Wisconsin.

    PubMed

    Nickles, R J; Avila-Rodriguez, M A; Nye, J A; Houser, E N; Selwyn, R G; Schueller, M J; Christian, B T; Jensen, M

    2008-06-01

    Over a hundred proton-induced reactions have been studied at the University of Wisconsin Medical Physics department since the installation of the first CTI RDS 112 in 1985. The focus has been to measure thick target yields at 11 MeV, in an effort to concentrate on the practical production of positron emitting radionuclides that have favorable decay characteristics, high yields and the potential for labeling pivotal biological tracers. This review covers our recent advances to scale-up the production of the heavy halogens and transition metals as feed-stock for non-conventional PET tracers that are currently attracting increased attention in oncology.

  20. Research remote laser methods for radionuclides monitoring

    NASA Astrophysics Data System (ADS)

    Kascheev, S. V.; Elizarov, Valentin V.; Grishkanich, Alexander S.; Bespalov, V. G.; Vasil'ev, Sergey K.; Zhevlakov, A. P.

    2014-05-01

    Laser sensing can serve as a highly effective method of searching and monitoring of radioactive contamination. The first method is essence consists in definition the Sr90 and Сs137 concentration by excitation and registration of fluorescence at wavelength of λ = 0.347÷7.0 μm at laser sounding. The second method experiments were carried out under the Raman-scattering circuit. Preliminary results of investigation show the real possibility to register of leakage of a radionuclide with concentration at level of 108÷109 сm-3 on a safe distance from the infected object.

  1. Radionuclides at Descartes in the central highlands

    NASA Technical Reports Server (NTRS)

    Wrigley, R. C.

    1973-01-01

    Throium, uranium, potassium, aluminium-26, and sodium-22 were measured by nondestructive gamma ray spectrometry in six soil and two rock samples gathered by Apollo 16 in the lunar central highlands. The soil samples probably include both major geologic formations in the vicinity, the Cayley and Descartes Formations, although it is possible that the Descartes Formation is not represented. The rock samples have low concentrations of primordial radionuclides. The Al concentrations were lower than could be expected from the high abundance of alumina in the Apollo 16 soils reported earlier, but this could be due to lower concentrations of target elements in these soils, sampling depth variations, or regolithic mixing (exposure age variations).

  2. Radionuclides in the Great Lakes basin.

    PubMed Central

    Ahier, B A; Tracy, B L

    1995-01-01

    The Great Lakes basin is of radiologic interest due to the large population within its boundaries that may be exposed to various sources of ionizing radiation. Specific radionuclides of interest in the basin arising from natural and artificial sources include 3H, 14C, 90Sr, 129I, 131I, 137Cs, 222Rn, 226Ra, 235U, 238U, 239Pu, and 241Am. The greatest contribution to total radiation exposure is the natural background radiation that provides an average dose of about 2.6 mSv/year to all basin residents. Global fallout from atmospheric nuclear weapons tests conducted before 1963 has resulted in the largest input of anthropogenic radioactivity into the lakes. Of increasing importance is the radionuclide input from the various components of the nuclear fuel cycle. Although the dose from these activities is currently very low, it is expected to increase if there is continued growth of the nuclear industry. In spite of strict regulations on design and operation of nuclear power facilities, the potential exists for a serious accident as a result of the large inventories of radionuclides contained in the reactor cores; however, these risks are several orders of magnitude less than the risks from other natural and man-made hazards. An area of major priority over the next few decades will be the management of the substantial amounts of radioactive waste generated by nuclear fuel cycle activities. Based on derived risk coefficients, the theoretical incidence of fatal and weighted nonfatal cancers and hereditary defects in the basin's population, attributable to 50 years of exposure to natural background radiation, is conservatively estimated to be of the order of 3.4 x 10(5) cases. The total number of attributable health effects to the year 2050 from fallout radionuclides in the Great Lakes basin is of the order of 5.0 x 10(3). In contrast, estimates of attributable health effects from 50 years of exposure to current nuclear fuel cycle effluent in the basin are of the order of 2

  3. Detection of gastrointestinal bleeding by radionuclide scintigraphy

    SciTech Connect

    Gupta, S.; Luna, E.; Kingsley, S.; Prince, M.; Herrera, N.

    1984-01-01

    Scanning with Technetium /sup 99m/ labeled autologous red blood cells was performed in 59 patients with clinical suspicion of acute and/or intermittent, chronic gastrointestinal bleeding. In 36 patients (61%), a definite site of bleeding could be demonstrated. A strong correlation with other modalities such as upper and lower gastrointestinal endoscopy, contrast angiography, and surgical exploration was found. Overall sensitivity of the procedure was 91%; specificity 100% and accuracy 93.3%. It is suggested that radionuclide scintigraphy provides a completely noninvasive, simple, and sensitive procedure which may be routinely used for the detection and localization of gastrointestinal bleeding.

  4. Natural contamination in radionuclide detection systems

    SciTech Connect

    Wogman, N.A.

    1980-10-01

    Through the use of low-level gamma-ray spectrometry, clean material for construction of radionuclide detection systems has been identified. In general aluminum contains high quantities of /sup 232/Th and /sup 238/U with minimal quantities of /sup 40/K. Stainless steels contain /sup 60/Co. The radioactive contents of foams, cements, and light reflective materials are quite variable. Molecular sieve materials used in germanium spectrometers contain from 4-9 dpm/g. Only through a judicious choice of materials can a spectrometer with the lowest achievable background be assembled.

  5. Measurement of radionuclides in waste packages

    SciTech Connect

    Brodzinski, R.L.; Perkins, R.W.; Rieck, H.G.; Wogman, N.A.

    1986-10-14

    A method is described for non-destructively assaying the radionuclide content of solid waste in a sealed container comprising: (a) determining the type of reactor responsible for the generation of the waste; (b) determining the degree of fuel enrichment of the reactor; (c) determining the decay time of the waste since exposure in the reactor; (d) measuring the gamma-ray spectrum of the waste; (e) determining the matrix density of the waste from ratios of photopeak pairs from individual radioisotopes in the gamma-ray spectrum; (f) measuring the total neutron flux and the coincidence neutron flux of the waste; and (g) determining neutron multiplicity from the coincidence neutron flux.

  6. Preparation of radiopharmaceuticals labeled with metal radionuclides

    SciTech Connect

    Welch, M.J.

    1992-06-01

    We recently developed a useful zinc-62/copper-62 generator and are presently evaluating copper-62 radiopharmaceuticals for clinical studies. While developing these copper-62 radiopharmaceuticals, in collaboration with the University of Missouri Research Reactor, Columbia we have also explored copper-64 radiopharmaceuticals. The PET images we obtained with copper-64 tracers were of such high quality that we have developed and evaluated copper-64 labeled antibodies for PET imaging. The major research activities described herein include: the development and assessment of gallium-68 radiopharmaceuticals; the development and evaluation of a new zinc-62/copper-62 generator and the assessment of copper-62 radiopharmaceuticals; mechanistic studies on proteins labeled with metal radionuclides.

  7. Radionuclide partitioning across great lakes natural interfaces

    NASA Astrophysics Data System (ADS)

    Platford, R. F.; Joshi, S. R.

    1989-11-01

    Several water and surface microlayer samples from Lake St. Clair, the Niagara River, and the North Shore of Lake Ontario collected during 1983 1986 have been assayed for a variety of radionuclides. In addition, the foam accumulating in the pool just below Niagara Falls was also analyzed and found to be the most efficient aqueous phase collector of137Cs,210Pb, and226Ra. The order of radioisotope specific activities from highest to lowest is: Lake Ontario sediment, Niagara River suspended solids, Niagara River foam, surface microlayer water, and subsurface water. Radiological dose rates to the sediments from137Cs,226Ra, and228Th total about 5 mGy/y.

  8. [Radionuclides for metastatic bone pain palliation].

    PubMed

    Lass, Piotr

    2002-10-01

    The paper overviews the role of systemic radionuclide therapy in patients with disseminated bone metastases. Most patients with bone metastases experience painful symptoms. Systemic radioisotope therapy is an alternative to traditional hemibody radiation in cases of multiple, diffuse metastases. Usually given as a single i.v. slow infusion it provides a pain relief beginning in one to three weeks, with a mean duration up to several months, depending on the kind of radioisotope applied. The paper overviews the role of unsealed source therapy with these bone-seeking radiopharmaceuticals in palliating pain, improving quality of life, indications, contraindications and complications of this therapy are discussed, as well as cost-benefit aspects.

  9. Radionuclide evaluation of nonmalignant bone disorders

    SciTech Connect

    Winzelberg, G.G.

    1983-02-01

    Recent advances in nuclear imaging have improved the noninvasive evaluation of patients with nonmalignant bone disorders. When bone scanning agents are combined with bone marrow scanning agents and gallium-67 scintigraphy, a more accurate diagnosis can be obtained. By selecting the appropriate imaging sequence, it is often possible to distinguish cellulitis from underlying osteomyelitis. In patients with total hip replacements, it may be possible to separate postsurgical changes from prosthetic loosening or infection. Stress fractures in joggers may be detected by radionuclide bone scintigraphy before radiographs become abnormal. These nuclear imaging procedures can be done in most hospitals.

  10. Selective laser ionisation of radionuclide 63Ni

    NASA Astrophysics Data System (ADS)

    Tsvetkov, G. O.; D’yachkov, A. B.; Gorkunov, A. A.; Labozin, A. V.; Mironov, S. M.; Firsov, V. A.; Panchenko, V. Ya.

    2017-02-01

    We report a search for a scheme of selective laser stepwise ionisation of radionuclide 63Ni by radiation of a dye laser pumped by a copper vapour laser. A three-stage scheme is found with ionisation through an autoionising state (AIS): 3d 84s2 3F4(E = 0) → 3d 94p 1Fo3(31030.99 cm‑1) → 3d 94d 2[7/2]4(49322.56 cm‑1) → AIS(67707.61 cm‑1) which, by employing saturated radiation intensities provides the ionisation selectivity of above 1200 for 63Ni.

  11. Critical review: Radionuclide transport, sediment transport, and water quality mathematical modeling; and radionuclide adsorption/desorption mechanisms

    SciTech Connect

    Onishi, Y.; Serne, R.J.; Arnold, E.M.; Cowan, C.E.; Thompson, F.L.

    1981-01-01

    This report describes the results of a detailed literature review of radionuclide transport models applicable to rivers, estuaries, coastal waters, the Great Lakes, and impoundments. Some representatives sediment transport and water quality models were also reviewed to evaluate if they can be readily adapted to radionuclide transport modeling. The review showed that most available transport models were developed for dissolved radionuclide in rivers. These models include the mechanisms of advection, dispersion, and radionuclide decay. Since the models do not include sediment and radionuclide interactions, they are best suited for simulating short-term radionuclide migration where: (1) radionuclides have small distribution coefficients; (2) sediment concentrations in receiving water bodies are very low. Only 5 of the reviewed models include full sediment and radionuclide interactions: CHMSED developed by Fields; FETRA SERATRA, and TODAM developed by Onishi et al, and a model developed by Shull and Gloyna. The 5 models are applicable to cases where: (1) the distribution coefficient is large; (2) sediment concentrations are high; or (3) long-term migration and accumulation are under consideration. The report also discusses radionuclide absorption/desorption distribution ratios and addresses adsorption/desorption mechanisms and their controlling processes for 25 elements under surface water conditions. These elements are: Am, Sb, C, Ce, Cm, Co, Cr, Cs, Eu, I, Fe, Mn, Np, P, Pu, Pm, Ra, Ru, Sr, Tc, Th, {sup 3}H, U, Zn and Zr.

  12. The effect of gravel size fraction on the distribution coefficients of selected radionuclides radionuclides

    SciTech Connect

    Um, Wooyong; Serne, R. Jeffrey; Last, George V.; Glossbrenner, Ellwood T.

    2009-06-26

    This manuscript addresses the consequences of the common practice of assuming that the gravel fraction of sediments does not participate in sorption reactions and thus sorption quantified by the distribution coefficient (Kd) construct can be estimated from laboratory tests on < 2mm fraction of sediments. As shown within the use of this common assumption can lead to inaccurate estimates of the mobility and sorption capacity of key radionuclides (Tc, U, and Np) at the Hanford Site where gravel dominates the lower Hanford formation and upper Ringold Formation. Batch sorption and column experiments showed that the distribution coefficient measured using only < 2mm fraction were not in agreement with those obtained from the bulk sediments depending on the radionuclide. The least reactive radionuclide, Tc showed the lowest effects from the presence of gravel. However, differences between measured Kds using < 2mm fractions of the sediment and the Kds measured on the bulk sediment were significant for strongly reactive radionuclides such as Np, especially on the sediment with gravel fractions that contained highly reactive sites. Highly reactive sites in the gravel fraction were attributed to the presence of Fe oxides coatings and/or reactive fracture faces on the gravel surfaces. Gravel correction factors that use the sum of the Kd,<2 mm and Kd,>2 mm values to estimate the Kd for the bulk sediment were found to best describe Kds for radionuclides on the bulk sediment. However, more detailed characterization of gravel surfaces should be also conducted to identify those gravels with higher reactive sorbents, if present. Gravel correction factors should be considered to predict precisely the sorption capacity of bulk sediments that contain more than 10% gravel and to estimate the mobility of contaminants in subsurface environments.

  13. Lutetium-177 Labeled Bombesin Peptides for Radionuclide Therapy.

    PubMed

    Reynolds, Tamila Stott; Bandari, Rajendra P; Jiang, Zongrun; Smith, Charles J

    2016-01-01

    The rare-earth radionuclides that decay by beta particle (β-) emission are considered to be ideal in the context of targeted radiotherapy. The rare-earth isotopes exist primarily in the 3+ oxidation state and are considered to be hard metal centers, requiring multidentate, hard donor ligands such as the poly(aminocarboxylates) for in vivo kinetic inertness. 177Lu is a rare-earth radionuclide that is produced in moderate specific activity (740 GBq/mg) by direct neutron capture of enriched 176Lu via the 176Lu(n,γ)177Lu nuclear reaction. 177Lu has a half-life of 6.71 d, decays by beta emission (Ebmax = 0.497 MeV), and emits two imagable photons (113keV, 3% and 208kev, 11%). High specific activity, no-carrier-added 177Lu can also be prepared by an indirect neutron capture nuclear reaction on a 176Yb target. Herein, we report upon bombesin (BBN) peptides radiolabeled with 177Lu. The impetus driving many of the research studies that we have described in this review is that the high-affinity gastrin releasing peptide receptor (GRPR, BBN receptor subtype 2, BB2) has been identified in tissue biopsy samples and immortalized cell lines of many human cancers and is an ideal biomarker for targeting early-stage disease. Early on, the ability of GRPR agonists to be rapidly internalized coupled with a high incidence of GRPR expression on various neoplasias was a driving force for the design and development of new diagnostic and therapeutic agents targeting GRP receptor-positive tumors. Recent reports, however, show compelling evidence that radiopharmaceutical design and development based upon antagonist-type ligand frameworks clearly bears reexamination. Last of all, the ability to target multiple biomarkers simultaneously via a heterodimeric targeting ligand has also provided a new avenue to investigate the dual targeting capacity of bivalent radioligands for improved in vivo molecular imaging and treatment of specific human cancers. In this report, we describe recent advances

  14. Radionuclide imaging of bone marrow disorders.

    PubMed

    Agool, Ali; Glaudemans, Andor W J M; Boersma, Hendrikus H; Dierckx, Rudi A J O; Vellenga, Edo; Slart, Riemer H J A

    2011-01-01

    Noninvasive imaging techniques have been used in the past for visualization the functional activity of the bone marrow compartment. Imaging with radiolabelled compounds may allow different bone marrow disorders to be distinguished. These imaging techniques, almost all of which use radionuclide-labelled tracers, such as (99m)Tc-nanocolloid, (99m)Tc-sulphur colloid, (111)In-chloride, and radiolabelled white blood cells, have been used in nuclear medicine for several decades. With these techniques three separate compartments can be recognized including the reticuloendothelial system, the erythroid compartment and the myeloid compartment. Recent developments in research and the clinical use of PET tracers have made possible the analysis of additional properties such as cellular metabolism and proliferative activity, using (18)F-FDG and (18)F-FLT. These tracers may lead to better quantification and targeting of different cell systems in the bone marrow. In this review the imaging of different bone marrow targets with radionuclides including PET tracers in various bone marrow diseases are discussed.

  15. Radionuclide complexation in xylem exudates of plants

    SciTech Connect

    Cataldo, D.A.; McFadden, D.M.; Garland, T.R.; Wildung, R.E.

    1985-04-01

    The plant xylem is the primary avenue for transport of nutrient and pollutant elements from the roots of aerial portions of the plant. It is proposed that the transport of reactive or hydrolyzable ions is facilitated by the formation of stable/soluble complexes with organic metabolites. The xylem exudates of soybean (Glycine max cv. Williams) were characterized as to their inorganic and organic components, complexation patterns for radionuclides, both in vivo and in vitro, and for class fractions of exudates using thin-layer electrophoresis. The radionuclides Pu-238 and Fe-59 were found primarily as organic acid complexes, while Ni-63 and Cd-109 were associated primarily with components of the amono acid fraction. Technetium-99 was found to be uncomplexed and transported as the pertechnetate ion. It was not possible to duplicate fully complexes formed in vivo by back reaction with whole exudates or class fractions, indicating the possible importance of plant induction processes, reaction kinetics and/or the formation of mixed ligand complexes. 28 refs., 4 figs.

  16. Traces of natural radionuclides in animal food

    NASA Astrophysics Data System (ADS)

    Merli, Isabella Desan; da Silveira, Marcilei A. Guazzelli; Medina, Nilberto H.

    2014-11-01

    Naturally occurring radioactive materials are present everywhere, e.g., in soil, air, housing materials, food, etc. Therefore, human beings and animals receive internal exposure from radioactive elements inside their bodies through breathing and alimentation. Gamma radiation has enough energy to remove an electron from the atom and compromise the rearrangement of electrons in the search for a more stable configuration which can disturb molecule chemical bonding. Food ingestion is one of the most common forms of radioisotopes absorption. The goal of this work is the measurement of natural gamma radiation rates from natural radioisotopes present in animal food. To determine the concentration of natural radionuclides present in animal food gamma-ray spectrometry was applied. We have prepared animal food samples for poultry, fish, dogs, cats and cattle. The two highest total ingestion effective doses observed refers to a sample of mineral salt cattle, 95.3(15) μSv/year, rabbit chow, with a value of 48(5) μSv/year, and cattle mineral salt, with a value of 69(7) μSv/year, while the annual total dose value from terrestrial intake radionuclide is of the order of 290 μSv/year.

  17. Application of radionuclide ventriculography to cardiac screening

    SciTech Connect

    Lindsay, J. Jr.; Milner, M.R.; Chandeysson, P.L.; Rodman, D.J.; Okin, P.M.; Goldstein, S.A.

    1989-05-01

    Screening asymptomatic individuals for latent coronary disease often requires sequential testing because exercise electrocardiography typically produces more false positive than true positive results in a population with a low prevalence of coronary disease. Cardiac scintigraphy is a technique that may be employed as a confirmatory test in lieu of coronary arteriography to further evaluate the significance of a positive exercise electrocardiogram. Radionuclide ventriculography was employed in 98 asymptomatic individuals who were considered to be at moderate risk of heart disease after risk factor analysis and exercise electrocardiography. Seventeen (17%) patients had an abnormal study and underwent cardiac catheterization. Seven had coronary artery disease, two had cardiomyopathy, and eight were normal. Eighty-one (83%) patients had a normal study. Because the sensitivity of radionuclide ventriculography is 63-80%, it was postulated that 2 to 5 individuals with disease were missed. Thus, from a population with an 11-14% prevalence of disease, two subsets were identified. A large subset in which a prevalence of 2-6% could be estimated was separated from a much smaller one in which a prevalence of approximately 50% was demonstrated.

  18. FOREWORD: Special issue on radionuclide metrology

    NASA Astrophysics Data System (ADS)

    Simpson, Bruce; Judge, Steven

    2007-08-01

    This special issue of Metrologia on radionuclide metrology is the first of a trilogy on the subject of ionizing radiation measurement, a field that is overseen by Sections I, II and III of the CIPM's Consultative Committee for Ionizing Radiation (CCRI). The idea was first proposed at the 2003 series of CCRI Section meetings, with the general aim of showcasing the relevance and importance of metrology in ionizing radiation to a broader metrological audience. After the 2005 meeting of Section II (measurement of radionuclides), the radioactivity aspect of the project began to move forward in earnest. A working group was set up with the brief that the special issue should be of use by experienced metrologists as an overview of the 'state of the art' to compare progress and scientific content with those in other fields of metrology, as a resource for new metrologists joining the field and as a guide for users of radioactivity to explain how traceability to the international measurement system may be achieved. Since mankind first became aware of the existence of radioactivity just over a century ago (due to its discovery by Becquerel and further work by the Curies), much has been learnt and understood in the interim period. The field of radionuclide metrology that developed subsequently is broad-based and encompasses, amongst others, nuclear physics (experimental and theory), chemistry, mathematics, mathematical statistics, uncertainty analysis and advanced computing for data analysis, simulation and modelling. To determine the activity of radionuclides accurately requires elements of all of these subjects. In more recent decades the focus has been on the practical applications of radioactivity in industry and the health field in particular. In addition, low-level environmental radioactivity monitoring has taken on ever greater importance in the nuclear power era. These developments have required new detection instrumentation and techniques on an ongoing basis to ensure

  19. Patient-specific internal radionuclide dosimetry.

    PubMed

    Tsougos, Ioannis; Loudos, George; Georgoulias, Panagiotis; Theodorou, Kiki; Kappas, Constantin

    2010-02-01

    The development of patient-specific treatment planning systems is of outmost importance in the development of radionuclide dosimetry, taking into account that quantitative three-dimensional nuclear medical imaging can be used in this regard. At present, the established method for dosimetry is based on the measurement of the biokinetics by serial gamma-camera scans, followed by calculations of the administered activity and the residence times, resulting in the radiation-absorbed doses of critical organs. However, the quantification of the activity in different organs from planar data is hampered by inaccurate attenuation and scatter correction as well as because of background and organ overlay. In contrast, dosimetry based on quantitative three-dimensional data can be more accurate and allows an individualized approach, provided that all effects that degrade the quantitative content of the images have been corrected for. In addition, inhomogeneous organ accumulation of the radionuclide can be detected and possibly taken into account. The aim of this work is to provide adequate information on internal emitter dosimetry and a state-of-the-art review of the current methodology and future trends.

  20. [Radionuclide therapy of endocrine-related cancer].

    PubMed

    Kratochwil, C; Giesel, F L

    2014-10-01

    This article gives an overview of the established radionuclide therapies for endocrine-related cancer that already have market authorization or are currently under evaluation in clinical trials. Radioiodine therapy is still the gold standard for differentiated iodine-avid thyroid cancer. In patients with bone and lung metastases (near) total remission is seen in approximately 50% and the 15-year survival rate for these patients is approximately 90%. In contrast to the USA, meta-iodobenzylguanidine (MIBG) therapy has market approval in Europe. According to the current literature, in the setting of advanced stage neuroblastoma and malignant pheochromocytoma or paraganglioma, radiological remission can be achieved in >30% and symptom control in almost 80% of the treated patients. Somatostatin receptor targeted radionuclide therapies (e.g. with DOTATATE or DOTATOC) demonstrated promising results in phase 2 trials, reporting progression-free survival in the range of 24-36 months. A first phase 3 pivotal trial for intestinal carcinoids is currently recruiting and another trial for pancreatic neuroendocrine tumors is planned. Radiopharmaceuticals based on glucagon-like peptide 1 (GLP1) or minigastrins are in the early evaluation stage for application in the treatment of insulinomas and medullary thyroid cancer. In general, radiopharmaceutical therapy belongs to the group of so-called theranostics which means that therapy is tailored for individual patients based on molecular imaging diagnostics to stratify target positive or target negative tumor phenotypes.

  1. Radionuclide measurement of differential glomerular filtration rate

    SciTech Connect

    Powers, T.A.; Stone, W.J.; Grove, R.B.; Plunkett, J.M.; Kadir, S.; Patton, J.A.; Bowen, R.D.

    1981-01-01

    The authors sought to determine whether radionuclides could provide a reasonable estimate of differential renal function in five normal dogs and six dogs with unilateral segmental renal infarction. Glomerular filtration rate (GFR) of each kidney was measured by the standard technique using constant infusions of 99mTc-DTPA, iothalamate, and creatinine following ureteral catheterization. These results were correlated with total GFR estimated by bolus injection of 99mTc-DTPA and analysis of the plasma 99mTc-DTPA disappearance curve obtained by blood sampling. Differential GFR was then calculated by multiplying the total GFR from double exponential analysis of this curve (DTPA2) by each of three measures of differential function. These include the percent differential uptake of 99mTc-DTPA and 99mTc-DMSA in the posterior projection as well as the geometric mean of 99mTc-DMSA uptake. There were good correlations between differential GFR calculated from iothalamate clearances obtained at ureteral catheterization and all noninvasive methods involving radionuclides and DTPA2 (r = 0.85 - 0.99). Single exponential analysis of the 99mTc-DTPA plasma disappearance curve was less satisfactory. The authors suggest that measurement of total and differential GFR calculated from plasma clearance of 99mTc-DTPA and external counting may be a useful method with potential clinical applications.

  2. Traces of natural radionuclides in animal food

    SciTech Connect

    Merli, Isabella Desan; Guazzelli da Silveira, Marcilei A.; Medina, Nilberto H.

    2014-11-11

    Naturally occurring radioactive materials are present everywhere, e.g., in soil, air, housing materials, food, etc. Therefore, human beings and animals receive internal exposure from radioactive elements inside their bodies through breathing and alimentation. Gamma radiation has enough energy to remove an electron from the atom and compromise the rearrangement of electrons in the search for a more stable configuration which can disturb molecule chemical bonding. Food ingestion is one of the most common forms of radioisotopes absorption. The goal of this work is the measurement of natural gamma radiation rates from natural radioisotopes present in animal food. To determine the concentration of natural radionuclides present in animal food gamma-ray spectrometry was applied. We have prepared animal food samples for poultry, fish, dogs, cats and cattle. The two highest total ingestion effective doses observed refers to a sample of mineral salt cattle, 95.3(15) μSv/year, rabbit chow, with a value of 48(5) μSv/year, and cattle mineral salt, with a value of 69(7) μSv/year, while the annual total dose value from terrestrial intake radionuclide is of the order of 290 μSv/year.

  3. Reuse of Material Containing Natural Radionuclides - 12444

    SciTech Connect

    Metlyaev, E.G.; Novikova, N.J.

    2012-07-01

    Disposal of and use of wastes containing natural radioactive material (NORM) or technologically enhanced natural radioactive material (TENORM) with excessive natural background as a building material is very important in the supervision body activity. At the present time, the residents of Octyabrsky village are under resettlement. This village is located just near the Priargunsky mining and chemical combine (Ltd. 'PPGHO'), one of the oldest uranium mines in our country. The vacated wooden houses in the village are demolished and partly used as a building material. To address the issue of potential radiation hazard of the wooden beams originating from demolition of houses in Octyabrsky village, the contents of the natural radionuclides (K-40, Th-232, Ra-226, U- 238) are being determined in samples of the wooden beams of houses. The NORM contents in the wooden house samples are higher, on average, than their content in the reference sample of the fresh wood shavings, but the range of values is rather large. According to the classification of waste containing the natural radionuclides, its evaluation is based on the effective specific activity. At the effective specific activity lower 1.5 kBq/kg and gamma dose rate lower 70 μR/h, the material is not considered as waste and can be used in building by 1 - 3 classes depending upon A{sub eff} value. At 1.5 kBq/kg < A{sub eff} ≤ 4 kBq/kg (4 class), the wooden beams might be used for the purpose of the industrial building, if sum of ratios between the radionuclide specific activity and its specific activity of minimum significance is lower than unit. The material classified as the waste containing the natural radionuclides has A{sub eff} higher 1.5 kBq /kg, and its usage for the purpose of house-building and road construction is forbidden. As for the ash classification and its future usage, such usage is unreasonable, because, according to the provided material, more than 50% of ash samples are considered as radioactive

  4. Sources of anthropogenic radionuclides in the environment: a review.

    PubMed

    Hu, Qin-Hong; Weng, Jian-Qing; Wang, Jin-Sheng

    2010-06-01

    Studies of radionuclides in the environment have entered a new era with the renaissance of nuclear energy and associated fuel reprocessing, geological disposal of high-level nuclear wastes, and concerns about national security with respect to nuclear non-proliferation. This work presents an overview on sources of anthropogenic radionuclides in the environment, as well as a brief discussion of salient geochemical behavior of important radionuclides. We first discuss the following major anthropogenic sources and current developments that have lead, or could potentially contribute, to the radionuclide contamination of the environment: (1) nuclear weapons program; (2) nuclear weapons testing; (3) nuclear power plants; (4) uranium mining and milling; (5) commercial fuel reprocessing; (6) geological repository of high-level nuclear wastes that include radionuclides might be released in the future, and (7) nuclear accidents. Then, we briefly summarize the inventory of radionuclides (99)Tc and (129)I, as well as geochemical behavior for radionuclides (99)Tc, (129)I, and (237)Np, because of their complex geochemical behavior, long half-lives, and presumably high mobility in the environment; biogeochemical cycling and environment risk assessment must take into account speciation of these redox-sensitive radionuclides.

  5. Radionuclide site survey report, Melbourne, Florida (RN-72). Final report

    SciTech Connect

    Walker, F.; Lucas, J.; Owen, M.; McKethan, E.M.; MacCartney, J.

    1998-11-16

    The format and content of this report are based on guidance provided by the Preparatory Commission for the CTBT Organization for conducting and documenting radionuclide site surveys (see GTBT/PC/IV/WGB/1) ``Requirements of Site Surveys for Radionuclide Stations``, (30 September 1997). The purpose of this report is to validate that the Melbourne site will fulfill the requirements for treaty compliance.

  6. 21 CFR 892.1420 - Radionuclide test pattern phantom.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Radionuclide test pattern phantom. 892.1420 Section 892.1420 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1420 Radionuclide test pattern...

  7. 21 CFR 892.1390 - Radionuclide rebreathing system.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Radionuclide rebreathing system. 892.1390 Section 892.1390 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1390 Radionuclide rebreathing...

  8. 21 CFR 892.1390 - Radionuclide rebreathing system.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Radionuclide rebreathing system. 892.1390 Section 892.1390 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1390 Radionuclide rebreathing...

  9. 21 CFR 892.1420 - Radionuclide test pattern phantom.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Radionuclide test pattern phantom. 892.1420 Section 892.1420 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1420 Radionuclide test pattern...

  10. 21 CFR 892.1360 - Radionuclide dose calibrator.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Radionuclide dose calibrator. 892.1360 Section 892.1360 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1360 Radionuclide dose calibrator....

  11. 21 CFR 892.1360 - Radionuclide dose calibrator.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Radionuclide dose calibrator. 892.1360 Section 892.1360 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1360 Radionuclide dose calibrator....

  12. 21 CFR 892.1360 - Radionuclide dose calibrator.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Radionuclide dose calibrator. 892.1360 Section 892.1360 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1360 Radionuclide dose calibrator....

  13. 21 CFR 892.1390 - Radionuclide rebreathing system.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Radionuclide rebreathing system. 892.1390 Section 892.1390 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1390 Radionuclide rebreathing...

  14. 21 CFR 892.1360 - Radionuclide dose calibrator.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Radionuclide dose calibrator. 892.1360 Section 892.1360 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1360 Radionuclide dose calibrator....

  15. 21 CFR 892.1360 - Radionuclide dose calibrator.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Radionuclide dose calibrator. 892.1360 Section 892.1360 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1360 Radionuclide dose calibrator....

  16. 21 CFR 892.1390 - Radionuclide rebreathing system.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Radionuclide rebreathing system. 892.1390 Section 892.1390 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1390 Radionuclide rebreathing...

  17. 21 CFR 892.1420 - Radionuclide test pattern phantom.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Radionuclide test pattern phantom. 892.1420 Section 892.1420 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1420 Radionuclide test pattern...

  18. 21 CFR 892.1390 - Radionuclide rebreathing system.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Radionuclide rebreathing system. 892.1390 Section 892.1390 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1390 Radionuclide rebreathing...

  19. 21 CFR 892.1420 - Radionuclide test pattern phantom.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Radionuclide test pattern phantom. 892.1420 Section 892.1420 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1420 Radionuclide test pattern...

  20. 21 CFR 892.1420 - Radionuclide test pattern phantom.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Radionuclide test pattern phantom. 892.1420 Section 892.1420 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Diagnostic Devices § 892.1420 Radionuclide test pattern...

  1. 21 CFR 892.5650 - Manual radionuclide applicator system.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Manual radionuclide applicator system. 892.5650 Section 892.5650 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES... system. (a) Identification. A manual radionuclide applicator system is a manually operated...

  2. 21 CFR 892.5750 - Radionuclide radiation therapy system.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Radionuclide radiation therapy system. 892.5750 Section 892.5750 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES... system. (a) Identification. A radionuclide radiation therapy system is a device intended to permit...

  3. 21 CFR 892.5750 - Radionuclide radiation therapy system.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Radionuclide radiation therapy system. 892.5750 Section 892.5750 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES... system. (a) Identification. A radionuclide radiation therapy system is a device intended to permit...

  4. 21 CFR 892.5750 - Radionuclide radiation therapy system.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Radionuclide radiation therapy system. 892.5750 Section 892.5750 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES... system. (a) Identification. A radionuclide radiation therapy system is a device intended to permit...

  5. 21 CFR 892.5750 - Radionuclide radiation therapy system.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Radionuclide radiation therapy system. 892.5750 Section 892.5750 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES... system. (a) Identification. A radionuclide radiation therapy system is a device intended to permit...

  6. 21 CFR 892.5650 - Manual radionuclide applicator system.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Manual radionuclide applicator system. 892.5650 Section 892.5650 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES... system. (a) Identification. A manual radionuclide applicator system is a manually operated...

  7. 21 CFR 892.5650 - Manual radionuclide applicator system.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Manual radionuclide applicator system. 892.5650 Section 892.5650 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES... system. (a) Identification. A manual radionuclide applicator system is a manually operated...

  8. Radionuclide concentrations in white sturgeon from the Columbia River

    SciTech Connect

    Dauble, D.D.; Price, K.R.; Poston, T.M.

    1992-09-01

    Although radioactive releases from the US Department of Energy`s Hanford Site have been monitored in the environment since the reactors began operating in 1945, recent information regarding historical releases of radionuclides has led to renewed interest in estimating human exposure to radionuclides at Hanford. Knowledge of the fate of radionuclides in some fish species may be important because of the potential for food-chain transfer to humans. White sturgeon (Acipenser transmontanus) were selected for study because they are long-lived, reside year-round in the Hanford Reach, are benthic, and are an important commercial and sport species in the Columbia River. They also have a greater potential for accumulating persistent radionuclides than shorter-lived species with pelagic and/or anadromous life histories. The purpose of our study was to summarize data on historical concentrations of industrial radionuclides in white sturgeon and to collect additional data on current body burdens in the Columbia River.

  9. Radionuclide concentrations in white sturgeon from the Columbia River

    SciTech Connect

    Dauble, D.D.; Price, K.R.; Poston, T.M.

    1992-09-01

    Although radioactive releases from the US Department of Energy's Hanford Site have been monitored in the environment since the reactors began operating in 1945, recent information regarding historical releases of radionuclides has led to renewed interest in estimating human exposure to radionuclides at Hanford. Knowledge of the fate of radionuclides in some fish species may be important because of the potential for food-chain transfer to humans. White sturgeon (Acipenser transmontanus) were selected for study because they are long-lived, reside year-round in the Hanford Reach, are benthic, and are an important commercial and sport species in the Columbia River. They also have a greater potential for accumulating persistent radionuclides than shorter-lived species with pelagic and/or anadromous life histories. The purpose of our study was to summarize data on historical concentrations of industrial radionuclides in white sturgeon and to collect additional data on current body burdens in the Columbia River.

  10. Atmospheric radionuclide concentrations measured by Pacific Northwest Laboratory since 1961

    SciTech Connect

    Young, J.A.; Thomas, C.W.

    1981-03-01

    The atmospheric concentrations of a wide spectrum of radionuclides produced by nuclear weapons, nuclear reactors, cosmic rays, radon and thoron decay and the SNAP-9A burn-up ({sup 238}Pu) have been measured at Richland, Washington, since 1961; at Barrow, Alaska, since 1964; and at other stations for shorter periods of time. There has been considerable concern over the health hazard presented by these radionuclides, but it has also been recognized that atmospheric mixing and deposition rates can be determined from their measurement. Therefore, Pacific Northwest Laboratory began the continuous measurement of the atmospheric concentrations of a wide spectrum of radionuclides produced by nuclear weapons, nuclear reactors, cosmic rays, and radon and thoron decay. This report will discuss the concentrations of the longer-lived radionuclides (T 1/2 > 12 days). The concentrations of shorter-lived radionuclides measured following Chinese nuclear tests since 1972 are discussed in another report.

  11. Atmospheric radionuclide concentrations measured by Pacific Northwest Laboratory since 1961

    SciTech Connect

    Young, J.A.; Thomas, C.W.

    1981-03-01

    The atmospheric concentrations of a wide spectrum of radionuclides produced by nuclear weapons, nuclear reactors, cosmic rays, radon and thoron decay and the SNAP-9A burn-up ([sup 238]Pu) have been measured at Richland, Washington, since 1961; at Barrow, Alaska, since 1964; and at other stations for shorter periods of time. There has been considerable concern over the health hazard presented by these radionuclides, but it has also been recognized that atmospheric mixing and deposition rates can be determined from their measurement. Therefore, Pacific Northwest Laboratory began the continuous measurement of the atmospheric concentrations of a wide spectrum of radionuclides produced by nuclear weapons, nuclear reactors, cosmic rays, and radon and thoron decay. This report will discuss the concentrations of the longer-lived radionuclides (T 1/2 > 12 days). The concentrations of shorter-lived radionuclides measured following Chinese nuclear tests since 1972 are discussed in another report.

  12. Quantitative modeling of Cerenkov light production efficiency from medical radionuclides.

    PubMed

    Beattie, Bradley J; Thorek, Daniel L J; Schmidtlein, Charles R; Pentlow, Keith S; Humm, John L; Hielscher, Andreas H

    2012-01-01

    There has been recent and growing interest in applying Cerenkov radiation (CR) for biological applications. Knowledge of the production efficiency and other characteristics of the CR produced by various radionuclides would help in accessing the feasibility of proposed applications and guide the choice of radionuclides. To generate this information we developed models of CR production efficiency based on the Frank-Tamm equation and models of CR distribution based on Monte-Carlo simulations of photon and β particle transport. All models were validated against direct measurements using multiple radionuclides and then applied to a number of radionuclides commonly used in biomedical applications. We show that two radionuclides, Ac-225 and In-111, which have been reported to produce CR in water, do not in fact produce CR directly. We also propose a simple means of using this information to calibrate high sensitivity luminescence imaging systems and show evidence suggesting that this calibration may be more accurate than methods in routine current use.

  13. Accumulation of radionuclides by plants as a monitor system.

    PubMed Central

    Koranda, J J; Robison, W L

    1978-01-01

    The accumulation of radionuclides by plants acting as a monitoring system in the environment may occur by two modes; foliar absorption by the leaves and shoot of the plant, or by root uptake from the soil. Data on plant accumulation of radionuclides may be obtained from studies of fission product radionuclides deposited as worldwide fallout, and from tracer studies of plant physiology. The epidermal features of plant foliage may exert an effect upon particle retention by leaves, and subsequent uptake of radionuclides from the surface. The transport of radionuclides across the cuticle and epidermis of plant leaves is determined in part by the anatomy of the leaf, and by physiological factors. The foliar uptake of fallout radionuclides, 99Sr, 131I, and 137Cs, is described with examples from the scientific literature. The environmental half-life of 131I, for example, is considerably shorter than its physical half-life because of physical and biological factors which may produce a half-life as short as 0.23/day. 99Sr and 137Cs are readily taken up by the leaf, but 137Cs undergoes more translocation into fruit and seeds than 99Sr which tends to remain in the plant part in which it was initially absorbed. Soil-root uptake is conditioned primarily by soil chemical and physical factors which may selectively retain a radionuclide, such as 137Cs. The presence of organic matter, inorganic colloids (clay), and competing elements will strongly affect the uptake of 99Sr and 137Cs by plants from the soil. The role of plants as monitors of radionuclides is twofold: as monitors of recent atmospheric releases of radionuclides; and as indicators of the long-term behavior of aged deposits of radionuclides in the soil. PMID:367767

  14. 49 CFR 173.433 - Requirements for determining basic radionuclide values, and for the listing of radionuclides on...

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... of the parent nuclide, will be considered as a single radionuclide, and the activity to be taken into account and the A1 or A2 value to be applied will be those corresponding to the parent nuclide of that... single radioactive decay chain in which the radionuclides are present in their...

  15. Radionuclides accumulation in milk and its products

    NASA Astrophysics Data System (ADS)

    Marmuleva, N. I.; Barinov, E. Ya.; Petukhov, V. L.

    2003-05-01

    The problem of radioactive pollution is extremely urgent in Russia in connection with presence of territories polluted by radionuclides on places of nuclear tests, in zones around the enterprises on production, processing and storage of radioactive materials, and also in areas of emergency pollution (Barakhtin, 2001). The aim of our investigation was a determination of the levels of the main radioactive elements - Cs-137 and Sr-90 in diary products. 363 samples of milk, dry milk, butter, cheese and yogurt from Novosibirsk region were examined. Cs-137 level was 3.7...9.2 times higher than Sr-90 one in milk, cheese and yogurt. At the same time the level of these radio nuclides in butter was identical (8.03 Bk/kg).

  16. Hydroponic phytoremediation of heavy metals and radionuclides

    SciTech Connect

    Hartong, J.; Szpak, J.; Hamric, T.; Cutright, T.

    1998-07-01

    It is estimated that the Departments of Defense, Energy, and Agriculture will spend up to 300 billion federal dollars on environmental remediation during the next century. Current remediation processes can be expensive, non-aesthetic, and non-versatile. Therefore, the need exists for more innovative and cost effective solutions. Phytoremediation, the use of vegetation for the remediation of contaminated sediments, soils, and ground water, is an emerging technology for treating several categories of persistent, toxic contaminants. Although effective, phytoremediation is still in a developmental stage, and therefore is not a widely accepted technology by regulatory agencies and public groups. Research is currently being conducted to validate the processes effectiveness as well as increase regulatory and community acceptance. This research will focus on the ability of plants to treat an aquifer contaminated with heavy metals and radionuclides. Specifically, the effectiveness of hydroponically grown dwarf sunflowers and mustard seed will be investigated.

  17. Cadastral valuation of land contaminated with radionuclides

    NASA Astrophysics Data System (ADS)

    Ratnikov, A. N.; Sapozhnikov, P. M.; Sanzharova, N. I.; Sviridenko, D. G.; Zhigareva, T. L.; Popova, G. I.; Panov, A. V.; Kozlova, I. Yu.

    2016-01-01

    The methodology and procedure for cadastral valuation of land in the areas contaminated with radionuclides are presented. The efficiency of rehabilitation measures applied to decrease crop contamination to the levels satisfying sanitary-hygienic norms is discussed. The differentiation of cadastral value of radioactively contaminated agricultural lands for the particular farms and land plots is suggested. An example of cadastral valuation of agricultural land contaminated during the Chernobyl Nuclear Power Plant accident is given. It is shown that the use of sandy and loamy sandy soddy-podzolic soils with the 137Cs contamination of 37-185 and >185 kBq/m2 for crop growing is unfeasible. The growing of grain crops and potatoes on clay loamy soddy-podzolic soils with the 137Cs contamination of 555-740 kBq/m2 is unprofitable. The maximum cadastral value of radioactively contaminated lands is typical of leached chernozems.

  18. Fracture occurrence from radionuclides in the skeleton

    SciTech Connect

    Lloyd, R.D.; Taylor, G.N.; Miller, S.C.

    2000-06-01

    Because skeletal fractures were an important finding among persons contaminated with {sup 226}Ra, experience with fractures among dogs in the colony was summarized to determine the projected significance for persons contaminated with bone-seeking radionuclides. Comparison by Fisher's Exact Test of lifetime fracture occurrence in the skeletons of beagles injected as young adults suggested that for animals given {sup 226}Ra, {sup 228}Ra, {sup 228}Th, or {sup 239}Pu citrate, there was probably an excess over controls in fractures of the ribs, leg bones, spinous processes, and pelvis (os coxae) plus the mandible for dogs given {sup 226}Ra and the scapulae for dogs given {sup 228}Ra or 228 Th. Regression analysis indicated that significantly elevated fracture occurrence was especially notable at the higher radiation doses, at about 50 Gy average skeletal dose for {sup 239}Pu, 140 Gy for {sup 226}Ra, about 40 Gy for {sup 228}Ra, and more than 15 Gy for {sup 228}Th. The average number of fractures per dog was significantly elevated over that noted in controls for the highest radiation doses of {sup 239}Pu and {sup 226}Ra and for the higher doses of {sup 228}Ra and {sup 228}Th. For those dogs given {sup 90}Sr citrate, there was virtually no important difference from control beagles not given radionuclides, even at group mean cumulative skeletal radiation doses up to 101 Gy. Because of a large proportion of dogs with fractures that died with bone malignancy (even at dosage levels lower than those exhibiting an excess average number of fractures per dog), they conclude that fracture would not be an important endpoint at lower levels of plutonium contamination in humans such as would be expected to occur from occupational or environmental exposure.

  19. Chancellor Water Colloids: Characterization and Radionuclide Association

    SciTech Connect

    Abdel-Fattah, Amr I.

    2012-06-18

    Concluding remarks about this paper are: (1) Gravitational settling, zeta potential, and ultrafiltration data indicate the existence of a colloidal phase of both the alpha and beta emitters in the Chancellor water; (2) The low activity combined with high dispersion homogeneity of the Chancellor water indicate that both alpha and beta emitters are not intrinsic colloids; (3) Radionuclides in the Chancellor water, particularly Pu, coexist as dissolved aqueous and sorbed phases - in other words the radionuclides are partitioned between the aqueous phase and the colloidal phase; (4) The presence of Pu as a dissolved species in the aqueous phase, suggests the possibility of Pu in the (V) oxidation state - this conclusion is supported by the similarity of the k{sub d} value of Pu determined in the current study to that determined for Pu(V) sorbed onto smectite colloids, and the similar electrokinetic behavior of the Chancellor water colloids to smectite colloids; (5) About 50% of the Pu(V) is in the aqueous phase and 50% is sorbed on colloids (mass concentration of colloids in the Chancellor water is 0.12 g/L); (6) The k{sub d} of the Pu and the beta emitters (fission products) between aqueous and colloidal phases in the Chancellor water is {approx}8.0 x 10{sup 3} mL/g using two different activity measurement techniques (LSC and alpha spectroscopy); (7) The gravitational settling and size distributions of the association colloids indicate that the properties (at least the physical ones) of the colloids to which the alpha emitters are associated with seem to be different that the properties of the colloids to which the beta emitters are associated with - the beta emitters are associated with very small particles ({approx}50 - 120 nm), while the alpha emitters are associated with relatively larger particles; and (8) The Chancellor water colloids are extremely stable under the natural pH and ionic strength conditions, indicating high potential for transport in the

  20. Identification of radionuclides of concern in Hanford Site environmental cleanup

    SciTech Connect

    Perkins, R.W.; Jenquin, U.P.

    1994-08-01

    The purpose of this document is to consider which radionuclides should be included in conducting environmental surveys relative to site remediation at Hanford. During the operation of the Hanford site, the fission product radionuclides and a large number of activation products including the transuranic radionuclides were formed. The reactor operations and subsequent chemical processing and metallurgical operations resulted in the environmental release of gaseous and liquid effluents containing some radionuclides; however, the majority of the radionuclides were stored in waste tanks or disposed to trenches and cribs. Since some contamination of both soils and subsurface waters occurred, one must decide which radionuclides still remain in sufficient amounts to be of concern at the time when site remediation is to be complete. Many of the radionuclides which have constituted the principal hazard during site operation have half-lives on the order of a year or less; therefore, they will have decayed to insignificant amounts by the year 2030, a possible date for completion of the remediation process.

  1. [Dependence of uniformity on the radionuclide in SPECT: test methods].

    PubMed

    Kalnischke, Heiko; Grebe, Gerhard; Zander, Andreas; Munz, Dieter Ludwig; Geworski, Lilli

    2004-01-01

    The aim of this study was to investigate test methods to clarify whether the non-uniformity of a gamma camera depends on individual radionuclides, and whether it is necessary to measure a separate correction matrix for each radionuclide used in single photon emission computed tomography (SPECT). Two methods were devised to verify the nuclide-dependence of the gamma camera. In order to test the energy correction of the detectors, the first approach was based on the evaluation of the intrinsic non-uniformity and on the production of images with asymmetrical energy window. The second method was based on the production of correction matrices for different radionuclides, as well as on the subsequent application to phantom data that were also generated with different radionuclides. The investigation of a dualhead gamma camera produced the same results with both methods. One detector head was found to be weakly dependent on the radionuclide, due to the insufficient quality of energy correction. In this case, the phantom or patient data should be corrected using a uniformity correction matrix measured with the same radionuclide. The second detector remained nuclide-independent; in this case the uniformity correction matrix acquired for only one radionuclide was sufficient.

  2. Dynamics and transformations of radionuclides in soils and ecosystem health

    SciTech Connect

    Fellows, Robert J. ); Ainsworth, Calvin C. ); Driver, Crystal J. ); Cataldo, Dominic A. )

    1998-12-01

    The chemical behavior of radionuclides can vary widely in soil and sediment environments. Equally important, for a given radionuclide the physico-chemical properties of the solids and aqueous phase can greatly influence a radionuclides behavior. Radionuclides can conceivably occur in soils as soluble-free, inorganic-soluble-complexed, organic-soluble, complexed, adsorbed, precipitated, coprecipitated, or solid structural species. While it is clear that an assessment of a radionuclide?s soil chemistry and potential shifts in speciation will yield a considerable understanding of its behavior in the natural environment, it does not directly translate to bioavailability or its impact on ecosystems health. The soil chemical factors have to be linked to food chain considerations and other ecological parameters that directly tie to an analysis of ecosystem health. In general, the movement of radionuclides from lower to higher trophic levels diminishes with each trophic level in both aqua tic and terrestrial systems. In some cases, transfer is limited because of low absorption/assimilation by successive trophic organisms (Pu, U); for other radionuclides (Tc, H) assimilation may be high but rapid metabolic turnover and low retention greatly reduce tissue concentrations available to predator species. Still others are chemical analogs of essential elements whose concentrations are maintained under strict metabolic control in tissues (Cs) or are stored in tissues seldom consumed by other organisms (Sr storage in exoskeleton, shells, and bone). Therefore, the organisms that receive the greatest ingestion exposures are those in lower trophic positions or are in higher trophic levels but within simple, short food chains. Food source, behavior, and habitat influence the accumulation of radionuclides in animals.

  3. Survey of radionuclides in foods, 1978-1982

    SciTech Connect

    Stroube, W.B. Jr.; Jelinek, C.F.; Baratta, E.J.

    1985-11-01

    Samples from the U.S. Food and Drug Administration's total-diet, market-basket program, samples of imported foods, and samples collected near nuclear power plants were analyzed for radionuclides. Most radionuclides were below the limit of detection for a majority of the samples; however, data are reported for 3H, 90Sr and 137Cs in certain samples. Generally a downward trend is observed for 90Sr when data for the 5-yr period were compared. The total dietary intake of either 90Sr or 137Cs is well within Range I of the Federal Radiation Council (FRC) radiation protection guides for these radionuclides.

  4. Geomorphic control of radionuclide diffusion in desert soils

    NASA Astrophysics Data System (ADS)

    Pelletier, Jon D.; Harrington, Charles D.; Whitney, John W.; Cline, Michael; DeLong, Stephen B.; Keating, Gordon; Ebert, K. Teryn

    2005-12-01

    Diffusion is a standard model for the vertical migration of radionuclides in soil profiles. Here we show that diffusivity values inferred from fallout 137Cs profiles in soils on the Fortymile Wash alluvial fan, Nye County, Nevada, have a strong inverse correlation with the age of the geomorphic surface. This result suggests that radionuclide-bound particles are predominantly transported by infiltration rather than by bulk-mixing processes such as wetting/drying, freeze/thaw, and bioturbation. Our results provide a preliminary basis for using soil-geomorphic mapping, point-based calibration data, and the diffusion model to predict radionuclide transport in desert soils within a pedotransfer-function approach.

  5. Selection of plants for phytoremediation of soils contaminated with radionuclides

    SciTech Connect

    Entry J.A.; Vance, N.C.; Watrud, L.S.

    1996-12-31

    Remediation of soil contaminated with radionuclides typically requires that soil be removed from the site and treated with various dispersing and chelating chemicals. Numerous studies have shown that radionuclides are generally not leached from the top 0.4 meters of soil, where plant roots actively accumulate elements. Restoration of large areas of land contaminated with low levels of radionuclides may be feasible using phytoremediation. Criteria for the selection of plants for phytoremediation, molecular approaches to increase radio nuclide uptake, effects of cultural practices on uptake and assessment of environmental effects of phytoremediation will be discussed.

  6. Pitfalls and Limitations of Radionuclide Hepatobiliary and Gastrointestinal System Imaging.

    PubMed

    Low, Chen Sheng; Ahmed, Haseeb; Notghi, Alp

    2015-11-01

    Radionuclide imaging for the hepatobiliary and gastrointestinal system covers a wide range of different indications and imaging techniques. This wide variety allows the different functional assessments of both systems. Therefore, the understanding of each technique and its indications is essential. Cholescintigraphy is a well-established method in the assessment of acute and chronic cholecystitis. It also has a role in the detection of biliary atresia. The assessment of gastrointestinal transit is also well-established in radionuclide imaging for functional investigation of the gastrointestinal tract. Furthermore, detection of acute gastrointestinal bleeding with radionuclide imaging is also standard practice. This article aims to review the pitfalls and limitations in all of these areas.

  7. Radionuclide Transport Models Under Ambient Conditions

    SciTech Connect

    G. Moridis; Q. Hu

    2000-03-12

    The purpose of this Analysis/Model Report (AMR) is to evaluate (by means of 2-D semianalytical and 3-D numerical models) the transport of radioactive solutes and colloids in the unsaturated zone (UZ) under ambient conditions from the potential repository horizon to the water table at Yucca Mountain (YM), Nevada. This is in accordance with the ''AMR Development Plan U0060, Radionuclide Transport Models Under Ambient Conditions'' (CRWMS M and O 1999a). This AMR supports the UZ Flow and Transport Process Model Report (PMR). This AMR documents the UZ Radionuclide Transport Model (RTM). This model considers: the transport of radionuclides through fractured tuffs; the effects of changes in the intensity and configuration of fracturing from hydrogeologic unit to unit; colloid transport; physical and retardation processes and the effects of perched water. In this AMR they document the capabilities of the UZ RTM, which can describe flow (saturated and/or unsaturated) and transport, and accounts for (a) advection, (b) molecular diffusion, (c) hydrodynamic dispersion (with full 3-D tensorial representation), (d) kinetic or equilibrium physical and/or chemical sorption (linear, Langmuir, Freundlich or combined), (e) first-order linear chemical reaction, (f) radioactive decay and tracking of daughters, (g) colloid filtration (equilibrium, kinetic or combined), and (h) colloid-assisted solute transport. Simulations of transport of radioactive solutes and colloids (incorporating the processes described above) from the repository horizon to the water table are performed to support model development and support studies for Performance Assessment (PA). The input files for these simulations include transport parameters obtained from other AMRs (i.e., CRWMS M and O 1999d, e, f, g, h; 2000a, b, c, d). When not available, the parameter values used are obtained from the literature. The results of the simulations are used to evaluate the transport of radioactive solutes and colloids, and

  8. Establishing equivalence for activity standards of short-lived radionuclides using the NPL secondary standard radionuclide calibrator.

    PubMed

    Woods, M J; Baker, M

    2004-01-01

    Conventional comparison techniques used between National Metrology Institutes are not practicable for short-lived radionuclides because of geographical separations and transport difficulties. The NPL Secondary Standard Radionuclide Calibrator provides an alternative approach and a comparison was conducted with 18F to investigate its feasibility. The exercise was successful and the paper details the protocol used, the quality assurance mechanisms introduced to underpin the comparison and an analysis of the results. It was also demonstrated that this approach could be linked to the BIPM SIR system. Recommendations are presented for the extension of this work to other suitable, short-lived radionuclides.

  9. Developments in Bioremediation of Soils and Sediments Pollutedwith Metals and Radionuclides: 2. Field Research on Bioremediation of Metals and Radionuclides

    SciTech Connect

    Hazen, Terry C.; Tabak, Henry H.

    2007-03-15

    Bioremediation of metals and radionuclides has had manyfield tests, demonstrations, and full-scale implementations in recentyears. Field research in this area has occurred for many different metalsand radionuclides using a wide array of strategies. These strategies canbe generally characterized in six major categories: biotransformation,bioaccumulation/bisorption, biodegradation of chelators, volatilization,treatment trains, and natural attenuation. For all field applicationsthere are a number of critical biogeochemical issues that most beaddressed for the successful field application. Monitoring andcharacterization parameters that are enabling to bioremediation of metalsand radionuclides are presented here. For each of the strategies a casestudy is presented to demonstrate a field application that uses thisstrategy.

  10. The continuing important role of radionuclide generator systems for nuclear medicine.

    PubMed

    Knapp, F F; Mirzadeh, S

    1994-10-01

    In this review, the continuing importance and status of development of radionuclide generator systems for nuclear medicine are discussed. Radioisotope costs and availability are two important factors, and both nuclear reactors and accelerator facilities are required for production of the parent radioisotopes. Radionuclide generator research is currently focused on the development of generators which provide radioisotopes for positron emission tomography (PET) applications and daughter radioisotopes for various therapeutic applications which decay primarily by particle emission. Generator research continues to be influenced by developments and requirements of complementary technologies, such as the increasing availability of PET. In addition, the availability of a wide spectrum of tumor-specific antibodies, fragments, and peptides for radioimmunodiagnosis and radioimmunotherapy has stimulated the need for generator-derived radioisotopes. The advantages of treatment of arthritis of the synovial joints with radioactive particles (radiation synovectomy) may be expected to be of increasing importance as the elderly population increases, and many of these agents are prepared using generator-derived radioisotopes such as yttrium-90 and rhenium-188. Therapeutic use of the "in vivo generator" is a new approach, where the less radiotoxic parent radioisotope is used to prepare tissue-specific therapeutic agents. Following in vivo site localization, decay of the parent provides the daughter for therapy at the target site. The principal foundation of most diagnostic agents will continue to require technetium-99m from the molybdenum-99/technetium-99m ("Moly") generator. With the limited availability of nuclear reactors and facilities necessary for production and processing of fission 99mTc and the significant issues and problems associated with radioactive waste processing, however, the possibility of utilizing lower specific activity 99Mo produced from neutron activation of

  11. Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy.

    PubMed

    Panigone, S; Nunn, A D

    2006-12-01

    Optimization of therapy for individual patients remains a goal of clinical practice. Radionuclide imaging can identify those patients who may benefit from subsequent targeted therapy by providing regional information on the distribution of the target. An ideal situation may be when the imaging and the therapeutic compounds are the same agent. Two antibodies ([ [90Y]ibritumomab, [131I]tositumomab) are now approved for the systemic radiotherapy of non-Hodgkin's lymphoma. The main hurdle is to deliver higher absorbed doses to the more refractory solid tumors paying particular regard to the bone marrow toxicity. The low dose is thought to be a result of the large size of antibodies slowing delivery to the target. Peptides having high affinity to receptors expressed on cancer cells are a promising alternative. They are usually rapidly excreted from the body through renal and/or hepatobiliary excretion thus creating a prolonged accumulation of the radioactivity in the kidneys, which represents a recognized issue for systemic radiotherapy. The first radiopeptide developed was a somatostatin analogue, which led to a major breakthrough in the field. Beside the kidney issue, somatostatin use remains limited to few cancers that express receptors in sufficiently large quantities, mainly neuroendocrine tumors. The gastrin releasing peptide (GRP) receptor is an attractive target for development of new radiopeptides with diagnostic and therapeutic potential. This is based upon the functional expression of GRP receptors in several of the more prevalent cancers including prostate, breast, and small cell lung cancer. This review covers the efforts currently underway to develop new and clinically promising GRP-receptor specific molecules labeled with imageable and therapeutic radionuclides.

  12. Subsurface Characterization To Support Evaluation Of Radionuclide Transport And Attenuation

    EPA Science Inventory

    Remediation of ground water contaminated with radionuclides may be achieved using attenuation-based technologies. These technologies may rely on engineered processes (e.g., bioremediation) or natural processes (e.g., monitored natural attenuation) within the subsurface. In gene...

  13. Monitored Natural Attenuation For Radionuclides In Ground Water - Technical Issues

    EPA Science Inventory

    Remediation of ground water contaminated with radionuclides may be achieved using attenuation-based technologies. These technologies may rely on engineered processes (e.g., bioremediation) or natural processes (e.g., monitored natural attentuation) within the subsurface. In gen...

  14. Modeling the Dispersal and Deposition of Radionuclides: Lessons from Chernobyl.

    ERIC Educational Resources Information Center

    ApSimon, H. M.; And Others

    1988-01-01

    Described are theoretical models that simulate the dispersion of radionuclides on local and global scales following the accident at the Chernobyl nuclear power plant. Discusses the application of these results to nuclear weapons fallout. (CW)

  15. Biomolecular Mechanisms Controlling Metal and Radionuclide Transformations in Anaeromyxobacter dehalogenans

    SciTech Connect

    Beliaev, Alexander S.; Fredrickson, James K.; Loeffler, Frank E.; Sanford, Robert A.

    2006-06-01

    Microbiological reduction and immobilization of U(VI) and Tc(VII) has been proposed as a strategy for remediating radionuclide-contaminated environments. Numerous studies focusing on the reduction kinetics and speciation of these metals have been carried out using contaminated sediment samples, microbial consortia, and pure bacterial cultures. While previous work with model organisms has increased the general understanding of radionuclide transformation processes, fundamental questions regarding radionuclide reduction mechanisms by indigenous microorganisms are poorly understood, especially under the commonly encountered scenario where multiple electron acceptors are present. Therefore, the overall goal of the proposed research is to elucidate the molecular mechanisms of radionuclide biotransformation by Anaeromyxobacter dehalogenans, a predominant member of indigenous microorganism commonly found in contaminated subsurface environments, and to assess the effects of relevant environmental factors affecting these transformation reactions.

  16. Site Characterization for MNA of Radionuclides in Ground Water

    EPA Science Inventory

    Monitored natural attenuation is often evaluated as a component of the remedy for ground water contaminated with radionuclides. When properly employed, monitored natural attenuation (MNA) may provide an effective knowledge-based remedy where a thorough engineering analysis inform...

  17. Radionuclide Inventory and Distribution Program: the Galileo area

    SciTech Connect

    McArthur, R.D.; Kordas, J.F.

    1983-12-28

    The Galileo area is the first region of the Nevada Test Site to be surveyed by the Radionuclide Inventory and Distribution Program (RIDP). This report describes in detail the use of soil sampling and in situ spectrometry to estimate radionuclide activities at selected sampling locations; the descriptions of these methods will be used as a reference for future RIDP reports. The data collected at Galileo were analyzed by kriging and the polygons of influence method to estimate the total inventory and the distribution of six man-made radionuclides. The results of the different statistical methods agree fairly well, although the data did not give very good estimates of the variogram for kriging, and further study showed the results of kriging to be highly dependent on the variogram parameters. The results also showed that in situ spectrometry gives better estimates of radionuclide activity than soil sampling, which tends to miss highly radioactive particles associated with vegetation. 18 references, 28 figures, 11 tables.

  18. SRNL RADIONUCLIDE FIELD LYSIMETER EXPERIMENT: BASELINE CONSTRUCTION AND IMPLEMENTATION

    SciTech Connect

    Roberts, K.; Kaplan, D.; Bagwell, L.; Powell, B.; Almond, P.; Emerson, H.; Hixon, A.; Jablonski, J.; Buchanan, C.; Waterhouse, T.

    2012-10-17

    The purpose of this document is to compile information regarding experimental design, facility design, construction, radionuclide source preparation, and path forward for the ten year Savannah River National Laboratory (SRNL) Radionuclide Field Lysimeter Experiment at the Savannah River Site (SRS). This is a collaborative effort by researchers at SRNL and Clemson University. The scientific objectives of this study are to: Study long-term radionuclide transport under conditions more representative of vadose zone conditions than laboratory experiments; Provide more realistic quantification of radionuclide transport and geochemistry in the vadose zone, providing better information pertinent to radioactive waste storage solutions than presently exists; Reduce uncertainty and improve justification for geochemical models such as those used in performance assessments and composite analyses.

  19. Monitored natural attenuation forum: MNA of metals and radionuclides

    EPA Science Inventory

    While the natural attenuation of many organic compounds is established and accepted by the regulated and regulatory communities, there is some debate whether monitored natural attenuation (MNA) of metals and radionuclides is a reasonable remedial alternative to consider. Do you...

  20. Radionuclide distributions and migration mechanisms at shallow land burial sites

    SciTech Connect

    Kirby, L.J.; Toste, A.P.; Thomas, C.W.; Rickard, W.H.; Nielson, H.L.; Campbell, R.M.; McShane, M.C.; Wilkerson, C.L.; Robertson, D.E.

    1991-02-01

    During the past several years, Pacific Northwest Laboratory (PNL) has conducted research at the Maxey Flats Disposal Site (MFDS) for the US Nuclear Regulatory Commission (NRC). This work has identified the spectrum of radionuclides present in the waste trenches, determined the processes that were occurring relative to degradation of radioactive material within the burial trenches, determined the chemical and physical characteristics of the trench leachates and the chemical forms of the leached radionuclides, determined the mobility of these radionuclides, investigated the subsurface and surface transport processes, determined the biological uptake by the native vegetation, developed strategies for environmental monitoring, and investigated other factors that influence the long-term fate of the radionuclide inventory at the disposal site. This report is a final summary of the research conducted by PNL and presents the results and discussions relative to the above investigative areas. 45 refs., 31 figs., 17 tabs.

  1. Numerical modeling of radionuclide migration through a borehole disposal site.

    PubMed

    Yeboah, Serwaa; Akiti, Thomas T; Fletcher, John J

    2014-01-01

    The migration of radionuclides from a borehole repository located about 20 km from the Akwapim fault line which lies in an area of high seismicity was analyzed for some selected radionuclides. In the event of a seismic activity, fractures and faults could be rejuvenated or initiated resulting in container failure leading to the release of radionuclides. A numerical model was solved using a two-dimensional finite element code (Comsol Multiphysics) by taking into account the effect of heterogeneities. Results showed that, the fractured medium created preferential pathways indicating that, fault zones generated potential paths for released radionuclides from a radioactive waste repository. The results obtained showed that variations in hydraulic conductivity as a result of the heterogeneity considered within the domain significantly affected the direction of flow.

  2. Personal dose-equivalent conversion coefficients for 1252 radionuclides.

    PubMed

    Otto, Thomas

    2016-01-01

    Dose conversion coefficients for radionuclides are useful for routine calculations in radiation protection in industry, medicine and research. They give a simple and often sufficient estimate of dose rates during production, handling and storage of radionuclide sources, based solely on the source's activity. The latest compilation of such conversion coefficients dates from 20 y ago, based on nuclear decay data published 30 y ago. The present publication provides radionuclide-specific conversion coefficients to personal dose based on the most recent evaluations of nuclear decay data for 1252 radionuclides and fluence-to-dose-equivalent conversion coefficients for monoenergetic radiations. It contains previously unknown conversion coefficients for >400 nuclides and corrects those conversion coefficients that were based on erroneous decay schemes. For the first time, estimates for the protection quantity Hp(3) are included.

  3. Using environmental radionuclides as fingerprints to study streambank erosion

    Technology Transfer Automated Retrieval System (TEKTRAN)

    The identification of sediment source areas in the watershed is a key component for designing management strategies to reduce sediment and chemical loads from watersheds. Potential sediment sources in watersheds can be characterized (fingerprinted) using diagnostic environmental radionuclides, chem...

  4. Using environmental radionuclides as fingerprints to study streambank erosion

    Technology Transfer Automated Retrieval System (TEKTRAN)

    The identification of sediment source areas in the watershed is a key component for designing management strategies to reduce sediment and chemical loads from the watershed. Potential sediment sources in a watershed can be characterized (fingerprinted) using diagnostic environmental radionuclides, ...

  5. Radionuclide-labeled nanostructures for In Vivo imaging of cancer

    NASA Astrophysics Data System (ADS)

    Rhim, Won-Kyu; Kim, Minho; Hartman, Kevin L.; Kang, Keon Wook; Nam, Jwa-Min

    2015-05-01

    Molecular imaging plays an important role in the non-invasive diagnosis and the guiding or monitoring of disease treatment. Different imaging modalities have been developed, and each method possesses unique strengths. While a variety of molecules have been used previously in nuclear imaging, the exceptional properties of nanostructures in recent research enable the deployment of accurate and efficient diagnostic agents using radionuclide-nanostructures. This review focuses on the radionuclide labeling strategies of various nanostructures and their applications for multimodality tumor imaging.

  6. Airborne radionuclides and radiation in buildings: a review.

    PubMed

    Nero, A V

    1983-08-01

    This paper reviews the literature on sources and measurement of natural airborne radionuclides and radiation in buildings. It also briefly reviews control measures and suggests areas for further research. The major emphasis is given to 222Rn and its daughters, since they typically cause the largest organ dose to the general population, most of which arises from indoor exposures. The indoor radiation field from radionuclides fixed in building materials and soil is also given substantial treatment.

  7. Methods for determining radionuclide retardation factors: status report

    SciTech Connect

    Relyea, J.F.; Serne, R.J.; Rai, D.

    1980-04-01

    This report identifies a number of mechanisms that retard radionuclide migration, and describes the static and dynamic methods that are used to study such retardation phenomena. Both static and dynamic methods are needed for reliable safety assessments of underground nuclear-waste repositories. This report also evaluates the extent to which the two methods may be used to diagnose radionuclide migration through various types of geologic media, among them unconsolidated, crushed, intact, and fractured rocks. Adsorption is one mechanism that can control radionuclide concentrations in solution and therefore impede radionuclide migration. Other mechanisms that control a solution's radionuclide concentration and radionuclide migration are precipitation of hydroxides and oxides, oxidation-reduction reactions, and the formation of minerals that might include the radionuclide as a structural element. The retardation mechanisms mentioned above are controlled by such factors as surface area, cation exchange capacity, solution pH, chemical composition of the rock and of the solution, oxidation-reduction potential, and radionuclide concentration. Rocks and ground waters used in determining retardation factors should represent the expected equilibrium conditions in the geologic system under investigation. Static test methods can be used to rapidly screen the effects of the factors mentioned above. Dynamic (or column) testing, is needed to assess the effects of hydrodynamics and the interaction of hydrodynamics with the other important parameters. This paper proposes both a standard method for conducting batch Kd determinations, and a standard format for organizing and reporting data. Dynamic testing methods are not presently developed to the point that a standard methodology can be proposed. Normal procedures are outlined for column experimentation and the data that are needed to analyze a column experiment are identified.

  8. Bioaccumulation of radionuclides in fertilized Canadian Shield lake basins.

    PubMed

    Bird, G A; Hesslein, R H; Mills, K H; Schwartz, W J; Turner, M A

    1998-07-11

    Radionuclide tracers of heavy metals (59Fe, 60Co, 65Zn, 75Se, 85Sr, 134Cs and 203Hg) representing potential contamination from nuclear power plants, industry and agriculture were added to separate basins of Lake 226, Experimental Lakes Area, northwestern Ontario. The two basins were part of a eutrophication experiment and differed in their trophic status; the north basin (L226N) was eutrophic whereas the south basin (L226S) was mesotrophic. Our objective was to determine the uptake of the radionuclides by biota and the effect of lake trophic status on their bioaccumulation. The trophic status of the lakes did not appear to have a marked effect on the accumulation of radionuclides by the biota. This may have been because of a mid-summer leakage of nutrients between the basins which enhanced primary production in L226S, because there is a time lag between primary production and the availability of the radionuclides to the fishes or because trophic status does not affect the uptake of at least some of these radionuclides. However, there was a tendency for faster uptake of the radionuclides in L226N by fish than L226S, but the differences were not significant. Concentrations in the biota generally decreased in the order: fathead minnow > pearl dace > tadpoles > slimy sculpin > leeches. Concentrations in biota generally decreased in the order. 65Zn > 203Hg > 75Se > 134Cs > 60Co > 85Sr = 59Fe. Cobalt-60 concentrations in tadpoles were greater than in the other biota. Radionuclide concentrations in the tissues of lake whitefish indicated that uptake was predominantly from food. Radionuclide concentrations were usually higher in the posterior gut, liver and kidney than in other tissues, whereas body burdens were generally high in the muscle for 75Se, 134Cs and 203Hg; kidney and gut for 60Co; and bone for 65Zn and 75Se. Mercury-203 burdens were also high in the bone and gut.

  9. Consultative committee on ionizing radiation: Impact on radionuclide metrology.

    PubMed

    Karam, L R; Ratel, G

    2016-03-01

    In response to the CIPM MRA, and to improve radioactivity measurements in the face of advancing technologies, the CIPM's consultative committee on ionizing radiation developed a strategic approach to the realization and validation of measurement traceability for radionuclide metrology. As a consequence, measurement institutions throughout the world have devoted no small effort to establish radionuclide metrology capabilities, supported by active quality management systems and validated through prioritized participation in international comparisons, providing a varied stakeholder community with measurement confidence.

  10. Statistical analyses of plume composition and deposited radionuclide mixture ratios

    SciTech Connect

    Kraus, Terrence D.; Sallaberry, Cedric Jean-Marie; Eckert-Gallup, Aubrey Celia; Brito, Roxanne; Hunt, Brian D.; Osborn, Douglas M.

    2014-01-01

    A proposed method is considered to classify the regions in the close neighborhood of selected measurements according to the ratio of two radionuclides measured from either a radioactive plume or a deposited radionuclide mixture. The subsequent associated locations are then considered in the area of interest with a representative ratio class. This method allows for a more comprehensive and meaningful understanding of the data sampled following a radiological incident.

  11. Compositions and methods for removal of toxic metals and radionuclides

    NASA Technical Reports Server (NTRS)

    Cuero, Raul G. (Inventor); McKay, David S. (Inventor)

    2007-01-01

    The present invention relates to compositions and methods for the removal of toxic metals or radionuclides from source materials. Toxic metals may be removed from source materials using a clay, such as attapulgite or highly cationic bentonite, and chitin or chitosan. Toxic metals may also be removed using volcanic ash alone or in combination with chitin or chitosan. Radionuclides may be removed using volcanic ash alone or in combination with chitin or chitosan.

  12. Consultative Committee on Ionizing Radiation: Impact on Radionuclide Metrology

    PubMed Central

    Karam, L.R.; Ratel, G.

    2016-01-01

    In response to the CIPM MRA, and to improve radioactivity measurements in the face of advancing technologies, the CIPM’s consultative committee on ionizing radiation developed a strategic approach to the realization and validation of measurement traceability for radionuclide metrology. As a consequence, measurement institutions throughout the world have devoted no small effort to establish radionuclide metrology capabilities, supported by active quality management systems and validated through prioritized participation in international comparisons, providing a varied stakeholder community with measurement confidence. PMID:26688351

  13. Simulation of radionuclide transport in U. S. agriculture

    SciTech Connect

    Sharp, R.D.; Baes, C.F. III

    1982-01-01

    Because of the recent concern about the impact of energy technologies on man and related health effects, there has emerged a need for models to calculate or predict the effects of radionuclides on man. A general overview is presented of a model that calculates the ingrowth of radionuclides into man's food chain. The FORTRAN IV computer program TERRA, Transport of Environmentally Released Radionuclides in Agriculture, simulates the build-up of radionuclides in soil, four plant food compartments, in meat and milk from beef, and in the livestock food compartments that cause radionuclide build-up in milk and meat from beef. A large data set of spatially oriented parameters has been developed in conjunction with TERRA. This direct-access data set is called SITE, Specific Information on the Terrestrial Environment, and contains 35 parameters for each of 3525 half-degree longitude-latitude cells which define the lower 48 states. TERRA and SITE are used together as a package for determining radionuclide concentrations in man's food anywhere within the conterminous 48 states due to atmospheric releases.

  14. Radionuclides' Content Speciation and Fingerprinting of Nigerian Tin Mining Tailings

    NASA Astrophysics Data System (ADS)

    Olise, F. S.; Oladejo, O. F.; Owoade, O. K.; Almeida, S. M.; Ho, M. D.; Olaniyi, H. B.

    2012-04-01

    Sediment and process-waste samples rich in cassiterite, monazite and zircon, which are of industrial interest, were analysed for the natural series radionuclides, 232Th and 238U and the non-series radionuclide, 40K using instrumental neutron activation analysis (INAA) technique. The natural radionuclides' radioactivity in the samples from the tin-rich areas of Jos, Nigeria was determined using K0-INAA. The obtained results have a high degree of reliability judging from the techniqués accuracy, precision and its non-dependence on secular equilibrium and density correction problems inherent in gamma spectrometry as well as rigorous contamination-prone sample preparation requirements of other methods. Radionuclides speciation and ratios, giving radionuclide fingerprinting of the tin mining tailings is reported. The measured radionuclides activity levels are several orders of magnitude higher than UNSCEAR reference values, revealing the pollution potential of the tin mining and process activities on the surrounding areas, vis-à-vis heavy particulate matter load, leaching into various water channels and direct exposure to gamma rays emitted from the houses and facilities built from the generated wastes. The observed activity levels reflects possible worst scenario situation and the data would not only be of use to the government in its remediation plan for the study area but will also serve as important information for the nuclear science and technology programme about to be embarked upon. Methods of checking exposure have also been suggested.

  15. Radionuclide Imaging of Musculoskeletal Infection: A Review.

    PubMed

    Palestro, Christopher J

    2016-09-01

    There are numerous imaging tests for diagnosing musculoskeletal infection. Radiographs are routinely performed, because even when not diagnostic, they provide an anatomic overview of the region of interest that could influence subsequent procedure selection and interpretation. MRI is sensitive and provides superb anatomic detail. Bone scintigraphy accurately diagnoses osteomyelitis in bones not affected by underlying conditions. (67)Ga is used primarily for spondylodiskitis. Although in vitro labeled leukocyte imaging is the radionuclide test of choice for complicating osteomyelitis such as diabetic pedal osteomyelitis and prosthetic joint infection, it is not useful for spondylodiskitis. Antigranulocyte antibodies and antibody fragments have limitations and are not widely available. (111)In-biotin is useful for spondylodiskitis. Radiolabeled synthetic fragments of the antimicrobial peptide ubiquicidin are promising infection-specific agents. (18)F-FDG is the radiopharmaceutical of choice for spondylodiskitis. Its role in diabetic pedal osteomyelitis and prosthetic joint infection is not established. Preliminary data suggest (68)Ga may be useful in musculoskeletal infection. (124)I-fialuridine initially showed promise as an infection-specific radiopharmaceutical, but subsequent investigations were disappointing. The development of PET/CT and SPECT/CT imaging systems, which combine anatomic and functional imaging, has revolutionized diagnostic imaging. These hybrid systems are redefining the diagnostic workup of patients with suspected or known infection and inflammation by improving diagnostic accuracy and influencing patient management.

  16. Radionuclide surveillance of the allografted pancreas

    SciTech Connect

    George, E.A.; Salimi, Z.; Carney, K.; Castaneda, M.; Garvin, P.J.

    1988-04-01

    To determine the value of scintigraphy to detect posttransplantation complications of the allografted pancreas, we retrospectively reviewed 209 scintigrams obtained with /sup 99m/Tc-sulfur colloid (/sup 99m/Tc-SC) and /sup 99m/Tc-glucoheptonate (/sup 99m/Tc-GH). The scintigraphic studies were performed in 37 recipients of simultaneous renal and pancreatic allografts harvested from the same donor. /sup 99m/Tc-SC was used as an indicator of thrombotic vasculitis; pancreatic perfusion and blood-pool parameters were monitored with /sup 99m/Tc-GH. In 11 of the 37 recipients, scintigraphic abnormalities suggested posttransplantation infarction. Recurrent episodes of acute rejection of the pancreatic allograft, which always coincided with acute rejection of the renal allograft, were monitored in 24 recipients. Rejection-induced ischemic pancreatitis was suggested in 12 of the 24 recipients and persisted in 10 recipients for several weeks after improvement of renal allograft rejection. Pancreatic atrophy was suggested scintigraphically in 16 of the 24 recipients with recurrent episodes of rejection. Spontaneous pancreatic-duct obstruction and obstructive pancreatitis were associated with a scintigraphic pattern similar to that of rejection-induced ischemic pancreatitis. We concluded that the specific radionuclides used in this series are useful for the surveillance and assessment of posttransplantation pancreatic infarction, acute rejection, pancreatitis, and atrophy

  17. Improving cancer treatment with cyclotron produced radionuclides

    SciTech Connect

    Larson, S.M.; Finn, R.D.

    1992-08-04

    Our goal is to improve the scientific basis for tumor diagnosis, treatment and treatment follow-up based on the use of cyclotron produced radiotracers in oncology. The grant includes 3 interactive components: Radiochemistry/Cyclotron; Pharmacology; and Immunology. The radiochemistry group seeks to develop innovative cyclotron targetry, radiopharmaceuticals, and radiolabeled antibodies, which are then used to assess important unanswered questions in tumor pharmacology and immunology. Examples include selected positron emitting radionuclides, such as Iodine-124, and Ga-66; I-124, I-123, I-131 labeled iododeoxyuridine, C-11 colchicine, and antimetabolites, like C-11 methotrexate; and radiolabeled antibodies, 3F8, M195, A33, and MRK16 for application in the pharmacology and immunology projects. The pharmacology program studies tumor resistance to chemotherapy, particularly the phenomenon of multidrug resistance and the relationship between tumor uptake and retention and the tumor response for anti-metabolite drugs. The immunology program studies the physiology of antibody localization at the tissue level as the basis for novel approaches to improving tumor localization such as through the use of an artificial lymphatic system which mechanically reduces intratumoral pressures in tumors in vivo. Quantitative imaging approaches based on PET and SPECT in radioimmunotherapy are studied to give greater insight into the physiology of tumor localization and dosimetry.

  18. Radionuclide Leaching from Organic Ion Exchange Resin

    SciTech Connect

    Delegard, C.H.; Rinehart, D.E.

    1999-04-02

    Laboratory tests were performed to examine the efficacy of leach treatments for decontaminating organic ion exchange resins (OIER), which have been found in a number of samples retrieved from K East Basin sludge. Based on process records, the OIER found in the K Basins is a mixed-bet strong acid/strong base material marketed as Purolite{trademark} NRW-037. Radionuclides sorbed or associated with the OIER can restrict its disposal to the Environmental Restoration Disposal Facility (ERDF). The need for testing to support development of a treatment process for K Basin sludge has been described in Section 4.2 of ''Testing Strategy to Support the Development of K Basins Sludge Treatment Process'' (Flament 1998). To help understand the effects of anticipated OIER elutriation and washing, tests were performed with well-rinsed OIER material from K East Basin floor sludge (sample H-08 BEAD G) and with well-rinsed OIER having approximately 5% added K East canister composite sludge (sample KECOMP). The rinsed resin-bearing material also contained the inorganic ion exchanger Zeolon-900{trademark}, a zeolite primarily composed of the mineral mordenite. The zeolite was estimated to comprise 27 weight percent of the dry H-08 BEAD G material.

  19. New Trends in Radionuclide Myocardial Perfusion Imaging

    PubMed Central

    Hung, Guang-Uei; Wang, Yuh-Feng; Su, Hung-Yi; Hsieh, Te-Chun; Ko, Chi-Lun; Yen, Ruoh-Fang

    2016-01-01

    Radionuclide myocardial perfusion imaging (MPI) with single photon emission computed tomography (SPECT) has been widely used clinically as one of the major functional imaging modalities for patients with coronary artery disease (CAD) for decades. Ample evidence has supported the use of MPI as a useful and important tool in the diagnosis, risk stratification and treatment planning for CAD. Although popular in the United States, MPI has become the most frequently used imaging modality among all nuclear medicine tests in Taiwan. However, it should be acknowledged that MPI SPECT does have its limitations. These include false-positive results due to certain artifacts, false-negative due to balanced ischemia, complexity and adverse reaction arising from current pharmacological stressors, time consuming nature of the imaging procedure, no blood flow quantitation and relatively high radiation exposure. The purpose of this article was to review the recent trends in nuclear cardiology, including the utilization of positron emission tomography (PET) for MPI, new stressor, new SPECT camera with higher resolution and higher sensitivity, dynamic SPECT protocol for blood flow quantitation, new software of phase analysis for evaluation of LV dyssynchrony, and measures utilized for reducing radiation exposure of MPI. PMID:27122946

  20. SU-E-T-256: Optimizing the Combination of Targeted Radionuclide Therapy Agents Using a Multi-Scale Patient-Specific Monte Carlo Dosimetry Platform

    SciTech Connect

    Besemer, A; Bednarz, B; Titz, B; Grudzinski, J; Weichert, J; Hall, L

    2014-06-01

    Purpose: Combination targeted radionuclide therapy (TRT) is appealing because it can potentially exploit different mechanisms of action from multiple radionuclides as well as the variable dose rates due to the different radionuclide half-lives. The work describes the development of a multiobjective optimization algorithm to calculate the optimal ratio of radionuclide injection activities for delivery of combination TRT. Methods: The ‘diapeutic’ (diagnostic and therapeutic) agent, CLR1404, was used as a proof-of-principle compound in this work. Isosteric iodine substitution in CLR1404 creates a molecular imaging agent when labeled with I-124 or a targeted radiotherapeutic agent when labeled with I-125 or I-131. PET/CT images of high grade glioma patients were acquired at 4.5, 24, and 48 hours post injection of 124I-CLR1404. The therapeutic 131I-CLR1404 and 125ICLR1404 absorbed dose (AD) and biological effective dose (BED) were calculated for each patient using a patient-specific Monte Carlo dosimetry platform. The optimal ratio of injection activities for each radionuclide was calculated with a multi-objective optimization algorithm using the weighted sum method. Objective functions such as the tumor dose heterogeneity and the ratio of the normal tissue to tumor doses were minimized and the relative importance weights of each optimization function were varied. Results: For each optimization function, the program outputs a Pareto surface map representing all possible combinations of radionuclide injection activities so that values that minimize the objective function can be visualized. A Pareto surface map of the weighted sum given a set of user-specified importance weights is also displayed. Additionally, the ratio of optimal injection activities as a function of the all possible importance weights is generated so that the user can select the optimal ratio based on the desired weights. Conclusion: Multi-objective optimization of radionuclide injection activities

  1. Therapeutic application of dysprosium-165-FHMA in the treatment of rheumatoid knee effusions

    SciTech Connect

    English, R.J.; Zalutsky, M.; Venkatesan, P.; Sledge, C.B.

    1986-03-01

    Radiation synovectomy utilizing a variety of radionuclides has proven to be an effective technique in the treatment of rheumatoid arthritis. The recent introduction of the short-lived radionuclide, Dysprosium-165 (/sup 165/Dy), as a replacement for the longer-lived radiocolloids has reduced nontarget dosimetry caused by leakage of the agent from the articular cavity. A review of the methods and status of radiation synovectomy, and the application of /sup 165/Dy-ferric hydroxide macroaggregates (FHMA) as an alternative therapeutic agent is described.

  2. An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation.

    PubMed

    McDevitt, M R; Finn, R D; Sgouros, G; Ma, D; Scheinberg, D A

    1999-05-01

    A method for construction and operation of an 225Ac/213Bi generator capable of producing 25-100 mCi of 213Bi suitable for clinical antibody labeling is described. The generator has been designed to have an effective lifetime of several weeks, producing up to six therapeutic doses of radionuclide per day. To date, 57 clinical doses have been prepared and injected into patients using the described 213Bi generator. Factors such as radiation damage, radioprotection, iodide eluate chemistry, radiolabeling chemistry and radionuclide purity are addressed.

  3. Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides

    NASA Astrophysics Data System (ADS)

    Hrycushko, Brian A.; Gutierrez, Alonso N.; Goins, Beth; Yan, Weiqiang; Phillips, William T.; Otto, Pamela M.; Bao, Ande

    2011-02-01

    Post-operative radiotherapy has commonly been used for early stage breast cancer to treat residual disease. The primary objective of this work was to characterize, through dosimetric and radiobiological modeling, a novel focal brachytherapy technique which uses direct intracavitary infusion of β-emitting radionuclides (186Re/188Re) carried by lipid nanoparticles (liposomes). Absorbed dose calculations were performed for a spherical lumpectomy cavity with a uniformly injected activity distribution using a dose point kernel convolution technique. Radiobiological indices were used to relate predicted therapy outcome and normal tissue complication of this technique with equivalent external beam radiotherapy treatment regimens. Modeled stromal damage was used as a measure of the inhibition of the stimulatory effect on tumor growth driven by the wound healing response. A sample treatment plan delivering 50 Gy at a therapeutic range of 2.0 mm for 186Re-liposomes and 5.0 mm for 188Re-liposomes takes advantage of the dose delivery characteristics of the β-emissions, providing significant EUD (58.2 Gy and 72.5 Gy for 186Re and 188Re, respectively) with a minimal NTCP (0.046%) of the healthy ipsilateral breast. Modeling of kidney BED and ipsilateral breast NTCP showed that large injected activity concentrations of both radionuclides could be safely administered without significant complications.

  4. Radionuclide Esophageal Transit Scintigraphy in Primary Hypothyroidism

    PubMed Central

    Khan, Shoukat H; Madhu, Vijay P; Rather, Tanveer A; Laway, Bashir A

    2017-01-01

    Background/Aims Esophageal dysmotility is associated with gastrointestinal dysmotility in various systemic and neuroregulatory disorders. Hypothyroidism has been reported to be associated with impaired motor function in esophagus due to accumulation of glycosaminoglycan hyaluronic acid in its soft tissues, leading to changes in various contraction and relaxation parameters of esophagus, particularly in the lower esophageal sphincter. In this study we evaluated esophageal transit times in patients of primary hypothyroidism using the technique of radionuclide esophageal transit scintigraphy. Methods Thirty-one patients of primary hypothyroidism and 15 euthyroid healthy controls were evaluated for esophageal transit time using 15–20 MBq of Technetium-99m sulfur colloid diluted in 10–15 mL of drinking water. Time activity curve was generated for each study and esophageal transit time was calculated as time taken for clearance of 90% radioactive bolus from the region of interest encompassing the esophagus. Esophageal transit time of more than 10 seconds was considered as prolonged. Results Patients of primary hypothyroidism had a significantly increased mean esophageal transit time of 19.35 ± 20.02 seconds in comparison to the mean time of 8.25 ± 1.71 seconds in healthy controls (P < 0.05). Esophageal transit time improved and in some patients even normalized after treatment with thyroxine. A positive correlation (r = 0.39, P < 0.05) albeit weak existed between the serum thyroid stimulating hormone and the observed esophageal transit time. Conclusions A significant number of patients with primary hypothyroidism may have subclinical esophageal dysmotility with prolonged esophageal transit time which can be reversible by thyroxine treatment. Prolonged esophageal transit time in primary hypothyroidism may correlate with serum thyroid stimulating hormone levels. PMID:27444283

  5. Activity size distribution of some natural radionuclides.

    PubMed

    Mohery, M; Abdallah, A M; Al-Amoudi, Z M; Baz, S S

    2014-03-01

    In this study, the results concerning the activity size distribution of the long-lived ((210)Pb) radon decay product aerosols and the thoron decay product aerosols ((212)Pb) and ((7)Be) of the outdoor atmosphere are presented. Also, the mass size distribution of the aerosol particles is determined. The low-pressure Berner cascade impactor Model 20/0.015 was used as a sampling device. The activity size distribution of these radionuclides was determined by one log-normal distribution (accumulation mode) whereas the mass size distribution was by two log-normal distributions (accumulation and coarse mode). The activity median aerodynamic diameter (AMAD) of (212)Pb was found to be 305 nm with a geometric standard deviation (σg) of 2.41. The specific air activity concentration of (212)Pb was found to be 0.14 ± 0.012 Bq m(-3). An AMAD of (210)Pb of 610 nm with σg of 1.8 was determined, whereas that of 550 nm with σg of 1.97 was determined for (7)Be. The specific air activity concentration of (210)Pb and (7)Be was found to be 0.0016±2.5×10(-4) and 0.00348 ± 4×10(-4) Bq m(-3), respectively. Using a dosimetric model, the total deposition fraction as well as the total equivalent dose has been evaluated considering the observed parameters of the activity size distribution of (212)Pb. At a total deposition fraction of ∼21 %, the total equivalent dose was found to be 0.41 µSv.

  6. Plant uptake of radionuclides in lysimeter experiments.

    PubMed

    Gerzabek, M H; Strebl, F; Temmel, B

    1998-01-01

    The results of seven years lysimeter experiments to determine the uptake of 60Co, 137Cs and 226Ra into agricultural crops (endive, maize, wheat, mustard, sugarbeet, potato, Faba bean, rye grass) are described. The lysimeter consists of twelve monolithic soil profiles (four soil types and three replicates) and is located in Seibersdorf/Austria, a region with a pannonian climate (pronounced differences between hot and semi-arid summers and humid winter conditions, annual mean of precipitation: 517 mm, mean annual temperature: 9.8 degrees C). Besides soil-to-plant transfer factors (TF), fluxes were calculated taking into account biomass production and growth time. Total median values of TF's (dry matter basis) for the three radionuclides decreased from 226Ra (0.068 kg kg(-1)) to 137Cs (0.043 kg kg(-1)) and 60Co (0.018 kg kg(-1)); flux values exhibited the same ranking. The varying physical and chemical properties of the four experimental soils resulted in statistically significant differences in transfer factors or fluxes between the investigated soils for 137Cs and 226Ra, but not for 60Co. Differences in transfer between plant species and plant parts are distinct, with graminaceous species showing, on average, TF values 5.8 and 15 times lower than dicotyledonous species for 137Cs and 60Co, respectively. This pattern was not found for 226Ra. It can be concluded that 137Cs transfer is heavily influenced by soil characteristics, whilst the plant-specific factors are the main source of TF variability for 60Co. The variability of 226Ra transfer originates both from soil properties and plant species behaviour.

  7. MICROBIAL TRANSFORMATIONS OF RADIONUCLIDES AND ENVIRONMENTAL RESTORATION THROUGH BIOREMEDIATION.

    SciTech Connect

    FRANCIS, A.J.

    2006-09-29

    Treatment of waste streams containing radionuclides, the remediation of contaminated materials, soils, and water, and the safe and economical disposal of radionuclides and toxic metals containing wastes is a major concern. Radionuclides may exist in various oxidation states and may be present as oxide, coprecipitates, inorganic, and organic complexes depending on the process and waste stream. Unlike organic contaminants, the metals cannot be destroyed, but must either be converted to a stable form or removed. Microorganisms present in the natural environment play a major role in the mobilization and immobilization of radionuclides and toxic metals by direct enzymatic or indirect non-enzymatic actions and could affect the chemical nature of the radionuclides by altering the speciation, solubility and sorption properties and thus could increase or decrease the concentrations of radionuclides in solution. Fundamental understanding of the mechanisms of microbiological transformations of various chemical forms of uranium present in wastes and contaminated soils and water has led to the development of novel bioremediation processes. One process uses anaerobic bacteria to stabilize the radionuclides by reductive precipitation from higher to lower oxidation state with a concurrent reduction in volume due to the dissolution and removal of nontoxic elements from the waste matrix. In an another process, uranium and other toxic metals are removed from contaminated surfaces, soils, and wastes by extracting with the chelating agent citric acid. Uranium is recovered from the citric acid extract after biodegradation followed by photodegradation in a concentrated form as UO{sub 3} {center_dot} 2H{sub 2}O for recycling or appropriate disposal. These processes use all naturally occurring materials, common soil bacteria, naturally occurring organic compound citric acid and sunlight.

  8. PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status.

    PubMed

    Lütje, Susanne; Heskamp, Sandra; Cornelissen, Alexander S; Poeppel, Thorsten D; van den Broek, Sebastiaan A M W; Rosenbaum-Krumme, Sandra; Bockisch, Andreas; Gotthardt, Martin; Rijpkema, Mark; Boerman, Otto C

    2015-01-01

    Prostate cancer (PCa) is the most common malignancy in men worldwide, leading to substantial morbidity and mortality. At present, imaging of PCa has become increasingly important for staging, restaging, and treatment selection. Until recently, choline-based positron emission tomography/computed tomography (PET/CT) represented the state-of-the-art radionuclide imaging technique for these purposes. However, its application is limited to patients with high PSA levels and Gleason scores. Prostate-specific membrane antigen (PSMA) is a promising new target for specific imaging of PCa, because it is upregulated in the majority of PCa. Moreover, PSMA can serve as a target for therapeutic applications. Currently, several small-molecule PSMA ligands with excellent in vivo tumor targeting characteristics are being investigated for their potential in theranostic applications in PCa. Here, a review of the recent developments in PSMA-based diagnostic imaging and therapy in patients with PCa with radiolabeled PSMA ligands is provided.

  9. Patient-specific dosimetry in peptide receptor radionuclide therapy: a clinical review.

    PubMed

    Chalkia, M T; Stefanoyiannis, A P; Chatziioannou, S N; Round, W H; Efstathopoulos, E P; Nikiforidis, G C

    2015-03-01

    Neuroendocrine tumours (NETs) belong to a relatively rare class of neoplasms. Nonetheless, their prevalence has increased significantly during the last decades. Peptide receptor radionuclide therapy (PRRT) is a relatively new treatment approach for inoperable or metastasised NETs. The therapeutic effect is based on the binding of radiolabelled somatostatin analogue peptides with NETs' somatostatin receptors, resulting in internal irradiation of tumours. Pre-therapeutic patient-specific dosimetry is essential to ensure that a treatment course has high levels of safety and efficacy. This paper reviews the methods applied for PRRT dosimetry, as well as the dosimetric results presented in the literature. Focus is given on data concerning the therapeutic somatostatin analogue radiopeptides (111)In-[DTPA(0),D-Phe(1)]-octreotide ((111)In-DTPA-octreotide), (90)Y-[DOTA(0),Tyr(3)]-octreotide ((90)Y-DOTATOC) and (177)Lu-[DOTA(0),Tyr(3),Thr(8)]-octreotide ((177)Lu-DOTATATE). Following the Medical Internal Radiation Dose (MIRD) Committee formalism, dosimetric analysis demonstrates large interpatient variability in tumour and organ uptake, with kidneys and bone marrow being the critical organs. The results are dependent on the image acquisition and processing protocol, as well as the dosimetric imaging radiopharmaceutical.

  10. MEDECOR--a medical decorporation tool to assist first responders, receivers, and medical reach-back personnel in triage, treatment, and risk assessment after internalization of radionuclides.

    PubMed

    Waller, Ed; Wilkinson, Diana

    2010-10-01

    After a radiological dispersal device (RDD) event, it is possible for radionuclides to enter the human body through inhalation, ingestion, and skin and wound absorption. From a health physics perspective, it is important to know the magnitude of the intake to perform dosimetric assessments. From a medical perspective, removal of radionuclides leading to dose aversion (hence risk reduction) is of high importance. The efficacy of medical decorporation strategies is extremely dependent upon the time of treatment delivery after intake. The "golden hour," or more realistically 3-4 h, is optimal when attempting to increase removal of radionuclides from extracellular fluids prior to cellular incorporation. To assist medical first response personnel in making timely decisions regarding appropriate treatment delivery modes, it is desirable to have a software tool that compiles existing radionuclide decorporation therapy data and allows a user to perform simple diagnosis leading to optimized decorporation treatment strategies. In its most simple application, the software is a large database of radionuclide decorporation strategies and treatments. The software can also be used in clinical interactive mode, in which the user inputs the radionuclide, estimated activity, route of intake and time since exposure. The software makes suggestions as to the urgency of treatment (i.e., triage) and the suggested therapy. Current developments include risk assessment which impacts the potential risk of delivered therapy and resource allocation of therapeutic agents. The software, developed for the Canadian Department of National Defence (DND), is titled MEDECOR (MEdical DECORporation). The MEDECOR tool was designed for use on both personal digital assistant and laptop computer environments. The tool was designed using HTML/Jscript, to allow for ease of portability amongst different computing platforms. This paper presents the features of MEDECOR, results of testing at a major NATO

  11. REPORTABLE RADIONUCLIDES IN DWPF SLUDGE BATCH 7A (MACROBATCH 8)

    SciTech Connect

    Reboul, S.; Diprete, D.; Click, D.; Bannochie, C.

    2011-12-20

    The Waste Acceptance Product Specifications (WAPS) 1.2 require that the waste producer 'shall report the curie inventory of radionuclides that have half-lives longer than 10 years and that are, or will be, present in concentrations greater than 0.05 percent of the total inventory for each waste type indexed to the years 2015 and 3115.' As part of the strategy to meet WAPS 1.2, the Defense Waste Processing Facility (DWPF) will report for each waste type all radionuclides that have half-lives longer than 10 years and contribute greater than 0.01 percent of the total curie inventory from the time of production through the 1100 year period from 2015 through 3115. The initial list of radionuclides to be reported is based on the design-basis glass identified in the Waste Form Compliance Plan (WCP) and Waste Form Qualification Report. However, it is required that the list be expanded if other radionuclides with half-lives greater than 10 years are identified that meet the 'greater than 0.01% of the curie inventory' criterion. Specification 1.6 of the WAPS, International Atomic Energy Agency Safeguards Reporting for High Level Waste (HLW), requires that the ratio by weights of the following uranium and plutonium isotopes be reported: U-233, U-234, U-235, U-236, and U-238; and Pu-238, Pu-239, Pu-240, Pu-241, and Pu-242. Therefore, the complete list of reportable radionuclides must also include these sets of U and Pu isotopes - and the U and Pu isotopic mass distributions must be identified. The DWPF receives HLW sludge slurry from Savannah River Site (SRS) Tank 40. For Sludge Batch 7a (SB7a), the waste in Tank 40 contained a blend of the heel from Sludge Batch 6 (SB6) and the Sludge Batch 7 (SB7) material transferred to Tank 40 from Tank 51. This sludge blend is also referred to as Macrobatch 8. Laboratory analyses of a Tank 40 sludge sample were performed to quantify the concentrations of pertinent radionuclides in the SB7a waste. Subsequently, radiological decay and in

  12. Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.

    PubMed

    Morgenstern, Alfred; Bruchertseifer, Frank; Apostolidis, Christos

    2012-07-01

    The alpha emitters (225)Ac and (213)Bi are promising therapeutic radionuclides for application in targeted alpha therapy of cancer and infectious diseases. Both alpha emitters are available with high specific activity from established radionuclide generators. Their favourable chemical and physical properties have led to the conduction of a large number of preclinical studies and several clinical trials, demonstrating the feasibility, safety and therapeutic efficacy of targeted alpha therapy with (225)Ac and (213)Bi. This review describes methods for the production of (225)Ac and (213)Bi and gives an overview of (225)Ac/(213)Bi radionuclide generator systems. Selected preclinical studies are highlighted and the current clinical experience with (225)Ac and (213)Bi is summarized.

  13. Focused interventional cancer radiation therapy using lipid nanoparticle-carried radionuclides

    NASA Astrophysics Data System (ADS)

    Hrycushko, Brian Andrew

    2011-07-01

    The overall goal in cancer therapy is to achieve complete tumor eradication while causing minimal damage to healthy organs and tissue. Based on the broadly accepted theory of tumor control being a probabilistic event, every fraction of radiation treatment kills a portion of cancer cells and higher radiation dose should result in improved tumor control. Ultimately, radiation oncologists must balance the delivery of high enough radiation to tumors for achieving tumor control while not delivering so much radiation as to cause unacceptable normal tissue risk. This project centers on the locoregional delivery of lipid (liposome) nanoparticle-carried therapeutic radionuclides (186Re/ 188Re) to apply a focal and ablative radiation dose to target regions while greatly decreasing normal tissue toxicity of surrounding tissues. Specific Aim 1 includes the development of dosimetric and radiobiological models to assess small animal / patient specific radionuclide therapy at a voxel level. This will be used for a proof of concept study to characterize a novel technique to treat the post-lumpectomy wall for residual early stage breast cancer while simultaneously treating draining lymph nodes. Specific Aim 2 will look at methods of improving therapeutic ratio by evaluating in vivo characteristics of different liposome formulations and tumor vasculature modification chemicals following direct intratumoral infusion of 99m Tc-liposomes within a human head and neck squamous cell carcinoma xenograft (HNSCC) model in nude rats. Specific Aim 3 will evaluate the therapy potential for direct intratumoral injection of 186Re-liposomes within a human HNSCC xenograft model in nude rats using the dosimetric and radiobiological models of Aim 1 with improved treatment modifications from Aim 2.

  14. Characterization of Tumor-Avid Antibody Fragments Genetically Engineered for Mono-Specific Radionuclide Chelation

    SciTech Connect

    Quinn, T.P.

    2003-12-31

    The successful clinical application of targeted-radiopharmaceuticals depends on the development of molecules that optimize tumor specific radionuclide deposition and minimize non-specific organ irradiation. To this end, this proposal outlines a research effort to identify and evaluate novel antibodies and antibody fragments that bind breast tumors. The tumor-avid antibodies will be investigated for as imaging and therapeutic agents and to gain a better understanding of the pharmacokinetics and metabolism of radiolabeled tumor-avid antibody fragments through the use of site-specifically labeled molecules. Antibodies or antibody fragments, that bind breast carcinoma carbohydrate antigens, will be obtained from hybridoma or bacteriophage library screening. More specifically, antibody fragments that bind the carcinoma-associated Thomsen-Friedenreich (T) antigen will be radiolabeled with {sup 99m}Tc and {sup 188}Re at a natural amino acid chelation site and will be investigated in vivo for their abilities to target human breast tumors. In addition, site-specific radiolabeled antibody fragments will be biosynthesized using misacylated suppressor tRNAs. Homogeneously radiolabeled populations of antibody fragments will be used to investigate the effects of radionuclide location and chelation chemistries on their biodistribution and metabolism. It is hypothesized that site-specifically radiolabeled antibody fragments will possess enhanced tumor imaging and therapeutic properties due to optimal label location and conjugation chemistries. New insights into the factors that govern antibody metabolism in vivo are also expected from this work. Results from these studies should enhance our ability to design and synthesize radiolabeled antibody fragments that have improved pharmacokinetic properties. The studies in this proposal involve basic research into the development of antibody-based radiopharmaceuticals, with the ultimate goal of application in humans. This type of basic

  15. Prosthetic joint infections: radionuclide state-of-the-art imaging.

    PubMed

    Gemmel, Filip; Van den Wyngaert, Hans; Love, Charito; Welling, M M; Gemmel, Paul; Palestro, Christopher J

    2012-05-01

    Prosthetic joint replacement surgery is performed with increasing frequency. Overall the incidence of prosthetic joint infection (PJI) and subsequently prosthesis revision failure is estimated to be between 1 and 3%. Differentiating infection from aseptic mechanical loosening, which is the most common cause of prosthetic failure, is especially important because of different types of therapeutic management. Despite a thorough patient history, physical examination, multiple diagnostic tests and complex algorithms, differentiating PJI from aseptic loosening remains challenging. Among imaging modalities, radiographs are neither sensitive nor specific and cross-sectional imaging techniques, such as computed tomography and magnetic resonance imaging, are limited by hardware-induced artefacts. Radionuclide imaging reflects functional rather than anatomical changes and is not hampered by the presence of a metallic joint prosthesis. As a result scintigraphy is currently the modality of choice in the investigation of suspected PJI. Unfortunately, there is no true consensus about the gold standard technique since there are several drawbacks and limitations inherent to each modality. Bone scintigraphy (BS) is sensitive for identifying the failed joint replacement, but cannot differentiate between infection and aseptic loosening. Combined bone/gallium scintigraphy (BS/GS) offers modest improvement over BS alone for diagnosing PJI. However, due to a number of drawbacks, BS/GS has generally been superseded by other techniques but it still may have a role in neutropenic patients. Radiolabelled leucocyte scintigraphy remains the gold standard technique for diagnosing neutrophil-mediated processes. It seems to be that combined in vitro labelled leucocyte/bone marrow scintigraphy (LS/BMS), with an accuracy of about 90%, is currently the imaging modality of choice for diagnosing PJI. There are, however, significant limitations using in vitro labelled leucocytes and considerable effort

  16. Exposure to radionuclides in smoke from vegetation fires.

    PubMed

    Carvalho, Fernando P; Oliveira, João M; Malta, Margarida

    2014-02-15

    Naturally occurring radionuclides of uranium, thorium, radium, lead and polonium were determined in bushes and trees and in the smoke from summer forest fires. Activity concentrations of radionuclides in smoke particles were much enriched when compared to original vegetation. Polonium-210 ((210)Po) in smoke was measured in concentrations much higher than all other radionuclides, reaching 7,255 ± 285 Bq kg(-1), mostly associated with the smaller size smoke particles (<1.0 μm). Depending on smoke particle concentration, (210)Po in surface air near forest fires displayed volume concentrations up to 70 m Bq m(-3), while in smoke-free air (210)Po concentration was about 30 μ Bq m(-3). The estimated absorbed radiation dose to an adult member of the public or a firefighter exposed for 24h to inhalation of smoke near forest fires could exceed 5 μSv per day, i.e, more than 2000 times above the radiation dose from background radioactivity in surface air, and also higher than the radiation dose from (210)Po inhalation in a chronic cigarette smoker. It is concluded that prolonged exposure to smoke allows for enhanced inhalation of radionuclides associated with smoke particles. Due to high radiotoxicity of alpha emitting radionuclides, and in particular of (210)Po, the protection of respiratory tract of fire fighters is strongly recommended.

  17. Studying the anthropogenic radionuclides in Puerto Rico: Preliminary Result

    NASA Astrophysics Data System (ADS)

    Ithier-Guzmán, W.; Pyrtle, A. J.; Smoak, J.

    2004-12-01

    Local introduction of anthropogenic radionuclides to Puerto Rico's terrestrial and aquatic environments began in 1962 as a result of US government-sponsored research activities. Some of the earlier experiments examined the effects of radiation in tropical rainforests and the potential of superheated boiling nuclear reactor technology. More recent activities involved the use of depleted uranium during military exercises on Vieques. While the presence of radionuclides in Puerto Rico is documented, little research has been done to assess the environmental impact of this anthropogenic material. After entering Puerto Rico's environment, it is likely that some radionuclides are transported away from initial introduction sites. It is important that the distributions and behavior of radionuclides in Puerto Rico be determined. As such an investigation of this material throughout Puerto Rico was initiated. Sediment Cs-137 and Pb-210 activities, as well as ancillary geochemistry data are presented. These preliminary findings will be utilized as part of an ongoing study to determine radionuclide distributions and behaviors, with respect to aquatic geochemistry and dominant transport processes.

  18. Radionuclides, radiotracers and radiopharmaceuticals for in vivo diagnosis

    NASA Astrophysics Data System (ADS)

    Wiebe, Leonard I.

    Radioactive tracers for in vivo clinical diagnosis fall within a narrow, strictly-defined set of specifications in respect of their physical properties, chemical and biochemical characteristics, and (approved) medical applications. The type of radioactive decay and physical half-life of the radionuclide are immutable properties which, along with the demands of production and supply, limit the choice of radionuclides used in medicine to only a small fraction of those known to exist. In use, the biochemical and physiological properties of a radiotracer are dictated by the chemical form of the radionuclide. This chemical form may range from elemental, molecular or ionic, to complex compounds formed by coordinate or covalent bonding of the radionuclide to either simple organic or inorganic molecules, or complex macromolecules. Few of the radiotracers which are tested in model systems ever become radiopharmaceuticals in the strictest sense. Radionuclides, radiotracers and radiopharmaceuticals in use are reviewed. Drug legislation and regulations concerning drug manufacture, as well as hospital ethical constraints and legislation concerning unsealed sources of radiation must all be satisfied in order to translate a radiopharmaceutical from the laboratory to clinical use.

  19. A model for radionuclide transport in the Cooling Water System

    SciTech Connect

    Kahook, S.D.

    1992-08-01

    A radionuclide transport model developed to assess radiological levels in the K-reactor Cooling Water System (CWS) in the event of an inadvertent process water (PW) leakage to the cooling water (CW) in the heat exchangers (HX) is described. During and following a process water leak, the radionuclide transport model determines the time-dependent release rates of radionuclide from the cooling water system to the environment via evaporation to the atmosphere and blow-down to the Savannah River. The developed model allows for delay times associated with the transport of the cooling water radioactivity through cooling water system components. Additionally, this model simulates the time-dependent behavior of radionuclides levels in various CWS components. The developed model is incorporated into the K-reactor Cooling Tower Activity (KCTA) code. KCTA allows the accident (heat exchanger leak rate) and the cooling tower blow-down and evaporation rates to be described as time-dependent functions. Thus, the postulated leak and the consequence of the assumed leak can be modelled realistically. This model is the first of three models to be ultimately assembled to form a comprehensive Liquid Pathway Activity System (LPAS). LPAS will offer integrated formation, transport, deposition, and release estimates for radionuclides formed in a SRS facility. Process water and river water modules are forthcoming as input and downstream components, respectively, for KCTA.

  20. Quantitative Modeling of Cerenkov Light Production Efficiency from Medical Radionuclides

    PubMed Central

    Beattie, Bradley J.; Thorek, Daniel L. J.; Schmidtlein, Charles R.; Pentlow, Keith S.; Humm, John L.; Hielscher, Andreas H.

    2012-01-01

    There has been recent and growing interest in applying Cerenkov radiation (CR) for biological applications. Knowledge of the production efficiency and other characteristics of the CR produced by various radionuclides would help in accessing the feasibility of proposed applications and guide the choice of radionuclides. To generate this information we developed models of CR production efficiency based on the Frank-Tamm equation and models of CR distribution based on Monte-Carlo simulations of photon and β particle transport. All models were validated against direct measurements using multiple radionuclides and then applied to a number of radionuclides commonly used in biomedical applications. We show that two radionuclides, Ac-225 and In-111, which have been reported to produce CR in water, do not in fact produce CR directly. We also propose a simple means of using this information to calibrate high sensitivity luminescence imaging systems and show evidence suggesting that this calibration may be more accurate than methods in routine current use. PMID:22363636

  1. Bioremediation: a genuine technology to remediate radionuclides from the environment.

    PubMed

    Prakash, Dhan; Gabani, Prashant; Chandel, Anuj K; Ronen, Zeev; Singh, Om V

    2013-07-01

    Radionuclides in the environment are a major human and environmental health concern. Like the Chernobyl disaster of 1986, the Fukushima Daiichi nuclear disaster in 2011 is once again causing damage to the environment: a large quantity of radioactive waste is being generated and dumped into the environment, and if the general population is exposed to it, may cause serious life-threatening disorders. Bioremediation has been viewed as the ecologically responsible alternative to environmentally destructive physical remediation. Microorganisms carry endogenous genetic, biochemical and physiological properties that make them ideal agents for pollutant remediation in soil and groundwater. Attempts have been made to develop native or genetically engineered (GE) microbes for the remediation of environmental contaminants including radionuclides. Microorganism-mediated bioremediation can affect the solubility, bioavailability and mobility of radionuclides. Therefore, we aim to unveil the microbial-mediated mechanisms for biotransformation of radionuclides under various environmental conditions as developing strategies for waste management of radionuclides. A discussion follows of '-omics'-integrated genomics and proteomics technologies, which can be used to trace the genes and proteins of interest in a given microorganism towards a cell-free bioremediation strategy.

  2. A Bayesian Algorithm for Assessing Uncertainty in Radionuclide Source Terms

    NASA Astrophysics Data System (ADS)

    Robins, Peter

    2015-04-01

    Inferring source term parameters for a radionuclide release is difficult, due to the large uncertainties in forward dispersion modelling as a consequence of imperfect knowledge pertaining to wind vector fields and turbulent diffusion in the Earth's atmosphere. Additional sources of error include the radionuclide measurements obtained from sensors. These measurements may either be subject to random fluctuations or are simple indications that the true, unobserved quantity is below a detection limit. Consequent large reconstruction uncertainties can render a "best" estimate meaningless. A Markov Chain Monte Carlo (MCMC) Bayesian Algorithm is presented that attempts to account for uncertainties in atmospheric transport modelling and radionuclide sensor measurements to quantify uncertainties in radionuclide release source term parameters. Prior probability distributions are created for likely release locations at existing nuclear facilities and seismic events. Likelihood models are constructed using CTBTO adjoint modelling output and probability distributions of sensor response. Samples from the resulting multi-isotope source term parameters posterior probability distribution are generated that can be used to make probabilistic statements about the source term. Examples are given of marginal probability distributions obtained from simulated sensor data. The consequences of errors in numerical weather prediction wind fields are demonstrated with a reconstruction of the Fukushima nuclear reactor accident from International Monitoring System radionuclide particulate sensor data.

  3. Bioremediation: a genuine technology to remediate radionuclides from the environment

    PubMed Central

    Prakash, Dhan; Gabani, Prashant; Chandel, Anuj K; Ronen, Zeev; Singh, Om V

    2013-01-01

    Summary Radionuclides in the environment are a major human and environmental health concern. Like the Chernobyl disaster of 1986, the Fukushima Daiichi nuclear disaster in 2011 is once again causing damage to the environment: a large quantity of radioactive waste is being generated and dumped into the environment, and if the general population is exposed to it, may cause serious life-threatening disorders. Bioremediation has been viewed as the ecologically responsible alternative to environmentally destructive physical remediation. Microorganisms carry endogenous genetic, biochemical and physiological properties that make them ideal agents for pollutant remediation in soil and groundwater. Attempts have been made to develop native or genetically engineered (GE) microbes for the remediation of environmental contaminants including radionuclides. Microorganism-mediated bioremediation can affect the solubility, bioavailability and mobility of radionuclides. Therefore, we aim to unveil the microbial-mediated mechanisms for biotransformation of radionuclides under various environmental conditions as developing strategies for waste management of radionuclides. A discussion follows of ‘-omics’-integrated genomics and proteomics technologies, which can be used to trace the genes and proteins of interest in a given microorganism towards a cell-free bioremediation strategy. PMID:23617701

  4. New best estimates for radionuclide solid-liquid distribution coefficients in soils. Part 3: miscellany of radionuclides (Cd, Co, Ni, Zn, I, Se, Sb, Pu, Am, and others).

    PubMed

    Gil-García, C; Tagami, K; Uchida, S; Rigol, A; Vidal, M

    2009-09-01

    New best estimates for the solid-liquid distribution coefficient (K(d)) for a set of radionuclides are proposed, based on a selective data search and subsequent calculation of geometric means. The K(d) best estimates are calculated for soils grouped according to the texture and organic matter content. For a limited number of radionuclides this is extended to consider soil cofactors affecting soil-radionuclide interaction, such as pH, organic matter content, and radionuclide chemical speciation. Correlations between main soil properties and radionuclide K(d) are examined to complete the information derived from the best estimates with a rough prediction of K(d) based on soil parameters. Although there are still gaps for many radionuclides, new data from recent studies improve the calculation of K(d) best estimates for a number of radionuclides, such as selenium, antimony, and iodine.

  5. A comparison of the dose from natural radionuclides and artificial radionuclides after the Fukushima nuclear accident

    PubMed Central

    Hosoda, Masahiro; Tokonami, Shinji; Omori, Yasutaka; Ishikawa, Tetsuo; Iwaoka, Kazuki

    2016-01-01

    Due to the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident, the evacuees from Namie Town still cannot reside in the town, and some continue to live in temporary housing units. In this study, the radon activity concentrations were measured at temporary housing facilities, apartments and detached houses in Fukushima Prefecture in order to estimate the annual internal exposure dose of residents. A passive radon–thoron monitor (using a CR-39) and a pulse-type ionization chamber were used to evaluate the radon activity concentration. The average radon activity concentrations at temporary housing units, including a medical clinic, apartments and detached houses, were 5, 7 and 9 Bq m−3, respectively. Assuming the residents lived in these facilities for one year, the average annual effective doses due to indoor radon in each housing type were evaluated as 0.18, 0.22 and 0.29 mSv, respectively. The average effective doses to all residents in Fukushima Prefecture due to natural and artificial sources were estimated using the results of the indoor radon measurements and published data. The average effective dose due to natural sources for the evacuees from Namie Town was estimated to be 1.9 mSv. In comparison, for the first year after the FDNPP accident, the average effective dose for the evacuees due to artificial sources from the accident was 5.0 mSv. Although residents' internal and external exposures due to natural radionuclides cannot be avoided, it might be possible to lower external exposure due to the artificial radionuclides by changing some behaviors of residents. PMID:26838130

  6. Geomorphic control of radionuclide diffusion in desert soils

    USGS Publications Warehouse

    Pelletier, J.D.; Harrington, C.D.; Whitney, J.W.; Cline, M.; DeLong, S.B.; Keating, G.; Ebert, T.K.

    2005-01-01

    Diffusion is a standard model for the vertical migration of radionuclides in soil profiles. Here we show that diffusivity values inferred from fallout 137CS profiles in soils on the Fortymile Wash alluvial fan, Nye County, Nevada, have a strong inverse correlation with the age of the geomorphic surface. This result suggests that radionuclide-bound particles are predominantly transported by infiltration rather than by bulk-mixing processes such as wetting/ drying, freeze/thaw, and bioturbation. Our results provide a preliminary basis for using soil-geomorphic mapping, point-based calibration data, and the diffusion model to predict radionuclide trans desert soils within a pedotransfer-function approach. Copyright 2005 by the American Geophysical Union.

  7. Deriving cleanup guidelines for radionuclides at Brookhaven National Laboratory

    SciTech Connect

    Meinhold, A.F.; Morris, S.C.; Dionne, B.; Moskowitz, P.D.

    1997-01-01

    Past activities at Brookhaven National Laboratory (BNL) resulted in soil and groundwater contamination. As a result, BNL was designated a Superfund site under the Comprehensive Environmental Response Compensation and Liability Act (CERCLA). BNL`s Office of Environmental Restoration (OER) is overseeing environmental restoration activities at the Laboratory. With the exception of radium, there are no regulations or guidelines to establish cleanup guidelines for radionuclides in soils at BNL. BNL must derive radionuclide soil cleanup guidelines for a number of Operable Units (OUs) and Areas of Concern (AOCs). These guidelines are required by DOE under a proposed regulation for radiation protection of public health and the environment as well as to satisfy the requirements of CERCLA. The objective of this report is to propose a standard approach to deriving risk-based cleanup guidelines for radionuclides in soil at BNL. Implementation of the approach is briefly discussed.

  8. Removal of dissolved heavy metals and radionuclides by microbial spores

    SciTech Connect

    Revis, N.W.; Hadden, C.T.; Edenborn, H.

    1997-11-01

    Microbial systems have been shown to remove specific heavy metals from contaminated aqueous waste to levels acceptable to EPA for environmental release. However, systems capable of removing a variety of heavy metals from aqueous waste to environmentally acceptable levels remain to be reported. The present studies were performed to determine the specificity of spores of the bacterium Bacillus megaterium for the adsorption of dissolved metals and radionuclides from aqueous waste. The spores effectively adsorbed eight heavy metals from a prepared metal mix and from a plating rinse waste to EPA acceptable levels for waste water. These results suggest that spores have multiple binding sites for the adsorption of heavy metals. Spores were also effective in adsorbing the radionuclides {sup 85}strontium and {sup 197}cesium. The presence of multiple sites in spores for the adsorption of heavy metals and radionuclides makes this biosorbent a good candidate for the treatment of aqueous wastes associated with the plating and nuclear industries. 17 refs., 4 tabs.

  9. MICROBIAL TRANSFORMATIONS OF RADIONUCLIDES RELEASED FROM NUCLEAR FUEL REPROCESSING PLANTS.

    SciTech Connect

    FRANCIS,A.J.

    2006-10-18

    Microorganisms can affect the stability and mobility of the actinides U, Pu, Cm, Am, Np, and the fission products Tc, I, Cs, Sr, released from nuclear fuel reprocessing plants. Under appropriate conditions, microorganisms can alter the chemical speciation, solubility and sorption properties and thus could increase or decrease the concentrations of radionuclides in solution and the bioavailability. Dissolution or immobilization of radionuclides is brought about by direct enzymatic action or indirect non-enzymatic action of microorganisms. Although the physical, chemical, and geochemical processes affecting dissolution, precipitation, and mobilization of radionuclides have been investigated, we have only limited information on the effects of microbial processes. The mechanisms of microbial transformations of the major and minor actinides and the fission products under aerobic and anaerobic conditions in the presence of electron donors and acceptors are reviewed.

  10. Radionuclide Incorporation and Long Term Performance of Apatite Waste Forms

    SciTech Connect

    Wang, Jianwei; Lian, Jie; Gao, Fei

    2016-01-04

    This project aims to combines state-of-the-art experimental and characterization techniques with atomistic simulations based on density functional theory (DFT) and molecular dynamics (MD) simulations. With an initial focus on long-lived I-129 and other radionuclides such as Cs, Sr in apatite structure, specific research objectives include the atomic scale understanding of: (1) incorporation behavior of the radionuclides and their effects on the crystal chemistry and phase stability; (2) stability and microstructure evolution of designed waste forms under coupled temperature and radiation environments; (3) incorporation and migration energetics of radionuclides and release behaviors as probed by DFT and molecular dynamics (MD) simulations; and (4) chemical durability as measured in dissolution experiments for long term performance evaluation and model validation.

  11. Radionuclides in plankton from the South Pacific Basin

    SciTech Connect

    Marsh, K.V.; Buddemeier, R.W.

    1984-03-23

    We have initiated an investigation of the utility of marine plankton as bioconcentrating samplers of low-level marine radioactivity in the southern hemisphere. A literature review has shown that both freshwater and marine plankton have trace element and radionuclide concentration factors (relative to water) of up to 10/sup 4/. We participated in Operations Deepfreeze 1981 and 1982, collecting a total of 48 plankton samples from the USCGC Glacier on its Antarctic cruises. Battelle Pacific Northwest Laboratories sampled air, water, rain, and fallout. We were able to measure concentrations in plankton of the naturally-occurring radionuclides /sup 7/Be, /sup 40/K, and the U and Th series, and we believe that we have detected low levels of /sup 144/Ce and /sup 95/Nb in seven samples ranging as far south as 68/sup 0/. Biological identification of the plankton suggests a possible correlation between radionuclide concentration and the protozoa content of the samples. 7 references, 5 figures.

  12. EOS7R: Radionuclide transport for TOUGH2

    SciTech Connect

    Oldenburg, C.M.; Pruess, K.

    1995-11-01

    EOS7R provides radionuclide transport capability for TOUGH2. EOS7R extends the EOS7 module (water, brine, and optional air) to model water, brine, parent component, daughter component, and optional air and heat. The radionuclide components follow a first-order decay law, and may adsorb onto the solid grains. Volatilization of the decaying components is modeled by Henry`s Law. The decaying components are normally referred to as radionuclides, but they may in fact by any trace components that decay, adsorb, and volatilize. The decay process need not be radioactive decay, but could be any process that follows a first-order decay law, such as biodegradation. EOS7R includes molecular diffusion for all components in gaseous and aqueous phases using a simplified binary diffusion model. When EOS7R is used with standard TOUGH2, transport occurs by advection and molecular diffusion in all phases. When EOS7R is coupled with the dispersion module T2DM, one obtains T2DMR, the radionuclide transport version of T2DM. T2DMR models advection, diffusion, and hydrodynamic dispersion in rectangular two-dimensional regions. Modeling of radionuclide transport requires input parameters specifying the half-life for first-order decay, distribution coefficients for each rock type for adsorption, and inverse Henry`s constants for volatilization. Options can be specified in the input file to model decay in inactive grid blocks and to read from standard EOS7 INCON files. The authors present a number of example problems to demonstrate application and accuracy of TOUGH2/EOS7R. One-dimensional simulation results agree well with analytical solutions. For a two-dimensional salt-dome flow problem, the final distribution of daughter radionuclide component is complicated by the presence of weak recirculation caused by density effects due to salinity.

  13. Radionuclide imaging in the diagnosis of osteoid osteoma.

    PubMed

    Park, Jong Hoon; Pahk, Kisoo; Kim, Sungeun; Lee, Soon Hyuck; Song, Sang Heon; Choe, Jae Gol

    2015-08-01

    Oseteoid osteoma is a well-known type of benign bone-forming tumor, which has previously been diagnosed using plain radiograph imaging. However, diagnosis of osteoid osteoma may be delayed due to ambiguities on plain radiograph images; despite the increasing use of magnetic resonance imaging (MRI), this type of misdiagnosis is not uncommon. The aim of the present study was to evaluate the effectiveness of radionuclide imaging scans for the diagnosis of osteoid osteoma, as this form of imaging was proposed to be a more sensitive test. The characteristics of 18 cases of osteoid osteoma were analyzed based on diagnostic imaging and the time from initial recognition of symptoms by the patient to diagnosis. Diagnostic modalities included plain radiograph, computed tomography (CT), MRI and radionuclide imaging. Among the 18 patients, 14 patients had unique positive findings in plain radiographs. The mean duration between initial cognition of symptoms to the diagnosis for these patients was 5.2 months (range, 3.8-9.3 months). A total of 4 patients exhibited no radiographic abnormalities in the initial plain radiographs and were diagnosed a mean of 18.5 months (range, 17-20 months) following the onset of symptoms. Overall, radionuclide imaging was performed on 16 patients and all of the cases demonstrated positive findings. In these cases, 28.6% of osteoid osteoma patients with clinical indications revealed no abnormal findings in plain radiographs. Therefore, in situations such as these, radionuclide imaging may be a useful indicator for diagnosis, as these results have demonstrated that it positively identified all cases of osteoid osteoma. In addition, the results of the present study indicated that if the radionuclide imaging was positive, CT scan was a more valuable diagnostic tool, whereas if the radionuclide imaging was negative, MRI should be recommended for the diagnosis of other undiscovered disease entities.

  14. Comparative Measures of Radionuclide Containment in the Crystalline Geophere

    SciTech Connect

    Cvetkovic, V.; Painter, S.; Selroos, J.O.

    2002-11-15

    A probabilistic model for assessing the capacity of a fractured crystalline rock volume to contain radionuclides is developed. The rock volume is viewed as a network of discrete fractures through which radionuclides are transported by flowing water. Diffusive mass transfer between the open fractures and the stagnant water in the pore space of the rock matrix allow radionuclides access to mineral grains where physical and chemical processes - collectively known as sorption - can retain radionuclides. A stochastic Lagrangian framework is adopted to compute the probability that a radionuclide particle will be retained by the rock, i.e., the probability that it will decay before being released from the rock volume. A dimensionless quantity referred to as the 'containment index' is related to this probability and proposed as a suitable measure for comparing different rock volumes; such a comparative measure may be needed, for example, in a site selection program for geological radioactive waste disposal. The probabilistic solution of the transport problem is based on the statistics of two Lagrangian variables: {tau}, the travel time of an imaginary tracer moving with the flowing water, and {beta}, a suitably normalized surface area available for retention. Statistics of {tau} and {beta} may be computed numerically using site-specific discrete fracture network simulations. Fracture data from the well-characterized Aespoe Hard Rock Laboratory site in southern Sweden are used to illustrate the implementation of the proposed containment index for six radionuclides ({sup 126}Sn, {sup 129}I, {sup 135}Cs, {sup 237}Np, {sup 239}Pu, and {sup 79}Se). It is found that fractures of small aperture imply prolonged travel times and hence long tails in both beta and tau. This, in turn, enhances retention and is favorable from a safety assessment perspective.

  15. Method for image reconstruction of moving radionuclide source distribution

    DOEpatents

    Stolin, Alexander V.; McKisson, John E.; Lee, Seung Joon; Smith, Mark Frederick

    2012-12-18

    A method for image reconstruction of moving radionuclide distributions. Its particular embodiment is for single photon emission computed tomography (SPECT) imaging of awake animals, though its techniques are general enough to be applied to other moving radionuclide distributions as well. The invention eliminates motion and blurring artifacts for image reconstructions of moving source distributions. This opens new avenues in the area of small animal brain imaging with radiotracers, which can now be performed without the perturbing influences of anesthesia or physical restraint on the biological system.

  16. Applicability of Gaussian plume dispersion parameters to acute radionuclide releases

    SciTech Connect

    Miller, C.W.; Fields, D.E.

    1980-01-01

    The Gaussian plume atmospheric dispersion model is one of the most widely used models for assessing the impact of radionuclides released to the atmosphere. This model is a statistical solution to the basic atmospheric diffusion equation. As a result, the Gaussian model should give more accurate results when used to calculate average air concentrations from long-term releases rather than for short-term concentrations from acute releases. However, the Gaussian model is routinely applied to such short-term radionuclide releases. The purpose of this paper is to examine the applicability of standard plume dispersion parameters for calculations of air concentrations resulting from such acute releases.

  17. Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease.

    PubMed

    Stacy, Mitchel R; Sinusas, Albert J

    2016-02-01

    Peripheral vascular disease (PVD) is a progressive atherosclerotic disease that leads to stenosis or occlusion of blood vessels supplying the lower extremities. Current diagnostic imaging techniques commonly focus on evaluation of anatomy or blood flow at the macrovascular level and do not permit assessment of the underlying pathophysiology associated with disease progression or treatment response. Molecular imaging with radionuclide-based approaches can offer novel insight into PVD by providing noninvasive assessment of biological processes such as angiogenesis and atherosclerosis. This article discusses emerging radionuclide-based imaging approaches that have potential clinical applications in the evaluation of PVD progression and treatment.

  18. Nopal I uranium deposit: A study of radionuclide migration

    SciTech Connect

    Wong, V.; Anthony, E.; Goodell, P.

    1996-12-01

    This summary reports on activities of naturally-occurring radionuclides for the Nopal I uranium deposit located in the Pena Blanca Uranium District, Chihuahua, Mexico. Activities were determined using gamma-ray spectroscopy. In addition, data reduction procedures and sample preparation (for Rn retention) will be discussed here. Nopal I uranium deposit has been identified as one of the most promising sites for analogue studies to the proposed high-level nuclear waste repository at Yucca Mountain, Nevada. The objective of this research is to study the potential for radionuclide migration by testing whether any portion of the deposit is in secular equilibrium.

  19. RADIONUCLIDE DISPERSION RATES BY AEOLIAN, FLUVIAL, AND POROUS MEDIA TRANSPORT

    SciTech Connect

    J. Walton; P. Goodell; C. Brashears; D. French; A. Kelts

    2005-07-11

    Radionuclide transport was measured from high grade uranium ore boulders near the Nopal I Site, Chihuahua, Mexico. High grade uranium ore boulders were left behind after removal of a uranium ore stockpile at the Prior High Grade Stockpile (PHGS). During the 25 years when the boulder was present, radionuclides were released and transported by sheetflow during precipitation events, wind blown resuspension, and infiltration into the unsaturated zone. In this study, one of the boulders was removed, followed by grid sampling of the surrounding area. Measured gamma radiation levels in three dimensions were used to derive separate dispersion rates by the three transport mechanisms.

  20. Software phantom for the synthesis of equilibrium radionuclide ventriculography images.

    PubMed

    Ruiz-de-Jesus, Oscar; Yanez-Suarez, Oscar; Jimenez-Angeles, Luis; Vallejo-Venegas, Enrique

    2006-01-01

    This paper presents the novel design of a software phantom for the evaluation of equilibrium radionuclide ventriculography systems. Through singular value decomposition, the data matrix corresponding to an equilibrium image series is decomposed into both spatial and temporal fundamental components that can be parametrized. This parametric model allows for the application of user-controlled conditions related to a desired dynamic behavior. Being invertible, the decomposition is used to regenerate the radionuclide image series, which is then translated into a DICOM ventriculography file that can be read by commercial equipment.

  1. Colloid-facilitated radionuclide transport: a regulatory perspective

    NASA Astrophysics Data System (ADS)

    Dam, W. L.; Pickett, D. A.; Codell, R. B.; Nicholson, T. J.

    2001-12-01

    What hydrogeologic-geochemical-microbial conditions and processes affect migration of radionuclides sorbed onto microparticles or native colloid-sized radionuclide particles? The U.S. Nuclear Regulatory Commission (NRC) is responsible for protecting public health, safety, and the environment at numerous nuclear facilities including a potential high-level nuclear waste disposal site. To fulfill these obligations, NRC needs to understand the mechanisms controlling radionuclide release and transport and their importance to performance. The current focus of NRC staff reviews and technical interactions dealing with colloid-facilitated transport relates to the potential nuclear-waste repository at Yucca Mountain, Nevada. NRC staff performed bounding calculations to quantify radionuclide releases available for ground-water transport to potential receptors from a Yucca Mountain repository. Preliminary analyses suggest insignificant doses of plutonium and americium colloids could be derived from spent nuclear fuel. Using surface complexation models, NRC staff found that colloids can potentially lower actinide retardation factors by up to several orders of magnitude. Performance assessment calculations, in which colloidal transport of plutonium and americium was simulated by assuming no sorption or matrix diffusion, indicated no effect of colloids on human dose within the 10,000 year compliance period due largely to long waste-package lifetimes. NRC staff have identified information gaps and developed technical agreements with the U.S. Department of Energy (DOE) to ensure sufficient information will be presented in any potential future Yucca Mountain license application. DOE has agreed to identify which radionuclides could be transported via colloids, incorporate uncertainties in colloid formation, release and transport parameters, and conceptual models, and address the applicability of field data using synthetic microspheres as colloid analogs. NRC is currently

  2. Pitfalls and Limitations of Radionuclide Renal Imaging in Pediatrics.

    PubMed

    Biassoni, Lorenzo

    2015-09-01

    The article presents common pitfalls encountered in pediatric radionuclide renography, illustrated with clinical cases. It is important to recognize normal variants. A good acquisition technique is essential. Correlation with other imaging techniques, with the clinical background and symptoms, is critical. A clear clinical question is essential: based on the question and knowing the strengths and weaknesses of each test, the test which can best answer the question can be selected. Awareness of the pitfalls of radionuclide renography helps avoid errors of interpretation and allows the selection of the most helpful test for clinical management.

  3. Improving cancer treatment with cyclotron produced radionuclides. Progress report

    SciTech Connect

    Larson, S.M.; Finn, R.D.

    1993-11-01

    This report describes our continuing long term goal of promoting nuclear medicine applications by improving the scientific basis for tumor diagnosis, treatment and treatment follow-up based on the use of cyclotron produced radiotracers in oncology. The program includes 3 interactive components: Radiochemistry/Cyclotron; Pharmacology; and Immunology. An essential strategy is as follows: novel radionuclides and radiotracers developed in the Radiochemistry/Cyclotron section will be employed in the Pharmacology and Immunology sections during the next year. The development of novel radionuclides and tracers is of course useful in and of itself, but their utility is greatly enhanced by the interaction with the immunology and pharmacology components of the program.

  4. Negative radionuclide scan in osteoid osteoma. A case report

    SciTech Connect

    Fehring, T.K.; Green, N.E.

    1984-05-01

    Advances in radionuclide imaging have facilitated the accurate diagnosis and surgical excision of osteoid osteoma. While radionuclide imaging has been inconsistent in the diagnosis of certain problems, its accuracy in the diagnosis of osteoid osteoma has been frequently stressed. To date, no case of a negative bone scan in the presence of a histologically proven osteoid osteoma has been reported. The present case report emphasizes that a negative bone scan does not preclude the diagnosis of osteoid osteoma. Clinical suspicion remains the most sensitive indicator of this lesion.

  5. 40 CFR Appendix D to Part 61 - Methods for Estimating Radionuclide Emissions

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... Table 1. Table 1—Adjustment to Emission Factors for Effluent Controls Controls Types of radionuclides... applicable to gaseous radionuclides; periodic testing is prudent to ensure high removal efficiency....

  6. 40 CFR Appendix D to Part 61 - Methods for Estimating Radionuclide Emissions

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Table 1. Table 1—Adjustment to Emission Factors for Effluent Controls Controls Types of radionuclides... applicable to gaseous radionuclides; periodic testing is prudent to ensure high removal efficiency....

  7. The effects of radionuclides on animal behavior.

    PubMed

    Gagnaire, Beatrice; Adam-Guillermin, Christelle; Bouron, Alexandre; Lestaevel, Philippe

    2011-01-01

    increased suicides, as well as modification of preferred nesting sites, reduced hatching success and fecundity in birds that live in the Chernobyl zone. No significant effect from caesium exposure was shown in laboratory experiments with rats, but few studies were conducted. Data on radioactive cadmium are not available in the literature, but the effects of its metallic form have been well studied. Cadmium induces mental retardation and psychomotor alterations in exposed populations and increases anxiety in rats, leading to depression. Cadmium exposure also results in well-documented effects on feeding and burrowing behavior in several invertebrate species (crustaceans, gastropods, annelids, bivalves) and on different kinds of fish behavior (swimming activity, fast-start response, antipredatory behavior). Cobalt induces memory deficits in humans and may be involved in Alzheimer's disease; gamma irradiation by cobalt also decreases fecundity and alters mating behavior in insects. Collectively, data are lacking or are meagre on radionuclide pollutants, and a better knowledge of their actions on the cellular and molecular mechanisms that control animal behavior is needed.

  8. SALTSTONE AND RADIONUCLIDE INTERACTIONS: RADIONUCLIDE SORPTION AND DESORPTION, AND SALTSTONE REDUCTION CAPACITY

    SciTech Connect

    Kaplan, D; Kimberly Roberts, K; Steven Serkiz, S; Matthew Siegfried, M

    2008-10-30

    The overall objective of this study was to measure a number of key input parameters quantifying geochemical processes in the subsurface environment of the Savannah River Site's (SRS's) Saltstone Facility. For the first time, sorption (K{sub d}) values of numerous radionuclides were measured with Saltstone and Vault 2 concrete. Particular attention was directed at understanding how Tc adsorbs and desorbs from these cementitious materials with the intent to demonstrate that desorption occurs at a much slower rate than adsorption, thus permitting the use of kinetic terms instead of (or along with) the steady state K{sub d} term. Another very important parameter measured was the reduction capacity of these materials. This parameter is used to estimate the duration that the Saltstone facility remains in a reduced chemical state, a condition that maintains several otherwise mobile radionuclides in an immobile form. Key findings of this study follow. K{sub d} values for Am, Cd, Ce, Co, Cs, Hg, I, Np, Pa, Pu, Se, Sn, Tc, U, and Y for Saltstone and Vault 2 concrete were measured under oxidized and reduced conditions. Precipitation of several of the higher valence state radionuclides was observed. There was little evidence that the Vault 2 and Saltstone K{sub d} values differed from previous SRS K{sub d} values measured with reducing grout (Kaplan and Coates 2007). These values also supported a previous finding that K{sub d} values of slag-containing cementitious materials, tend to be greater for cations and about the same for anions, than regular cementitious materials without slag. Based on these new findings, it was suggested that all previous reducing concrete K{sub d} values be used in future PAs, except Np(V) and Pu(IV) K{sub d} values, which should be increased, and I values, which should be slightly decreased in all three stages of concrete aging. The reduction capacity of Saltstone, consisting of 23 wt-% blast furnace slag, was 821.8 microequivalents per gram

  9. External exposure to radionuclides in air, water, and soil

    SciTech Connect

    Eckerman, K.F.; Ryman, J.C.

    1996-05-01

    Federal Guidance Report No. 12 tabulates dose coefficients for external exposure to photons and electrons emitted by radionuclides distributed in air, water, and soil. The dose coefficients are intended for use by Federal Agencies in calculating the dose equivalent to organs and tissues of the body.

  10. Status of ceramic waste form degradation and radionuclide release modeling.

    SciTech Connect

    Fanning, T. H.; Ebert, W. L.; Frank, S. M.; Hash, M. C.; Morris, E. E.; Morss, L. R.; O'Holleran, T. P.; Wigeland, R. A.

    2003-02-26

    As part of the spent fuel treatment program at Argonne National Laboratory (ANL), a ceramic waste form is being developed for disposition of the salt waste stream generated during the treatment process. Ceramic waste form (CWF) degradation and radionuclide release modeling is being carried out for the purpose of estimating the impact of the CWF on the performance of the proposed repository at Yucca Mountain. The CWF is composed of approximately 75 wt% salt-loaded sodalite encapsulated in 25 wt% glass binder. Most radionuclides are present as small inclusion phases in the glass. Since the release of radionuclides can only occur as the glass and sodalite phases dissolve, the dissolution rates of the glass and sodalite phases are modeled to provide an upper bound to radionuclide release rates from the CWF. Transition-state theory for the dissolution of aluminosilicate minerals provides a mechanistic basis for the CWF degradation model, while model parameters are obtained by experimental measurements. Performance assessment calculations are carried out using the engineered barrier system model from the Total System Performance Assessment--Viability Assessment (TSPA-VA) for the proposed repository at Yucca Mountain. The analysis presented herein suggests that the CWF will perform in the repository environment in a manner that is similar to other waste forms destined for the repository.

  11. Predicting radionuclide leaching from root zone soil for assessment applications

    SciTech Connect

    Baes, C.F. III.; Sharp, R.D.

    1981-01-01

    A simple leaching model is given for estimation of leaching rates of thirteen radioisotopes. A literature search with radionuclide migration data is presented in tabular form. This data must be considered in any model for predicting radiation doses from agricultural products or drinking water obtained from contaminated soils. (PSB)

  12. The fate of radionuclides in sewage sludge applied to land

    SciTech Connect

    Boston, H.L.; Van Miegroet, H.; Larsen, I.L.; Walzer, A.E. ); Carlton, J.E. )

    1990-01-01

    Municipal sewage sludge containing up to 12 pCi/g {sup 137}Cs, 20 pCi/g {sup 60}Co, and 300 ppm U was injected in a pasture (43 Mg/ha) and sprayed over a young pine plantation (34 Mg/ha). In the pasture, radionuclides were largely retained in the upper 15 cm of the soil, and only about 15% moved below 15 cm. Sludge rapidly infiltrated the soil on the pine plantation. One year after application, at least 85% of the {sup 137}Cs, {sup 60}Co, and U were found in the upper 7 cm of the pine plantation, with only about 15% moving into the 7- to 15-cm strata. On-site total added radiation dose was 2 to 6 mrem/year. Radionuclides were not detected above background in soil solutions at {approximately}50 cm depth or in shallow down-gradient groundwater wells. Surface runoff from application areas did not have elevated radionuclide concentrations. Concentrations of these radionuclides increased slightly in vegetation on treated sites, and uranium was notably higher in earthworms. 9 refs., 2 tabs.

  13. Chernobyl radionuclide distribution, migration, and environmental and agricultural impacts.

    PubMed

    Alexakhin, R M; Sanzharova, N I; Fesenko, S V; Spiridonov, S I; Panov, A V

    2007-11-01

    The distribution and migration of radionuclides released into the environment following the Chernobyl accident in 1986 are described. The Chernobyl disaster resulted in the consumption of farm products containing radionuclides as a source of irradiation of the population due to the prevalence of a rural type of human nutrition in the affected region. Economic and radiologic importance of countermeasures for reducing the impacts of the accident are described. The basic radioecological problem is described in which the area where direct radiation contamination of biota was observed is considerably smaller than the zone where concentrations of radionuclides through the food chain exceeded the permissible standards. The radiation-induced effects in biota in the affected area are described. In the long-term post-accident period, the radionuclide distribution between components of ecosystems (including humans) and doses are considered in comparison to a technologically normal situation of nuclear power plant operation. This analysis demonstrates that if radiation standards protect humans, then biota are also adequately protected against ionizing radiation.

  14. Modeling of radionuclide migration at nuclear facility sites

    SciTech Connect

    Tsang, C.F.; Alexander, D.; Haselow, J.

    1993-12-31

    The United States and Russia are conducting technology exchanges in the area of radionuclide migration in the environment. This paper will give an overview of the various scientific issues and physical and chemical processes associated with migration, thus laying the framework by which the data from the Chelyabinsk-65 site in Russia and the Savannah River Site in the USA can be analyzed.

  15. Radionuclides in Ecosystems| RadTown USA | US EPA

    EPA Pesticide Factsheets

    2016-12-13

    Radioactive elements are part of our ecosystem, part of the air we breathe, the water we drink and the food we eat. Radionuclides can occur naturally, or can be man-made. Over half of the average annual radiation exposure of people in the U.S. comes from natural sources.

  16. Detection of varicocele by radionuclide blood-pool scanning

    SciTech Connect

    Freund, J.; Handelsman, D.J.; Bautovich, G.J.; Conway, A.J.; Morris, J.G.

    1980-10-01

    Varicocele is a common and treatable cause of male subfertility. The authors describe a new technique for varicocele detection using radionuclide blood-pool imaging of the scrotum. The results indicate that this technique detects unilateral varicoceles with high sensitivity, including some which are subclinical. There may be significant implications for treatment of infertility.

  17. 40 CFR 141.66 - Maximum contaminant levels for radionuclides.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... levels for radionuclides. (a) (b) MCL for combined radium-226 and -228. The maximum contaminant level for combined radium-226 and radium-228 is 5 pCi/L. The combined radium-226 and radium-228 value is determined by the addition of the results of the analysis for radium-226 and the analysis for radium-228....

  18. 40 CFR 141.66 - Maximum contaminant levels for radionuclides.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... levels for radionuclides. (a) (b) MCL for combined radium-226 and -228. The maximum contaminant level for combined radium-226 and radium-228 is 5 pCi/L. The combined radium-226 and radium-228 value is determined by the addition of the results of the analysis for radium-226 and the analysis for radium-228....

  19. 40 CFR 141.66 - Maximum contaminant levels for radionuclides.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... levels for radionuclides. (a) (b) MCL for combined radium-226 and -228. The maximum contaminant level for combined radium-226 and radium-228 is 5 pCi/L. The combined radium-226 and radium-228 value is determined by the addition of the results of the analysis for radium-226 and the analysis for radium-228....

  20. 40 CFR 141.66 - Maximum contaminant levels for radionuclides.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... levels for radionuclides. (a) (b) MCL for combined radium-226 and -228. The maximum contaminant level for combined radium-226 and radium-228 is 5 pCi/L. The combined radium-226 and radium-228 value is determined by the addition of the results of the analysis for radium-226 and the analysis for radium-228....

  1. 40 CFR 141.66 - Maximum contaminant levels for radionuclides.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... levels for radionuclides. (a) (b) MCL for combined radium-226 and -228. The maximum contaminant level for combined radium-226 and radium-228 is 5 pCi/L. The combined radium-226 and radium-228 value is determined by the addition of the results of the analysis for radium-226 and the analysis for radium-228....

  2. Isonitrile radionuclide complexes for labelling and imaging agents

    DOEpatents

    Jones, Alun G.; Davison, Alan; Abrams, Michael J.

    1984-06-04

    A coordination complex of an isonitrile ligand and radionuclide such as Tc, Ru, Co, Pt, Fe, Os, Ir, W, Re, Cr, Mo, Mn, Ni, Rh, Pd, Nb and Ta, is useful as a diagnostic agent for labelling liposomes or vesicles, and selected living cells containing lipid membranes, such as blood clots, myocardial tissue, gall bladder tissue, etc.

  3. Radionuclides in sediments and seawater at Rongelap Atoll

    SciTech Connect

    Noshkin, V.E.; Robison, W.L.; Eagle, R.J.; Brunk, J.L.

    1998-03-01

    The present concentrations and distributions of long-lived, man-made radionuclides in Rongelap Atoll lagoon surface sediments, based on samples collected and analyzed in this report. The radionuclides were associated with debris generated with the 1954 Bravo thermonuclear test at Bikini Atoll. Presently, only {sup 90}Sr and the transuranic radionuclides are found associated with the surface sediments in any quantity. Other radionuclides, including {sup 60}Co and {sup 137} Cs, are virtually absent and have either decayed or migrated from the deposits to the overlying seawater. Present inventories of {sup 241}Am and {sup 249+240}Pu in the surface layer at Rongelap are estimated to be 3% of the respective inventories in surface sediments from Bikini Atoll. There is a continuous slow release of the transuranics from the sediments back to the water column. The inventories will only slowly change with time unless the chemical-physical processes that now regulate this release to the water column are changed or altered.

  4. Radionuclide transport behavior in a generic geological radioactive waste repository.

    PubMed

    Bianchi, Marco; Liu, Hui-Hai; Birkholzer, Jens T

    2015-01-01

    We performed numerical simulations of groundwater flow and radionuclide transport to study the influence of several factors, including the ambient hydraulic gradient, groundwater pressure anomalies, and the properties of the excavation damaged zone (EDZ), on the prevailing transport mechanism (i.e., advection or molecular diffusion) in a generic nuclear waste repository within a clay-rich geological formation. By comparing simulation results, we show that the EDZ plays a major role as a preferential flowpath for radionuclide transport. When the EDZ is not taken into account, transport is dominated by molecular diffusion in almost the totality of the simulated domain, and transport velocity is about 40% slower. Modeling results also show that a reduction in hydraulic gradient leads to a greater predominance of diffusive transport, slowing down radionuclide transport by about 30% with respect to a scenario assuming a unit gradient. In addition, inward flow caused by negative pressure anomalies in the clay-rich formation further reduces transport velocity, enhancing the ability of the geological barrier to contain the radioactive waste. On the other hand, local high gradients associated with positive pressure anomalies can speed up radionuclide transport with respect to steady-state flow systems having the same regional hydraulic gradients. Transport behavior was also found to be sensitive to both geometrical and hydrogeological parameters of the EDZ. Results from this work can provide useful knowledge toward correctly assessing the post-closure safety of a geological disposal system.

  5. Waste site reclamation with recovery of radionuclides and metals

    DOEpatents

    Francis, Arokiasamy J.; Dodge, Cleveland J.

    1994-01-01

    A method for decontaminating radionuclides and other toxic metal-contaminate The U.S. government has certain rights in this invention pursuant to Contract Number DE-AC02-76CH00016 between the U.S. Department of Energy and Associated Universities, Inc.

  6. Analytical methods for radionuclides in liquid and solid media

    SciTech Connect

    Sedlet, J.

    1983-01-01

    This lecture describes in vitro techniques for the radiochemical determination and dosimetry of radionuclides in the body that have been metabolized and are in the circulatory system. Measurements are made in the excretions and other body specimens such as blood, perspiration, hair, exhaled air, and tissue. 13 references, 4 tables. (ACR)

  7. Waste site reclamation with recovery of radionuclides and metals

    DOEpatents

    Francis, A.J.; Dodge, C.J.

    1994-03-08

    A method for decontaminating radionuclides and other toxic metal-contaminate The U.S. government has certain rights in this invention pursuant to Contract Number DE-AC02-76CH00016 between the U.S. Department of Energy and Associated Universities, Inc.

  8. Hydrology and radionuclide migration program 1987 progress report

    SciTech Connect

    Marsh, K.V.

    1991-03-01

    This report presents results from the Lawrence Livermore National Laboratory's participation in the Hydrology and Radionuclide Migration Program at the Nevada Test Site (NTS) during the fiscal year 1987. The report discussed initial data from a new well (UE20n-1) drilled at the Cheshire site; presents a description of a proposed laboratory study of migration of colloids in fractured media; lists data collected during the drilling and initial sampling of UE20n-1; and describes a tentative proposal for work to be performed in FY88 by Lamont-Doherty Geological Observatory. Groundwater sampled from the new well at the Cheshire site contains tritium concentrations comparable to those measured in previous years from locations above and within the Cheshire cavity. This presence of tritium, as well as several other radionuclides, in a well 100 m away from the cavity region indicates transport of radionuclides, validates a proposed model of the flow path, and provides data on rates of groundwater flow. Previous work at the Cheshire site has shown that radionuclides are transported by colloids through fractured media. However, we have no data that can be used for predictive modeling, and existing theories are not applicable. While physical transport mechanisms of sub-micrometer colloids to defined mineral surfaces are well known, predictions based on well-defined conditions differ from experimental observations by orders of magnitude. The U.C. Berkeley group has designed a laboratory experiment to quantify colloid retention and permeability alteration by the retained colloids.

  9. Prognostic value of radionuclide exercise testing after myocardial infarction

    SciTech Connect

    Schocken, D.D.

    1984-08-01

    Abnormal systolic ventricular function and persistent ischemia are sensitive indicators of poor prognosis following myocardial infarction. The use of exercise improves the utility of both radionuclide ventriculography and myocardial perfusion scintigraphy in the identification of postinfarction patients at high risk of subsequent cardiac events. 51 references.

  10. The Production of Radionuclides for Radiotracers in Nuclear Medicine

    NASA Astrophysics Data System (ADS)

    Ruth, Thomas J.

    Medical applications represent the vast majority of the uses for radiotracers. This review addresses how accelerators are employed for the production of high purity radionuclides that are used in basic biomedical research, as well as for clinical medicine both for diagnosing disease and for treatment.

  11. Sources of secondary radionuclide releases from Hanford Operations

    SciTech Connect

    Heeb, C.M.; Gydesen, S.P.

    1994-05-01

    This report considers Hanford facilities and operations with the potential to be secondary radionuclide release sources. Facilities that produced radionuclides or processed products of fission reactions and were not covered in previous source term reports are included in this report. The following facilities are described and any potentially significant releases from them are estimated: PUREX (1956--1972, 1983--1988) and REDOX (1952--1967)--campaigns with non-standard feed material (materials other than fuel from single-pass reactors); C PLANT (Hot Semi-Works)--pilot plant and strontium recovery; Z Plant--plutonium finishing; U and UO{sub 3} Plants--uranium recovery; 108 B Plant--tritium extraction; 300 Area Plutonium Recycle Test Reactor (PRTR); 300 Area Low Power Test Reactors; Criticality Accidents; and 400 Area Fast Flux Test Facility (FFTF). The method of analysis was to examine each facility, give a brief description of its purpose and operations, and describe the types of material the facility processed as an indication of the radionuclides it had the potential to release. Where possible, specific radionuclides are estimated and values from the original documents are reported.

  12. Review of Distribution Coefficients for Radionuclides in Carbonate Minerals

    SciTech Connect

    Sutton, M

    2009-08-14

    An understanding of the transport of radionuclides in carbonate minerals is necessary to be able to predict the fate of (and potentially remediate) radionuclides in the environment. In some environments, carbonate minerals such as calciate, aragonite, dolomite and limestone are present and an understanding of the sorption of radionuclides in these carbonate minerals is therefore advantageous. A list of the radionuclides of interest is given in Table 1. The distribution coefficient, K{sub d} is defined as the ratio of the contaminant concentration bound on the solid phase to the contaminant concentration remaining in the liquid phase at equilibrium. Some authors report distribution coefficients and other report partition coefficients, the data presented in this work assumes equality between these two terms, and data are presented and summarized in this work as logarithmic distribution coefficient (log K{sub D}). Published literature was searched using two methods. Firstly, the JNC Sorption Database, namely Shubutani et al (1999), and Suyama and Sasamoto (2004) was used to select elements of interest and a number of carbonate minerals. Secondly, on-line literature search tools were used to locate relevant published articles from 1900 to 2009. Over 300 data points covering 16 elements (hydrogen, carbon, calcium, nickel, strontium, technetium, palladium, iodine, cesium, samarium, europium, holmium, uranium, neptunium, plutonium and americium) were used to calculate an average and range of log K{sub d} values for each element. Unfortunately, no data could be found for chlorine, argon, krypton, zirconium, niobium, tin, thorium and curium. A description of the data is given below, together with the average, standard deviation, minimum, maximum and number of inputs for radionuclide K{sub d} values for calcite, aragonate, limestone, dolomite and unidentified carbonate rocks in Table 2. Finally, the data are condensed into one group (carbonate minerals) of data for each

  13. Assessment of radionuclide vapor-phase transport in unsaturated tuff

    SciTech Connect

    Smith, D.M.; Updegraff, C.D.; Bonano, E.J.; Randall, J.D.

    1986-11-01

    This report describes bounding calculations performed to investigate the possibility of radionuclide migration in a vapor phase associated with the emplacement of high-level waste canister in unsaturated tuff formations. Two potential radionuclide transport mechanisms in the vapor phase were examined: aerosol migration and convection/diffusion of volatile species. The former may have significant impact on the release of radionuclides to the accessible environment as the concentration in the aerosols will be equal to that in the ground water. A conservative analysis of air diffusion in a stagnant liquid film indicated that for all expected repository conditions, aerosol formation is not possible. The migration of volatile species was examined both in the vicinity of a waste canister and outside the thermally disturbed zone. Two-dimensional (radial) and three-dimensional (radial-vertical) coupled heat transfer-gas flow-liquid flow simulations were performed using the TOUGH computer code. The gas flow rate relative to the liquid flow rate predicted from the simulations allowed calculations of mobility ratios due to convection which led to the conclusion that, except for the immediate region near the canister, transport in the liquid phase will be dominant for radionuclides heavier than radon. Near the waste canister, iodine transport may also be important in the vapor phase. Bounding calculations for vertical mobility ratios were carried out as a function of saturation. These calculations are conservative and agree well with the two-dimensional simulations. Based on this analysis, it is clear that vapor-phase transport will not be important for radionuclides such as cesium and heavier species. Vapor transport for iodine may play a role in the overall release scenario depending on the particular repository conditions.

  14. Radionuclide Transport in Fracture-Granite Interface Zones

    SciTech Connect

    Hu, Q; Mori, A

    2007-09-12

    In situ radionuclide migration experiments, followed by excavation and sample characterization, were conducted in a water-conducting shear zone at the Grimsel Test Site (GTS) in Switzerland to study diffusion paths of radionuclides in fractured granite. In this work, we employed a micro-scale mapping technique that interfaces laser ablation sampling with inductively coupled plasma-mass spectrometry (LA/ICP-MS) to measure the fine-scale (micron-range) distribution of actinides ({sup 234}U, {sup 235}U, and {sup 237}Np) in the fracture-granite interface zones. Long-lived {sup 234}U, {sup 235}U, and {sup 237}Np were detected in flow channels, as well as in the adjacent rock matrix, using the sensitive, feature-based mapping of the LA/ICP-MS technique. The injected sorbing actinides are mainly located within the advective flowing fractures and the immediately adjacent regions. The water-conducting fracture studied in this work is bounded on one side by mylonite and the other by granitic matrix regions. These actinides did not penetrate into the mylonite side as much as the relatively higher-porosity granite matrix, most likely due to the low porosity, hydraulic conductivity, and diffusivity of the fracture wall (a thickness of about 0.4 mm separates the mylonite region from the fracture) and the mylonite region itself. Overall, the maximum penetration depth detected with this technique for the more diffusive {sup 237}Np over the field experimental time scale of about 60 days was about 10 mm in the granitic matrix, illustrating the importance of matrix diffusion in retarding radionuclide transport from the advective fractures. Laboratory tests and numerical modeling of radionuclide diffusion into granitic matrix was conducted to complement and help interpret the field results. Measured apparent diffusivity of multiple tracers in granite provided consistent predictions for radionuclide transport in the fractured granitic rock.

  15. Arctic Ocean sea ice drift origin derived from artificial radionuclides.

    PubMed

    Cámara-Mor, P; Masqué, P; Garcia-Orellana, J; Cochran, J K; Mas, J L; Chamizo, E; Hanfland, C

    2010-07-15

    Since the 1950s, nuclear weapon testing and releases from the nuclear industry have introduced anthropogenic radionuclides into the sea, and in many instances their ultimate fate are the bottom sediments. The Arctic Ocean is one of the most polluted in this respect, because, in addition to global fallout, it is impacted by regional fallout from nuclear weapon testing, and indirectly by releases from nuclear reprocessing facilities and nuclear accidents. Sea-ice formed in the shallow continental shelves incorporate sediments with variable concentrations of anthropogenic radionuclides that are transported through the Arctic Ocean and are finally released in the melting areas. In this work, we present the results of anthropogenic radionuclide analyses of sea-ice sediments (SIS) collected on five cruises from different Arctic regions and combine them with a database including prior measurements of these radionuclides in SIS. The distribution of (137)Cs and (239,240)Pu activities and the (240)Pu/(239)Pu atom ratio in SIS showed geographical differences, in agreement with the two main sea ice drift patterns derived from the mean field of sea-ice motion, the Transpolar Drift and Beaufort Gyre, with the Fram Strait as the main ablation area. A direct comparison of data measured in SIS samples against those reported for the potential source regions permits identification of the regions from which sea ice incorporates sediments. The (240)Pu/(239)Pu atom ratio in SIS may be used to discern the origin of sea ice from the Kara-Laptev Sea and the Alaskan shelf. However, if the (240)Pu/(239)Pu atom ratio is similar to global fallout, it does not provide a unique diagnostic indicator of the source area, and in such cases, the source of SIS can be constrained with a combination of the (137)Cs and (239,240)Pu activities. Therefore, these anthropogenic radionuclides can be used in many instances to determine the geographical source area of sea-ice.

  16. Assessment of radionuclide contents in food in Hong Kong

    SciTech Connect

    Yu, K.N.; Mao, S.Y.

    1999-12-01

    Baseline values of concentrations of the natural radionuclides ({sup 238}U, {sup 226}Ra, {sup 228}Ra/{sup 232}Th, {sup 210}Pb) and artificial radionuclides ({sup 137}Cs, {sup 60}Co) in food and drinks (tap water, milk, and water-based drinks) were determined by gamma spectroscopy. All food and drinks were found to contain detectable {sup 40}K contents: 0.1 to 160 Bq Kg{sup {minus}1} for food and 0.006 to 61 Bq L{sup {minus}1} for drinks. Most of the other natural radionuclides in solid food were found to have contents below the minimum detectable activities (MDA). More samples in the leafy vegetable, tomato, carrot and potato categories contained detectable amounts of {sup 228}Ra than the meat, cereal, and fish categories, with concentrations up to 1.2 Bq kg{sup {minus}1} for the former categories and 0.35 Bq kg{sup {minus}1} for the latter categories. The {sup 238}U and {sup 226}Ra radionuclides were detectable in most of the water-based drink samples, and the {sup 228}Ra and {sup 210}Pb radionuclides were detectable in fewer water-based drink samples. The {sup 137}Cs contents in solid food were detectable in most of the solid food samples (reaching 0.59 Bq kg{sup {minus}1}), but in drinks the {sup 137}Cs contents were very low and normally lower than the MDA values. Nearly all the {sup 60}Co contents in food and drinks were below the MDA values and their contents were below those of {sup 137}Cs.

  17. Trends in Therapeutic Recreation.

    ERIC Educational Resources Information Center

    Smith, Ralph W.

    1995-01-01

    Discusses the implications of the rapid, dramatic changes taking place in therapeutic recreation for individuals with physical disabilities. The article notes the impact of changes in managed care, examines programming trends in therapeutic recreation (adventure/outdoor education, competitive sports, handcycling, health enhancement activities, and…

  18. Therapeutic Recreation Practicum Manual.

    ERIC Educational Resources Information Center

    Schneegas, Kay

    This manual provides information on the practicum program offered by Moraine Valley Community College (MVCC) for students in its therapeutic recreation program. Sections I and II outline the rationale and goals for providing practical, on-the-job work experiences for therapeutic recreation students. Section III specifies MVCC's responsibilities…

  19. Chicanoizing the Therapeutic Community

    ERIC Educational Resources Information Center

    Aron, William S.; And Others

    1974-01-01

    Focusing on the drug addiction problem and its antecedent conditions in a Chicano population, the article examines several therapeutic interventions suggested by these conditions and indicates how they might be incorporated into a drug addiction Therapeutic Community treatment program designed to meet the needs of Chicano drug addicts. (Author/NQ)

  20. Impact of Therapeutic Camping

    ERIC Educational Resources Information Center

    Shniderman, Craig M.

    1974-01-01

    There has been little interest in, and only slight illumination of, the impact of therapeutic camping for emotionally disturbed children. This study seeks to validate the belief that camping is therapeutic. Subjects were 52 boys, 5 to 11 1/2 years of age. Results support the hypothesis. (Author/HMV)

  1. 49 CFR 173.433 - Requirements for determining basic radionuclide values, and for the listing of radionuclides on...

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... single radioactive decay chain in which the radionuclides are present in their naturally-occurring... SHIPMENTS AND PACKAGINGS Class 7 (Radioactive) Materials § 173.433 Requirements for determining basic... the following conditions: (1) For special form Class 7 (radioactive) material, the activity which...

  2. 49 CFR 173.433 - Requirements for determining basic radionuclide values, and for the listing of radionuclides on...

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... single radioactive decay chain in which the radionuclides are present in their naturally-occurring... SHIPMENTS AND PACKAGINGS Class 7 (Radioactive) Materials § 173.433 Requirements for determining basic... the following conditions: (1) For special form Class 7 (radioactive) material, the activity which...

  3. 49 CFR 173.433 - Requirements for determining basic radionuclide values, and for the listing of radionuclides on...

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... single radioactive decay chain in which the radionuclides are present in their naturally-occurring... SHIPMENTS AND PACKAGINGS Class 7 (Radioactive) Materials § 173.433 Requirements for determining basic... the following conditions: (1) For special form Class 7 (radioactive) material, the activity which...

  4. Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy

    SciTech Connect

    Baechler, Sebastien; Hobbs, Robert F.; Boubaker, Ariane; Buchegger, Franz; He Bin; Frey, Eric C.; Sgouros, George

    2012-10-15

    Purpose: Peptide receptor radionuclide therapy (PRRT) delivers high absorbed doses to kidneys and may lead to permanent nephropathy. Reliable dosimetry of kidneys is thus critical for safe and effective PRRT. The aim of this work was to assess the feasibility of planning PRRT based on 3D radiobiological dosimetry (3D-RD) in order to optimize both the amount of activity to administer and the fractionation scheme, while limiting the absorbed dose and the biological effective dose (BED) to the renal cortex. Methods: Planar and SPECT data were available for a patient examined with {sup 111}In-DTPA-octreotide at 0.5 (planar only), 4, 24, and 48 h post-injection. Absorbed dose and BED distributions were calculated for common therapeutic radionuclides, i.e., {sup 111}In, {sup 90}Y and {sup 177}Lu, using the 3D-RD methodology. Dose-volume histograms were computed and mean absorbed doses to kidneys, renal cortices, and medullae were compared with results obtained using the MIRD schema (S-values) with the multiregion kidney dosimetry model. Two different treatment planning approaches based on (1) the fixed absorbed dose to the cortex and (2) the fixed BED to the cortex were then considered to optimize the activity to administer by varying the number of fractions. Results: Mean absorbed doses calculated with 3D-RD were in good agreement with those obtained with S-value-based SPECT dosimetry for {sup 90}Y and {sup 177}Lu. Nevertheless, for {sup 111}In, differences of 14% and 22% were found for the whole kidneys and the cortex, respectively. Moreover, the authors found that planar-based dosimetry systematically underestimates the absorbed dose in comparison with SPECT-based methods, up to 32%. Regarding the 3D-RD-based treatment planning using a fixed BED constraint to the renal cortex, the optimal number of fractions was found to be 3 or 4, depending on the radionuclide administered and the value of the fixed BED. Cumulative activities obtained using the proposed simulated

  5. The management of painful bone metastases with an emphasis on radionuclide therapy.

    PubMed Central

    Hillegonds, Darren J.; Franklin, Stephen; Shelton, David K.; Vijayakumar, Srinivasan; Vijayakumar, Vani

    2007-01-01

    OBJECTIVE: This review provides an update on the management of painful bone metastases, with an emphasis on radionuclide therapy, and introduces oligometastases and quantitative imaging evaluations for clinical trials. METHODS: The current use of radionuclides, alone and in combination with chemotherapy and radiation therapy for painful bone metastases, is discussed, including toxicity, cost and overall outcomes. RESULTS: Radionuclide therapy is shown to be a useful and cost-effective means of alleviating bone pain in metastatic disease and may be more effective when combined with chemotherapy, bisphosphonates and radiation therapy. Early use of radionuclides in pain therapy may limit cancer progression by inhibiting oligometastases development. Thus, radionuclides can significantly decrease patient morbidity, prolong patient survival, and may decrease the occurrence of new bone metastases. CONCLUSION: Palliative pain therapy is critical for effectively managing bone metastases, with treatment options including analgesics, external beam radiotherapy, chemotherapy and radionuclides. Radionuclide therapy is underutilized. Recent studies using radionuclides with chemotherapy and bisphosponates, or using newer radionuclides or combinations of radionuclides and treatment paradigms (e.g., higher activities, repetitive or cyclic administration, chemo sensitization, chemo supplementation), are encouraging. A comprehensive, inter-disciplinary clinical approach is needed. Clinical collaborations will optimize radionuclide therapy for pain palliation and increase awareness of its benefits. PMID:17668645

  6. National Low-Level Waste Management Program Radionuclide Report Series. Volume 1, Introduction

    SciTech Connect

    Rudin, M.J.; Garcia, R.S.

    1992-02-01

    This volume serves as an introduction to the National Low-Level Radioactive Waste Management Program Radionuclide Report Series. This report includes discussions of radionuclides listed in Title 10 of the Code of Federal Regulations Part 61.55, Tables 1 and 2 (including alpha-emitting transuranics with half-lives greater than five years). Each report includes information regarding radiological and chemical characteristics of specific radionuclides. Information is also included discussing waste streams and waste forms that may contain each radionuclide, and radionuclide behavior in the environment and in the human body. Not all radionuclides commonly found at low-level radioactive waste sites are included in this report. The discussion in this volume explains the rationale of the radionuclide selection process.

  7. Radionuclide Inventory Distribution Project Data Evaluation and Verification White Paper

    SciTech Connect

    NSTec Environmental Restoration

    2010-05-17

    Testing of nuclear explosives caused widespread contamination of surface soils on the Nevada Test Site (NTS). Atmospheric tests produced the majority of this contamination. The Radionuclide Inventory and Distribution Program (RIDP) was developed to determine distribution and total inventory of radionuclides in surface soils at the NTS to evaluate areas that may present long-term health hazards. The RIDP achieved this objective with aerial radiological surveys, soil sample results, and in situ gamma spectroscopy. This white paper presents the justification to support the use of RIDP data as a guide for future evaluation and to support closure of Soils Sub-Project sites under the purview of the Federal Facility Agreement and Consent Order. Use of the RIDP data as part of the Data Quality Objective process is expected to provide considerable cost savings and accelerate site closures. The following steps were completed: - Summarize the RIDP data set and evaluate the quality of the data. - Determine the current uses of the RIDP data and cautions associated with its use. - Provide recommendations for enhancing data use through field verification or other methods. The data quality is sufficient to utilize RIDP data during the planning process for site investigation and closure. Project planning activities may include estimating 25-millirem per industrial access year dose rate boundaries, optimizing characterization efforts, projecting final end states, and planning remedial actions. In addition, RIDP data may be used to identify specific radionuclide distributions, and augment other non-radionuclide dose rate data. Finally, the RIDP data can be used to estimate internal and external dose rates. The data quality is sufficient to utilize RIDP data during the planning process for site investigation and closure. Project planning activities may include estimating 25-millirem per industrial access year dose rate boundaries, optimizing characterization efforts, projecting final

  8. Biomimetic Particles as Therapeutics

    PubMed Central

    Green, Jordan J.

    2015-01-01

    In recent years, there have been major advances in the development of novel nanoparticle and microparticle-based therapeutics. An emerging paradigm is the incorporation of biomimetic features into these synthetic therapeutic constructs to enable them to better interface with biological systems. Through the control of size, shape, and material consistency, particle cores have been generated that better mimic natural cells and viruses. In addition, there have been significant advances in biomimetic surface functionalization of particles through the integration of bio-inspired artificial cell membranes and naturally derived cell membranes. Biomimetic technologies enable therapeutic particles to have increased potency to benefit human health. PMID:26277289

  9. Biomimetic particles as therapeutics.

    PubMed

    Meyer, Randall A; Sunshine, Joel C; Green, Jordan J

    2015-09-01

    In recent years, there have been major advances in the development of novel nanoparticle- and microparticle-based therapeutics. An emerging paradigm is the incorporation of biomimetic features into these synthetic therapeutic constructs to enable them to better interface with biological systems. Through the control of size, shape, and material consistency, particle cores have been generated that better mimic natural cells and viruses. In addition, there have been significant advances in biomimetic surface functionalization of particles through the integration of bio-inspired artificial cell membranes and naturally derived cell membranes. Biomimetic technologies enable therapeutic particles to have increased potency to benefit human health.

  10. Situ formation of apatite for sequestering radionuclides and heavy metals

    DOEpatents

    Moore, Robert C.

    2003-07-15

    Methods for in situ formation in soil of a permeable reactive barrier or zone comprising a phosphate precipitate, such as apatite or hydroxyapatite, which is capable of selectively trapping and removing radionuclides and heavy metal contaminants from the soil, while allowing water or other compounds to pass through. A preparation of a phosphate reagent and a chelated calcium reagent is mixed aboveground and injected into the soil. Subsequently, the chelated calcium reagent biodegrades and slowly releases free calcium. The free calcium reacts with the phosphate reagent to form a phosphate precipitate. Under the proper chemical conditions, apatite or hydroxyapatite can form. Radionuclide and heavy metal contaminants, including lead, strontium, lanthanides, and uranium are then selectively sequestered by sorbing them onto the phosphate precipitate. A reducing agent can be added for reduction and selective sequestration of technetium or selenium contaminants.

  11. Model of colloidal transportation of radionuclides by groundwater

    NASA Astrophysics Data System (ADS)

    Malkovsky, V. I.; Yudintsev, S. V.

    2016-09-01

    The transportation of colloidal radionuclides by groundwater was subject to theoretical analysis. The far field of radioactive contamination of the underground environment (liquid waste pumping sites or storage of solidified waste) is dominated by pseudocolloids, i.e., colloidal particles of natural origin contaminated with radionuclides upon contact of groundwater with radioactive materials. Properties of real pseudocolloids were analyzed at sites of radioactive contamination of the underground environment. Based on a probabilistic approach, we developed a mathematical model of pseudocolloid transportation by groundwater, taking into account the difference in size of colloidal particles and the occurrence of nonradioactive natural particles with a similar composition in the groundwater. It is proved that nonuniform dimensions of the particles considerably affect the water transportation rate.

  12. Molecular and cellular radiobiological effects of Auger emitting radionuclides

    PubMed Central

    Kassis, Amin I.

    2011-01-01

    Although the general radiobiologic principles underlying external beam therapy and radionuclide therapy are similar, significant differences in the biophysical and radiobiologic effects from the two types of radiation continue to accumulate. Here, I will address the unique features that distinguish the molecular and cellular radiobiological effects of Auger electron-emitting radionuclides consequent to (1) the physical characteristics of the decaying atom and its subcellular localisation, (2) DNA topology and (3) the bystander effect. Based on these experimental findings, I postulate that the ability of track structural simulations as primary tools in modelling DNA damage and cellular survival at the molecular level would be greatly enhanced when these contributions are factored in. PMID:21106639

  13. Molluscs as indicators of environmental pollution by radionuclides

    SciTech Connect

    Frantsevich, L.I.; Pan`kov, I.V.; Ermakov, A.A.

    1995-01-01

    Theoretical and systematical aspects of the utilization of molluscs were elaborated in an effort to bioindicate pollution by radionuclides after the accident at Chernobyl` Atomic Electric Power Station (CAEPS). Beta-radiometry of shells, gamma-spectroscopy of shells and animals, and a number of chemical and radiochemical analyses were carried out. The composition of radionuclides, incorporated by molluscs before and after the accident, is cited. Average values of the factors of transition and accumulation (relative to water) {sup 90}Sr and {sup 137}Cs are estimated. Individual variability and taxonomic distinction of these parameters for {sup 90}Sr are analyzed. The results of radioecological monitoring of rivers of the Dnieper basin and reservoirs of the Dnieper cascade are shown. Direct beta-radiometry of molluscan shells is recommended as the most convenient method of rapidly estimating the level of pollution of the area of {sup 90}Sr.

  14. Development of the national radionuclide dose calibrator standardisation service.

    PubMed

    van der Gaast, H; Buckman, S; Sherlock, S

    1993-03-01

    The Australian Nuclear Science and Technology Organisation, acting as agent for the CSIRO Division of Applied Physics, maintains the Australian standard of measurement for activity. The standard includes all nuclear medicine gamma emitters and a new standard for pure positron emitters. Under Section 10 of the National Measurement Act 1960, if a measurement is made for a legal purpose, or if the legality of a measurement is in dispute, it can only be confirmed if the following two conditions are fulfilled: (a) that the measurement be in terms of the prescribed Australian legal units of measurement. (b) that it can be proven to be traceable to an Australian primary standard of measurement. To satisfy these requirements, radionuclide dose calibrators require a calibration report determined by Ansto. For this reason, Ansto has developed the national radionuclide dose calibrator standardisation service.

  15. Radio-nuclide mixture identification using medium energy resolution detectors

    DOEpatents

    Nelson, Karl Einar

    2013-09-17

    According to one embodiment, a method for identifying radio-nuclides includes receiving spectral data, extracting a feature set from the spectral data comparable to a plurality of templates in a template library, and using a branch and bound method to determine a probable template match based on the feature set and templates in the template library. In another embodiment, a device for identifying unknown radio-nuclides includes a processor, a multi-channel analyzer, and a memory operatively coupled to the processor, the memory having computer readable code stored thereon. The computer readable code is configured, when executed by the processor, to receive spectral data, to extract a feature set from the spectral data comparable to a plurality of templates in a template library, and to use a branch and bound method to determine a probable template match based on the feature set and templates in the template library.

  16. Theoretical approach to explore the production routes of astatine radionuclides

    NASA Astrophysics Data System (ADS)

    Maiti, Moumita; Lahiri, Susanta

    2009-02-01

    To fulfill the recent thrust of astatine radionuclides in the field of nuclear medicine, various production routes have been explored in the present work. The possible production routes of At209-211 comprise both light- and heavy-ion-induced reactions at the bombarding energy range starting from threshold to a maximum of 100 MeV. Excitation functions of those radionuclides, produced through various production routes, have been calculated by using nuclear reaction model codes TALYS, ALICE91, and PACE-II and are compared with the available measured data. Contributions of various reaction mechanisms, such as direct, pre-equilibrium, and equilibrium reactions, to the total reaction cross section have been studied using the codes. Results show that the equilibrium reaction dominates in all cases over other reaction mechanisms.

  17. Theoretical approach to explore the production routes of astatine radionuclides

    SciTech Connect

    Maiti, Moumita; Lahiri, Susanta

    2009-02-15

    To fulfill the recent thrust of astatine radionuclides in the field of nuclear medicine, various production routes have been explored in the present work. The possible production routes of {sup 209-211}At comprise both light- and heavy-ion-induced reactions at the bombarding energy range starting from threshold to a maximum of 100 MeV. Excitation functions of those radionuclides, produced through various production routes, have been calculated by using nuclear reaction model codes TALYS, ALICE91, and PACE-II and are compared with the available measured data. Contributions of various reaction mechanisms, such as direct, pre-equilibrium, and equilibrium reactions, to the total reaction cross section have been studied using the codes. Results show that the equilibrium reaction dominates in all cases over other reaction mechanisms.

  18. Determination of radionuclides and pathways contributing to cumulative dose

    SciTech Connect

    Napier, B.A.

    1992-12-01

    A series of scoping calculations has been undertaken to evaluate the absolute and relative contributions of different radionuclides and exposure pathways to doses that may have been received by individuals living in the vicinity of the Hanford Site. This scoping calculation (Calculation 004) examined the contributions of numerous radionuclides to cumulative dose via environmental exposures and accumulation in foods. Addressed in this calculation were the contributions to organ and effective dose of infants and adults from (1) air submersion and groundshine external dose, (2) inhalation, (3) ingestion of soil by humans, (4) ingestion of leafy vegetables, (5) ingestion of other vegetables and fruits, (6) ingestion of meat, (7) ingestion of eggs, and (8) ingestion of cows' milk from Feeding Regime 1, as described in calculation 002. This calculation specifically addresses cumulative radiation doses to infants and adults resulting from releases occurring over the period 1945 through 1972.

  19. Determination of radionuclides and pathways contributing to dose in 1945

    SciTech Connect

    Napier, B.A.

    1992-12-01

    A series of scoping calculations has been undertaken to evaluate the absolute and relative contributions of different radionuclides and exposure pathways to doses that may have been received by individuals living in the vicinity of the Hanford Site. This scoping calculation (Calculation 003) examined the contributions of numerous radionuclides to dose via environmental exposures and accumulation in foods. This study builds on the work initiated in the first scoping study of iodine in cow's milk (calculation 001). Addressed in this calculation were the contributions to organ and effective dose of infants and adults from (1) air submersion and groundshine external dose, (2) inhalation, (3) ingestion of soil by humans, (4) ingestion of leafy vegetables, (5) ingestion of other vegetables and fruits, (6) ingestion of meat, (7) ingestion of eggs, and (8) ingestion of cows' milk from Feeding Regime 1, as described in Calculation 001.

  20. ENERGETIC PROTONS, RADIONUCLIDES, AND MAGNETIC ACTIVITY IN PROTOSTELLAR DISKS

    SciTech Connect

    Turner, N. J.; Drake, J. F.

    2009-10-01

    We calculate the location of the magnetically inactive dead zone in the minimum-mass protosolar disk, under ionization scenarios including stellar X-rays, long- or short-lived radionuclide decay, and energetic protons arriving from the general interstellar medium, from a nearby supernova explosion, from the disk corona, or from the corona of the young star. The disk contains a dead zone in all scenarios except those with small dust grains removed and a fraction of the short-lived radionuclides remaining in the gas. All the cases without exception have an 'undead zone' where intermediate resistivities prevent magneto-rotational turbulence while allowing shear-generated large-scale magnetic fields. The mass column in the undead zone is typically greater than the column in the turbulent surface layers. The results support the idea that the dead and undead zones are robust consequences of cold, dusty gas with mass columns exceeding 1000 g cm{sup -2}.

  1. LITERATURE REVIEW ON MAXIMUM LOADING OF RADIONUCLIDES ON CRYSTALLINE SILICOTITANATE

    SciTech Connect

    Adu-Wusu, K.; Pennebaker, F.

    2010-10-13

    Plans are underway to use small column ion exchange (SCIX) units installed in high-level waste tanks to remove Cs-137 from highly alkaline salt solutions at Savannah River Site. The ion exchange material slated for the SCIX project is engineered or granular crystalline silicotitanate (CST). Information on the maximum loading of radionuclides on CST is needed by Savannah River Remediation for safety evaluations. A literature review has been conducted that culminated in the estimation of the maximum loading of all but one of the radionuclides of interest (Cs-137, Sr-90, Ba-137m, Pu-238, Pu-239, Pu-240, Pu-241, Am-241, and Cm-244). No data was found for Cm-244.

  2. Radionuclide sorption on drill core material from the Canadian Shield

    SciTech Connect

    Vandergraat, T.T.; Abry, D.R.

    1982-06-01

    The sorption of four radionuclides, /sup 90/Sr, /sup 137/Cs, /sup 144/Ce, and /sup 237/Pu, on drill core material from two rock formations in the Canadian Shield has been studied as part of the Canadian Nuclear Fuel Waste Management Program. For all four radionuclides, sorption increased with increased mafic mineral content of the rock. Autoradiographic investigations showed enhanced sorption on dark, or mafic, minerals and high sorption on chlorite infilling material in a closed fracture. Desorption was less complete than sorption after the same equilibration time, indicating a degree of irreversible sorption, or slower desorption kinetics. The effect of surface roughness (measured by mercury porosimetry) on sorption was not as great as that of the chemical and mineral composition of the rock.

  3. Detection of ureteral obstruction on radionuclide bone scans

    SciTech Connect

    Pollen, J.J.; Gerber, K.; Heil, B.J.; Talner, L.B.

    1983-09-01

    The kidneys are nearly always visible on a routine radionuclide bone scan. To assess the reliability of the bone scan in detecting ureteral obstruction, 220 bone scans and excretory urograms were compared in 53 patients followed serially for prostatic cancer. There were 15 kidneys obstructed on excretory urograms. Only nine were diagnosed as obstructed on the bone scans. Seven of the nine cases of unilaterally obstructed kidneys were detected, whereas only two of the six kidneys in three patients with bilateral obstruction were correctly diagnosed. The results indicate that unilateral obstruction is more likely to be detected, whereas bilateral obstruction is more likely to be missed, on bone scans. Therefore, the routine radionuclide bone scan is an unreliable test for ureteral obstruction.

  4. EANM/ESC guidelines for radionuclide imaging of cardiac function.

    PubMed

    Hesse, B; Lindhardt, T B; Acampa, W; Anagnostopoulos, C; Ballinger, J; Bax, J J; Edenbrandt, L; Flotats, A; Germano, G; Stopar, T Gmeiner; Franken, P; Kelion, A; Kjaer, A; Le Guludec, D; Ljungberg, M; Maenhout, A F; Marcassa, C; Marving, J; McKiddie, F; Schaefer, W M; Stegger, L; Underwood, R

    2008-04-01

    Radionuclide imaging of cardiac function represents a number of well-validated techniques for accurate determination of right (RV) and left ventricular (LV) ejection fraction (EF) and LV volumes. These first European guidelines give recommendations for how and when to use first-pass and equilibrium radionuclide ventriculography, gated myocardial perfusion scintigraphy, gated PET, and studies with non-imaging devices for the evaluation of cardiac function. The items covered are presented in 11 sections: clinical indications, radiopharmaceuticals and dosimetry, study acquisition, RV EF, LV EF, LV volumes, LV regional function, LV diastolic function, reports and image display and reference values from the literature of RVEF, LVEF and LV volumes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "prevailing or general consensus". The guidelines are designed to assist in the practice of referral to, performance, interpretation and reporting of nuclear cardiology studies for the evaluation of cardiac performance.

  5. Commercial Availability of Alpha-Emitting Radionuclides for Medicine

    SciTech Connect

    Fisher, Darrell R.

    2008-09-15

    Alpha-emitting radionuclides provide effective cell-killing properties and have been shown to be effective in cancer treatment. The number of different alpha emitters having suitable physical and chemical characteristics for applications in medicine is relatively few. Development and testing of new radiopharmaceuticals requires a reliable supply of alpha-emitters in high quality, with timely delivery, but at reasonable cost. Applications and commercial availability of the follow alpha emitters are reviewed: Actinium-225, bismuth-213, astatine-211, radium-223, bismuth-212, radium-224, radium-226, terbium-149, and thorium-227. Recommendations for improving the supply of these alpha emitters include an increased federal commitment (through funding and joint-agency cooperation), establishing new production capabilities, and strengthening federal-private partnerships with companies involved in helping to meet critical radionuclide supplies.

  6. Radionuclide transit: a sensitive screening test for esophageal dysfunction

    SciTech Connect

    Russell, C.O.; Hill, L.D.; Holmes, E.R. III; Hull, D.A.; Gannon, R.; Pope, C.E. II

    1981-05-01

    The purpose of this study was to extend existing nuclear medicine techniques for the diagnosis of esophageal motor disorders. A standard homogeneous bolus of 99mtechnetium sulfur colloid in water was swallowed in the supine position under the collimator of a gamma camera linked to a microprocessor. Bolus transit was recorded at 0.4-s intervals, and the movie obtained was used to analyze transit in an objective manner. Ten normal volunteers and 30 subjects with dysphagia not related to mechanical obstruction were studied with this technique. Radionuclide transit studies detected a higher incidence of esophageal motor abnormality than manometry or radiology in the dysphagia group. In addition a definitive description of the functional problem was possible in most cases. Radionuclide transit is a safe noninvasive test and suitable as a screening test for esophageal motor disorders.

  7. The necessity of nuclear reactors for targeted radionuclide therapies.

    PubMed

    Krijger, Gerard C; Ponsard, Bernard; Harfensteller, Mark; Wolterbeek, Hubert T; Nijsen, Johannes W F

    2013-07-01

    Nuclear medicine has been contributing towards personalized therapies. Nuclear reactors are required for the working horses of both diagnosis and treatment, i.e., Tc-99m and I-131. In fact, reactors will remain necessary to fulfill the demand for a variety of radionuclides and are essential in the expanding field of targeted radionuclide therapies for cancer. However, the main reactors involved in the global supply are ageing and expected to shut down before 2025. Therefore, the fields of (nuclear) medicine, nuclear industry and politics share a global responsibility, faced with the task to secure future access to suitable nuclear reactors. At the same time, alternative production routes should be industrialized. For this, a coordinating entity should be put into place.

  8. Characterization and radionuclide retention properties of heat-treated concrete

    NASA Astrophysics Data System (ADS)

    Kienzler, B.; Borkel, C.; Finck, N.; Heck, S.; Hilpp, S.; Schlieker, M.; Metz, V.; Plaschke, M.; Soballa, E.; Cron, T.; Miassoedov, A.

    This study was performed to obtain insight into the characteristics of contaminated cementitious materials which may result from a light water reactor core melt down accident. Such material arose in a huge amount from the Fukushima disaster. We analyzed the elemental and mineralogical composition of similar, heat-treated material and investigated its radionuclide retention properties. We present the radionuclide retention properties of concrete samples which originally were part of an experiment using a thick-walled concrete recipient that had been heated by simulating a reactor melt down. Batch sorption experiments have been performed with the elements Cs(I), Co(II), and Eu(III) in seawater under aerobic conditions. Sorption coefficients were measured: Rs(Eu) ∼5800 ml g-1 and Rs(Co) ∼110 ml g-1. A tentative value for Cs was determined, adulterated by the relatively high release of Cs from the concrete itself.

  9. RADIONUCLIDE TRANSPORT IN FRACTURED TUFF UNDER EPISODIC FLOW CONDITIONS

    SciTech Connect

    O. Hu; Y. Sun; R.P. Ewing

    2005-09-19

    The current conceptual model of radionuclide transport in unsaturated fractured rock includes water movement in fractures, with migration of the entrained radionuclides being retarded by diffusion into and sorption within the rock matrix. Water infiltration and radionuclide transport through low-permeability unsaturated fractured rock are episodic and intermittent in nature, at least at local scales. Under episodic flow conditions, the matrix is constantly imbibing or draining, and this fluctuating wetness both drives two-way advective movement of radionuclides, and forces changes in the matrix diffusivity. This work is intended to examine, both experimentally and numerically, how radionuclide transport under episodic flow conditions is affected by the interacting processes of imbibition and drainage, diffusion, and matrix sorption. Using Topopah Spring welded volcanic tuff, collected from the potential repository geologic unit at Yucca Mountain for storing high-level nuclear waste, we prepared a saw-cut fracture core (length 10.2 cm, diameter 4.4 cm, and fracture aperture 100 {micro}m). The dry core was packed into a flow reactor, flushed with CO{sub 2}, then saturated via slow pumping (0.01 mL/min) of synthetic groundwater. The fractured core was then flushed with air at >97% relative humidity (to simulate in situ unsaturated fractured rock conditions at Yucca Mountain), then the episodic transport experiment was conducted. Episodic flow involved 4 cycles of tracer solution flow within the fracture, followed by flushing with high humidity air. Each flow episode contained a different suite of non-sorbing and sorbing tracers, which included {sup 3}H, ReO{sub 4}{sup -} (a chemical analog for {sup 99}TcO{sub 4}{sup -}), I{sup -} (for {sup 129}I{sup -}), Sr and Cs (for {sup 90}Sr and {sup 137}Cs), plus the radionuclides {sup 235}U, {sup 237}Np, and {sup 241}Pu. These radionuclides span a variety of sorption strengths and represent a large fraction of the radionuclides

  10. Criteria for the selection of radionuclides for tumor radioimmunotherapy

    SciTech Connect

    Srivastava, S.C.; Mausner, L.F.; Mease, R.C.

    1991-01-01

    The potential of utilizing monoclonal antibodies as carriers of radionuclides for the selective destruction of tumors (radioimmunotherapy, RIT) has stimulated much research activity. From dosimetric and other considerations, the choice of radiolabel is an important factor that needs to be optimized for maximum effectiveness of RIT. This paper reviews and assesses a number of present and future radionuclides that are particularly suitable for RIT based on the various physical, chemical, and biological considerations. Intermediate to high-energy beta emitters' (with and without gamma photons in their emission) are emphasized since they possess a number of advantages over alpha and Auger emitters. Factors relating to the production and availability of candidate radiometals as well as their stable chemical attachment to monoclonal antibodies are discussed. 34 refs., 4 tabs.

  11. Oncogene mRNA Imaging with Radionuclide-PNA-Peptides

    SciTech Connect

    Wickstrom, Eric

    2008-03-19

    New cancer gene hybridization probes to carry radionuclides were made. Noninvasive technetium-99m gamma imaging of CCND1 cancer gene activity in human breast cancer tumors in mice was demonstrated, followed by noninvasive technetium-99m imaging of MYC cancer gene activity. Noninvasive imaging of CCND1 cancer gene activity in human breast cancer tumors in mice was demonstrated with a positron-emitting copper-64 probe, followed by noninvasive positron imaging of IRS1 cancer gene activity.

  12. Comparison of radionuclide imaging and ultrasonography of the liver

    SciTech Connect

    Elyaderani, M.K.; Gabriele, O.F.

    1983-01-01

    Radionuclide liver scans and gray scale ultrasonography of the liver were compared in 456 patients with various abnormalities including normal variants, jaundice, abscesses, and metastatic diseases. In general the better resolution of sonography detected smaller and deeper focal lesions than nuclide scans, but nuclide studies were more informative in hepatocellular disorders. Nuclide studies frequently demonstrated lesions that could be further delineated by sonography as either cystic or solid. This ability was of particular significance in isolated liver lesions found during metastatic surveys.

  13. Comparison of radionuclide imaging and ultrasonography of the liver

    SciTech Connect

    Elyaderani, M.K.; Gabriele, O.F.

    1983-01-01

    Radionuclide liver scans and gray scale ultrasonography of the liver were compared in 456 patients with various abnormalities including normal variants, jaundice, abscesses, and metastatic diseases. In general the better resolution of sonography detected smaller and deeper focal lesions than nuclide scans, but nuclide studies were more informative in heptatocellular disorders. Nuclide studies frequently demonstrated lesions that could be further delineated by sonography as either cystic or solid. This ability was of particular significance in isolated liver lesions found during metastatic surveys.

  14. Radionuclide counting technique for measuring wind velocity and direction

    NASA Technical Reports Server (NTRS)

    Singh, J. J. (Inventor)

    1984-01-01

    An anemometer utilizing a radionuclide counting technique for measuring both the velocity and the direction of wind is described. A pendulum consisting of a wire and a ball with a source of radiation on the lower surface of the ball is positioned by the wind. Detectors and are located in a plane perpendicular to pendulum (no wind). The detectors are located on the circumferene of a circle and are equidistant from each other as well as the undisturbed (no wind) source ball position.

  15. Summary Report for the Development of Materials for Volatile Radionuclides

    SciTech Connect

    Strachan, Denis M.; Chun, Jaehun; Henager, Charles H.; Matyas, Josef; Riley, Brian J.; Ryan, Joseph V.; Thallapally, Praveen K.

    2010-11-22

    The materials development summarized here is in support of the Waste Forms campaign, Volatile Radionuclide task. Specifically, materials are being developed for the removal and immobilization of iodine and krypton, specifically 129I and 85Kr. During FY 2010, aerogel materials were investigated for removal and immobilization of 129I. Two aerogel formulations were investigated, one based on silica aerogels and the second on chalcogenides. For 85Kr, metal organic framework (MOF) structures were investigated.

  16. CRITICAL RADIONUCLIDE AND PATHWAY ANALYSIS FOR THE SAVANNAH RIVER SITE

    SciTech Connect

    Jannik, T.

    2011-08-30

    This report is an update to the analysis, Assessment of SRS Radiological Liquid and Airborne Contaminants and Pathways, that was performed in 1997. An electronic version of this large original report is included in the attached CD to this report. During the operational history (1954 to the present) of the Savannah River Site (SRS), many different radionuclides have been released to the environment from the various production facilities. However, as will be shown by this updated radiological critical contaminant/critical pathway analysis, only a small number of the released radionuclides have been significant contributors to potential doses and risks to offsite people. The analysis covers radiological releases to the atmosphere and to surface waters, the principal media that carry contaminants offsite. These releases potentially result in exposure to offsite people. The groundwater monitoring performed at the site shows that an estimated 5 to 10% of SRS has been contaminated by radionuclides, no evidence exists from the extensive monitoring performed that groundwater contaminated with these constituents has migrated off the site (SRS 2011). Therefore, with the notable exception of radiological source terms originating from shallow surface water migration into site streams, onsite groundwater was not considered as a potential exposure pathway to offsite people. In addition, in response to the Department of Energy's (DOE) Order 435.1, several Performance Assessments (WSRC 2008; LWO 2009; SRR 2010; SRR 2011) and a Comprehensive SRS Composite Analysis (SRNO 2010) have recently been completed at SRS. The critical radionuclides and pathways identified in these extensive reports are discussed and, where applicable, included in this analysis.

  17. Single-photon ultrashort-lived radionuclides: symposium proceedings

    SciTech Connect

    Paras, P.; Thiessen, J.W.

    1985-01-01

    The purpose was to define the current role and state-of-the-art regarding the development, clinical applications, and usefulness of generator-produced single-photon ultrashort-lived radionuclides (SPUSLR's) and to predict their future impact on medicine. Special emphasis was placed on the generator production of iridium-191, gold-195, and krypton-81. This report contains expanded summaries of the included papers. (ACR)

  18. EFFECT OF TEMPERATURE ON THE SORPTION OF CHELATED RADIONUCLIDES.

    USGS Publications Warehouse

    Maest, Ann S.; Crerar, David A.; Dillon, Edward C.; Trehu, Stephen M.; Rountree, Tamara N.; ,

    1985-01-01

    Temperature effects in the near-field radioactive waste disposal environment can result in changes in the adsorptive capacity and character of the substrate and the chemistry of the reacting fluids. This work examines the effect of temperature on 1) the kinetics of radionuclide sorption onto clays from 25 degree -75 degree C and 2) the degradation and metal-binding ability of two organic complexing agents found in chelated radioactive wastes and natural groundwaters.

  19. Cosmogenic radionuclides on LDEF: An unexpected Be-10 result

    NASA Technical Reports Server (NTRS)

    Gregory, J. C.; Albrecht, A.; Herzog, G.; Klein, J.; Middleton, R.; Dezfouly-Arjomandy, B.; Harmon, B. A.

    1993-01-01

    Following the discovery of the atmospheric derived cosmogenic radionuclide Be-7 on the Long Duration Exposure Facility (LDEF), a search began for other known nuclides produced by similar mechanisms. None of the others have the narrow gamma-ray line emission of Be-7 decay which enabled its rapid detection and quantification. A search for Be-10 atoms on LDEF clamp plates using accelerator mass spectrometry is described. An unexpected result was obtained.

  20. IAEA proficiency tests for determination of radionuclides in sea water.

    PubMed

    Harms, Arend; Khanh Pham, Mai; Blinova, Oxana; Tarjan, Sandor; Nies, Hartmut; Osvath, Iolanda

    2017-02-14

    The International Atomic Energy Agency organised four proficiency tests between 2012 and 2015 to test the performance of participating laboratories in an analysis of radionuclides in sea water samples. These exercises were initiated to support IAEA Member States in sea water analyses of tritium, strontium-90 and caesium isotopes in relation to the accident at the Fukushima Daiichi nuclear power station, in March 2011, and subsequent contamination of the marine environment.

  1. Surface charge accumulation of particles containing radionuclides in open air.

    PubMed

    Kim, Yong-ha; Yiacoumi, Sotira; Tsouris, Costas

    2015-05-01

    Radioactivity can induce charge accumulation on radioactive particles. However, electrostatic interactions caused by radioactivity are typically neglected in transport modeling of radioactive plumes because it is assumed that ionizing radiation leads to charge neutralization. The assumption that electrostatic interactions caused by radioactivity are negligible is evaluated here by examining charge accumulation and neutralization on particles containing radionuclides in open air. A charge-balance model is employed to predict charge accumulation on radioactive particles. It is shown that particles containing short-lived radionuclides can be charged with multiple elementary charges through radioactive decay. The presence of radioactive particles can significantly modify the particle charge distribution in open air and yield an asymmetric bimodal charge distribution, suggesting that strong electrostatic particle interactions may occur during short- and long-range transport of radioactive particles. Possible effects of transported radioactive particles on electrical properties of the local atmosphere are reported. The study offers insight into transport characteristics of airborne radionuclides. Results are useful in atmospheric transport modeling of radioactive plumes.

  2. Application of Monte Carlo Methods in Molecular Targeted Radionuclide Therapy

    SciTech Connect

    Hartmann Siantar, C; Descalle, M-A; DeNardo, G L; Nigg, D W

    2002-02-19

    Targeted radionuclide therapy promises to expand the role of radiation beyond the treatment of localized tumors. This novel form of therapy targets metastatic cancers by combining radioactive isotopes with tumor-seeking molecules such as monoclonal antibodies and custom-designed synthetic agents. Ultimately, like conventional radiotherapy, the effectiveness of targeted radionuclide therapy is limited by the maximum dose that can be given to a critical, normal tissue, such as bone marrow, kidneys, and lungs. Because radionuclide therapy relies on biological delivery of radiation, its optimization and characterization are necessarily different than for conventional radiation therapy. We have initiated the development of a new, Monte Carlo transport-based treatment planning system for molecular targeted radiation therapy as part of the MINERVA treatment planning system. This system calculates patient-specific radiation dose estimates using a set of computed tomography scans to describe the 3D patient anatomy, combined with 2D (planar image) and 3D (SPECT, or single photon emission computed tomography) to describe the time-dependent radiation source. The accuracy of such a dose calculation is limited primarily by the accuracy of the initial radiation source distribution, overlaid on the patient's anatomy. This presentation provides an overview of MINERVA functionality for molecular targeted radiation therapy, and describes early validation and implementation results of Monte Carlo simulations.

  3. An environmental radionuclide baseline study near three Canadian naval ports

    SciTech Connect

    Waller, E.J.; Cole, D. )

    1999-07-01

    This paper summarizes an environmental radionuclide baseline study undertaken for the Department of National Defence in Canada. The purpose of the project was to establish levels of radionuclides present in the environment around areas where nuclear propelled vessels may be berthed. Specifically, this report describes environmental baselines near Halifax (Nova Scotia), Esquimalt (British Columbia), and Nanoose Bay (British Columbia). Valued ecosystem component samples were taken from dairy farms, beef producers, market gardens, vegetables, tree fruits and berries within the study areas, as well as marine bivalves (mussels and clams), salmon, seaweed, and food from native fisheries. Numerous naturally occurring isotopes were detected and quantified. The only non-naturally occurring isotope positively identified was in the form of trace quantities of [sup 131]I, measured in the Halifax study zone (attributed to local hospital cancer therapy). [sup 137]Cs is the only other anthropogenic radionuclide detected. Its origin may be the combination of fallout from the Chernobyl accident and fallout from atmospheric nuclear weapon tests. The results indicate that nuclear-powered vessels have not resulted in activity levels that would contribute a significant radiation exposure to the public, the biota, and the environment within the three study zones.

  4. Surface charge accumulation of particles containing radionuclides in open air

    SciTech Connect

    Kim, Yong-ha; Yiacoumi, Sotira; Tsouris, Costas

    2015-05-01

    Radioactivity can induce charge accumulation on radioactive particles. But, electrostatic interactions caused by radioactivity are typically neglected in transport modeling of radioactive plumes because it is assumed that ionizing radiation leads to charge neutralization. The assumption that electrostatic interactions caused by radioactivity are negligible is evaluated here by examining charge accumulation and neutralization on particles containing radionuclides in open air. Moreover, a charge-balance model is employed to predict charge accumulation on radioactive particles. It is shown that particles containing short-lived radionuclides can be charged with multiple elementary charges through radioactive decay. The presence of radioactive particles can significantly modify the particle charge distribution in open air and yield an asymmetric bimodal charge distribution, suggesting that strong electrostatic particle interactions may occur during short- and long-range transport of radioactive particles. Possible effects of transported radioactive particles on electrical properties of the local atmosphere are reported. Our study offers insight into transport characteristics of airborne radionuclides. Results are useful in atmospheric transport modeling of radioactive plumes.

  5. Complications of renal transplantation: evaluation with US and radionuclide imaging.

    PubMed

    Brown, E D; Chen, M Y; Wolfman, N T; Ott, D J; Watson, N E

    2000-01-01

    Following renal transplantation, patients are often evaluated with ultrasonography (US) or radionuclide imaging to assess renal function and the presence of possible complications. Both modalities are inexpensive, noninvasive, and nonnephrotoxic. A basic understanding of the surgical techniques commonly used for renal transplantation is useful when imaging these patients in order to recognize complications and to direct further imaging or intervention. The most frequent complications of renal transplantation include perinephric fluid collections; decreased renal function; and abnormalities of the vasculature, collecting system, and renal parenchyma. Perinephric fluid collections are common following transplantation, and their clinical significance depends on the type, location, size, and growth of the fluid collection, features that are well-evaluated with US. Causes of diminished renal function include acute tubular necrosis, rejection, and toxicity from medications. Radionuclide imaging is the most useful modality for assessing renal function. Vascular complications of transplantation include occlusion or stenosis of the arterial or venous supply, arteriovenous fistulas, and pseudoaneurysms. Although the standard for evaluating these vascular complications is angiography, US is an excellent noninvasive method for screening. Other transplant complications such as abnormalities of the collecting system and renal parenchyma are well-evaluated with both radionuclide imaging and US.

  6. Trace metals and radionuclides in macroalgae from Moroccan coastal waters.

    PubMed

    Benkdad, Azzouz; Laissaoui, Abdelmourhit; Tornero, Maria Victoria; Benmansour, Moncef; Chakir, ElMahjoub; Garrido, Ignacio Moreno; Moreno, Julian Blasco

    2011-11-01

    Macroalgae species Codium sp, Bangia atropurpurea, Membranoptera alata, Plocamium cartilagineum, Dictyota dichotoma, Fucus spiralis and Stypocaulon scoparia were collected from seven stations along the north coast of Morocco. Samples were analysed to determine activities of naturally occurring radionuclides ((210)Pb, U isotopes and (40)K) and concentrations of metals (Zn, Fe, Co, Cu, Ni, Mn, Pb, Cd, As and Cr) using radiometric and ICP-OES techniques, respectively. Metal concentrations were within ranges reported in the scientific literature, and concentrations of bio-essential elements were in the order Mn>Fe> Zn>Cu in all samples. Brown algae had the highest concentrations of almost all metals, and concentrations decreased in the order brown>red>green algae. With respect to radionuclides, the red alga P. cartilagineum had the highest activities of (210)Pb, in most cases an order of magnitude higher than for the green alga Codium sp. (234)U and (238)U activities in all algae samples were in the range 0.96- 7.61 and 1.16-6.14 Bq/kg dry weight, respectively. Our analyses of radionuclide activities and metal concentrations in marine macroalgae showed large differences among taxa. These results provide insights into which algal species should be used for biomonitoring programmes.

  7. Surface charge accumulation of particles containing radionuclides in open air

    DOE PAGES

    Kim, Yong-ha; Yiacoumi, Sotira; Tsouris, Costas

    2015-05-01

    Radioactivity can induce charge accumulation on radioactive particles. But, electrostatic interactions caused by radioactivity are typically neglected in transport modeling of radioactive plumes because it is assumed that ionizing radiation leads to charge neutralization. The assumption that electrostatic interactions caused by radioactivity are negligible is evaluated here by examining charge accumulation and neutralization on particles containing radionuclides in open air. Moreover, a charge-balance model is employed to predict charge accumulation on radioactive particles. It is shown that particles containing short-lived radionuclides can be charged with multiple elementary charges through radioactive decay. The presence of radioactive particles can significantly modify themore » particle charge distribution in open air and yield an asymmetric bimodal charge distribution, suggesting that strong electrostatic particle interactions may occur during short- and long-range transport of radioactive particles. Possible effects of transported radioactive particles on electrical properties of the local atmosphere are reported. Our study offers insight into transport characteristics of airborne radionuclides. Results are useful in atmospheric transport modeling of radioactive plumes.« less

  8. Effect of Concrete Waste Form Properties on Radionuclide Migration

    SciTech Connect

    Mattigod, Shas V.; Bovaird, Chase C.; Wellman, Dawn M.; Skinner, De'Chauna J.; Cordova, Elsa A.; Wood, Marcus I.

    2009-09-30

    Assessing long-term performance of Category 3 waste cement grouts for radionuclide encasement requires knowledge of the radionuclide-cement interactions and mechanisms of retention (i.e., sorption or precipitation) the mechanism of contaminant release, the significance of contaminant release pathways, how waste form performance is affected by the full range of environmental conditions within the disposal facility, the process of waste form aging under conditions that are representative of processes occurring in response to changing environmental conditions within the disposal facility, the effect of waste form aging on chemical, physical, and radiological properties and the associated impact on contaminant release. This knowledge will enable accurate prediction of radionuclide fate when the waste forms come in contact with groundwater. Numerous sets of tests were initiated in fiscal years (FY) 2006-2009 to evaluate (1) diffusion of iodine (I) and technetium (Tc) from concrete into uncontaminated soil after 1 and 2 years, (2) I and rhenium (Re) diffusion from contaminated soil into fractured concrete, (3) I and Re (set 1) and Tc (set 2) diffusion from fractured concrete into uncontaminated soil, (4) evaluate the moisture distribution profile within the sediment half-cell, (5) the reactivity and speciation of uranium (VI) (U(VI)) compounds in concrete porewaters, (6) the rate of dissolution of concrete monoliths, and (7) the diffusion of simulated tank waste into concrete.

  9. Radionuclides in Peconic River fish, mussels, and sediments.

    PubMed

    Rapiejko, A; Rosson, R; Lahr, J; Garcia, R; Kahn, B

    2001-12-01

    For regulatory oversight and quality control of Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) actions, fish, mussels, and sediments were analyzed from the Peconic River system on Long Island, NY, downstream of the Brookhaven National Laboratory, as well as from control locations. The analyses were for photon-emitting radionuclides (notably 60Co and 137Cs), uranium, plutonium, and americium. Sediments were cored in 4 sections to 0.37 m depth, whole fish were analyzed, and mussels were separated into flesh and shells. Radioisotopes of the cited elements were detected in sediment, some of the fish contained 137Cs, 241Am, and uranium, and mussel flesh contained 137Cs and uranium. All of the 60Co, 233U, and enriched uranium, and some of the 137Cs and 241Am, can most likely be attributed to Brookhaven National Laboratory. The other radionuclides (and some of the 137Cs and 241Am) are believed to have either fallout or nature as their origin. The New York State Department of Health (NYSDOH) evaluated the radiological data in terms of adverse health implications due to consumption of fish with the levels of reported radioactivity. The NYSDOH determined that the added radiation doses likely to result from eating this fish are a small fraction of the radiation dose that normally results from radionuclides present in the body from natural sources.

  10. Radionuclide angiocardiography in the diagnosis of congenital heart disorders

    SciTech Connect

    Jones, R.H.; Austin, E.H.; Peter, C.A.; Sabiston, D.C. Jr.

    1981-06-01

    Radionuclide angiocardiography provides a noninvasive assessment of cardiac function and blood flow through the heart and lungs. During the past three years, this procedure has been used at the Duke University Medical Center for evaluation of 343 patients with congenital heart disorders. A review of this experience shows tat the resulting data were frequently useful in the surgical management of these patients. In patients with abnormal blood flow patterns, noninvasive imaging of blood flow was useful before and after operative correction. Radionuclide measurements of left-to-right intracardiac shunts were sufficiently accurate for use in the initial evaluation of patients with murmurs and to document the absence of shunt after operative closure of intracardiac septal defects. Moreover, measurements of right-to-left cardiac shunts were of benefit in the management of children with cyanotic heart disease. Measurements of left ventricular function obtained during rest and exercise were most useful in patients with origin of the left coronary artery from the pulmonary artery and in patients with congenital valvular insufficiency. This experience demonstrates that radionuclide angiocardiography provides important measurements of central hemodynamics and cardiac function which are useful in the management of patients with congenital heart disorders.

  11. Phosphate-Mediated Remediation of Metals and Radionuclides

    DOE PAGES

    Martinez, Robert J.; Beazley, Melanie J.; Sobecky, Patricia A.

    2014-01-01

    Worldwide industrialization activities create vast amounts of organic and inorganic waste streams that frequently result in significant soil and groundwater contamination. Metals and radionuclides are of particular concern due to their mobility and long-term persistence in aquatic and terrestrial environments. As the global population increases, the demand for safe, contaminant-free soil and groundwater will increase as will the need for effective and inexpensive remediation strategies. Remediation strategies that include physical and chemical methods (i.e., abiotic) or biological activities have been shown to impede the migration of radionuclide and metal contaminants within soil and groundwater. However, abiotic remediation methods aremore » often too costly owing to the quantities and volumes of soils and/or groundwater requiring treatment. The in situ sequestration of metals and radionuclides mediated by biological activities associated with microbial phosphorus metabolism is a promising and less costly addition to our existing remediation methods. This review highlights the current strategies for abiotic and microbial phosphate-mediated techniques for uranium and metal remediation.« less

  12. Yucca Mountain Project - Science & Technology Radionuclide Absorbers Development Program Overview

    SciTech Connect

    Hong-Nian Jow; R.C. Moore; K.B. Helean; S. Mattigod; M. Hochella; A.R. Felmy; J. Liu; K. Rosso; G. Fryxell; J. Krumhansl; Y. Wang

    2005-01-14

    The proposed Yucca Mountain repository is anticipated to be the first facility for long-term disposal of commercial spent nuclear fuel and high-level radioactive waste in the United States. The facility, located in the southern Nevada desert, is currently in the planning stages with initial exploratory excavations completed. It is an underground facility mined into the tuffaceous volcanic rocks that sit above the local water table. The focus of the work described in this paper is the development of radionuclide absorbers or ''getter'' materials for neptunium (Np), iodine (I), and technetium (Tc) for potential deployment in the repository. ''Getter'' materials retard the migration of radionuclides through sorption, reduction, or other chemical and physical processes, thereby slowing or preventing the release and transport of radionuclides. An overview of the objectives and approaches utilized in this work with respect to materials selection and modeling of ion ''getters'' is presented. The benefits of the ''getter'' development program to the United States Department of Energy (US DOE) are outlined.

  13. Radionuclide studies in postoperative evaluation of the Fontan procedure

    SciTech Connect

    Brendel, A.J.; Wynchank, S.; Choussat, A.; Barat, J.L.; Deville, C.; Ducassou, D.; Fontan, F.

    1984-10-01

    Radionuclide studies were performed on 12 patients who had had a Fontan operation for cyanotic congenital heart disease, six of whom had undergone a prior palliative Glenn procedure. The patients without prior Glenn anastomoses were studied by radionuclide first-pass angiocardiography, using a right antecubital vein injection of /sup 99m/Tc pertechnetate. The patients with Glenn anastomoses required two injections, one by femoral vein to study the Fontan procedure, using bolus injection of /sup 99m/Tc pertechnetate or microspheres, and the second by right anetcubital vein to study the Glenn anastomosis and right lung, using a bolus of microspheres. Noninvasive radionuclide methods seem to be dependable in the postoperative evaluation of patients after the Fontan procedure. First-pass angiocardiography is most helpful in evaluating the dynamics and distribution of blood flow, especially the right atrial output, and gated blood-pool scintigraphy offers a better evaluation of right atrial and left ventricular contraction, so both supply complementary information.

  14. Reactor-released radionuclides in Susquehanna River sediments

    USGS Publications Warehouse

    Olsen, C.R.; Larsen, I.L.; Cutshall, N.H.; Donoghue, J.F.; Bricker, O.P.; Simpson, H.J.

    1981-01-01

    Three Mile Island (TMI) and Peach Bottom (PB) reactors have introduced 137Cs, 134Cs, 60Co, 58Co and several other anthropogenic radionuclides into the lower Susquehanna River. Here we present the release history for these nuclides (Table 1) and radionuclide concentration data (Table 2) for sediment samples collected in the river and upper portions of the Chesapeake Bay (Fig. 1) within a few months after the 28 March 1979 loss-of-coolant-water problem at TMI. Although we found no evidence for nuclides characteristic of a ruptured fuel element, we did find nuclides characteristic of routine operations. Despite the TMI incident, more than 95% of the total 134Cs input to the Susquehanna has been a result of controlled low-level releases from the PB site. 134Cs activity released into the river is effectively trapped by sediments with the major zones of reactor-nuclide accumulation behind Conowingo Dam and in the upper portions of Chesapeake Bay. The reported distributions document the fate of reactor-released radionuclides and their extent of environmental contamination in the Susquehanna-Upper Chesapeake Bay System. ?? 1981 Nature Publishing Group.

  15. Environmental radionuclide distribution in Georgia after the Chernobyl accident

    SciTech Connect

    Mosulishvili, L.M.; Shoniya, N.I.; Katamadze, N.M.

    1994-01-01

    Atmospheric Chernobyl-released radioactivity, assessed at about 2 x 10{sup 18} Bq, caused global environmental contamination. Contaminated air masses appeared in the Transcaucasian region in early May, 1986. Rains that month promoted intense radionuclide deposition all over Georgia. The contamination level of western Georgia considerably exceeded the contamination level of eastern Georgia. The Black Sea coast of Georgia suffered from the Chernobyl accident as much as did strongly contaminated areas of the Ukraine and Belarus`. Unfortunately, governmental decrees on countermeasures against the consequences of the Chernobyl accident at that time did not even refer to the coast of Georgia. The authors observed the first increase in radioactivity background in rainfall samples collected on May 2, 1986, in Tbilisi. {gamma}-Spectrometric measurements of aerosol filters, vegetation, food stuffs, and other objects, in addition to rainfall, persistently confirmed the occurrence of short-lived radionuclides, including {sup 131}I. At first, this fact seemed unbelievable, because the Chernobyl accident had occurred only 4-5 days earlier and far from Georgia. However, these arguments proved to be faulty. Soon, environmental monitoring of radiation in Georgia became urgent. Environmental radionuclide distribution in Georgia shortly after the Chernobyl accident, as well as the methods of analysis, are reported in this paper.

  16. Usefulness of radionuclide angiocardiography in predicting stenotic mitral orifice area

    SciTech Connect

    Burns, R.J.; Armitage, D.L.; Fountas, P.N.; Tremblay, P.C.; Druck, M.N.

    1986-12-01

    Fifteen patients with pure mitral stenosis (MS) underwent high-temporal-resolution radionuclide angiocardiography for calculation of the ratio of peak left ventricular (LV) filling rate divided by mean LV filling rate (filling ratio). Whereas LV filling normally occurs in 3 phases, in MS it is more uniform. Thus, in 13 patients the filling ratio was below the normal range of 2.21 to 2.88 (p less than 0.001). In 11 patients in atrial fibrillation, filling ratio divided by mean cardiac cycle length and by LV ejection fraction provided good correlation (r = 0.85) with modified Gorlin formula derived mitral area and excellent correlation with echocardiographic mitral area (r = 0.95). Significant MS can be detected using radionuclide angiocardiography to calculate filling ratio. In the absence of the confounding influence of atrial systole calculation of 0.14 (filling ratio divided by cardiac cycle length divided by LV ejection fraction) + 0.40 cm2 enables accurate prediction of mitral area (+/- 4%). Our data support the contention that the modified Gorlin formula, based on steady-state hemodynamics, provides less certain estimates of mitral area for patients with MS and atrial fibrillation, in whom echocardiography and radionuclide angiocardiography may be more accurate.

  17. Use of the GEANT4 Monte Carlo to determine three-dimensional dose factors for radionuclide dosimetry

    NASA Astrophysics Data System (ADS)

    Amato, Ernesto; Italiano, Antonio; Minutoli, Fabio; Baldari, Sergio

    2013-04-01

    The voxel-level dosimetry is the most simple and common approach to internal dosimetry of nonuniform distributions of activity within the human body. Aim of this work was to obtain the dose "S" factors (mGy/MBqs) at the voxel level for eight beta and beta-gamma emitting radionuclides commonly used in nuclear medicine diagnostic and therapeutic procedures. We developed a Monte Carlo simulation in GEANT4 of a region of soft tissue as defined by the ICRP, divided into 11×11×11 cubic voxels, 3 mm in side. The simulation used the parameterizations of the electromagnetic interaction optimized for low energy (EEDL, EPDL). The decay of each radionuclide (32P, 90Y, 99mTc, 177Lu, 131I, 153Sm, 186Re, 188Re) were simulated homogeneously distributed within the central voxel (0,0,0), and the energy deposited in the surrounding voxels was mediated on the 8 octants of the three dimensional space, for reasons of symmetry. The results obtained were compared with those available in the literature. While the iodine deviations remain within 16%, for phosphorus, a pure beta emitter, the agreement is very good for self-dose (0,0,0) and good for the dose to first neighbors, while differences are observed ranging from -60% to +100% for voxels far distant from the source. The existence of significant differences in the percentage calculation of the voxel S factors, especially for pure beta emitters such as 32P or 90Y, has already been highlighted by other authors. These data can usefully extend the dosimetric approach based on the voxel to other radionuclides not covered in the available literature.

  18. Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl) isothiouronium bromide hydrobromide (AET)

    SciTech Connect

    Narra, V.R.; Harapanhalli, R.S.; Goddu, M.

    1995-02-01

    Radionuclides employed in diagnostic and therapeutic nuclear medicine impart radiation energy to tissue over an extended period of time, which depends on the physical half-life and the biological properties of the radiochemical employed. It is therefore important to examine the capacity of chemical radioprotectors to mitigate damage caused by chronic irradiation by incorporated radionuclides. Spermatogenesis in mouse testis is used as the experimental model, and spermatogonial cell survival as measured by testicular spermhead count is the biological end point. The capacity of S-(2-aminoethyl) isothiouronium bromide hydrobromide (AET) to mitigate radiation damage caused by chronic irradiation by the radiochemicals {sup 125}IUdR, H{sup 125}IPDM and {sup 210}Po-citrate, is investigated. The radioprotection provided by AET is substantial and similar for both of the radioiodinated compounds with dose modification factors (DMF) of 4.0 {plus_minus} 1.2 for {sup 125}IUdR and 3.4 {plus_minus}0.4 for H{sup 125}IPDM. In contrast, the damage caused by {sup 210}Po alpha particles is protected against to a lesser degree (DMF = 2.4 {plus_minus} 005). The present radioprotection data for AET, in conjunction with earlier findings for the chemical protectors cysteamine and vitamin C in the same experimental model, suggest that such compounds may be clinically useful as mitigating agents against biological damage caused by incorporated radionuclides. The observed DMFs for AET also support an earlier premise that the mechanism by which DNA-incorporated Auger emitters impart biological damage is primarily radical mediated, and hence indirect in nature. 43 refs., 7 figs., 2 tabs.

  19. The scope and potentials of functional radionuclide imaging towards advancing personalized medicine in oncology: emphasis on PET-CT.

    PubMed

    Basu, Sandip

    2012-01-01

    Behavioral heterogeneity within a given patient cohort has been a major challenge in clinical practice and is probably most prominently observed in the field of oncology. This has been the prime impetus of the cutting-edge preclinical and clinical research studies over recent times, many of which seek to further stratify patients based on patients' genetic, proteomic, and metabolic profile (the three key components of "-omics" research), in order to select the appropriate therapy according to an individual's best-fit. Data from functional radionuclide imaging particularly that obtained from PET-CT, with regard to characterization of an individual's tumor phenotype, can play a very important role in answering some of the critical decision-making questions on an individual basis. The role of molecular imaging with PET, SPECT, and planar radionuclide technologies is not confined to early response assessment of administered therapeutics (which is its major benefit compared to conventional methods), rather it has a much broader perspective and encompasses multiple steps in decision making steps of patient management. The immense impact of the radionuclide-based molecular imaging techniques on the selection of an appropriate treatment (at initial diagnosis, during therapy, or after therapy) or in defining the tumor biology has been documented and increasingly recognized through both large and small-scale studies. However, there has been relatively less systematic effort towards the development of a successful and definitive clinical model of "personalized cancer medicine" (based on accurate disease triaging on an individual basis) by the medical community that would be suitable for routine adoption. In this paper, an endeavor has been made to explore the potential of this approach and underscore the areas that would require further critical evaluation to make this a reality.

  20. Distribution coefficients for radionuclides in aquatic environments. Volume 2. Dialysis experiments in marine environments

    SciTech Connect

    Sibley, T.H.; Nevissi, A.E.; Schell, W.R.

    1981-05-01

    The overall objective of this research program was to obtain new information that can be used to predict the fate of radionuclides that may enter the aquatic environment from nuclear power plants, waste storage facilities or fuel reprocessing plants. Important parameters for determining fate are the distribution of radionuclides between the soluble and particulate phases and the partitioning of radionuclides among various suspended particulates. This report presents the results of dialysis experiments that were used to study the distribution of radionuclides among suspended sediments, phytoplankton, organic detritus, and filtered sea water. Three experiments were conducted to investigate the adsorption kinetics and equilibrium distribution of (59)Fe, (60)Co, (65)Zn, (106)Ru, (137)Cs, (207)Bi, (238)Pu, and (241)Am in marine system. Diffusion across the dialysis membranes depends upon the physico-chemical form of the radionuclides, proceeding quite rapidly for ionic species of (137)Cs and (60)Co but much more slowly for radionuclides which occur primarily as colloids and solid precipitates such as (59)Fe, (207)Bi, and (241)Am. All the radionuclides adsorb to suspended particulates although the amount of adsorption depends upon the specific types and concentration of particulates in the system and the selected radionuclide. High affinity of some radionuclides - e.g., (106)Ru and (241)Am - for detritus and phytoplankton suggests that suspended organics may significantly affect the eventual fate of those radionuclides in marine ecosystems.

  1. Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009).

    PubMed

    Goffredo, Veronica; Paradiso, Angelo; Ranieri, Girolamo; Gadaleta, Cosmo Damiano

    2011-12-01

    The clinical application of the pure beta emitter (90)Y constitutes a fundamental advancement in non-invasive medicine. Nowadays, mainly three oncological therapies exploit the intrinsic emissive characteristic of (90)Y. Radionuclide therapies include peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumour (NET) treatment, radioimmunotherapy (RIT) in non-Hodgkin's lymphoma (NHL) treatment and transarterial radioembolization therapy (TARET) in unresectable hepatocellular carcinoma (HCC) and liver metastatic colorectal cancer (mCRC) treatment. The last ten years of clinical experience from E-PubMed research have been reviewed and an efficacy correlation between (90)Y-therapies has shown a better objective response rate for RIT (ORR 80±15%; range 53-100) compared to PRRT (ORR 23.5±14%; range 9-50), and TARET (ORR for mCRC, 40±25%; range 19-91, and ORR for HCC, 42±20%; range 20-82). This review reports on the state of the art of the efficacy of (90)Y-therapies from the last decade and discusses new perspectives of therapeutic development.

  2. NPL secondary standard radionuclide calibrator. Syringe calibration factors for radionuclides used in nuclear medicine. National Physical Laboratory.

    PubMed

    Tyler, D K; Baker, M; Woods, M J

    2002-01-01

    The measurement of the activity of a radiopharmaceutical administration to a patient is normally achieved via the use of a radionuclide calibrator. Although these radionuclides are normally measured initially in a standard glass vial, an aliquot of the solution is then usually withdrawn into a syringe prior to the administration. Both for general quality assurance good practice and for additional guarantees for patient safety, a confirmatory measurement of the syringe is almost obligatory Because of the different geometries and elemental compositions between plastic syringes and glass vials, the calibration factors for syringes may well be significantly different from those for the glass containers. The magnitude of these differences depends on the energies of the emitted photons. A variety of syringes typically used in hospital administrations, and covering a range of volumes and manufacturers, were obtained. The results obtained were compared to those for glass vials and show the large errors that can be produced by ignoring these differences in container format.

  3. Radionuclide concentrations in underground waters of Mururoa and Fangataufa Atolls.

    PubMed

    Mulsow, S; Coquery, M; Dovlete, C; Gastaud, J; Ikeuchi, Y; Pham, M K; Povinec, P P

    1999-09-30

    In 1997 an expedition to Mururoa and Fangataufa Atolls was carried out to sample underground waters from cavity-chimneys and carbonate monitoring wells. The aim of this study was to determine the prevailing concentration and distribution status of radionuclides. Elemental analysis of interstitial waters was carried out in the water fraction as well as in particles collected at 11 underground monitoring wells. 238Pu, 239,240Pu, 241Am, 137Cs, 90Sr, 3H, 125Sb, 155Eu and 60Co were analyzed in both fractions by alpha-, beta- and gamma-spectrometry. Measurements showed that at 60% of the sites, pH and Eh seemed to be related to tidal cycles; in contrast HTO was constant during the sampling time. Interstitial waters from carbonates and transition zones shared similar chemical composition that were not different from that of the surrounding seawater. Waters collected from basalt cavities left after nuclear tests, (Aristee and Ceto) have a different chemical signature characterized by a deficiency in Mg, K and SO4 as well as enrichment in Sr, Si, Al and Cl compared to the rest of the stations. Radionuclide concentrations present in both, water and particulate fractions, were significantly higher at Ceto and Aristee than at any other monitoring wells, except for Fuseau and Mitre monitoring wells (Fangataufa) where values similar to Ceto were found (e.g. 239,240Pu: > 20 mBq g-1). Considering that Pu isotopes showed high Kd values compared to non-sorbing radionuclides such as 3H, 90Sr and 137Cs it is very unlikely that migration from cavities to monitoring wells accounts for the concentration of Pu isotopes and Am at Fuseau 30 and Mitre 27. Perhaps the contact of lagoon waters with the well before sealing could be a possible source of the transuranics found at these sites. The 238Pu/239,240Pu ratios measured in the particles were similar to that of the lagoon (0.38), thus supporting this hypothesis. The fact that transuranics were found only in the particle fraction, in the

  4. SOLID PHASE MICROEXTRACTION SAMPLING OF HIGH EXPLOSIVE RESIDUES IN THE PRESENCE OF RADIONUCLIDES AND RADIONUCLIDE SURROGATE METALS

    SciTech Connect

    Duff, M; S Crump, S; Robert02 Ray, R; Donna Beals, D

    2007-04-13

    The Federal Bureau of Investigation (FBI) Laboratory currently does not have on site facilities for handling radioactive evidentiary materials and there are no established FBI methods or procedures for decontaminating high explosive (HE) evidence while maintaining evidentiary value. One experimental method for the isolation of HE residue involves using solid phase microextraction or SPME fibers to remove residue of interest. Due to their high affinity for organics, SPME fibers should have little affinity for most metals. However, no studies have measured the affinity of radionuclides for SPME fibers. The focus of this research was to examine the affinity of dissolved radionuclide ({sup 239/240}Pu, {sup 238}U, {sup 237}Np, {sup 85}Sr, {sup 133}Ba, {sup 137}Cs, {sup 60}Co and {sup 226}Ra) and stable radionuclide surrogate metals (Sr, Co, Ir, Re, Ni, Ba, Cs, Nb, Zr, Ru, and Nd) for SPME fibers at the exposure conditions that favor the uptake of HE residues. Our results from radiochemical and mass spectrometric analyses indicate these metals have little measurable affinity for these SPME fibers during conditions that are conducive to HE residue uptake with subsequent analysis by liquid or gas phase chromatography with mass spectrometric detection.

  5. Tracing Fukushima Radionuclides in the Northern Hemisphere -An Overview

    NASA Astrophysics Data System (ADS)

    Thakur, Punam; Ballard, Sally; Nelson, Roger

    2013-04-01

    A massive 9.0 earthquake and ensuing tsunami struck the northern coast of the Honshu-island, Japan on March 11, 2011 and severely damaged the electric system of the Fukushima- Daiichi Nuclear Power Plant (NPP). The structural damage to the plant disabled the reactor's cooling systems. Subsequent fires, a hydrogen explosion and possible partial core meltdowns released radioactive fission products into the atmosphere. The atmospheric release from the crippled Fukushima NPP started on March 12, 2011 with a maximum release phase from March 14 to 17. The radioactivity released was dominated by volatile fission products including isotopes of the noble gases xenon (Xe-133) and krypton (Kr-85); iodine (I-131,I-132); cesium (Cs-134,Cs-136,Cs-137); and tellurium (Te-132). The non-volatile radionuclides such as isotopes of strontium and plutonium are believed to have remained largely inside the reactor, although there is evidence of plutonium release into the environment. Global air monitoring across the northern hemisphere was increased following the first reports of atmospheric releases. According to the source term, declared by the Nuclear and Industrial Safety Agency (NISA) of Japan), approximately 160 PBq (1 PBq (Peta Becquerel = 10^15 Bq)) of I-131 and 15 PBq of Cs-137 (or 770 PBq "iodine-131 equivalent"), were released into the atmosphere. The 770 PBq figure is about 15% of the Chernobyl release of 5200 PBq of "iodine-131 equivalent". For the assessment of contamination after the accident and to track the transport time of the contaminated air mass released from the Fukushima NPP across the globe, several model calculations were performed by various research groups. All model calculations suggested long-range transport of radionuclides from the damaged Fukushima NPP towards the North American Continent to Europe and to Central Asia. As a result, an elevated level of Fukushima radionuclides were detected in air, rain, milk, and vegetation samples across the northern

  6. Development of modern approach to absorbed dose assessment in radionuclide therapy, based on Monte Carlo method simulation of patient scintigraphy

    NASA Astrophysics Data System (ADS)

    Lysak, Y. V.; Klimanov, V. A.; Narkevich, B. Ya

    2017-01-01

    One of the most difficult problems of modern radionuclide therapy (RNT) is control of the absorbed dose in pathological volume. This research presents new approach based on estimation of radiopharmaceutical (RP) accumulated activity value in tumor volume, based on planar scintigraphic images of the patient and calculated radiation transport using Monte Carlo method, including absorption and scattering in biological tissues of the patient, and elements of gamma camera itself. In our research, to obtain the data, we performed modeling scintigraphy of the vial with administered to the patient activity of RP in gamma camera, the vial was placed at the certain distance from the collimator, and the similar study was performed in identical geometry, with the same values of activity of radiopharmaceuticals in the pathological target in the body of the patient. For correct calculation results, adapted Fisher-Snyder human phantom was simulated in MCNP program. In the context of our technique, calculations were performed for different sizes of pathological targets and various tumors deeps inside patient’s body, using radiopharmaceuticals based on a mixed β-γ-radiating (131I, 177Lu), and clear β- emitting (89Sr, 90Y) therapeutic radionuclides. Presented method can be used for adequate implementing in clinical practice estimation of absorbed doses in the regions of interest on the basis of planar scintigraphy of the patient with sufficient accuracy.

  7. PATHWAY: a simulation model of radionuclide-transport through agricultural food chains

    SciTech Connect

    Kirchner, T.B.; Whicker, F.W.; Otis, M.D.

    1982-01-01

    PATHWAY simulates the transport of radionuclides from fallout through an agricultural ecosystem. The agro-ecosystem is subdivided into several land management units, each of which is used either for grazing animals, for growing hay, or for growing food crops. The model simulates the transport of radionuclides by both discrete events and continuous, time-dependent processes. The discrete events include tillage of soil, harvest and storage of crops,and deposition of fallout. The continuous processes include the transport of radionuclides due to resuspension, weathering, rain splash, percolation, leaching, adsorption and desorption of radionuclides in the soil, root uptake, foliar absorption, growth and senescence of vegetation, and the ingestion assimilation, and excretion of radionuclides by animals. Preliminary validation studies indicate that the model dynamics and simulated values of radionuclide concentrations in several agricultural products agree well with measured values when the model is driven with site specific data on deposition from world-wide fallout.

  8. Anthropogenic radionuclides in atmospheric air over Switzerland during the last few decades.

    PubMed

    Alvarado, J A Corcho; Steinmann, P; Estier, S; Bochud, F; Haldimann, M; Froidevaux, P

    2014-01-01

    The atmospheric nuclear testing in the 1950s and early 1960s and the burn-up of the SNAP-9A satellite led to large injections of radionuclides into the stratosphere. It is generally accepted that current levels of plutonium and caesium radionuclides in the stratosphere are negligible. Here we show that those radionuclides are present in the stratosphere at higher levels than in the troposphere. The lower content in the troposphere reveals that dry and wet deposition efficiently removes radionuclides within a period of a few weeks to months. Since the stratosphere is thermally stratified and separated from the troposphere by the tropopause, radioactive aerosols remain longer. We estimate a mean residence time for plutonium and caesium radionuclides in the stratosphere of 2.5-5 years. Our results also reveal that strong volcanic eruptions like Eyjafjallajökull in 2010 have an important role in redistributing anthropogenic radionuclides from the stratosphere to the troposphere.

  9. Pluristem Therapeutics, Inc.

    PubMed

    Prather, William

    2008-01-01

    Pluristem Therapeutics, Inc., based in Haifa, Israel, is a regenerative, biotherapeutics Company dedicated to the commercialization of nonpersonalized (allogeneic) cell therapy products. The Company is expanding noncontroversial placental-derived mesenchymal stem cells via a proprietary 3D process, named PluriX, into therapeutics for a variety of degenerative, malignant and autoimmune disorders. Pluristem will be conducting Phase I trials in the USA with its first product, PLX-I, which addresses the global shortfall of matched tissue for bone marrow transplantation by improving the engraftment of hematopoietic stem cells contained in umbilical cord blood.

  10. Therapeutics for cognitive aging.

    PubMed

    Shineman, Diana W; Salthouse, Timothy A; Launer, Lenore J; Hof, Patrick R; Bartzokis, George; Kleiman, Robin; Luine, Victoria; Buccafusco, Jerry J; Small, Gary W; Aisen, Paul S; Lowe, David A; Fillit, Howard M

    2010-04-01

    This review summarizes the scientific talks presented at the conference "Therapeutics for Cognitive Aging," hosted by the New York Academy of Sciences and the Alzheimer's Drug Discovery Foundation on May 15, 2009. Attended by scientists from industry and academia, as well as by a number of lay people-approximately 200 in all-the conference specifically tackled the many aspects of developing therapeutic interventions for cognitive impairment. Discussion also focused on how to define cognitive aging and whether it should be considered a treatable, tractable disease.

  11. DELIVERY OF THERAPEUTIC PROTEINS

    PubMed Central

    Pisal, Dipak S.; Kosloski, Matthew P.; Balu-Iyer, Sathy V.

    2009-01-01

    The safety and efficacy of protein therapeutics are limited by three interrelated pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives. Novel drug modifications for overcoming these issues are under investigation and include covalent attachment of poly(ethylene glycol) (PEG), polysialic acid, or glycolic acid, as well as developing new formulations containing nanoparticulate or colloidal systems (e.g. liposomes, polymeric microspheres, polymeric nanoparticles). Such strategies have the potential to develop as next generation protein therapeutics. This review includes a general discussion on these delivery approaches. PMID:20049941

  12. Therapeutic Antioxidant Medical Gas

    PubMed Central

    Nakao, Atsunori; Sugimoto, Ryujiro; Billiar, Timothy R; McCurry, Kenneth R

    2009-01-01

    Medical gases are pharmaceutical gaseous molecules which offer solutions to medical needs and include traditional gases, such as oxygen and nitrous oxide, as well as gases with recently discovered roles as biological messenger molecules, such as carbon monoxide, nitric oxide and hydrogen sulphide. Medical gas therapy is a relatively unexplored field of medicine; however, a recent increasing in the number of publications on medical gas therapies clearly indicate that there are significant opportunities for use of gases as therapeutic tools for a variety of disease conditions. In this article, we review the recent advances in research on medical gases with antioxidant properties and discuss their clinical applications and therapeutic properties. PMID:19177183

  13. Method for immobilizing mixed waste chloride salts containing radionuclides and other hazardous wastes

    DOEpatents

    Lewis, Michele A.; Johnson, Terry R.

    1993-09-07

    The invention is a method for the encapsulation of soluble radioactive waste chloride salts containing radionuclides such as strontium, cesium and hazardous wastes such as barium so that they may be permanently stored without future threat to the environment. The process consists of contacting the salts containing the radionuclides and hazardous wastes with certain zeolites which have been found to ion exchange with the radionuclides and to occlude the chloride salts so that the resulting product is leach resistant.

  14. Method for preparing radionuclide-labeled chelating agent-ligand complexes

    DOEpatents

    Meares, Claude F.; Li, Min; DeNardo, Sally J.

    1999-01-01

    Radionuclide-labeled chelating agent-ligand complexes that are useful in medical diagnosis or therapy are prepared by reacting a radionuclide, such as .sup.90 Y or .sup.111 In, with a polyfunctional chelating agent to form a radionuclide chelate that is electrically neutral; purifying the chelate by anion exchange chromatography; and reacting the purified chelate with a targeting molecule, such as a monoclonal antibody, to form the complex.

  15. Microbial stabilization and mass reduction of wastes containing radionuclides and toxic metals

    DOEpatents

    Francis, Arokiasamy J.; Dodge, Cleveland J.; Gillow, Jeffrey B.

    1991-01-01

    A process is provided to treat wastes containing radionuclides and toxic metals with Clostridium sp. BFGl to release a large fraction of the waste solids into solutin and convert the radionuclides and toxic metals to a more concentrated and stable form with concurrent volume and mass reduction. The radionuclides and toxic metals being in a more stable form are available for recovery, recycling and disposal.

  16. Chapter II.C Transport of Radionuclides through Soil and Ground Water

    SciTech Connect

    Corey, J.C.

    1980-12-23

    The purpose of this report is to provide a clearer perspective of the impact of radionuclides in soil and groundwater, particularly for those not well-versed in soil science, hydrology, and geology. Through nuclear waste disposal or accidents, radionuclides come in contact with soil and groundwater. Man is exposed to radiation as a result of movement (or transport) of the radionuclides into his environment. Water is the principal carrier that induces transport, but chemical characteristics of soil inhibit the transport.

  17. Method for immobilizing mixed waste chloride salts containing radionuclides and other hazardous wastes

    DOEpatents

    Lewis, Michele A.; Johnson, Terry R.

    1993-01-01

    The invention is a method for the encapsulation of soluble radioactive waste chloride salts containing radionuclides such as strontium, cesium and hazardous wastes such as barium so that they may be permanently stored without future threat to the environment. The process consists of contacting the salts containing the radionuclides and hazardous wastes with certain zeolites which have been found to ion exchange with the radionuclides and to occlude the chloride salts so that the resulting product is leach resistant.

  18. Microbial stabilization and mass reduction of wastes containing radionuclides and toxic metals

    DOEpatents

    Francis, A.J.; Dodge, C.J.; Gillow, J.B.

    1991-09-10

    A process is provided to treat wastes containing radionuclides and toxic metals with Clostridium sp. BFGl to release a large fraction of the waste solids into solution and convert the radionuclides and toxic metals to a more concentrated and stable form with concurrent volume and mass reduction. The radionuclides and toxic metals being in a more stable form are available for recovery, recycling and disposal. 18 figures.

  19. Radionuclide concentrations in white sturgeon from the Columbia River. Revision 1

    SciTech Connect

    Dauble, D.D.; Price, K.R.; Poston, T.M.

    1993-11-01

    The objectives of this study were to (1) review and summarize historical data on radionuclide concentrations in white sturgeon from the Columbia River, (2) determine present-day radionuclide tissue burdens from different locations in the Columbia River, and (3) compare historical data with current data. We first reviewed and summarized the historical literature on radionuclide concentrations in white sturgeon from the Hanford Reach. Field studies were then conducted to evaluate the relationship among sample locations, age/length of white sturgeon, and present radionuclide tissue burdens. Results and comparisons are discussed in the remainder of this report.

  20. Critical Radionuclide and Pathway Analysis for the Savannah River Site, 2016 Update

    SciTech Connect

    Jannik, Tim; Hartman, Larry

    2016-09-08

    During the operational history of Savannah River Site, many different radionuclides have been released from site facilities. However, as shown in this analysis, only a relatively small number of the released radionuclides have been significant contributors to doses to the offsite public. This report is an update to the 2011 analysis, Critical Radionuclide and Pathway Analysis for the Savannah River Site. SRS-based Performance Assessments for E-Area, Saltstone, F-Tank Farm, H-Tank Farm, and a Comprehensive SRS Composite Analysis have been completed. The critical radionuclides and pathways identified in those extensive reports are also detailed and included in this analysis.